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ABSTRACT 
 
In humans, little is known about the entrainment of peripheral clocks by environmental cues 
or the circadian transcriptome of peripheral tissues. Meal timing entrains peripheral clocks 
rhythms of rodents but the effect of this on the human circadian system is unknown. It was 
hypothesised that meal timing would phase shift peripheral clock rhythms, but not master 
clock markers. Also hypothesised was that the transcriptome of subcutaneous adipose 
tissue would be under circadian regulation. 
Healthy male participants underwent two, separate clinical trials; one gave a food pulse 
containing 50% of the daily energetic need in one meal during a 4-hour ultradian light/dark 
cycle; another gave three isocaloric meals at 5-hourly intervals beginning at 0.5 then 5.5 
hours after wake under a fixed light/dark cycle. All circadian rhythms were assessed before 
and after interventions, under constant routine conditions. 
Master clock marker, melatonin, was not significantly phase shifted by meal timing, as 
hypothesised. Plasma glucose and leptin rhythms showed large phase shifts in response to 
meal timing. Plasma triglycerides were minimally phase shifted by food pulse, but not by a 
change to meal schedule. A 5-hour delay in three isocaloric meals caused approximately a 1-
hour delay in clock gene expression in serial adipose biopsies (PER2, PER3) but no shift in 
expression in whole blood (PER3, REVERB-β).  
Subcutaneous adipose biopsies taken under controlled conditions revealed that 1% of the 
transcriptome was circadian, with bimodal distribution of morning and evening peak times. 
Gene ontology enrichment analysis identified evening peaking probes as primarily involved 
in lipid metabolism. Morning peaking probes were involved in circadian rhythms and 
transcriptional regulation. 
These results demonstrate for the first time that meal timing differentially affects some 
peripheral, but not central, components of the human circadian system and that key 
metabolic processes are under circadian variation in the human adipose tissue 
transcriptome.   
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1 INTRODUCTION 
1.1 Circadian Rhythms 
 
Surviving in an environment that experiences regularly timed fluctuations in light, 
temperature and food availability would be easier if there was a way to predict these 
changes and alter behaviours accordingly. Circadian rhythms (named from the Latin circa 
dies – about a day) are endogenous, self-sustaining, daily oscillating physiological rhythms 
with a period of approximately 24 hours. They can be identified in numerous species, from 
prokaryotes such as cyanobacteria, to plants and Drosophila, all the way up to mammals. 
The highly conserved nature of circadian rhythms across taxa indicates the importance they 
have in optimising survival.  
These daily oscillating rhythms allow for the temporal segregation of opposite behavioural, 
metabolic and physiological functions, and need to be appropriately timed in order to 
predict the demands of the external environment. In an environment free of time 
information, circadian rhythms of plasma melatonin in humans are thought to free run with 
an average period of 24.2 hours (Czeisler et al. 1999). Therefore, circadian rhythms need to 
be reset daily in order to synchronise to the external 24-hour environment; this is called 
entrainment and requires a time cue or ‘zeitgeber’ (German for “time-giver”). 
1.1.1 Defining characteristics of circadian rhythms 
 
Since the discovery by Jean Jacques d’Ortous de Mairan that plant leaves maintained their 
opening and closing cycle in dark conditions (de Mairan, 1729), circadian rhythms have been 
studied in numerous species. As a result, defining characteristics of circadian rhythms have 
been identified and consist of: (1) a free-running rhythm with a period of approximately 24 
hours, (2) being capable of undergoing entrainment and (3) temperature compensation 
(Roenneberg & Merrow 2005). These three properties are explained below. 
The existence of sustained, free-running circadian rhythms under constant conditions 
highlights the role of the circadian system in predicting changes to the environment; if it 
was reacting, a rhythm would not be continued in the absence of stimuli (Edery 2000; 
Roenneberg & Merrow 2005). For the circadian system to confer a survival advantage, the 
Introduction 
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endogenous rhythm must be able to synchronise its timing to timed environmental events, 
and have the capacity to reset if there is a change to the timing of the stimulus. This process 
of synchronisation is referred to as entrainment and is a key characteristic of circadian 
rhythms; without entrainment there is an oscillator but it will not be in time with the 
external environment.  
Entrainment requires a zeitgeber from the environment, but in order to change the phase of 
a rhythm, the new timing of the zeitgeber needs to be sustained over several cycles. This is 
to indicate that a true change has occurred in the environment rather than a transient acute 
change. The result is a system that is robust to small fluctuations whilst also being adaptable 
to large changes (Roenneberg & Merrow 2005). However, this also means that responding 
to a stimulus is not instant and that there is an “inertia” to the system, as the rate at which 
the change occurs will depend on the existing phase of the rhythm, and the timing of the 
new phase (Roenneberg & Merrow 2005). Entrainment will be discussed in more detail in 
section 1.3. 
Temperature compensation is a vital component of circadian rhythms, especially within a 
biological system. For many biological reactions increasing the temperature leads to an 
increase in the rate of reaction; in these cases the temperature coefficient, Q10, is between 
2 to 3. Circadian rhythms need to robustly keep time and a difference to their period from a 
temperature change would result in an ineffective system. This is especially true in 
poikilothermic species which cannot regulate their internal temperature (Ukai & Ueda 
2010). A Q10 equal to 1 indicates an unchanging rate in the presence of different 
temperatures. For circadian rhythms, the Q10 has a value between 0.8 and 1.2 (Pittendrigh 
1954; Roenneberg & Merrow 2005; Lowrey & Takahashi 2011). 
1.1.2 Physiological circadian rhythms 
 
Many aspects of our physiology are under the control of the circadian system and as a result 
exhibit circadian rhythms in their function. Perhaps the most obvious change viewed in 
physiology is the daily cycle between wakefulness and sleep. Although the processes 
regulating the onset of sleep are complex and outside the scope of this literature review, 
the role of the circadian system in humans is to time the onset of sleep to occur in the dark 
period and wake to occur during the light period of the light/dark cycle (Wright et al. 2012). 
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The circadian system promotes arousal during waking hours, and works to overcome the 
homeostatic sleep drive (i.e., the need to sleep, which increases the longer you are awake) 
especially during the afternoon and evening hours (Wright et al. 2012). These arousal signals 
are reduced at night to allow for the onset of sleep (Wright et al. 2012). Due to these 
arousal signals, cognition and alertness have been found to be under circadian regulation 
with both being at their lowest during the usual sleep episode (Rajaratnam & Arendt 2001; 
Wright et al. 2012). Alertness can be measured subjectively with the use of validated 
questionnaires (Akerstedt & Gillberg 1990) or objectively measured using various 
performance tests, along with cognition.   
The cardiovascular system has been shown to exhibit circadian rhythms in its function 
(Muller et al. 1989; Scheer et al. 2010; Takeda & Maemura 2010). Heart rate exhibits 
circadian rhythmicity when at rest, with its lowest levels in the middle of the biological 
night, and highest levels in the middle of biological day (Scheer et al. 2010). Coinciding with 
the increased heart rate, there is also an increase in systolic and diastolic blood pressure, 
with levels rising during the biological day and peaking in the evening (Scheer et al. 2010). 
These circadian changes are likely related to the demands on the cardiovascular system as a 
result of the usual sleep/wake cycle. 
One of the most widely studied circadian rhythms is the secretion of the hormone 
melatonin, which exhibits peak blood concentration at night. Melatonin is produced by the 
pineal gland in the brain, which receives information from the central pacemaker of the 
circadian system (Skene & Arendt 2006). Melatonin cannot be stored in vesicles and is made 
on demand and released at night; the central pacemaker of the circadian system will drive 
the timing of melatonin production, but synthesis can be acutely suppressed by light (Skene 
& Arendt 2006). Melatonin is the only hormone that peaks at the same time in both 
nocturnal and diurnal species and so has been called the “darkness hormone” (Skene & 
Arendt 2006; Arendt 2010). Furthermore, the duration of its release has been found to 
correlate with night length (Arendt 2010) and in humans the presence of melatonin signifies 
the endogenous biological night. Due to low levels of melatonin during the day and being 
predominately present at night, a key measure that is used for assessing human circadian 
phase is the timing of the dim light melatonin onset (DLMO), where melatonin 
concentration passes a threshold (Skene & Arendt 2006). The timing of the DLMO signifies 
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the start of biological night and is often used as a way of aligning circadian phases between 
individuals. Melatonin can be measured in plasma, saliva, and its main metabolite, 6-
sulphatoxymelatonin, is also present in urine (Skene & Arendt 2006; Middleton 2006). 
The adrenal glucocorticoid hormone, cortisol, also shows a robust circadian rhythm (Czeisler 
et al. 1999) but in contrast to melatonin is involved in arousal. Glucocorticoids play an 
important role in energy regulation, as too much cortisol results in increased weight gain in 
humans (Boscaro et al. 2001), whilst too low results in weight loss (Mitchell & Pearce 2012). 
Cortisol is at a low concentration during the night, rises prior to the onset of waking and 
peaks shortly after wake (Van Cauter 1990). This phase of peaking will remain tied to the 
central pacemaker, rather than acute behavioural changes, such as those seen during shift 
work or in jet lag (Scheer et al. 2009). Cortisol release is also known to have a pulsatile 
(ultradian) as well as a circadian rhythm (Challet 2015). In rodents, the equivalent hormone 
is corticosterone and it peaks at the same time in the behavioural cycle, but in antiphase to 
diurnal species. The role of cortisol will be discussed in more detail in section 1.3.4. 
Under conditions where melatonin cannot be assessed or used to align circadian phase 
between individuals, core body temperature can be used instead. The core body 
temperature minimum occurs at approximately 04:00, and coincides with the peak 
concentration of melatonin (Rajaratnam & Arendt 2001). Core body temperature has a 
persistent rhythm even under alterations to the sleep/wake cycle (Morgan et al. 1998; 
Scheer et al. 2010; Buxton et al. 2012). As it is not suppressed by light in the way melatonin 
is, it is another reliable marker when assessing circadian rhythms. 
Although only a few limited examples of physiological circadian rhythms have been given, 
the influence of the circadian system is extensive. Furthermore, many of these rhythms can 
be measured across species and under controlled conditions. Of particular interest are the 
circadian rhythms viewed in metabolism, and these will be discussed in more detail in 
section 1.5. 
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1.2 Circadian System Organisation 
 
The circadian system is not one isolated, self-sustaining oscillator, but rather many 
oscillators contributing to the timing of physiological events (Dibner et al. 2010). The co-
ordination of these many oscillators is vital to produce a reliable circadian rhythm to 
coincide with a timed environmental event. Therefore, the circadian system is organised 
into different hierarchical levels to ensure that the timing of rhythms remains robust, whilst 
allowing for the system to adapt to sustained perturbations in environmental zeitgebers. 
1.2.1 Mammalian molecular clock 
 
At the core of the self-sustaining oscillator is a molecular clock in the form of an intricate 
network of transcription-translation feedback loops (TTFL) (Figure 1.1) (Reppert & Weaver 
2002; Dibner et al. 2010; Lowrey & Takahashi 2011). The core TTFL consists of positive and 
negative arms, with the interaction leading to the oscillatory nature of the clock. Forming 
the positive arm are the basic helix-loop-helix PAS (Per-Arnt-Sim) transcription factors, brain 
and muscle aryl hydrocarbon receptor translocator-like protein 1 (BMAL1, also known as 
ARNTL) and circadian locomotor output cycles kaput (CLOCK) (Gekakis et al. 1998; 
Hogenesch et al. 1998; Bunger et al. 2000). In the brain and other tissues, neural period-
arnt-singleminded 2 (NPAS2), a paralogue of CLOCK, also forms part of the positive arm 
(Reick et al. 2001).  
BMAL1 and CLOCK/NPAS2 form a heterodimer and bind to E-box sequences (5’-CACGTG-3’) 
(Gekakis et al. 1998) in the promoter region of the PERIOD (PER1, PER2 and PER3) and 
CRYPTOCHROME genes (CRY1 and CRY2). After translation, PER and CRY proteins form a 
complex and translocate to the nucleus, repressing the transcriptional action of the 
BMAL1:CLOCK/NPAS2 heterodimer (Kume et al. 1999; Zheng et al. 2001); PER and CRY 
proteins form the negative arm of the TTFL. Over time, protein degradation leads to a 
decrease in levels of both PER and CRY proteins, lifting the inhibition on 
BMAL1:CLOCK/NPAS2 mediated transcription, allowing the cycle to continue; this process 
takes around 24 hours.  
Introduction 
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Figure 1.1: Schematic of the mammalian molecular clock network. The positive arm of the core TTFL molecular machinery 
consists of the transcription factor proteins BMAL1 (blue circle) and CLOCK (and CLOCK paralogue, NPAS2 – white circle), 
which form a complex and bind to the E-box sequences in the promoter region of genes. BMAL1:CLOCK/NPAS2 will induce 
the expression of the negative arm of the TTFL; these are the Period genes (PER1, PER2 and PER3 – dark pink) and the 
Cryptochrome genes (CRY1 and CRY2 – green). PER and CRY proteins form a complex with casein kinase 1 delta (CK1δ – 
purple hexagon) or epsilon (CK1ε – purple hexagon) and translocate to the nucleus where it inhibits (dashed lines) the 
action of the BMAL1:CLOCK/NPAS2 complex. This inhibition by the PER:CRY:CK1 complex will lead to the decrease in PER 
and CRY levels and over time this lifts the repression on BMAL1:CLOCK/NPAS2. Further regulation to the core TTFL is done 
by the auxiliary loop consisting of REVERB (orange circle) and ROR (lilac circle). BMAL1:CLOCK/NPAS2 complex will bind to 
the E-box region of both REVERB and ROR to induce their expression. REVERB and ROR will then translocate to the nucleus 
and REVERB will recruit co-repressors HDAC3 and NCor1 to repress BMAL1 expression, whilst ROR will recruit co-activator 
PGC1α to activate BMAL1 expression. Degradation of the negative arm components by the 26S proteasome (salmon 
cylinder) is regulated by the CK1ε or CK1δ and AMP kinase (AMPK – red-brown triangle) which phosphorylate (black circles) 
PER and CRY proteins, respectively. This leads to polyubiquitination by the S-phase kinase associated protein 1-Cullin-F-box 
protein (SCF) E3 ubiquitin ligase, which is regulated by β-Transducin Repeat-Containing Protein (β-TrCP) and F-Box protein 
(FBXL3) for PER and CRY, respectively. An action of the positive arm of the TTFL is to also induce the expression of clock 
controlled genes (CCG) which it will either do directly, through inducing the expression of the D-element binding protein 
(DBP – light blue) which binds to the D-box region of promoter genes, or through the action of REVERB and ROR which also 
bind to E-box regions. Adapted from (Mohawk et al. 2012). 
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In addition to the core TTFL, there exist auxiliary loops to enhance the robustness of the 
oscillator. BMAL1:CLOCK/NPAS2 induces the expression of retinoic acid receptor related 
orphan receptor α (RORα) (Sato et al. 2004) and nuclear receptor reverse erythroblastosis 
virus α (REVERBα) (Preitner et al. 2002). These clock genes go on to stimulate and repress 
BMAL1 transcription, respectively, by competing for binding on the REVERB/ROR-response 
elements (ROREs) in the BMAL1 promoter region.  RORα forms a complex with peroxisome 
proliferator-activated receptor-γ coactivator 1 α (PGC1α) to induce expression, whilst 
REVERB recruits nuclear receptor corepressor 1 (NCoR1) and histone deacetylase 3 (HDAC3) 
co-repressors to repress expression, thus leading to the circadian expression profile of 
BMAL1 (Dibner & Schibler 2015). This competitive binding is possible due to the antiphasic 
cycling of the RORα and REVERB transcripts (Yang et al. 2006).  
Post-transcriptional modifications play a crucial role in maintaining the 24-hour period of 
the molecular clock. The casein kinases, casein kinase 1 delta (CK1δ) and casein kinase 1 
epsilon (CK1ε), and glycogen synthase kinase 3 beta (GSK3β) phosphorylate many 
components of the molecular clock. CK1δ and CK1ε phosphorylate PER proteins, which 
allows for nuclear translocation of PER, as CK1δ/ε associates with the PER:CRY complex to 
increase its stability (Vielhaber et al. 2000; Lee et al. 2001). However, CK1δ/ε also promotes 
the degradation of PER via the 26S proteasome (Eide et al. 2005) and increased degradation 
results in a shortened period length. GSK3β phosphorylation acts to increase the repression 
on the positive arm of the clock. It promotes nuclear localisation of PER2 (Iitaka et al. 2005), 
stabilises REVERB-α (Yin et al. 2006) and leads to the degradation of both CLOCK and BMAL1 
(Spengler et al. 2009; Sahar et al. 2010). Additionally, adenosine monophosphate (AMP) 
dependent kinase (AMPK) phosphorylates CRY proteins to target them for degradation 
(Lamia et al. 2009). 
Phosphorylation of the PER and CRY proteins allows for polyubiquitination by the S-phase 
kinase associated protein 1-Cullin-F-box protein (SCF) E3 ubiquitin ligase, which is regulated 
by β-Transducin Repeat-Containing Protein (β-TrCP) and F-Box leucine rich protein 3 (FBXL3) 
for PER and CRY, respectively (Shirogane et al. 2005). This targets PER and CRY for the 
proteasome and the degradation of PER and CRY proteins will lift the repression on 
BMAL1:CLOCK/NPAS2 allowing for the cycle to begin again. 
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An output of the molecular clock is to induce the expression of clock-controlled genes 
(CCGs). CCGs may be under the direct transcriptional regulation of the core clock 
components as BMAL1:CLOCK/NPAS bind to the E-box regions of these genes and induce 
expression (Jin et al. 1999). CCGs may also be indirectly controlled via a key transcription 
factor, D-box element binding proteins (DBP), binding to D-box regions in their promoters; 
DBP expression is itself directly controlled by the TTFL (Ripperger et al. 2000). Nuclear 
receptors can also induce expression of CCGs by binding to ROREs and nuclear receptors are 
controlled via the main molecular clock (Ueda et al. 2005; Lowrey & Takahashi 2011; 
Albrecht 2012). 
1.2.2 The suprachiasmatic nuclei 
 
Located in the anterior hypothalamus, adjacent to the optic chiasm and on either side of the 
third ventricle are the paired nuclei, the suprachiasmatic nuclei (SCN). Although small in 
number, these 20,000 neurones form the central pacemaker for circadian rhythms, and sit 
at the top of the hierarchy for regulating the timing of rhythms in mammals. Lesioning the 
SCN was found to completely abolish rhythmic behaviour such as activity and drinking in 
rats maintained under light/dark cycles (Stephan & Zucker 1972; Moore & Eichler 1972). The 
SCN were also found to generate a self-sustaining electrical rhythm in isolation from other 
neuronal input (Inouye & Kawamura 1979) but their role as the pacemaker was cemented 
with implantation studies.  
Implantation of SCN from a donor into an arrhythmic SCN-lesioned recipient was found to 
restore rhythmic behaviours (Drucker-Colín et al. 1984; Sawaki et al. 1984). A chance 
mutation which resulted in Syrian hamsters with a shorter period length (tau) than wild type 
(Ralph & Menaker 1988) indicated that the SCN was a pacemaker. Implantation of donor 
SCN into recipients with a different tau resulted in rhythmic behaviour with a tau equal to 
the donor highlighting its position at the top of the circadian system hierarchy (Ralph et al. 
1990). 
The SCN receives direct neuronal input from the retina via the retinohypothalamic tract 
(Moore & Lenn 1972), which is important for synchronisation to the environment (see 
section 1.3.2 for details). An important role of the SCN is to measure the photoperiod of the 
external environment and transmit this information to the rest of circadian system. The 
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electrical activity of the SCN peaks during the daytime and is low at night-time (Inouye & 
Kawamura 1979). Crucially, this electrical activity profile is the same for nocturnal and 
diurnal species (Coomans et al. 2015).  
The SCN are split into two sub-regions, the ventrolateral (also called the “core”) and 
dorsomedial region (also called the “shell”). Although both produce the most common 
neurotransmitter in the structure, γ-aminobutyric acid (GABA), the ventrolateral expresses 
vasoactive intestinal polypeptide (VIP) and the dorsomedial region expresses arginine 
vasopression (AVP) (Moore et al. 2002; Coomans et al. 2015). Interestingly, only the 
ventrolateral region receives photic information from the retina and this region contains 
almost all the cells responsive to this information (Coomans et al. 2015). By contrast, the 
dorsomedial region receives no photic information from the retina, receiving input from the 
cortex, basal forebrain and hypothalamus instead. It also receives input from the 
ventrolateral region to synchronise it to the photoperiod (Coomans et al. 2015).  
1.2.3 Peripheral clocks 
 
The evidence that oscillators may exist outside of the SCN was first shown when cultured 
hamster retinal cells generated melatonin rhythms that were entrained, free-running and 
temperature-compensated (Tosini & Menaker 1996). Furthermore, the melatonin rhythms 
produced by tau mutant retinal cells showed the same period as the SCN, indicating that the 
mutation in the SCN oscillator was also present in the retinal oscillator (Tosini & Menaker 
1996). The identification of the core components of the molecular oscillating clock allowed 
for the discovery of peripheral clocks in mammals. The seminal paper from Balsalobre et al. 
(1998) showed that serum shock to a cultured immortalised fibroblast cell line was capable 
of producing oscillating circadian gene expression, which dampened out over time. Use of 
bioluminescent reporter gene constructs allowed for the real time measurement of 
peripheral tissues’ gene expression.  
Assessment of Per1:luciferase transgenic rats demonstrated that explanted SCN tissue 
maintained rhythmicity in culture for 32 days, whilst peripheral tissues were rhythmic for 2 
to 7 cycles (Yamazaki et al. 2000). Interestingly, they also showed that rhythms in peripheral 
tissues adjusted at different rates to a change in the light/dark cycle, with the liver being the 
slowest to adjust (Yamazaki et al. 2000). In a different study, explanted peripheral tissues 
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from mPER2:LUC mice maintained rhythmicity in culture for more than 20 days, albeit with 
reducing amplitude (Yoo et al. 2004). Importantly, peripheral tissues from SCN-lesioned 
animals were still rhythmic, highlighting that the rhythms were self-derived and not a result 
of SCN input (Yoo et al. 2004). However, the need of input from a synchronising agent for 
peripheral tissues was made clear when individual cells were measured (Welsh et al. 2004; 
Nagoshi et al. 2004). Single-cell resolution revealed that each cell maintained circadian 
rhythmicity, but would drift out of phase with neighbouring cells, leading to an overall 
dampening of the rhythm when measured as a population (Welsh et al. 2004; Nagoshi et al. 
2004). 
The existence of circadian rhythms in anuclear red blood cells has highlighted that the 
presence of rhythms is not dependant on a TTFL clock (O’Neill & Reddy 2011). 
Peroxiredoxins exhibited circadian oscillation in their oxidation status and, importantly, 
these rhythms were entrainable and showed temperature compensation, fulfilling the key 
requirements of a circadian rhythm (O’Neill & Reddy 2011).  
Crucially, molecular clock rhythms in peripheral clocks can be measured and respond to 
zeitgebers, giving an additional method for studying the circadian system. Whole tissues are 
often used in animal studies, but other strategies including the use of blood (Boivin et al. 
2003; Archer et al. 2003; Kusanagi et al. 2004; James et al. 2007; Kusanagi et al. 2008; 
Archer et al. 2008; Ackermann et al. 2009; Ebisawa et al. 2010), subcutaneous adipose tissue 
(Otway et al. 2011) and hair follicles (Brown et al. 2005; Watanabe et al. 2012) are required 
for human studies. 
In addition to identifying the molecular clock in peripheral tissues, peripheral clocks have 
been found to regulate local tissue-specific processes. Knockout studies have shown that 
the liver clock is important in regulating energy homeostasis (Lamia et al. 2008), whilst the 
pancreas clock regulates insulin release (Marcheva et al. 2010). In addition, the local clock 
can regulate sensitivity to signalling, as the adrenal clock is known to regulate sensitivity to  
adrenocorticotropic hormone (ACTH) (Oster et al. 2006). This highlights that peripheral 
clocks are not just “slaves” to the master clock but have important roles in regulating 
physiology. Further to this, the transcriptome of peripheral tissues in rodents were found to 
have tissue-specific circadian transcripts (Akhtar et al. 2002; Panda et al. 2002), which 
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related to the function of the tissue and differed to those seen in the SCN. This has also 
been seen in human peripheral clocks and will be discussed in more detail in section 1.4.3. 
1.3 Circadian Synchronisation 
1.3.1 Entrainment 
 
Due to the free-running characteristic of the circadian system, entrainment is required to 
ensure that internal circadian rhythms are converted to diurnal rhythms that are 
synchronised with the external 24-hour environment (Roenneberg & Merrow 2005). The 
process of entrainment requires zeitgebers from the environment, and the strength and 
timing of the zeitgeber will determine the extent that the circadian system will synchronise. 
The effect of the zeitgeber will differ across the circadian phase because if zeitgebers had 
the same effect across the day, entrainment could not occur.    
Zeitgebers have a phase response curve (PRC) profile that details the phase shift (the 
direction that rhythms move as a result of the zeitgeber) and the magnitude (amount in 
hours) that a zeitgeber has on the timing of rhythms across the circadian period. A positive 
phase shift means the system has advanced its timing by moving rhythms to peak earlier 
whereas a negative phase shift means the system has delayed its timing by moving rhythms 
to peak later. In addition to the direction, the magnitude of the phase shift highlights how 
the responsiveness of the system differs across the circadian phase.  
There are different types of PRC: type 0 and type 1 (Czeisler et al. 1989; St Hilaire et al. 
2012). A type 0 PRC is where the zeitgeber produces large shifts in the phase of the 
circadian system and when the new phase is plotted against the original phase, denoted as a 
phase transition curve (PTC), the average slope is 0 (Czeisler et al. 1989; St Hilaire et al. 
2012); this is termed as a strong resetting response. In contrast, a type 1 PRC is where the 
zeitgeber produces modest phase shifts, the transition between advances and delays is 
continuous and the PTC produces a slope close to 1 (St Hilaire et al. 2012); this is termed a 
weak resetting response. 
However, entrainment of circadian rhythms by a zeitgeber depends on the length of the 
zeitgeber’s cycle (T-cycle) as there is a range of entrainment, outside of which the circadian 
system cannot entrain rhythms and will instead free-run. For example, a light/dark cycle 
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that deviates far from 24 hours, such as 20 hours or 28 hours, will result in free-running 
circadian rhythms. This is often used in animal or human studies to uncouple the 
behavioural cycle from the circadian cycle, and allows for the assessment of the 
contribution that both make to a particular measure (Czeisler et al. 1999).  
However, our phase of entrainment, more commonly referred to as chronotype, will affect 
our individual responses to a zeitgeber (Roenneberg & Merrow 2007). Chronotype is the 
relationship between external time and internal time and is grouped into morning, evening 
or intermediate types. It can be assessed by validated questionnaires which consider both 
diurnal preference (Horne & Ostberg 1976) and actual behaviour (Roenneberg et al. 2003). 
Chronotype is dependent on genetics (Ebisawa et al. 2001; Archer et al. 2003; Viola et al. 
2007; Archer et al. 2008), age (Roenneberg et al. 2004), sex (Roenneberg et al. 2004) and is 
affected by the strength of zeitgebers (Roenneberg et al. 2007; Wright Jr. et al. 2013).   
1.3.2 Photic zeitgebers 
 
Light is a well-established zeitgeber and its effect on the timing of the circadian system has 
been extensively studied (Lucas et al. 2014). Assessment of melatonin rhythms in blind 
patients revealed that some patients still maintained an entrained melatonin rhythm that 
could be suppressed with a light pulse, even though they had no visual perception of light 
(Czeisler et al. 1995; Lockley et al. 1997). However, this phenomenon was mostly absent in 
those individuals whose both eyes were enucleated (Lockley et al. 1997). In addition to this, 
animal experimentation using mice that lacked the visual photoreceptors of rods and cones 
showed that light could phase-shift wheel running activity (Freedman et al. 1999) and could 
also suppress melatonin production (Lucas et al. 1999) in these animals. This information, 
combined with action spectrum analysis of wavelengths of light pointed to a novel non-rod, 
non-cone photoreceptor that was responsible for photo-entrainment (Thapan et al. 2001; 
Brainard et al. 2001).  
A photosensitive opsin, melanopsin (Provencio et al. 2000), was found to be present in 
retinal ganglion cells that provided direct innervations to the SCN (Gooley et al. 2001; 
Berson et al. 2002). These ganglion cells, called intrinsically photosensitive retinal ganglion 
cells (ipRGCs), formed a photoreceptive “net” in the inner retina, differing to the visual-
forming photoreceptors that had more discrete localisation to allow for fine, spatial 
Introduction 
24 
 
resolution (Provencio et al. 2002). Furthermore, the ipRGCs were deduced to play a role in 
photo entrainment as they required a light stimulus of high intensity and long duration to 
cause depolarisation (Berson et al. 2002), which would mimic the light exposure over the 
photoperiod. Action spectrum analysis found that humans are more sensitive to light within 
the blue range (440 – 500 nm) as this caused the highest level of melatonin suppression at 
the lowest irradiance (Thapan et al. 2001; Brainard et al. 2001). Melanopsin had a peak 
sensitivity of around 484nm which fell within the blue light range, further linking it to photo 
entrainment (Berson et al. 2002). 
Although different studies have varied in their methodology, especially regarding length of 
exposure, wavelength and irradiance used, the PRC of light has been relatively consistent in 
its findings (Czeisler et al. 1989; Khalsa et al. 2003; St Hilaire et al. 2012; Revell et al. 2012). 
Receiving light early in subjective night causes a phase delay to rhythms, whereas receiving 
light late at subjective night/ early subjective morning results in a phase advance to rhythms 
(Czeisler et al. 1989; Khalsa et al. 2003; St Hilaire et al. 2012; Revell et al. 2012). 
Interestingly, light intensity has the ability to change the phase of entrainment (Roenneberg 
et al. 2007; Wright Jr. et al. 2013). One study found that people who lived in rural areas and 
were exposed to more natural light, a stronger zeitgeber in intensity compared with artificial 
light, had a chronotype more closely coupled to sun time compared with those who lived in 
a larger city (Roenneberg et al. 2007). This was also seen in a study that assessed exposure 
to only natural light for a week and found that melatonin onset and offset became tightly 
coupled to sunset and sunrise, respectively, regardless of chronotype (Wright Jr. et al. 
2013). This highlights the effect that a strong zeitgeber has on entrainment and the phase of 
circadian rhythms. 
The mechanism through which light stimulation affects the timing of the clock is via the 
cyclic AMP (cAMP) response element binding protein (CREB). Light stimulation, especially at 
night, of the ipRGCs results in glutamate release at the ipRGC synapses with the ventral SCN 
neurons and subsequent calcium influx into SCN neurons (Lowrey & Takahashi 2011). The 
calcium influx activates various kinases that phosphorylate CREB (Ginty et al. 1993), allowing 
it to rapidly induce the expression of PER1 and PER2 via their cAMP response element 
(Albrecht et al. 1997); this then alters the timing of the TTFL and phase advances or delays 
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rhythms. The robustness of the TTFL is maintained by the salt inducible kinase 1 (SIK1) 
(Jagannath et al. 2013). Knockdown of Sik1 resulted in rapid re-entrainment of mice 
following a 6-hour phase advance. This was due to the lack of inhibition of CREB regulated 
transcription coactivator 1 (CRTC1), a coactivator of CREB, by SIK1 (Jagannath et al. 2013). 
1.3.3 Nonphotic zeitgebers 
 
Although light is considered to be the dominant time cue in humans, studies have indicated 
that nonphotic zeitgebers may also play a role in entraining the circadian system in humans 
(Mistlberger & Skene 2004; Mistlberger & Skene 2005). Initially, it was believed that social 
cues were the dominant zeitgeber, based on the work of Aschoff and Wever (Aschoff et al. 
1971; Wever 1989), but these studies did not control for light exposure and it has since been 
discovered that even relatively low levels of light are enough to suppress melatonin (Thapan 
et al. 2001; Mistlberger & Skene 2004). Subsequent studies looking at cohabiting individuals 
in dim light found no evidence of synchrony (Middleton et al. 1996) and it is believed that 
social cues do not cause entrainment (Mistlberger & Skene 2004); one reason for this is that 
social cues can be ignored. 
Nonphotic zeitgebers that show more promise are exercise, pharmacological agents and 
food (Mistlberger & Skene 2005). A PRC has been constructed for exercise and has the 
opposite profile to that of the photic PRC (Buxton et al. 2003; Mistlberger & Skene 2005). 
Evening exercise causes advances and late morning exercise causes delays to melatonin 
rhythms (Buxton et al. 2003; Mistlberger & Skene 2005). However, exercise still appears to 
be a weak zeitgeber as the phase shifts which occur to melatonin rhythms do not last for 
more than a cycle, indicating it was not a stable reset (Buxton et al. 2003; Mistlberger & 
Skene 2005).   
One of the best models for studying nonphotic zeitgebers is using blind individuals with no 
light perception that have free running rhythms despite imposing a 24-hour behavioural 
cycle on themselves (Mistlberger & Skene 2005). Administering exogenous melatonin and 
examining the effect it has on cortisol rhythms in these individuals has been extensively 
studied (Lockley et al. 2000; Hack et al. 2003). The PRC for exogenous melatonin was similar 
to that for exercise, with advances to rhythms when given in the late evening, and delays 
when given in the early morning. Administering melatonin to these individuals to restore 
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entrainment has shown improvement to their sleep and lifestyle (Hack et al. 2003) 
indicating the importance of nonphotic zeitgebers.  
The ability of a nonphotic zeitgeber to entrain may depend on the individual’s internal tau 
(Mistlberger & Skene 2005). For blind individuals with a tau close to 24 hours, entrainment 
was achieved though nonphotic zeitgebers as the necessary phase shift would be within the 
range of entrainment for the weak zeitgebers (Klerman et al. 1998). As the average tau in 
humans is 24.2 hours (Czeisler et al. 1999) identifying strong nonphotic zeitgebers which are 
capable larger phase shifts to rhythms, and maintaining this shift are necessary. 
Food could potentially be a powerful nonphotic zeitgeber as animal studies have shown 
food timing and restriction to have a phase resetting effect on peripheral clocks (Damiola et 
al. 2000; Stokkan et al. 2001). However, whether food is a nonphotic zeitgeber in humans 
has yet to be elucidated and current evidence from animal and human data will be 
discussed in more detail in section 1.5.3. 
1.3.4 Communication between the central and peripheral clocks 
 
In order for the circadian system to be fully entrained, the central pacemaker must have the 
ability to communicate external time information to peripheral oscillators to ensure that 
they are all synchronised; similar to a conductor (SCN) keeping an orchestra (peripheral 
clocks) in time (Johnston et al. 2009). To do this the SCN uses a combination of neuronal 
input, endocrine signalling and local cues to transmit light/dark information to peripheral 
clocks (Figure 1.2). 
Autonomic innervations regulated by SCN entrain peripheral clocks in one of two ways; 
either through direct neuronal activity or via the effect on an endocrine organ (Kalsbeek et 
al. 2010; Pevet & Challet 2011; Mohawk et al. 2012; Tsang et al. 2014). Within the brain 
itself, the SCN has neuronal projections to many areas, including the hypothalamic areas of 
the paraventricular nucleus (PVN), medial preoptic area (MPOA) and dorsomedial nuclei 
(DMH) (Buijs 1996). These areas will then innervate peripheral organs, transmitting time 
information and regulating circadian rhythms. In rats the PVN, which receive input from the 
SCN, regulates plasma glucose concentrations through its sympathetic projections to the 
liver (Kalsbeek et al. 2004). Glucose rhythms are further regulated by the PVN, and the SCN, 
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as its parasympathetic projections to the pancreas control meal-induced insulin responses 
(Kalsbeek et al. 2008). In addition to glucose, hepatic lipid metabolism will also be controlled 
by PVN-mediated innervation highlighting the direct effect of the SCN on rhythms 
(Bruinstroop et al. 2014). However, endocrine signalling will also have an important role in 
mediating synchronisation between the central and peripheral clocks.  
 
 
Figure 1.2: Communication between the central clock and peripheral clocks. The master clock, the SCN, receive 
photoperiod information via the retinohypothalamic to entrain its rhythms. The SCN can then synchronise the phase of 
peripheral clocks using a variety of methods. The SCN can entrain peripheral clocks via direct neuronal innervation which is 
a strong synchroniser. It can synchronise to a lesser extent through the generation of melatonin as well as core body 
temperature (dashed lines). The SCN will not be phase shifted by core body temperature, but can be entrained by 
melatonin. The sleep/wake cycle, which the SCN governs the timing of, will act to reinforce the photoperiod to peripheral 
clocks, but the feed/fast cycle will have a greater synchronising effect on peripheral clocks. In addition, the adrenal 
glucocorticoid hormone also synchronises the phase of peripheral clocks, and this rhythm is driven by SCN innervation. 
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It is likely that melatonin has a role in synchronising and conveying information about the 
scotoperiod to peripheral oscillators, due to the phase resetting effects of melatonin already 
discussed in section 1.3.3 (Challet 2015). The synthesis and release of melatonin by the 
pineal gland is intimately linked to the SCN and the light/dark cycle. GABA-abundant SCN 
neurones are rhythmically active and inhibit the production and release of melatonin from 
the pineal gland. Glutamatergic SCN neurones fire continuously and can overcome the 
suppression by GABA-abundant SCN neurones to stimulate melatonin production (Perreau-
Lenz et al. 2004). The light/dark cycle will entrain this rhythm as light is able to activate the 
GABA-abundant that suppress melatonin synthesis (Perreau-Lenz et al. 2004). 
Melatonin binds to melatonin receptors to mediate its effects and in humans and mammals 
and two high-affinity G-protein coupled melatonin receptors have been cloned: mel1a (MT1) 
(Reppert et al. 1994) and mel1b (MT2) (Reppert, Godson, et al. 1995). In birds a third non-
mammalian receptor has also been cloned, mel1c (Reppert, Weaver, et al. 1995). Although 
assessment of receptor location and density in humans is not easy, both human and animal 
studies have found a high density of receptors within the SCN. In rodents, it is thought that 
melatonin acting on MT1 in the SCN suppresses its neuronal activity, whilst melatonin acting 
on MT2 in the SCN is responsible for phase shifting activity (Liu et al. 1997; Dubocovich et al. 
2005). This shows that melatonin is able to feedback onto the central pacemaker and more 
recently, melatonin treatment altered the free-running period of PER2::LUC rhythms in SCN 
explants from mice with a Clock mutation that causes deficient pineal melatonin synthesis 
(Shimomura et al. 2010). In peripheral tissues, it is less clear what effect melatonin has as 
circadian rhythms can still be maintained in pinealectomised animals with an intact SCN 
(Quay 1970). However, the sensitivity of peripheral clocks to melatonin is likely lower than 
to other stimuli, such as feeding time, which will be discussed in section 1.5.3. 
Glucocorticoids are likely to have a role in the communication between the SCN and 
peripheral clocks. The SCN mediates the release of corticosterone in rodents through 
innervation via the PVN and activation of the hypothalamic-pituitary-axis. Furthermore, the 
adrenal clock also gates the sensitivity of the adrenal gland to ACTH (Oster et al. 2006). 
Unlike melatonin, the SCN in rats and mice were shown to not express mRNA for the 
glucocorticoid receptor (GR), indicating that the SCN may not be a target of glucocorticoids 
and does not feedback onto the central clock.   
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Glucocorticoids have the ability to entrain peripheral clocks, highlighted by their phase 
resetting ability of Per1 rhythms in the liver (Balsalobre et al. 2000). This entrainment is 
mediated by the GR as mice with mutant GR in the liver did not exhibit phase resetting after 
glucocorticoid administration (Balsalobre et al. 2000). Furthermore, glucocorticoids have 
been found to phase-shift the rhythms of many peripheral tissues in rodents (Pezük et al. 
2012) as well as adipose tissue in humans (Gomez-Abellan et al. 2012). Further work has 
identified a glucocorticoid response element in the regulatory region of many core clock 
genes (Reddy et al. 2007). Together, this highlights that glucocorticoids play a pivotal role in 
entraining peripheral tissues.  
Body temperature rhythms may also be a potential synchroniser of the circadian system. 
Core body temperature exhibits a circadian rhythm and a study examining the effect of 
natural body temperature cycles on peripheral rhythms found that these cycles could 
maintain existing gene expression rhythms in vitro, but could not generate a rhythm that 
had already dampened (Brown et al. 2002). Furthermore, experiments in vivo showed that 
external temperature cycles were able to phase-shift core body temperature rhythms, 
which in turn altered the phase of gene expression rhythms in the liver (Brown et al. 2002). 
The SCN was resistant to phase shifting by temperature cycles and stayed locked to the 
light/dark cycle (Brown et al. 2002; Buhr et al. 2010). It is important that the phase of the 
SCN is not affected by the core body temperature rhythm, and stays in phase with the 
light/dark cycle. In humans, anuclear red blood cells’ peroxiredoxin rhythms were phase 
shifted by temperature (O’Neill & Reddy 2011), but the lower temperature used (32°C) was 
outside the normal physiological range that would be found on a daily basis in humans 
(O’Neill & Reddy 2011). This shows that temperature may help to maintain synchrony 
between peripheral tissues. 
More indirect synchronisers of the circadian system may be the sleep/wake cycle and the 
feed/fast cycle. As mentioned previously in section 1.3.3, exercise can phase shift rhythms in 
humans. Furthermore, as posture is known to affect plasma melatonin concentration 
(Deacon & Arendt 1994) this highlights that activity can affect the circadian system, and 
similarly to temperature, reinforce existing rhythms. Feeding and fasting rhythms are also 
normally separated temporally, and the rodent liver clock is believed to be very sensitive to 
feeding; this will be discussed in more detail in section 1.5.3 (Damiola et al. 2000; Stokkan et 
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al. 2001). There are numerous ways in which the central and peripheral clocks will 
communicate time information in order to maintain synchrony of the whole system. 
However, even with these measures circadian desynchrony can still occur and lead to 
adverse outcomes.    
1.4 Circadian Desynchrony 
1.4.1 External desynchrony 
 
There are times when humans are out of synchrony with the environment even though they 
are in the presence of zeitgebers. For example, jet lag is an acute condition where an abrupt 
change to the timing of the environmental light/dark cycle means the circadian system 
requires a few days to resynchronise all rhythms to the new light schedule (Rajaratnam & 
Arendt 2001; Arendt 2010). Chronically, individuals undergoing shift work experience long 
term desynchrony with the external environment (Rajaratnam & Arendt 2001; Arendt 
2010).  
Shift work broadly describes work conducted outside of “normal” hours and can include the 
weekend and nights (Arendt 2010). The shift work schedule could be fixed (only working 
nights) or rotating shifts where the individual will cycle through day, evening and night shifts 
(Arendt 2010). Epidemiological studies have found that shift work increases the risk of 
developing metabolic disease, cardiovascular disease and cancer (Karlsson et al. 2001; 
Esquirol et al. 2009; De Bacquer et al. 2009; Chen et al. 2010). Limitations of these studies 
include the definition of shift work, cross sectional assessment of the populations, and that 
it can be difficult to prise apart the contribution of circadian desynchrony, sleep deprivation 
and lifestyle factors as the causative agents. Therefore, to better ascertain the effects of 
circadian desynchrony and sleep loss on the development of these disease states, controlled 
animal and human studies have been conducted. 
Through circadian misalignment protocols, such as forced desynchrony (FD) where 
participants live a >24 hour day, the effect of desynchrony on metabolic markers was 
assessed. It was found that a meal consumed under circadian misalignment resulted in 
altered postprandial levels of glucose and insulin compared with circadian alignment, seen 
both under controlled laboratory conditions (Morgan et al. 1998; Scheer et al. 2009; Buxton 
et al. 2012) and in field studies (Lund et al. 2001). Postprandial glucose was found to be 
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increased under circadian misalignment (Morgan et al. 1998; Lund et al. 2001; Scheer et al. 
2009; Buxton et al. 2012), but insulin gave conflicting results with some showing an increase 
(Lund et al. 2001; Scheer et al. 2009) and others a decrease (Buxton et al. 2012). Despite the 
conflicting insulin results, under circadian misalignment glucose metabolism is consistently 
impaired.  
Animal studies have shown that eating during the biological night leads to an increase in 
weight, despite there being no difference between calories consumed and levels of activity 
(Arble et al. 2009). Assessment of appetite hormones in humans found that the satiety 
hormone, leptin, decreased under circadian misalignment (Scheer et al. 2009; Buxton et al. 
2012; McHill et al. 2014), whilst the orexigenic hormone ghrelin was either unchanged 
(McHill et al. 2014) or increased (Buxton et al. 2012). Despite the orexigenic profile of the 
hormone changes, one study found that subjective hunger decreased under circadian 
misalignment (McHill et al. 2014); subjective hunger is known to be under circadian control 
(Scheer et al. 2013). However, in these studies food was controlled (macronutrient content, 
calories and timing) and different results might be expected if food was available ad libitum. 
The above studies highlighted changes in metabolism under acute periods of simulated shift 
work. However, people who had a history of >5 years of shift work were found to have a 
worse cardiovascular profile after sleep deprivation and recovery compared with non-shift 
worker controls (Wehrens et al. 2012). This highlights that there are long term effects of 
shift work and circadian desynchrony on health and responses to challenge, further 
increasing the need to identify zeitgebers that can maintain the phase between clocks in the 
circadian system. 
1.4.2 Internal desynchrony 
 
Internal desynchrony relates to the loss of synchrony between clocks within the circadian 
system. One of the primary causes of internal desynchrony is jet-lag due to the change in 
the light/dark cycle. Both phase advances and phase delays to the light/dark cycle revealed 
differences in the phase shifting kinetics of the SCN and peripheral clocks (Yamazaki et al. 
2000; Davidson et al. 2009). The SCN were found to phase-shift Per1 and Per2 gene 
expression rhythms the fastest to the new light/dark schedule, usually within 3 days 
(Yamazaki et al. 2000; Davidson et al. 2009). Furthermore, it was found that the SCN ventral 
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region contained fast shifting neurones, which would relate to this region receiving direct 
light information via the retinohypothalamic tract and highlights the role of the SCN as a 
photoperiod detector (Davidson et al. 2009; Coomans et al. 2015).  
In contrast to the SCN, peripheral clocks showed far greater variability in the time taken to 
phase shift gene expression rhythms to the new light/dark cycle. Similar to the SCN, the 
phase of the lung (Yamazaki et al. 2000; Davidson et al. 2009) and skeletal muscle (Yamazaki 
et al. 2000) were adjusted to the new light/dark cycle in approximately 3 days. However, 
other tissues, such as the spleen, liver, oesophagus and the thymus needed 5 or more days 
to readjust, with smaller phase shifts seen each day (Yamazaki et al. 2000; Davidson et al. 
2009). This highlights that in situations of continuingly altering light/dark schedules, such as 
rotating shift work, the internal desynchrony between peripheral clocks and the SCN would 
worsen as clocks readjusting at different rates would become further out of phase with each 
other. 
However, internal desynchrony between the central and peripheral clocks can occur without 
a change to the light/dark schedule. Restricting feeding to the usual rest phase has been 
found to cause internal desynchrony between the SCN and peripheral clocks (Damiola et al. 
2000; Stokkan et al. 2001). Similarly to phase shifts from altered light/dark cycles, phase 
shifting of peripheral rhythms to restricted feeding schedules were also found to have 
different kinetics (Damiola et al. 2000; Stokkan et al. 2001); this will be discussed in more 
detail in section 1.5.3.  
1.4.3 Circadian transcriptome 
 
Transcriptomics looks at the RNA transcripts in cells or tissues. Studies in both animals and 
humans have revealed that a proportion of the transcriptome is under circadian control 
(Zhang et al. 2014; Laing et al. 2015). In mice, it is thought that approximately 43% of genes 
that code for proteins are circadian in at least one organ (Zhang et al. 2014) with tissue 
specific differences in the circadian genes relating to the function of the tissue (Storch et al. 
2002; Zhang et al. 2014). Crucially, transcriptomics analysis reveals changes to the entire 
transcriptome under different conditions (Barclay et al. 2012; Möller-Levet et al. 2013; 
Archer et al. 2014), highlighting the potential for identifying disease states and biomarkers. 
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An exploratory study assessing circadian gene regulation in liver and heart in mice 
discovered that although a similar percentage of genes were circadian in each tissue (10% 
and 8%, respectively) only 52 genes were common to both tissues (Storch et al. 2002). 
Within these 52 genes, all the core clock genes, apart from Per3, Cry1 and Cry2, were 
present. Assessment of the circadian gene set in both tissues were found to be involved in 
an array of biological processes, such as cell growth, metabolism and stress response, but 
showed specific enrichment too (Storch et al. 2002). In the liver, there were circadian genes 
involved in amino acid metabolism, whilst in the heart, circadian genes were involved in G-
protein coupled receptor signalling (Storch et al. 2002). 
Being able to identify how different conditions or diseases affect the transcriptome is 
important for understanding pathologies. One study applied timed sleep restriction (TSR) to 
mice to simulate shift work and assessed the liver transcriptome (Barclay et al. 2012). It was 
found that 15% of genes that were rhythmic under control conditions became arrhythmic 
after TSR (Barclay et al. 2012). Importantly, these genes were normally involved in metabolic 
processes, especially carbohydrate metabolism, highlighting a possible explanation for 
adverse metabolic changes seen in shift workers (Barclay et al. 2012). 
Moderate sleep restriction to 5.7 hours from 8.5 hours per night resulted in pronounced 
changes in the human blood transcriptome (Möller-Levet et al. 2013). One week of sleep 
restriction reduced the number of genes with a circadian expression profile (8.8% to 6.9%) 
although some of the genes only became circadian after sleep restriction (Möller-Levet et al. 
2013). The clock genes whose average expression levels were down-regulated through sleep 
restriction were PER2, PER3 and RORα; those up-regulated were CK1ε and DEC1 (Möller-
Levet et al. 2013). Furthermore, sleep restriction up-regulated genes associated with 
inflammatory and stress responses, including oxidative stress and response to reactive 
oxygen species (Möller-Levet et al. 2013).  
Although sleep restriction highlighted adverse changes to the blood transcriptome, 
mistimed sleep which is often experienced by shift workers showed even greater effects 
(Archer et al. 2014). There was a 6-fold reduction in the number of circadian transcripts as a 
result of mistimed sleep (6.4% down to 1%) (Archer et al. 2014). From the core clock genes, 
only REVERB-β and CK1ε remained circadian in both conditions (Archer et al. 2014). In 
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addition to the reduction in number, the amplitude of the circadian transcripts was also 
reduced, indicating a dampening in the system. The transcripts most affected by mistimed 
sleep were those associated with gene transcription and translation (Archer et al. 2014).  
A comparison of blood transcriptomics data from humans under different conditions, 
including sleep deprivation and desynchronised sleep, revealed that there was a core set of 
28 genes that were rhythmic under any condition assessed (Laing et al. 2015). From the 
canonical clock genes, only REVERB-β and CK1ε were circadian under all conditions (Laing et 
al. 2015). The biological processes that these 28 genes were involved with were 
predominantly blood specific (response to wounding, B cell receptor signalling, humoral 
immune response) but were also involved in lipid metabolic processes (Laing et al. 2015).  
Interestingly, when transcriptome data across humans and mouse samples were analysed, 
REVERB-β was found to be rhythmic in almost all samples (96%) (Laing et al. 2015). REVERB-
β, as well as inhibiting BMAL1 transcription, binds to genes associated with lipid metabolism 
and PPAR signalling (Bugge et al. 2012; Cho et al. 2012).  In addition, REVERB-α, PER2, PER3 
and BMAL1 were rhythmic in around 90% of samples (Laing et al. 2015). However, although 
the blood transcriptome is considered to co-express a number of genes found in other 
tissues (Liew et al. 2006; Mohr & Liew 2007), in order to properly assess tissue specific 
transcripts and their association with disease states, novel ways of sampling tissues of 
interest in humans need to be found. 
1.5 Circadian Metabolism 
 
Due to the change in the light/dark cycle over the course of the day, many of our behaviours 
are timed to either occur in the light phase or the dark phase. The feeding/fasting cycle is 
one such behaviour, where feeding occurs in the light phase, and fasting during the dark 
phase in diurnal species such as humans. However, even in the absence of feeding and 
fasting stimuli, circadian rhythms in many metabolic processes are evident.  
1.5.1 Metabolic circadian rhythms 
 
The regulation of glucose concentration is under tight homeostatic control but it does 
exhibit circadian rhythmicity (Van Cauter et al. 1997).  It was found that glucose clearance 
and tolerance decreases from morning to evening, deduced from both the administration of 
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identical meals at different times of day (Van Cauter et al. 1992) as well as through a 
continuous infusion of glucose (Van Cauter et al. 1989). This indicates that glucose 
concentration reaches its acrophase (time of peak) during the night. Studies previously done 
at Surrey have shown the acrophase of glucose to occur at night under constant routine 
conditions (Morgan et al. 1998). Linked to the regulation of glucose is the hormone insulin. 
Insulin has been observed to have a circadian rhythm, but can lack consistency in possessing 
a rhythm between studies. Interestingly, insulin concentrations increased during the night 
(Morgan et al. 1998; Chua et al. 2013) and when taken with the increase in glucose 
concentration at night, points towards decreased insulin sensitivity in tissues over the 
course of the day. The anorexigenic hormone leptin is linked to insulin release, and is 
produced by white adipose tissue to signal satiety (Klok et al. 2007). It has been found to 
exhibit a diurnal rhythm in its release, with a rise at night, and is also related to the time of 
food intake (Schoeller et al. 1997).  
Plasma lipids exhibit very robust circadian rhythms with different subclasses peaking at 
different times across the day (Chua et al. 2013). Triglyceride concentrations were found to 
rise at night with a peak in the early morning; triglycerides show circadian rhythmicity at an 
individual and group level. By contrast, sphingolipids had an antiphasic profile, peaking in 
the afternoon whilst glycerophophoslipids did not have a clear circadian expression profile.  
In addition to circadian rhythms in hormones and energy sources, small molecule 
metabolites are also known to exhibit circadian rhythmicity when examined under constant 
conditions. Looking at both plasma and saliva metabolites, it was found that 15% of 
metabolites showed circadian variation (Dallmann et al. 2012), although the metabolites 
differed between the examined matrices. In plasma, it was found that fatty acids formed the 
majority of the circadian metabolites and peaked mid-morning to noon (Dallmann et al. 
2012). By contrast, saliva had a greater majority of amino acids exhibiting a circadian profile, 
but these compounds peaked at different times through the day (Dallmann et al. 2012). 
Subsequent studies have looked at plasma metabolites in an untargeted approach. In one 
study, approximately 19% of metabolites showed time of day variation and consisted of 
many chemical classes (Ang et al. 2012); of these, only acylcarnitines were not previously 
reported as having time-of-day variation. Acylcarnitines are intermediates produced when 
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fatty acids undergo β-oxidation, with levels of the long-chain version peaking in the morning 
(Ang et al. 2012); this is consistent with peaks in triglycerides and fatty acids occurring in the 
morning (Dallmann et al. 2012; Chua et al. 2013). The amino acids that were identified as 
diurnal peaked in the mid-to-late afternoon (Ang et al. 2012). 
Interestingly, many metabolites that exhibited circadian rhythmicity continued to do so 
under periods of acute sleep deprivation (Davies et al. 2014). Instead it was found that 
those that peaked at night had increased levels and a higher amplitude under sleep 
deprivation; for day peaking, the amplitude was reduced (Davies et al. 2014). Acylcarnitines 
showed increased levels highlighting a potential increase in fatty acids undergoing β-
oxidation (Davies et al. 2014). Amino acids serotonin, tryptophan and taurine also increased 
pointing to the antidepressive effect of acute sleep deprivation (Davies et al. 2014).  
These data highlight that many biochemical and metabolite compounds exhibit circadian 
rhythmicity in their concentration levels. This indicates that metabolism and the circadian 
system are closely linked. 
1.5.2 Metabolism and the molecular clock 
 
The relationship of metabolism and the circadian clock is tightly coupled, with both affecting 
the timing of each other. On the molecular level, the metabolic status of the cell, as 
described below, is known to have a direct and indirect impact on the function of the clock 
(Rutter et al. 2001; Hirota et al. 2002; Asher et al. 2008; Nakahata et al. 2008; Asher et al. 
2010). Incubating cultured fibroblasts with a low concentration of 5.6mM of glucose was 
found to down-regulate key clock genes after an hour of incubation (Hirota et al. 2002). This 
was thought to be mediated by transforming growth factor beta-inducible early gene 1 
(TIEG1), a transcriptional repressor (Hirota et al. 2002). 
Nicotinamide adenine dinucleotide (phosphate) (NAD(P)) exists as either the oxidised 
(NAD+)/(NADP+) or reduced (NADH)/(NADPH) form in cells, with the ratio being dependent 
on the energy status of the cell. NAD+ levels oscillate throughout the day (Nakahata et al. 
2009), mediated in part by the CCG, nicotinamide phosphoribosyltransferase (NAMPT) 
(Ramsey et al. 2009). One study found that DNA binding of the BMAL1:CLOCK/NPAS2 
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heterodimer depended on the ratio of NAD(P)H: NAD(P)+; the reduced form promoted DNA 
binding whereas the oxidised form inhibited it (Rutter et al. 2001).  
Further to the action of NAD+ itself, NAD+ sensing enzymes sirtuins (SIRT) and poly-ADP-
ribose polymerase (PARP) interact with the molecular clock to maintain the rigor in 
oscillations (Nakahata et al. 2008; Asher et al. 2008; Asher et al. 2010). SIRT1 enzymes 
require NAD+ to catalyse their deacetylation reaction (Sauve et al. 2006). SIRT1 binds to the 
BMAL1:CLOCK/NPAS2 heterodimer where it deacetylates BMAL1 in order to conserve 
rhythms of a strict period and transcriptional levels (Nakahata et al. 2008). Furthermore, 
SIRT1 regulates the negative arm of the clock as it deacetylate PER2 resulting in increased 
degradation (Asher et al. 2008). 
PARP1 is also a NAD+ dependent enzyme and binds to the BMAL1:CLOCK/NPAS2 
heterodimer and regulates its ability to bind to DNA (Asher et al. 2010). It has been shown 
to play a role in mediating changes to molecular clock rhythms following a change in feeding 
time (Asher et al. 2010). PARP1 activity was shown to be cyclic with the rhythm inverting 
when mice were changed from exclusive night feeding to exclusive day feeding (Asher et al. 
2010). Furthermore, Parp1-/- mice took longer to phase-shift core clock gene rhythms than 
their wild type counterparts after a change to day feeding (Asher et al. 2010).   
In addition to nutrient sensors interacting with the clock, knocking out one or more of the 
core clock genes resulted in adverse metabolic phenotypes for the animals (Table 1.1). 
Animals with a mutated form of Clock, either Clockmut (Rudic et al. 2004; Turek et al. 2005) 
or ClockΔ19/Δ19 (Marcheva et al. 2010), were found to have an increased susceptibility to 
obesity, glucose intolerance and hepatic steatosis (Rudic et al. 2004; Turek et al. 2005; 
Marcheva et al. 2010). Similarly, whole body knockouts for Bmal1 saw an increase in body 
fat, as BMAL1 plays a role in adipose differentiation (Shimba et al. 2005), and increased 
glucose intolerance (Rudic et al. 2004; Lamia et al. 2008). Tissue-specific knockouts of Bmal1 
highlighted the tissue-specific roles of the clock within those tissues. Liver- and pancreas-
specific Bmal1 knockouts both exhibited glucose dysregulation, with fasting hypoglycaemia 
in the liver knockout (Lamia et al. 2008) and glucose intolerance and hypoinsulinaemia in 
the pancreas knockout (Marcheva et al. 2010). For adipose tissue specific knockouts, there 
was an increase in obesity as well as a change in feeding behaviour with more calories being 
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consumed in the light, inactive phase compared with their wild type controls (Paschos et al. 
2012). 
 
 
Gene mutation Metabolic phenotype Reference 
Clock whole body 
mutant 
Impaired gluconeogenesis, insulin-stimulated hypoglycaemia, 
reduced diurnal variation of glucose and TAG 
(Rudic et al. 
2004) 
Hyperglycaemia, hypercholesterolaemia, hypertriglyceridaemia, 
hyperleptinaemia, increased weight gain  
(Turek et al. 
2005) 
Hyperglycaemia, altered glucose tolerance 
(Marcheva et 
al. 2010) 
Bmal1 whole body 
knockout 
Impaired gluconeogenesis, insulin-stimulated hypoglycaemia 
(Rudic et al. 
2004) 
Impaired glucose tolerance, hypoinsulinaemia, increased total 
fat content 
(Lamia et al. 
2008) 
Bmal1 pancreas-
specific knockout 
Hyperglycaemia, impaired glucose tolerance, decreased insulin 
secretion 
(Marcheva et 
al. 2010) 
Bmal1 liver-specific 
knockout 
Fasting hypoglycaemia, increased postprandial glucose 
clearance, reduced glucose export 
(Lamia et al. 
2008) 
Bmal1 adipose-
specific knockout 
Increased body weight, hyperleptinaemia, 
hypertriglyceridaemia, increased light-phase eating 
(Paschos et al. 
2012) 
Per1; Per2 whole 
body double 
knockout 
Impaired glucose tolerance, insulin-stimulated hypoglycaemia 
(Lamia et al. 
2008) 
Per2 whole body 
knockout 
Hypotriglyceridaemia, reduced non-esterified fatty acid 
concentration 
(Grimaldi et al. 
2010) 
Cry1; Cry2 whole 
body double 
knockout 
Postprandial hyperglycaemia, impaired glucose tolerance and 
clearance, increased corticosterone 
(Lamia et al. 
2011) 
Reverb-α; Reverb-β 
whole body double 
knockout 
Hepatosteatosis, hypertriglyceridaemia 
(Bugge et al. 
2012) 
Hyperglycaemia, hypertriglyceridaemia  
(Cho et al. 
2012) 
Ror-α whole body 
knockout 
Reduced high-density lipoprotein, hypocholesterolaemia,  
(Mamontova 
et al. 1998) 
Hypocholesterolaemia, hypotriglyceridaemia 
(Lau et al. 
2008) 
Table 1.1: Summary table of metabolic phenotypes resulting from the mutation or knockout of core circadian clock 
genes. 
 
 
 
 
Introduction 
39 
 
Loss of the negative arm components of the molecular clock exhibited metabolic changes 
relating to both glucose and lipid regulation. Per1-/- Per2-/- double knockout resulted in 
glucose intolerance and hypoglycaemia following insulin administrations (Lamia et al. 2008). 
Loss of only Per2 resulted in changes to circulating lipids, with a reduction in triglycerides 
and non-esterified fatty acids in vivo, as well as an increase in adipogenesis in vitro (Grimaldi 
et al. 2010). It is thought that the increase in adipose tissue is due to the lack of PER2-
mediated repression on peroxisome proliferator-activated receptor gamma (PPARγ) activity. 
Interestingly, knockout of both Cry1 and Cry2 was found to increase circulating 
corticosterone and glucose intolerance (Lamia et al. 2011).  
The loss of the auxiliary loop clock genes has mixed effects on the metabolic phenotype of 
animals. Loss of Reverb-α increased plasma cholesterol and reduced bile acid levels, 
however, reports of triglyceride levels were conflicting. Knockout of both Reverb-α and 
Reverb-β saw an increase in circulating triglycerides and glucose, and severe hepatic 
steatosis (Bugge et al. 2012; Cho et al. 2012). The corepressor, HDAC3, which normally 
combines with REVERB-α and REVERB-β, plays an important role in repressing lipogenic 
genes that cannot occur in Reverb-α -/- and Reverb-β -/- animals. In contrast, loss of Rorα was 
beneficial as it was protective against diet-induced obesity, reduced adiposity and 
circulating triglyceride levels (Mamontova et al. 1998; Lau et al. 2008). However, Ror-α-/- did 
have reduced levels of high-density lipoprotein, which is known to have an important role in 
protecting against cardiovascular disease. 
Diet is known to play a role in modulating circadian rhythms. A high fat diet has been shown 
to affect molecular rhythms in mice (Kohsaka et al. 2007; Eckel-Mahan et al. 2013). Mice 
administered a high fat diet saw tissue- and gene-specific changes in molecular rhythms. In 
adipose and liver tissue, the key clock genes, Clock, Bmal1 and Per2 saw attenuation to their 
rhythms, but no change was observed in the hypothalamus (Kohsaka et al. 2007). Another 
study found that a high fat diet caused changes to the liver transcriptome (Eckel-Mahan et 
al. 2013). There was a reduction in circadian transcripts after a high fat diet, thought to be 
caused by decreased recruitment of BMAL1:CLOCK to promoter regions on CCGs (Eckel-
Mahan et al. 2013). Furthermore, NAD+ and Nampt were found to no longer oscillate as a 
result of a high-fat diet (Eckel-Mahan et al. 2013). These results were not caused by obesity, 
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as just 3 days on a high fat diet resulted in the abolishment of rhythms (Eckel-Mahan et al. 
2013), and a return of a normal chow diet reinstated rhythms (Eckel-Mahan et al. 2013). 
Interestingly, studies into single nucleotide polymorphisms (SNPs) of core clock genes have 
revealed effects on metabolism in humans (Scott et al. 2008; Garaulet et al. 2009). An initial 
study looking at metabolic syndrome, CLOCK gene polymorphisms and heritability found 
that the CLOCK CGC haplotype was less common and appeared protective against metabolic 
syndrome (Scott et al. 2008). Other CLOCK SNPs, rs4580704, rs1801260 and rs3749474, 
were also associated with increased prevalence of markers of metabolic syndrome, whilst 
the rs4580704 SNPs instead exhibited a protective effect, especially against hypertension 
(Garaulet et al. 2009). All of these studies indicate just how interlinked metabolism and the 
molecular clock are. 
1.5.3 Timed feeding 
 
The impact of meal timing in SCN-lesioned animals was studied long before the discovery of 
peripheral clocks (Stephan et al. 1979a; Stephan et al. 1979b). SCN-lesioned animals 
consuming food ad libitum did not show any clear rhythm in activity, but food restriction 
caused increased activity preceding the food opportunity, which was termed food 
anticipatory activity (FAA) (Stephan et al. 1979a; Stephan et al. 1979b). Subsequent studies 
have shown that this FAA persisted when animals were starved (Stephan 2002), and due to 
the lack of SCN, must be mediated by an extra-SCN oscillator, termed the food entrainable 
oscillator (FEO). The identity of the FEO has been debated for many years, but the 
anatomical location has not been discovered (Stephan 2002; Mistlberger 2009). 
The work that highlighted the role of food as a zeitgeber to peripheral clocks was that of 
Damiola et al (2000). When mice had food availability restricted to the light phase, the 
phase of gene expression of core circadian clock genes was inverted in the peripheral 
tissues, but not in the SCN, which remained locked to the light/dark cycle (Damiola et al. 
2000). This showed for the first time that food could uncouple the central pacemaker from 
peripheral clocks (Damiola et al. 2000). This effect was also seen in rats that were day fed 
for either 4 hours or 8 hours during the light phase (Stokkan et al. 2001).  
Introduction 
41 
 
Importantly, both studies highlighted that there was a differential response of peripheral 
tissues to the food timing (Damiola et al. 2000; Stokkan et al. 2001). Liver tissue was the 
fastest at resetting the phase of rhythms to the new feeding regime, whilst other tissues 
such as the pancreas, kidney, heart and lung took longer to phase shift (Damiola et al. 2000; 
Stokkan et al. 2001). Further studies have revealed that under hypocaloric condition, the 
SCN can be phase shifted under time-restricted feeding conditions (Caldelas et al. 2005; 
Mendoza et al. 2005). 
Although restricting feeding to certain hours outside of normal activity was found to have a 
strong entraining effect on peripheral clocks in rodents, such feeding is not akin to how 
humans consume food. One study administered food as “meals” in mice and determined 
how changes in meal timing affected PER2::LUC rhythms in various tissues (Kuroda et al. 
2012). They found that delaying the evening meal phase-advanced these rhythms, but if the 
evening meal was split into two smaller meals the phase shift did not occur (Kuroda et al. 
2012). This highlighted that under a “humanised” feeding pattern, meal timing was capable 
of phase-shifting PER2::LUC timing (Kuroda et al. 2012). The study also found that if meals 
were isocaloric and administered at equal intervals, ranging from two meals a day to six 
meals, the phase of the PER2::LUC rhythms remained unchanged (Kuroda et al. 2012); this is 
synonymous with humans being given isocaloric meals during constant routines (Duffy & 
Dijk 2002). 
Further to the changes in clock gene expression, many biochemical and hormonal markers 
have been assessed under restricted feeding conditions (Escobar et al. 1998; Díaz-Muñoz et 
al. 2000). Both studies assessed how food restriction to a 2-hour window during the light 
phase changed the metabolic profile of rats, compared with their ad libitum controls 
(Escobar et al. 1998; Díaz-Muñoz et al. 2000). They found that a catabolic state was 
favoured prior to the feeding window, as shown by an increase in circulating free fatty acids 
and ketone bodies, and a decrease in triglycerides in the serum (Escobar et al. 1998). This 
was also seen in hormones with a decrease in insulin and increase in glucagon prior to the 
feeding window (Díaz-Muñoz et al. 2000). Furthermore, assessment of redox markers 
(lactate, pyruvate, β-hydroxybutyrate and acetoacetate) saw an oxidised profile, which 
reverted to control levels following the ingestion of food (Díaz-Muñoz et al. 2000).  
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Time restricted feeding was found to overcome the metabolic consequences of simulated 
shift work in rodents (Salgado-Delgado et al. 2010; Barclay et al. 2012). One study looked at 
the effects on metabolism when food was either ad libitum, restricted to the light phase or 
to the dark phase in rats either undergoing a protocol mimicking shift work or their non-
working controls (Salgado-Delgado et al. 2010). Glucose rhythms peaked at the transition 
between the light to dark phase in non-shift working animals, but rhythms were abolished in 
the rats undergoing the model of shift work, unless food was restricted to the dark phase 
(Salgado-Delgado et al. 2010). Triglyceride rhythms were found to respond to food timing as 
they peaked in the dark phase for control ad libitum, control dark-phase fed and shift 
working dark-phase fed rats, but peaked in the light phase for control light-phase fed, shift 
working ad libitum and shift working light-phase fed rats (Salgado-Delgado et al. 2010). A 
different study simulating shift work in mice by timed sleep restriction (TSR) found changes 
in the liver transcriptome and metabolism as a result of shift work (Barclay et al. 2012). 
However, when animals experienced TSR and food was restricted only to the night phase, as 
opposed to TSR and ad libitum feeding, peripheral clock and metabolic disruption was 
prevented and resembled control mice with no TSR (Barclay et al. 2012). These studies 
highlight the role timed feeding may have on synchronising peripheral clocks and preventing 
adverse outcomes. 
Time-restricted feeding was also found to overcome the adverse health effects of eating a 
high-fat diet in mice (Hatori et al. 2012; Sherman et al. 2012). Restricting the consumption 
of a high-fat diet to 8 hours in the dark phase was found to reduce weight gain, maintain 
glucose tolerance and decrease hepatic steatosis, when compared with high-fat ad libitum 
controls (Hatori et al. 2012). Restricting food to the light phase still found that body weight 
was reduced in the time-restricted high-fat group compared with the ad libitum high-fat 
group (Sherman et al. 2012). Although this study did not have a normal chow control (only 
low-fat chow) or a dark phase restricted feeding group, they showed that glucose 
intolerance was reduced when high-fat diet was time-restricted compared the ad libitum 
control (Sherman et al. 2012). These studies highlight how meal timing, not just meal 
composition, may affect metabolic disease development and progression. 
The effect of meal timing on human weight loss effectiveness was studied in a 
Mediterranean population (Garaulet et al. 2013). Those who consumed their main meal 
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(lunch in this population) at a later time of day lost less weight over the 20-week 
observation period (Garaulet et al. 2013). Furthermore, assessment of energy expenditure 
and glucose in healthy females found that late lunch eaters (16:30) had lower respiratory 
quotient pre-meal than early lunch eaters (13:00); this indicated that the late lunch eaters 
had lower glucose utilisation (Bandín et al. 2015). Furthermore, after consumption of lunch, 
the later lunch eaters had a larger postprandial area under the curve for glucose than the 
early lunch eaters (Bandín et al. 2015). 
A different study found obese woman having a higher calorie breakfast lost more weight 
than those having a higher calorie dinner when both groups were on a calorie controlled 
diet; lunch was the same calorific content in both groups (Jakubowicz et al. 2013). 
Furthermore, fasting glucose and insulin decreased in both groups compared with baseline, 
but more so in the larger breakfast group (Jakubowicz et al. 2013), whilst triglyceride 
decreased in the larger breakfast group, but increased in the larger dinner group compared 
with baseline (Jakubowicz et al. 2013). These studies looked at the effect of when food is 
consumed on metabolic and health markers. Although meal timing has been shown to effect 
the phase of peripheral clock rhythms in rodents, it is not well understood if food has the 
potential to act as a zeitgeber to the human circadian timing system. 
One study looked at how a single high carbohydrate (75%) meal given either in the morning 
(08:30 to 09:00) or evening (21:30 to 22:00) under normal light/dark conditions affected the 
phase of core body temperature (CBT), heart rate and melatonin rhythms in humans 
(Kräuchi et al. 2002). They found that morning meals phase advanced CBT by an hour 
compared with evening meals, and a similar phase advance of 45 minutes was seen with 
heart rate (Kräuchi et al. 2002). Melatonin rhythms were not shifted, which was concurrent 
with animal studies, but there was a decrease in rising concentration after the evening meal 
(Kräuchi et al. 2002); a sleep episode did not allow for sampling of the melatonin peak. 
Although this study showed that meal timing was able to phase-shift some circadian 
rhythms in humans, the single meal intake would have resulted in large periods of fasting 
that may have confounded the results. In addition, the high carbohydrate meal and the 
single meal did not fully represent the meal patterns of free-living people. 
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A study focussing on leptin found that meal timing was capable of shifting the rhythm in 
humans (Schoeller et al. 1997). Under diurnal conditions, meals were delayed from baseline 
by 6.5 hours for 3 days, and this caused a delay of approximately 5 hours to the leptin 
rhythm (Schoeller et al. 1997). However, this study did not assess phase under constant 
conditions and only focused on leptin, using cortisol as the central clock marker (Schoeller et 
al. 1997). Therefore, further work is needed to clarify the effect of meal timing on circadian 
rhythms in humans. 
To summarise, the need for synchronisation of our internal circadian rhythms to the 
external environment is essential for the fitness of an individual. Desynchrony, be it external 
or internal, leads to maladaptive metabolic responses, which over prolonged periods of time 
result in adverse health outcomes. Exposure to appropriately timed zeitgebers will help to 
reduce this desynchrony, but little is known about how nonphotic zeitgebers affect the 
human circadian system. Based on animal data, food could potentially be an alternative to 
the dominant photic zeitgeber in humans, with a focus on synchronising peripheral clocks. 
Understanding the effect food has on peripheral clock rhythms, as well as identifying key 
circadian rhythmic genes in metabolic tissues, may provide a treatment of circadian 
desynchrony. 
1.6 Aims and Hypotheses  
 
The aims of this thesis are to identify if food is a zeitgeber to the human circadian system, 
when food is administered either as a pulse or as meals. In addition, this thesis aims to 
identify circadian transcripts in a novel human tissue, subcutaneous adipose tissue, to gain 
insight into circadian regulation of a human metabolic tissue. 
To investigate whether food is a zeitgeber to the human circadian system, participants will 
be given a food pulse whilst undergoing an ultradian routine outside the range of 
entrainment (Burgess et al. 2008; Burgess et al. 2010; Revell et al. 2012). Using a 4-hour 
ultradian sleep/wake cycle routine under dark/dim light conditions participants will receive 
meals every 2 hours, with one meal representing 50% of their caloric needs. This meal will 
be received at the same time every 24 hours for 72 hours. As the food pulse will be given at 
one-of-six possible meal times following a sleep episode, groups of individuals will be used 
to determine the response of the circadian system to food across the circadian period.  
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Circadian rhythms in each participant will be assessed under a controlled 25-hour constant 
routine before and after the food pulse intervention. This will identify phase shifts to 
rhythms as a result of food, and the direction and magnitude can then be correlated to the 
time of the food pulse to produce a PRC. The hypothesis for this study is as follows: 
(1) Food, when given as a pulse, acts as a synchroniser to peripheral clocks of the 
human circadian system, producing a PRC similar to that of other nonphotic 
zeitgebers. This would be a phase advance of rhythms when administered in the 
early evening, and a delay of rhythms when given in the early morning.  
To determine if food has the ability to affect the circadian system when administered as 
meals under entrained conditions, a delayed food intervention will be conducted. Three 
meals, representing breakfast, lunch and dinner will be given under 2 schedules: early (0.5, 
5.5 and 10.5 hours after wake) and delayed (5.5, 10.5 and 15.5 hours after wake). Both food 
schedules will be given under the same fixed light/dark and sleep/wake cycle. Rhythms will 
be assessed in a controlled 37-hour constant routine following exposure to each meal 
schedule. The hypothesis for this study is as follows: 
(2) When timing of meals is delayed under fixed light/dark and sleep/wake cycles, 
peripheral clock rhythms will phase delay, whilst those of the central pacemaker 
remain unchanged and fixed to the light/dark cycle. 
Finally, using a technique developed by our group for serial sampling of subcutaneous 
adipose biopsy in humans (Otway et al. 2011), the transcriptome of this tissue will be 
assessed for circadian transcripts. Following strict entrainment conditions, where 
sleep/wake, light exposure and meal timing was controlled for 10 days, subcutaneous 
adipose tissue will be taken under controlled constant conditions. The hypothesis for this 
study is as follows: 
(3) Subcutaneous adipose tissue taken under constant conditions exhibit circadian 
transcripts, including both core clock genes and transcripts associated with key 
physiological functions of the tissue. 
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2 MATERIALS AND METHODS 
 
Two clinical trials were carried out to determine whether food could be a zeitgeber to the 
human circadian system. The first of the studies, the food pulse trial (section 2.3.1), gave a 
meal representative of 50% of an individual’s daily caloric need under an ultradian cycle 
(less than a day) in order to produce a phase response curve of the human circadian system 
to food (Figure 2.1 and Figure 2.2). The second trial, the food delay trial (section 2.3.2), used 
a 3 meal schedule under a normal 16:8 light/dark and sleep/wake cycle to determine if a    
5-hour delay to only the meal schedule, but nothing else, would phase shift the circadian 
system (Figure 2.3). Within the food delay trial, another objective was to determine and 
characterise if subcutaneous adipose tissue exhibited circadian rhythmicity in its 
transcriptome. 
2.1 Recruitment and Screening 
2.1.1 Food pulse trial screening 
 
All procedures were reviewed and received a favourable ethical opinion from the University 
of Surrey Ethics Committee (EC/2011/FHMS/62) and were approved by the London–
Hampstead Research Ethics Committee (12/LO/0075). The study was conducted in 
accordance with the principle of the Declaration of Helsinki. All participants were given a 
detailed explanation of the study aims and protocol and gave written informed consent 
prior to any procedures being undertaken.  
Advertisements for the study were circulated in various forms including posters, emails, 
newspaper advertisements, websites and the Surrey branch of the Primary Care Research 
Network. Participants were either directed to the study website to fill in an online form or 
underwent a telephone recruitment script to assess their general eligibility. If eligible, they 
were invited for a formal screening at the University of Surrey where a member of the 
research team explained the study and received and witnessed written informed consent 
from the participant. Participants then filled in study questionnaires where they needed to 
fulfil the following inclusion criteria: 
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 Male  
 Aged between 18-30 years 
 Body mass index (BMI):  ≥19kg/m2 and ≤30kg/m2 
 Scored appropriately on validated sleep and well-being questionnaires; 
o Horne-Östberg diurnal preference questionnaire: ≥30, ≤70, (Horne & Ostberg 
1976) 
o Pittsburgh Sleep Quality Index: ≤5, (Buysse et al. 1989) 
o Beck Depression Inventory: <8, (Beck & Beamesderfer 1974; Beck et al. 1974) 
o Epworth Sleepiness Scale: <10, (Johns 1991; Johns 1992) 
o Munich Chronotype Questionnaire (Roenneberg et al. 2003); sleep, wake 
times and average sleep on workdays   
 Habitual sleep time between 22:00 and 01:00 and wake time between 
6:00-09:00 for 5 nights a week 
 Sleep duration between 7 and 9 hours. 
 Have not undertaken shift work in the 6 months prior to the study. 
 Have not crossed more than 2 time zones in the month prior to the study. 
 Have no medical history which indicated a sleep disorder or metabolic disease. 
If the inclusion criteria were met by participants they were invited to attend the Surrey 
Clinical Research Centre (SCRC) for a medical screening. As part of the medical screen, each 
participant’s vital signs were checked by taking an electrocardiogram and measuring their 
blood pressure, heart rate, oral temperature and respiration rate. They were tested for 
drugs of abuse such as opiates and underwent an alcohol breath test and a cotinine (a 
metabolite of nicotine) test; if any of these tests came back positive, they were excluded. A 
full blood and biochemistry screen was conducted to assess health, and blood was screened 
for diseases such as HIV and Hepatitis B and C. In addition, participants were weighed to 
check that BMI criteria were still met and any medication they were taking was reviewed to 
ensure study results would not be affected.  
2.1.2 Food delay trial screening 
 
All procedures were reviewed and received a favourable ethical opinion from the University 
of Surrey Ethics Committee (EC/2013/42/FHMS) and the study was conducted in accordance 
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to the principle of the Declaration of Helsinki. Advertisement of the study was conducted in 
the same way as for the food pulse trial (section 2.1.1) with the exception that the Primary 
Care Research Network was not used as it had failed to recruit any participants for the food 
pulse trial. Eligible participants were invited for a formal screening and were required to 
fulfil the same inclusion criteria as for the food pulse trial, with the addition of: 
 Fat mass >14% for inclusion 
All exclusion criteria also remained the same as for the phase delay trial (section 2.1.1). 
2.2 Pre-study Environmental Entrainment Protocol 
2.2.1 Food pulse trial environmental entrainment 
 
Participants underwent two separate laboratory study sessions that consisted of the control 
session and the food pulse session (Figure 2.1 and Figure 2.2, respectively). The order of the 
sessions was randomised between participants to remove bias. Due to the study requiring 
separate sessions, a strict pre-study environmental entrainment protocol was undertaken 
by participants to optimise circadian entrainment prior to the laboratory sessions and to 
minimise variation between the two study periods. The pre-study protocol was completed 
in the 10 days prior to the study in both instances, and the conditions remained the same. 
Ten days prior to the study session, participants were instructed to select a sleep time 
between 22:00 and 01:00 and wake time between 06:00 and 09:00 that closely matched 
their habitual sleep-wake time; this was their sleep and wake time for the entirety of both 
pre-study sessions. A 4-hour nap window was allowed, with the middle of the nap window 
occurring 12 hours after the midpoint of their sleep period. Additionally, participants were 
required to obtain 15 minutes of unobstructed natural light exposure within 1.5 hours of 
wake, although this did not need to be consecutive.  
Participants were given two L-actiwatches (Cambridge Neurotechnology, Cambridge, 
Cambridgeshire, UK) that measured movement and light exposure at 1 minute epochs, 
which were worn on the neck and wrist. Actiwatches objectively assessed each participant’s 
compliance to the sleep and wake times and light exposure criteria. Actiwatches were 
checked at regular intervals prior to the onset of the laboratory sessions and participants 
also had to call a time-stamped voice mail within 10 minutes of their selected sleep and 
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wake time. The participants also maintained a sleep diary to report sleep and wake times, 
quality and disturbances to sleep, time when light exposure was obtained and any instances 
when actiwatches were removed. 
Seven days prior to the study session, restrictions were placed on when participants could 
consume food. Participants would eat their breakfast within 90 minutes of waking, their 
lunch between 12:00 and 14:00 and dinner between 18:00 and 21:00. The food consumed 
was noted in a diet diary provided by the research team. Physical activity was also noted 
using the Borg scale to assess the perceived exertion. Caffeine intake was restricted to no 
more than 300mg in a day and alcohol to 2 drinks a day.  
Seventy-two hours prior to the laboratory session, participants were provided with food by 
the research team to have for their meals. Snacks and drinks that were naturally free from 
caffeine were also provided. Participants were also allowed to consume up to 5 portions of 
fruit and vegetables of their choice per day. Food was consumed in the time windows 
previously mentioned and was noted in the diet diary. Participants were instructed not to 
undertake any strenuous exercise in the 72 hours prior to the laboratory session, as well as 
to abstain from caffeine and alcohol.  In order to remove variation between the two pre-
study sessions, the diet and activity diary from the first session was copied and given to 
participants to follow for the second session. 
2.2.2 Food delay trial 
 
The pre-study environmental entrainment protocol was similar to that of the food pulse trial 
protocol, but with a few key alterations. Firstly, only one pre-study environmental 
entrainment took place as participants only had one laboratory session. The selection and 
monitoring of the sleep/wake cycle, and light exposure conditions remained the same as 
described in section 2.2.1. Seven days prior to the study, participants were asked to restrict 
the time they ate their meals to the following: breakfast 30 minutes after waking up, lunch 5 
hours after breakfast and dinner 5 hours after lunch. These times were selected to be the 
same as the meal times they would experience in the first 3 days of the laboratory protocol 
(Figure 2.3). Caffeine intake was restricted to no more than 100mg in the first 3 hours after 
waking up, and a maximum of 2 alcoholic drinks a day was permitted. Diet diaries were used 
by the participants to document the time at which they ate and the food that they 
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consumed. They were also asked to note down their activity and their perceived level of 
exertion using the Borg scale.   
Seventy-two hours prior to the laboratory study, participants were given food by the study 
team which would closely resemble the food they would consume during the study. 
Participants were required to keep to the meal schedule detailed above. In addition, they 
were not allowed to consume any caffeine or alcohol, and were asked to refrain from any 
heavy exercise. 
2.3 Study Protocol 
2.3.1 Food pulse trial 
 
Participants were invited to the SCRC where their actiwatches were assessed by the post-
doctoral researcher. This allowed for an objective assessment of their compliance to the 
pre-study environmental entrainment protocol, and any participants who had failed to 
comply were not accepted onto the laboratory session. On day 0 (Figure 2.1 and Figure 2.2) 
participants had a final medical assessment where alcohol levels, drugs of abuse and 
cotinine were examined to ensure they were still eligible. They had an interstitial glucose 
monitor (Medtronic, Minnesota, USA) fitted which would record continuous glucose levels 
for the duration of the laboratory session. Following this, participants were given a standard 
evening meal and allowed to adapt to their surroundings; they went to bed in individual 
sleep laboratories at their selected sleep time that had been kept for the pre-study session 
(Figure 2.1 and Figure 2.2). This procedure upon entering the SCRC was identical to both 
study sessions which consisted of either the control protocol or food pulse protocol. 
2.3.1.1 Food pulse trial – control protocol 
 
On day 1 (Figure 2.1), participants underwent the first 25-hour constant routine. In the 
constant routine, participants remained isolated in their individual sleep laboratory under 
strict and controlled conditions (Duffy & Dijk 2002). The participants remained in bed, in a 
semi-recumbent position, and awake for the entire duration in dim light (<8 lux) conditions. 
They were given isocaloric meals every 2 hours that represented 1/12th of their daily caloric 
intake and meals were tailored to their individual energy requirements based on the 
Schofield equation (Schofield 1985). The Schofield equation is a way of calculating an 
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individual’s estimated energy requirement based on an individual’s weight (kg), age and 
level of activity and will be discussed further in section 2.4.  
Hourly blood sampling occurred during the constant routine with 1.25ml blood being 
collected into pre-coated tubes containing the anticoagulant di-potassium 
ethylenediaminetetraacetic acid (K2-EDTA) (Teklab, Durham, UK). Two and a half millilitres 
of blood was also collected into PAXgene tubes (PreAnalytiX, Hombrechtikon, Switzerland). 
Saliva samples were taken hourly, but around the time of dim light melatonin onset (DLMO) 
at approximately 19:00 hours, they were taken every 30 minutes for 5 hours. Prior to every 
meal, mood, alertness, sleepiness and appetite were assessed through a series of validated 
questionnaires. Finally, subcutaneous adipose tissue biopsies from the upper gluteal region 
(Otway et al. 2011) were collected every 6 hours throughout the constant routine, with up 
to 500mg tissue being taken per biopsy. 
Following the first constant routine, participants underwent a 3-day ultradian routine, which 
consisted of 2.5 hours awake in light (<50 lux) and 1.5 hours sleep opportunity in 0 lux 
(Figure 2.1). Saliva samples were taken and subjective questionnaires were answered every 
2 hours followed by a meal that was consumed in their individual sleep laboratory room. 
Participants were kept in their room for 30 minutes whilst completing the questionnaire and 
consuming the food. These meals all represented 1/12th of the daily caloric intake needed 
by the individual. Following the ultradian routine, participants underwent another 25-hour 
constant routine, with the same sampling and conditions as previously stated. They then 
had a recovery sleep for 8 hours before being discharged from the SCRC. 
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2.3.1.2 Food pulse trial – food pulse protocol 
 
All aspects of the food pulse protocol were the same as the control protocol, described in 
section 2.3.1.1, except for the ultradian cycle. As described previously in section 2.3.1.1, the 
ultradian routine comprised of 2.5 hours awake in light <50 lux, followed by 1.5 hours asleep 
in 0 lux. Participants gave a saliva sample and completed questionnaires prior to receiving 
food every 2 hours.  For one of the meal times that occurred after the sleep episode, 
participants were given 50% of their entire daily caloric intake in one meal (Figure 2.2). This 
meal was administered at the same time across the 3-day ultradian routine, but the 
participant may have received this meal at one of the following times: 08:40, 12:40, 16:40, 
20:40, 00:40 or 04:40. The other 11 meals represented 1/22nd of the daily caloric intake 
required by the individual. Participants remained in their individual rooms for 30 minutes to 
consume the meal. 
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2.3.2 Food delay trial 
 
Participants entered the SCRC on day 0 (Figure 2.3) and their actiwatches were objectively 
assessed by the post-doctoral researcher for their compliance to the sleep, wake and light 
exposure schedule. A failure to comply meant that participants were not accepted into the 
trial session. Participants received a standard meal and went to bed in individual sleep 
laboratories at the same time as they had selected during the pre-study environmental 
entrainment protocol. 
On days 1 to 3 of the protocol participants maintained the same sleep and wake times and 
ate 3 isocaloric meals under the same schedule (breakfast: 0.5hr, lunch: 5.5hr and dinner 
10.5hr after wake) as during the pre-study environmental entrainment protocol (section 
2.2.2). All meals had the same macronutrient and caloric composition, and the breakfast 
meal, lunch meal and dinner meals were the same throughout the protocol. All meals were 
eaten in individual sleep rooms in the presence of a light box. A fourth period in the 
individual rooms in the presence of a light box was also conducted to account for the 
difference in meal timing (15.5 hours after wake during days 1-3, and 0.5 hours after wake 
for days 6-11) and to keep light exposure consistent. Participants were allowed to move 
around when not eating, but no strenuous activity was permitted. All meals were calorie 
adjusted to meet the individual energy requirements of the participant. This was calculated 
using the Schofield equation and will be discussed in more detail in section 2.4.  
Over days 4 and 5 participants underwent a 37-hour constant routine, with conditions the 
same as described in section 2.3.1.1. During the constant routine, participants were given a 
subjective questionnaire, which preceded each hourly isocaloric meals. Sampling during the 
constant routine began after 5 hours into constant conditions to eliminate any run-in effects 
and consisted of hourly blood sampling and 5 x 6-hourly subcutaneous adipose tissue 
biopsies from the upper gluteal region.  
Following the constant routine, participants underwent 6 days with the same conditions as 
days 1 to 3, but with all meals delayed by 5 hours (breakfast: 5.5hr, lunch: 10.5hr and 
dinner: 15.5hr after wake); no other parameters changed. Following these 6 days, 
participants underwent a second constant routine with the same conditions and sampling as 
the previous constant routine followed by a recovery sleep then a medical discharge. 
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Figure 2.3: Delayed food laboratory protocol. Participants attended the clinical research centre on day 0 where they 
were assessed for their compliance to the pre-study environmental entrainment protocol. They received their dinner 
10.5 hours after wake and went to sleep at the same time as that chosen for the pre-study protocol. For the next 3 days 
(days 1-3) participants maintained the same sleep (0 lux) /wake (>500 lux) time as during their pre-study protocol and 
received 3 isocaloric meals, with breakfast being 0.5 hours, lunch 5.5 hours and dinner 10.5 hours after wake. The 
content of the breakfast meal, lunch meal and dinner meal remained the same throughout the entire protocol. 
Following the 3 sleep/wake days, participants underwent a 37-hour constant routine (awake, dim light <8lux, semi-
recumbent, hourly isocaloric meals, social isolation) where sampling of the circadian system took place. Prior to every 
hourly meal, subjective questionnaires relating to mood, alertness, sleepiness and appetite were taken. Hourly blood 
samples were collected into lithium heparin tubes for the assessment of the central hormonal markers, melatonin and 
cortisol. Blood was also collected hourly into potassium (K2) – EDTA tubes for assessment of insulin and biochemical 
molecules glucose, triglycerides and non-esterified fatty acids. Blood was collected 2 hourly into PAXgene tubes for 
assessment of RNA expression. Finally, subcutaneous adipose biopsies were taken at 6-hourly intervals for qPCR and 
microarray analysis. Sampling took place over a 32-hour period (hour 5 to 37 of constant routine) to remove any run in 
effects of the constant routine. Following the constant routine, all conditions remained the same as days 1-3 
(sleep/wake timing, light exposure, meal content and activity level) but all meals were delayed by 5 hours. Breakfast 
occurred 5.5 hours, lunch 10.5 hours and dinner 15.5 hours after wake. The delayed meals intervention was for 6 days 
(days 6-11) and following this, participants underwent a second 37-hour constant routine. Conditions and sampling 
remained the same as stated above, except that adipose tissue for RNA expression was only used for qPCR analysis. 
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2.4 Study food 
 
The diet used in both clinical trials was designed by Cheryl Isherwood. The food was 
selected to reflect a typical macronutrient intake of men in the UK and the macronutrient 
composition was calculated using data from the national diet and nutrition survey (2011) 
and dietary reference values. This was done by taking an average was taken between self-
reported food intake from the national diet and nutrition survey, and governmental 
guidelines from dietary reference values for men aged 19-64 years. In addition, the diet 
ensured that 5 portions of fruit and vegetables were incorporated. The macronutrient 
composition selected was 55% carbohydrates, of which 15% were sugars, 15% protein and 
30% fat, of which 11% was from saturated fat. 
The calorie requirement for each individual was determined using the Schofield equation for 
men aged between 18 and 29 years (Equation 2.1). Using the participant’s weight in 
kilograms, the basal metabolic rate (BMR) was calculated then multiplied by an activity 
factor. During a constant routine when participants were bedbound, the BMR was 
multiplied by 1.15. For the non-constant routine laboratory days when participants were 
allowed to move around the ward, BMR was multiplied by 1.2. 
                              
    
   
                                       
Equation 2.1: Schofield equation calculating estimated energy requirement (kcal/day) required by male participants 
aged between 18-29 years. W indicates the weight of the individual in kilograms, and SEE is the standard error of 
estimation, an adjustment value within the confidence limit; no adjustments were made. The activity factor multiplies the 
basal metabolic rate calculation (bracketed) by a factor to add kilocalories based on the intensity of activity.  
2.4.1 Food pulse trial food 
 
There were several components to the study meal, all of which could be adjusted to meet 
individual caloric needs. The study meal consisted of pasta quills with a blended vegetarian 
meat substitute in a tomato and mixed vegetable sauce, a homemade fruit yogurt made 
with plain yogurt, frozen forest fruits and enriched with fat (vegetable oil and double cream) 
and protein powder (pea protein), and a wafer biscuit. This was the only food given at meal 
times throughout the study and thus each meal had the same macronutrient proportion 
irrespective of serving size. Participants were given 200ml of water every 2 hours 
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throughout the study to avoid a large bolus volume from being delivered to the stomach. 
More water could be requested by the participants, which was noted by clinical staff. 
2.4.2 Food delay trial food 
 
The meals given during the study differed between the sleep/wake cycle days and during 
the constant routine, but always had the same macronutrient composition. During the 
sleep/wake days, participants received 3 isocaloric meals which contained a liquid 
component which could be adjusted to meet the individual caloric needs. Each meal was 
also tailored to represent a “typical” breakfast, lunch and dinner option. The breakdown of 
each meal can be found in Table 2.1. 
 
  Meal Menu   
  
Breakfast 
Cornflake Cereal, 2 x White Sliced Bread (toasted), 
Butter, Strawberry Jam, Smooth Peanut Butter, 
Satsuma, Enriched Milk   
  
Lunch 
Chargrilled vegetable and hummus sandwich, Apple 
and Grape Snack Pot, Walkers Ready Salted Crisps, 
White Cheddar Portion, Enriched Leek and Potato 
Soup   
  
Dinner 
Quorn Cottage Pie, Steamed Carrots, Broccoli and 
Sweetcorn, Walkers Shortbread Rounds, 2 x Sherbet 
Lemons, Enriched Yogurt   
 
Table 2.1: Breakdown of the menu for each meal given during the sleep/wake days for the food delay trial. For every 
breakfast, lunch and dinner meal given during the food delay trial, participants would have the detailed menu. In order to 
adjust for individual caloric needs as calculated by the Schofield equation, one or more components of the meal could be 
adjusted (highlighted in bold). 
 
During the constant routine, participants were given an hourly isocaloric snack which 
consisted of a small sandwich, containing Quorn chicken slices and Primula cheese spread, 
and an enriched milkshake. Participants were given 100ml of water every hour throughout 
the study to avoid a large bolus volume from being delivered to the stomach. More water 
could be requested by the participants, which was measured by clinical staff. 
2.5 Subjective Measures 
 
Questionnaires were given to participants prior to each meal during the laboratory sessions 
of both clinical trials. Participants circled the most appropriate response in the 9-point 
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Karolinska sleepiness scale (Akerstedt & Gillberg 1990), assigned a discrete number between 
1 and 9 to questions in the mood and alertness questionnaire (Lockley et al. 2008), and put 
a strike through a line between 2 opposite extremes for the visual analogue scales for 
appetite (Flint et al. 2000). The visual analogue scales asked the same 8 questions (Table 
2.2) in a randomised order. After completion, the date and time was entered on the 
questionnaire. 
Manual measuring of the visual analogue scales was done with a ruler with 1mm 
increments, with 0mm placed at the left hand side (negative extreme) and all values 
measured left to right. Values were expressed as a percentage of the scale length. 
Visual Analogue Scale Questions 
Assessing Appetite 
Negative Extreme  
(Left hand side) 
Positive Extreme 
 (Right hand side) 
How hungry do you feel? I am not hungry at all 
I have never been more 
hungry 
How much do you think you can 
eat? 
Nothing at all A lot 
How full do you feel? Not at all full Extremely full 
How thirsty do you feel? Not at all thirsty Extremely thirsty 
Would you like to eat something 
sweet? 
No, not at all Yes, very much 
Would you like to eat something 
salty? 
No, not at all Yes, very much 
Would you like to eat something 
savoury? 
No, not at all Yes, very much 
Would you like to eat something 
fatty? 
No, not at all Yes, very much 
Table 2.2: Visual analogue scale appetite questions. 
 
2.6 Whole Blood RNA Extraction 
 
Whole blood (2.5ml) was collected directly into PAXgene Blood RNA tubes (PreAnalytiX) 
containing an RNA stabilising solution. Samples were mixed by inversion and incubated at 
room temperature for 4 hours, before being frozen at -20°C. Upon processing, samples were 
thawed for 1 hour at room temperature and inspected for volume and blood clots, before 
RNA was extracted using the PAXgene Blood RNA Kit (Qiagen, Hilden, Germany) and a 
QIACube (Qiagen). Instructions for total RNA extraction were followed as per the 
manufacturer’s handbook with the following amendments: samples were initially 
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centrifuged at 2,500g for 15 minutes at 18°C before the supernatant was removed. Four 
millilitres of RNase-free water was added, and samples were vortexed on full power, twice, 
for 50 seconds. Samples were centrifuged again and the supernatant removed. Pellets were 
resuspended by manual pipetting rather than vortexing as suggested in the handbook. 
Following this, samples were placed in the QIACube with the provided reagents and 
automated RNA extraction occurred, including the optional on-column DNase step. Isolated 
RNA was stored at -80°C until complementary DNA (cDNA) synthesis. Please note that RNA 
from the food delay study was extracted by Mohammed Muse. 
2.7 RNA Quantification and Quality Control 
2.7.1 RNA quantification 
 
All RNA samples were quantified using a NanoDrop 2000 spectrophotometer (Thermo 
Scientific, Massachusetts, USA) with the concentration given as nanograms per microlitre. 
Purity of the samples was determined from the A260/280nm and A260/230nm ratios provided, 
where a value of 2 was desired to indicate minimal contamination.  
2.7.2 Quality control 
 
RNA quality was evaluated by using the Agilent 2100 Bioanalyzer (Agilent Technologies, 
California, USA) with the RNA 6000 Nano Kit (Agilent Technologies). A selection of samples 
from each constant routine (approximately 15% of all samples) was placed on the lab-on-a-
chip technology as per the RNA 6000 Nano Kit Handbook. An RNA integrity number (RIN) 
between 0 and 10 was generated by the Bioanalyzer, where 0 indicated completely 
degraded RNA and 10 demonstrated perfectly intact RNA. On average, samples had a RIN of 
8.5 ± 0.95 (mean ± SD) and a RIN of >6 was required for quantitative polymerase chain 
reaction (qPCR). 
2.8 Complementary DNA Synthesis  
2.8.1 Whole blood RNA 
 
Following RNA quantification, all RNA samples were converted to cDNA using the 
AffinityScript multiple temperature cDNA synthesis kit (Agilent Technologies). cDNA was 
synthesised according to the instructions in the kit’s manual.  
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In brief, total RNA was first diluted to a concentration of 25ng/µl using RNase-free water 
(Qiagen). 200ng of total RNA was added to a reaction containing 0.3µg of random primers 
that were provided by the kit. The reaction was made up to 15.7µl using RNase-free water 
and incubated for 5 minutes at 65°C. The reaction was cooled for 10 minutes at room 
temperature before the addition of 1X AffinityScript RT buffer, 4mM of dNTPs (1mM of each 
dNTP), 20U of RNase block ribonuclease inhibitor and 25U of AffinityScript multiple 
temperature reverse transcriptase enzyme.  
Samples then underwent incubations of 25°C for 10 minutes, 42°C for 60 minutes and 70°C 
for 15 minutes. Samples were then frozen at -20°C until qPCR was performed. 
2.8.2 Adipose tissue RNA 
 
RNA was extracted from adipose tissue by Dr Sophie Wehrens. Adipose tissue was cut into 
pieces weighing a maximum of 30mg. RNA was extracted using the RNeasy mini kit (Qiagen) 
and an automated procedure in the QIAcube. In brief, adipose tissue was suspended in 
Buffer RLT containing 10µl of β-mercaptoethanol (β-ME) per 1ml. The tissue was then 
disrupted using the TissueLyser II (Qiagen) set at 4°C at 30Hz for two minutes, twice, turning 
the adaptor plates by 180° in between. The lysate was transferred to the QIAcube where a 
customized protocol was carried out (Protocol ID3340), which included an on-column DNase 
digestion step and a double elution step to increase yield. 
cDNA was created to test the relative gene expression of PER2. The same protocol was 
followed as in section 2.8.1 with the following alterations: 100ng of RNA was used and 
added directly into the reaction without a previous dilution being made. One hundred 
nanograms of sample was used due to the adipose RNA extraction having a lower yield, but 
was still within the recommended range given by the kit. 
2.8.3 Positive and no reverse transcriptase controls 
 
Positive and no reverse transcriptase (no RT) controls were created to be used during the 
qPCR experiments. The positive controls were made by pooling RNA samples from 1 
individual to create a stock of 50ng/µl large enough for all reactions. The same principle was 
used to create the no RT controls. The samples used are listed below (Table 2.3).  
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Trial Positive Control Samples 
No Reverse Transcriptase 
Samples 
 
FAB28 FAB31 
Food Pulse Session 1, Constant Routine 2 Session 1, Constant Routine 2 
 
14:00, 04:00, 06:00, 12:00 20:30, 22:30, 02:30, 04:30, 06:30 
 
FAB6b FAB6b 
Food Delay Constant Routine 2 Constant Routine 2 
  21:10 21:10 
Table 2.3: Identification of samples used to create positive and no reverse transcriptase controls. 
 
Positive cDNA controls were made in the same way as the samples, with no changes to the 
protocol. The no RT cDNA controls had the 25U of AffinityScript multiple temperature 
reverse transcriptase enzyme replaced with 1µl of RNase-free water, but no other changes 
were made. Samples were stored at -20°C until required.  
2.9 Polymerase Chain Reaction and Electrophoresis 
2.9.1 Polymerase chain reaction 
 
The quality of the cDNA synthesised was assessed by polymerase chain reaction (PCR), using 
a selection of samples and primers designed to amplify PER3. One microlitre of cDNA was 
added to a reaction mix containing 1X GoTaq® G2 hot start green master mix (Promega, 
Wisconsin, USA), 1µM of the forward QPER3F primer and 1µM of the reverse QPER3R 
primer (Sigma Aldrich, Missouri, USA) (Table 2.4). RNase-free water was added to make 
each reaction to a final volume of 20µl (Qiagen). A negative sample was also created which 
replaced 1µl of cDNA with 1µl of RNase-free water. Each reaction then underwent 
thermocycling (Table 2.5).  
 
 
  
Oligo 
Name 
Melting 
Temperature (°C) 
Sequence 
  
 
QPER3F 67.4 5’-GGTCGGGCATAAGCCAATG-3’ 
   QPER3R 64.9 5’-GTGTTTAAATTCTCCGAGGTCAAA-3’   
 
Table 2.4: Sequence of primers used for cDNA quality assessment. 
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  Denaturation Annealing Extension 
  
 
95°C 95°C 60°C 72°C 72°C 
 
 
3 minutes 30 seconds 30 seconds 30 seconds 5 minutes 
 
  40 cycles 
  
     Table 2.5: Thermocycling conditions for polymerase chain reaction. 
 
2.9.2 Electrophoresis 
 
The PCR products were visualised via electrophoresis. A 2% agarose-TAE (40mM Tris base, 
20mM glacial acetic acid and 1mM EDTA) gel with 1X of Gel Green (Web Scientific, Cheshire, 
UK) per 100ml was cast. The gel was allowed to cool and set and, just prior to 
electrophoresis, was submerged into the tank containing the TAE buffer.  
Five hundred nanograms (100ng/µl) of the φX174 DNA/Hae III marker (Promega) containing 
blue/orange 6X loading dye, was loaded next to the PCR products and the gel was run at 
12V/cm. When the PCR products had run halfway down the gel, visualised by the position of 
the yellow loading dye contained in the GoTaq® G2 hot start green master mix, the gel was 
removed an placed on a UV light box. Bands were visualised under UV light and an image of 
the gel was taken. 
2.10 Quantitative Polymerase Chain Reaction 
2.10.1 Quantitative polymerase chain reaction 
 
Quantitative polymerase chain reaction (qPCR) was carried out on all cDNA samples using 
the brilliant III ultra-fast qpcr master mix (Agilent Technologies) and the Stratagene 
Mx3005P QPCR system (Agilent Technologies). The qPCR procedure was carried out 
according to the manufacturer’s handbook with optimised conditions. 
In brief, under dark conditions, a mix containing 1X of the brilliant III ultra-fast qpcr master 
mix, 0.375µM of the probe, forward and reverse primer (Table 2.6), 30nM of the provided 
reference ROX dye and RNase-free water was made to a volume of 19.25µl per reaction. A 
singleplex mix was made for β-actin (ACTB) (primers and probes from Sigma Aldrich) and 
BMAL1/ARNTL (Sigma Aldrich), whilst a multiplex mix was made containing PER3 (Sigma 
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Aldrich), REVERB-β/NR1D2 (Eurofins Scientific, Luxembourg, Luxembourg) and GR/NR3C1 
(Eurofins Scientific); RNase-free water was adjusted to keep the same reaction volume. 
Gene Oligo Name 
Melting 
Temperature 
(°C) 
Sequence (5’ – 3’) 
Period 
Homologue 
3 
PER3F 67.4 GGTCGGGCATAAGCCAATG 
PER3R 64.9 GTGTTTAAATTCTTCCGAGGTCAAA 
PER3PR 75.0 [6FAM]CCCAGAGACAGCCAGGGATGCTACC[BHQ1] 
Brain and 
Muscle Arnt-
Like Protein 1 
ARNTLF 65.5 AAACCAACTTTTCTATCAGACGATGAA 
ARNTLR 66.0 TCGGTCACATCCTACGACAAAC 
ARNTLPR 73.9 [6FAM]ACCTCATTCTCAGGGCAGCAGATGG[BHQ1] 
Β-Actin 
ACTBF 67.6 GGATCGGCGGCTCCAT 
ACTBR 66.9 TACTCCTGCTTGCTGATCCACAT 
ACTBPR 77.0 [6FAM]TGGCCTCGCTGTCCACCTTCCA[BHQ1] 
Reverse 
Erythroblastosis 
Virus-β 
NR1D2F 55.9 GCTTGCGGAAAATGAGAATTG 
NR1D2R 61.0 AGTGCCTATCTCCCAAGAGGTAAA 
NR1D2P 65.8 [HEX]TGGTGTCCCCAATGCCCCACC[BHQ1] 
Glucocorticoid  
Receptor 
NR3C1F 59.8 CCAGAACCATGGTAGCCTTCA 
NR3C1R 58.4 GAAACTCCACCCAAAGGGTTTA 
NR3C1P 66.5 [CY5]ATTTCCATCTTGGCTGGTCACTCCCTG[BHQ3] 
Period 
Homologue 2 
PER2F 56.7 AAGCCCACATCACATCTCC 
PER2R 57.3 CACTGCACCCCTGAAAATAC 
PER2P 66.5 [FAM]ACTCAGTCTGACAGCTTGCGACTGCAT[BHQ1] 
Table 2.6: Primer and probe sequences used for quantitative polymerase chain reaction experiments. 
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One single mix was made for all experimental reactions for one plate, including those for the 
positive, no RT and no template controls, and was thoroughly mixed by pipetting to reduce 
the introduction of bubbles. Reaction mixes were loaded onto a semi-skirted, clear 96 well 
plate (Agilent Technologies) and 0.75µl of cDNA was added to each reaction well to bring 
the final reaction volume to 20µl. Reactions were mixed by pipetting, sealed (Thermo 
Scientific) and the plate was centrifuged at 1200g for 4 minutes at room temperature. All 
samples and controls were run in triplicate to allow outlier identification. 
Centrifuged plates were placed into the Mx3005P with a gasket to maintain a tight seal. The 
plate then underwent thermocycling (Table 2.7). Please note that qPCR was conducted on 
adipose tissue cDNA for period homologue 2 (PER2) (Eurofins Scientific). Concentrations of 
the qPCR master mix, primers, probes and reference dye remained unchanged, but the 
volume was made to 19µl; this was for both the ACTB and PER2 reaction mix. One microlitre 
of the adipose cRNA was then added to each reaction and the procedure carried out as 
described above. 
  
Annealing - Extension 
  Denaturation Data Collection 
95°C 95°C 60°C 
3 
minutes 15 seconds 20 seconds 
  40 cycles 
  Table 2.7: Thermocycling conditions for quantitative polymerase chain reaction experiments. 
 
2.10.2 Relative expression calculations 
 
Each plate contained a gene of interest (GOI), either BMAL1, the PER3 multiplex or PER2, 
and the normalising gene, ACTB. In addition, the same positive control sample was placed 
on each of the plates that belonged to the same experimental condition, which acted as the 
calibrator sample.  
Having a GOI, a normalising gene (expression remained the same over time) and a calibrator 
sample enabled the calculation of the GOI relative expression (2-ΔΔCT) to the calibrator 
(Equation 2.2).  
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Equation 2.2: Calculating the relative expression of a gene. Where Ct is the threshold cycle, the PCR cycle where the 
fluorescence reaches a defined threshold and crosses the amplification plots during the exponential phase. The ΔΔCT was 
calculated automatically using the MxPro software (Agilent Technologies). 
 
2.10.3 Outlier methodology 
 
Prior to generating the relative expression for each sample, the data needed to be cleaned 
and outliers removed. A standardised procedure was created for the identification and 
removal of outliers. 
For each individual plate, the no RT and no template control were deselected and the 
threshold fluorescence was automatically set by the MxPro software. The fluorescence was 
locked, and all the data (no RT and no template control included) were exported containing 
the cycle threshold (Ct) for each sample and gene. The Ct for all of the ACTB were plotted to 
identify samples that needed to be excluded due to having either a low volume of blood or a 
large clot at the base of the tube, as identified during the RNA extraction phase. These 
samples would be highlighted by having a higher Ct than the rest of the samples in that 
constant routine (Figure 2.4). 
 
 
 
 
 
 
 
To identify outliers, for each technical triplicate the mean Ct was calculated and this value 
was subtracted from the Ct of each replicate within the triplicate. This value represented 
the difference and was turned into an absolute value. The standard deviation was then 
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Figure 2.4: Example plot to identify outliers based on cycle threshold of the housekeeping gene. The cycle threshold for 
time point 02:00 for the second constant routine was far higher (approximately 32) compared to the rest of the samples 
(approximately 20) indicating a 2
12
 difference in RNA level. 
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calculated from the absolute difference values for each gene, using the samples and the 
calibrator value. The calculated standard deviation was multiplied by 2, and any absolute 
differences that were more than this 2 standard deviation value was identified as an outlier. 
These samples were then removed and the software calculated the relative expression using 
the outlier cleaned data. 
2.11 Plasma Glucose, Triglyceride and Non-esterified Fatty Acid 
Quantification 
 
Blood was collected into tubes containing the anticoagulant K2-EDTA (Teklab). Samples were 
inverted 10 times in the tube, cooled and centrifuged at 1,620g at 4°C for 10 minutes within 
30 minutes of collection to separate the plasma portion of the blood. Plasma was then 
stored at -20°C until further analysis. 
Samples were thawed overnight at 4°C prior to measurement in the ILab 650 Clinical 
Analyser (Instrumentation Laboratory, North Risley, Cheshire, UK). Two hundred microlitres 
of plasma were placed into ILab tubes for each assay (Alpha Laboratories, Hampshire, UK) 
and were centrifuged at 10,621g for 4 minutes at 4°C. Following centrifugation, samples 
were placed into the sample carousel on the ILab and tested for either glucose, non-
esterified fatty acids (NEFA) or triglycerides (TAG), and each sample was tested in duplicate. 
NEFA was tested before TAG in the machine due to interference between the assays, and 
different vials were used for the glucose analysis and the NEFA/TAG analysis to minimise 
freeze-thaw effects; 1 vial for glucose and 1 vial for both NEFA and TAG. 
At the start of every experimental run, the ILab was calibrated using standard ReferrIL G 
(Instrumentation Laboratory). In addition to this, quality controls multi-sera level 2 (MSL2) 
and multi-sera level 3 (MSL3) (Randox Laboratories Ltd, Crumlin, Ulster, UK) were run with 
the samples in order to determine assay drift; these were tested in triplicate. The quality 
controls were placed at the beginning and end for the food delay experiment (sample total 
32 aliquots, 64 duplicates) and for the larger food pulse experiment, at the beginning, 
middle and end of the sample run (sample total 52 aliquots, placed after 26 samples which 
was 52 duplicates).  
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2.11.1 Glucose concentration 
 
A colorimetric method for the determination of the glucose concentration (mmol/L) using 
the glucose (oxidase) clinical chemistry kit (Instrumentation Laboratories) was used on the 
ILab. The 2-step enzymatic reaction produced red quinoneimine (Equation 2.3) and the 
absorbance of the red dye had a proportional relationship to the concentration of glucose in 
the sample. The absorbance was measured at wavelengths 510/700nm.  
 
Step 1: 
                                             Glucose Oxidase  
β-D-glucose + O2 + H2O                                          Gluconic acid + H2O2 
 
 
Step 2: 
                                                                            Peroxidase 
2 H2O2  + phenol  + 4-aminoantipyrine                                          red quinoneimine +2 H2O 
 
Equation 2.3: Two-step enzymatic reaction to determine glucose concentration. The reaction produced a coloured 
compound and the absorbance of the compound was directly proportional to the concentration of glucose. Equation was 
taken from the clinical chemistry insert (Instrumentation Laboratories). 
 
For the food pulse trial samples, the average intra-assay coefficient of variation (CV) for the 
low quality control (QC) was 1.95 ± 1.9% (mean ± SD) and 1.66 ± 1.8% for the high QC. The 
average inter-assay CV was 7.5 ± 0.93% and 7.87 ± 0.99% for the low and high QC, 
respectively.  
For the food delay trial samples the average intra-assay CV was 1.15 ± 0.6% and 1.95 ± 1.4% 
for the low and high QC, respectively. The average inter-assay CV was 6.65 ± 0.3% and 6.66 
± 0.7% for the low and high QC, respectively. 
2.11.2 Non-esterified fatty acid concentration 
 
The ILab used a colorimetric method for the determination of the NEFA concentration 
(mmol/L) using the non-esterified fatty acid kit (Randox Laboratories). Prior to use, the 
reagents were reconstituted according to kit instructions and left at room temperature for 
30 minutes to ensure complete reconstitution. The 3-step enzymatic reaction required 2 
incubation periods to convert NEFA into a purple adduct product (Equation 2.4), which 
could then be measured by spectrophotometry; the absorbance was read at 550nm. 
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Step 1: 
                                 Acyl CoA Synthetase  
NEFA +ATP + CoA                                            Acyl CoA + AMP + PPi 
 
10 minute incubation at 37°C 
 
Step 2: 
                               Acyl CoA Oxidase 
Acyl CoA + O2                                          2,3,-trans-Enoyl-CoA + H2O2 
 
Step 3: 
                                            Peroxidase 
H2O2 + TOOS + 4-AAP                                         purple adduct +4H2O 
 
10 minute incubation at 37°C 
 
Equation 2.4: Three-step enzymatic reaction to determine non-esterified fatty acid concentration. The reaction produced 
a coloured compound and the absorbance of the compound was directly proportional to the concentration of non-
esterified fatty acid in the sample. TOOS: N-ethyl-N-(2hydroxyl-3-sulphopropyl) m-toluidine, 4-AAP: 4-aminoantipyrine. 
Equation was taken from the clinical chemistry insert (Randox Laboratories). 
 
For the food pulse trial samples, the average intra-assay CV for the low QC was 5.75 ± 4.8% 
and 5.17 ± 4.3% for the high QC. The average inter-assay CV was 9.72 ± 1.91% and 8.76 ± 
1.36% for the low and high QC respectively.  
For the food delay trial samples the average intra-assay CV was 3.76 ± 1.9% and 3.80 ± 3.4% 
for the low and high QC, respectively. The average inter-assay CV was 8.15 ± 1.5% and 9.55 
± 1.36% for the low and high QC, respectively. 
2.11.3 Triglyceride concentration 
 
The ILab used a colorimetric method for the determination of the TAG concentration 
(mmol/L) using the triglycerides clinical chemistry kit (Instrumentation Laboratories). Using 
end point analysis, the 4-step enzymatic reaction converted TAG to the coloured red 
quinoneimine product (Equation 2.5), where the TAG concentration was proportional to the 
absorbance of the red dye component. The absorbance was measured at 510/700nm. 
For the food pulse trial samples, the average intra-assay CV for the low QC was 1.83 ± 1.1% 
and 1.51 ± 1.4% for the high QC. The average inter-assay CV was 9.17 ± 0.15% and 7.98 ± 
0.13% for the low and high QC respectively.  
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For the food delay trial samples the average intra-assay CV was 1.23 ± 0.5% and 1.16 ± 0.8% 
for the low and high QC, respectively. The average inter-assay CV was 7.05 ± 1.02% and 7.91 
± 0.4% for the low and high QC, respectively. 
Step 1: 
                          Lipoprotein lipase 
Triglyceride                                            glycerol + fatty acids 
 
Step 2: 
                               Glycerol kinase 
Glycerol + ATP                                          glycerol-3-phosphate + ADP 
 
Step 3: 
                                             Glycerophosphate oxidase 
Glycerol-3-phosphate  + O2                                          dihydroxyacetone phosphate + H2O2 
 
Step 4: 
                                                                                         Peroxidase 
H2 O2 + 4-chlorophenol + 4-aminoantipyrine                                         red quinoneimine +2 H2O 
 
 
Equation 2.5: Four-step enzymatic reaction to determine triglyceride concentration. The reaction produced a coloured 
compound and the absorbance of the compound was directly proportional to the concentration triglyceride. Equation was 
taken from the clinical chemistry insert (Instrumentation Laboratories).  
2.12 Insulin Radioimmunoassay  
 
Blood samples collected into tubes containing the anti-coagulant K2-EDTA were inverted 10 
times, cooled and centrifuged at 1,620g for 10 minutes at 4°C within 30 minutes of 
collection. Plasma was stored at -20°C until further analysis. Insulin concentration was 
assessed using Human insulin specific radioimmunoassay kits (Merck Millipore, Darmstadt, 
Germany).  
The protocol detailed in the manufacturer’s handbook was followed with minor 
modifications. In brief, a standard curve was made through a serial dilution of the 200 
µU/ml human insulin standard provided. The volumes used were half that stated in the 
protocol to reduce waste of the standards. Assay buffer was added to tubes in the following 
amounts: zero to the total count tubes, 300µl to non-specific binding tubes, 200µl to zero 
tubes, and 100µl to all standard curve, quality control and sample tubes. One hundred 
microlitres of standard curve solution, or 100µl of one of the 2 quality controls provided, 
were added to the relevant tubes. Samples were thawed at room temperature, and 
centrifuged at 5,000g for 5 minutes at 4°C prior to adding 100µl to the tubes containing 
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assay buffer. One hundred microlitres of the rehydrated 125I – Insulin label was then added 
to all tubes, followed by 100µl of the Insulin antibody solution to all tubes, except total 
count and non-specific binding tubes. Samples were covered, mixed and incubated for 20-24 
hours at room temperature. 
Following the incubation, 1ml of cold (4°C) precipitation agent was added to all tubes, 
expect the total count tubes, and incubated for 20 minutes at 4°C. Samples were then 
centrifuged for 35 minutes at 1652g at 4°C. Following centrifugation, samples were 
aspirated, taking care to leave the pellet undisturbed, then measured with in a gamma 
counter for 2 minutes. To convert insulin from µU/ml to the SI units or pM, all values were 
multiplied by 6, as per the handbook instructions. 
The average intra-assay CV for the low QC was 12.38 ± 7.2%, and 9.76 ± 9.6% for the high 
QC. The inter-assay CV was 18.51 ± 4.39% and 17.11 ± 8.87% for the low and high QC 
respectively.  
2.13 Melatonin Radioimmunoassay 
2.13.1 Saliva melatonin radioimmunoassay 
 
Saliva samples were collected into scintillation tubes hourly during constant routines and 
every 4 hours during the ultradian days in the food pulse protocol (section 2.3.1, Figure 2.1 
and Figure 2.2). After collection they were immediately frozen at -20°C and remained stored 
ready for analysis.  
All saliva melatonin determination was conducted by Dr Benita Middleton (Stockgrand Ltd, 
Surrey, UK) using the iodine-125 (125I) based assay as described elsewhere (Middleton 2006).  
2.13.2 Plasma melatonin radioimmunoassay 
 
Blood samples were collected hourly into tubes containing the anticoagulant lithium heparin 
and were inverted 10 times, cooled and centrifuged at 1,620g for 10 minutes at 4°C within 
30 minutes of collection. Plasma was then stored at -20°C ready for analysis. 
All plasma melatonin determination was conducted by Dr Benita Middleton (Stockgrand) 
using the tritium (3H) based assay as described elsewhere (Middleton 2006).  
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2.14 Cortisol Radioimmunoassay 
 
Blood samples were collected hourly into tubes containing the anticoagulant lithium heparin 
and were inverted 10 times, cooled and centrifuged at 1,620g for 10 minutes at 4°C within 
30 minutes of collection. Plasma was then stored at -20°C ready for analysis. All plasma 
cortisol determination was carried out by Dr Benita Middleton (Stockgrand). The protocol 
for cortisol was similar to that of insulin, where 200µl of cortisol antiserum rabbit anti-
cortisol-3-0-(carboxymethyl) oxime – bovine serum albumin conjugate (Biogenesis Ltd, 
Dorset, UK) was added to 20µl of samples along with 200µl of the cortisol-3-0-
(carboxymethyl)-oximino-125iodohistamine radiolabel (Institute of Isotopes, Budapest, 
Hungray). This mixture was vortexed and incubated at room temperature overnight. 
Following incubation, 100µl of anti-rabbit IgG (SacCell, IDS Ltd, Boldon Tyne and Wear, 
England) was added and samples were incubated at room temperature for 1 hour where 
they underwent vortexing every 15 minutes. One-millilitre of Brij 35/ saline solution was 
added to tubes, and these were then centrifuged at 1652g for 15 minutes. The supernatant 
was then discarded and the pellet was measured with the gamma radiation counter. 
2.15 Leptin Radioimmunoassay 
 
Leptin concentration was determined by radioimmunoassay and carried out by Cheryl 
Isherwood. Blood samples collected into tubes containing the anti-coagulant K2-EDTA were 
inverted 10 times, cooled and centrifuged at 1,620g for 10 minutes at 4°C within 30 minutes 
of collection. Plasma was stored at -20°C ready for analysis. Leptin concentration was 
assessed using Human leptin radioimmunoassay kits (Merck Millipore).  
The protocol detailed in the manufacturer’s handbook was followed. Standards came 
prepared and the protocol was the same as that described for insulin (section 2.12), apart 
from the use of rehydrated 125I – Human Leptin label and Human Leptin antibody. 
The average intra-assay CV for the low QC was 8.86 ± 8.2% and 11.17 ± 12.2% for the high 
QC. The average inter-assay CV was 52.72 ± 2.08% and 30.5 ± 3.03% for the low and high 
QC, respectively.  
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2.16 Microarray Protocol 
2.16.1 Preparation of adipose tissue 
 
Subcutaneous adipose tissue biopsies were taken during the constant routines of the food 
delay protocol (section 2.3.2). These 200mg of tissue were flash frozen in liquid nitrogen 
within 5 minutes of collection; please note that the 200mg of tissue may have been split 
across multiple collection tubes to ensure freezing within the stated time. 
Prior to the microarray procedure, the adipose tissue was cut into smaller pieces to allow 
for better penetration of the RNAlater-ICE frozen tissue transition solution (Ambion/Life 
Technologies, Massachusetts, USA). Samples were cut one at a time to prevent thawing, in 
individual Petri dishes using a different sterile surgical blade each time to prevent cross 
contamination, and were weighed into new vials. RNAlater-ICE solution was pre-chilled at     
-80°C and then 10 volumes compared to weight were added to the frozen adipose tissue. 
The tissue was then thawed for a minimum of 16 hours at -20°C. 
2.16.2 RNA extraction 
 
RNA was extracted from the thawed adipose tissue using the RNeasy mini kit (Qiagen) and 
the manufacturer’s protocol was followed. In brief, 10µl of β-mercaptoethanol (β-ME) was 
added to every 1ml of buffer RLT needed. Thawed adipose tissue was added into individual 
autoclaved TissueLyser II (Qiagen) tubes containing a magnetic bead. To this tube, the buffer 
RLT+ β-ME solution was added according to the manual’s guidelines. For <20mg of tissue, 
350µl was added and ≤30mg, 600µl was added. If a sample was above 30mg, it was 
separated into two TissueLyser II tubes and 600µl was added to each. 
The adipose tissue was disrupted in the TissueLyser II at 4°C at 30Hz for two minutes, twice, 
turning the adaptor plates by 180° in between. The lysate was then centrifuged at maximum 
speed of 15,700g for 3 minutes at room temperature. The supernatant was transferred to 
an RNase/ DNase free tube and 1 volume of 70% ethanol, made with nuclease-free water, 
was added to the supernatant and mixed by pipetting; volume was determined by the 
amount of buffer RLT+ β-ME originally added. 
Seven hundred microlitres of the supernatant/ethanol mix was transferred to an RNeasy 
spin column and centrifuged at 8,000g for 30 seconds at room temperature. The flow-
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through was discarded and the centrifugation repeated with any remaining supernatant. To 
the RNeasy spin column, 700µl of buffer RW1 was added and centrifuged at 8,000g for 30 
seconds at room temperature. The flow through was discarded and 500µl of reconstituted 
buffer RPE was added to the RNeasy spin column and centrifuged again under the same 
conditions. The flow through was again discarded and another 500µl of buffer RPE was 
added. This was centrifuged at 8,000g for 2 minutes at room temperature. The RNeasy spin 
column was transferred to a new 2ml collection tube and centrifuged for 1 minute at full 
speed to dry the membrane. 
The RNeasy spin column was placed into a 1.5ml collection tube and 30µl of RNase-free 
water was added directly onto the membrane of the spin column. This was centrifuged at 
8,000g for 1 minute at room temperature to elute the RNA.  The RNA was then assessed for 
quantity and quality using the Nanodrop and Bioanalyser procedure respectively, described 
in section 2.7. 
2.16.3 Labelling and amplification of cRNA 
 
RNA samples with adequate RIN values were used for the microarray procedure. Where 
necessary, extractions were repeated and samples had an average RIN of 7.3 ± 0.72. RNA 
underwent labelling and amplifying to produce cRNA using the one-color microarray-based 
gene expression analysis low input quick amp labelling kit (Agilent Technologies); the 
protocol in the kit’s handbook was followed. Please note that throughout the procedure, 
solutions were briefly centrifuged in order to bring content down. 
The spike mix, an experimental positive control, was prepared by vortexing the spike mix 
vigorously before being heated at 37°C for 5 minutes. Three serial dilutions were made with 
dilution buffer and spike mix and differed depending on the starting amount of RNA (Table 
2.8). Initially 100ng of RNA was used, and if the specific activity was not reached (see section 
2.16.5 for details) the labelling step was repeated with 200ng of RNA. 
 
  Total RNA (ng) First Dilution Second Dilution Three Dilution 
 
100 1:20 1:25 1:20 
  200 1:20 1:25 1:10 
Table 2.8: Spike mix dilution calculation for differing starting concentrations of total RNA. 
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The starting amount of RNA (100ng or 200ng) was added to a microcentrifuge tube in a final 
volume of 1.5µl. If samples required concentrating, they were placed into the Eppendorf 
Concentrator plus (Eppendorf, Hamburg, Germany) for 15 minutes on the aqueous setting, 
and were centrifuged at 250g. Samples were then reconstituted to a final volume of 1.5µl 
using nuclease-free water. To this, 2µl of the appropriate third dilution of the spike mix was 
added. The T7 primer mix was prepared in a separate aliquot with 0.8µl of T7 primer and 1µl 
nuclease-free water per reaction. 1.8µl of the T7 primer mix was added to each sample and 
mixed through vortexing before being incubated at 65°C for 10 minutes. Samples were then 
put on ice and incubated for 5 minutes. 
The 5X first strand buffer was pre-warmed at 80°C for 3-4 minutes to allow for the re-
suspension of the buffer components; this was vortexed and centrifuged briefly. The cDNA 
master mix was prepared in a separated aliquot (Table 2.9) and the Affinity Script RNase 
block mix was added just prior to use to prevent denaturing. The cDNA master mix was 
gently mixed by pipetting before 4.7µl was added to each sample. This was mixed by 
pipetting before being incubated at 40°C for 2 hours. Samples were then incubated at 70°C 
for 15 minutes before being put on ice and incubated for 5 minutes. 
 
 
  
Reagent 
Volume per reaction 
(µl)   
 
5X First Strand Buffer 2 
 
 
0.1M DTT 1 
 
 
10mM dNTP Mix 0.5 
 
 
Affinity Script RNase Block Mix 1.2 
   Final volume 4.7   
Table 2.9: cDNA master mix for microarray reactions. 
 
The transcription mix was prepared in a separate aliquot with components being added in 
the order listed (Table 2.10) and mixed by pipetting. The T7 RNA polymerase blend was 
added just prior to use to reduce denaturing. Six microlitres of the transcription mix was 
added to each sample tube and mixed by pipetting. Samples were incubated at 40°C for 3-4 
hours under dark conditions and then placed at -20°C for short-term storage. 
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Reagent 
Volume per reaction 
(µl)   
 
Nuclease—free water 0.75 
 
 
5X Transcription Buffer 3.2 
 
 
0.1M DTT 0.6 
 
 
NTP Mix 1 
 
 
T7 RNA Polymerase Blend 0.21 
 
 
Cyanine 3-CTP 0.24 
   Final volume 6   
Table 2.10: Transcription master mix for microarray reactions 
2.16.4 Purification of cRNA 
 
Using an RNeasy mini kit (Qiagen) the cRNA samples were purified. Eighty-four microlitres of 
nuclease-free water, 350µl of buffer RLT and 250µl of absolute ethanol was added to the 
cRNA samples, with mixing by pipetting taking place between each addition. Seven hundred 
microlitres of the cRNA sample was added to an RNeasy spin column and centrifuged at 4°C 
for 30 seconds at 15,700g. The flow through and collection tube were discarded. 
In a new collection tube, 500µl of buffer RPE was added to the spin column and centrifuged 
again at 4°C for 30 seconds at 15,700g and the flow through discarded. 500µl of buffer RPE 
was again added to the spin column and centrifuged at 4°C for 60 seconds at 15,700g and 
the flow through and collection tube were discarded. In a new collection tube, the spin 
column was centrifuged at 4°C for 30 seconds at 15,700g to dry the membrane and the spin 
column was placed into the 1.5ml collection tube. 
Thirty microlitres of RNase-free water was added directly to the membrane and left for 60 
seconds before being centrifuged at 4°C for 30 seconds at 15,700g. The eluted cRNA was 
then placed on ice and quantified. 
2.16.5 Quantifying cRNA 
 
Quantification of the purified cRNA was performed using a NanoDrop (Thermo Scientific) on 
the “Microarray” setting. The arm was calibrated and “RNA-40” selected for sample type. It 
was blanked with MilliQ water and samples were read one at a time. 
Using the cRNA and cyanine 3 (Cy3) concentrations, the yield and specific activity could be 
calculated (Equation 2.6 and Equation 2.7, respectively).  
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Equation 2.6: Calculation of yield in micrograms of cRNA for microarray reactions. 
                                             
                     
                      
      
Equation 2.7: Calculation of specific activity in picomoles of cyanine 3 per microgram of cRNA for microarray reactions. 
 
For the 4-pack microarray format, the recommended yield and specific activity was 1.65µg 
and 6pmol Cy3/ µg cRNA, respectively. All samples met these criteria prior to proceeding to 
the hybridisation stage. 
2.16.6 Hybridisation 
 
The 10X blocking agent was prepared by Dr Giselda Bucca. Briefly, 500µl nuclease-free 
water was added to the lyophilized 10X gene expression blocking agent. This was gently 
mixed by vortexing then heated for 4 to 5 minutes at 37°C. The mix was spun in a centrifuge 
to drive down contents and then put into individual aliquots to prevent multiple free thaw 
cycles; it was stored at -20°C until needed. 
The fragmentation mix for each sample was made. For FAB1b, 2b and 3b, an error was 
made when creating the fragmentation mix (Table 2.11) leading to a larger final volume. 
Reagent 
Mix for 4b,7-9b  
(Correct volumes) 
Mix for FAB1-3b  
(Incorrect volumes) 
Cyanine 3-labelled cRNA 1.65µg 1.65µg 
10X gene expression blocking agent 11µl (2X) 11µl (1.67X) 
Nuclease free water Bring volume to 52.8µl Bring volume to 62.8µl 
25X fragmentation buffer 2.2µl (1X) 2.2µl (0.83X) 
Final volume (µl) 55 66 
Table 2.11: Fragmentation mix for microarray reactions  
 
 
The samples were mixed by flicking the tube, then incubated for exactly 30 minutes at 60°C. 
Samples were then cooled on ice for 1 minute prior to 55µl of the 2X Hi-RPM hybridisation 
being added. This was then mixed by pipetting and was ready to be applied to the 
hybridization slides. 
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The hybridisation chamber was preheated to 65°C. A clean gasket slide was loaded into the 
SureHyb chamber (Agilent Technologies) with the label facing up. 100µl of the hybridised 
sample was slowly dispensed onto the gasket well, going from the barcode (left) to the end 
(right) (Table 2.12); note that all wells needed to be filled. The array slide was then gently 
put “active side” down parallel to gasket slide. The SureHyb chamber cover was then put 
onto the slides and the chamber was assembled and the clamp tightened. The chamber was 
rotated and the motility of the bubbles assessed. The chamber was placed into the pre-
heated hybridisation chamber and was left to hybridize for 17 hours at 65°C, at a rotation of 
10rpm. On the array slide, custom probes, which were comprised of the canonical clock 
genes, were present due to the interest of this project in circadian genes and rhythms. 
Please note that the assembly and loading was completed by Dr Giselda Bucca. In addition 
the gene expression wash buffer 2 was warmed overnight at 37°C. 
Barcode Array Position 1 Array Position 2 Array Position 3 Array Position 4 
252681710268 
Fab1b CR1 #1 
16:16 
Fab1b CR1 #2 
22:23 
Fab1b CR1 #3 
04:15 
Fab1b CR1 #4 
10:22 
252681710269 
Fab2b CR1 #1 
17:16 
Fab2b CR1 #2 
23:23 
Fab2b CR1 #3 
05:24 
Fab2b CR1 #4 
11:30 
252681710270 
Fab3b CR1 #1 
18:24-18:27 
Fab3b CR1 #2 
00:31 
Fab3b CR1 #3 
06:30 
Fab3b CR1 #4 
12:34 
252681710271 
Fab4b CR1 #1 
16:43 
Fab4b CR1 #2 
22:19 
Fab4b CR1 #3 
04:19 
Fab4b CR1 #4 
10:18 
252681710272 
Fab7b CR1 #1 
17:25 
Fab7b CR1 #2 
23:15 
Fab7b CR1 #3 
05:10 
Fab7b CR1 #4 
11:12 
252681710273 
Fab1b CR1 #5 
16:19 
Fab2b CR1 #5 
17:22 
Fab3b CR1 #5 
18:28 
Fab4b CR1 #5 
16:26 
252681710274 
Fab8b CR1 #1 
18:33 
Fab8b CR1 #2 
00:27 
Fab8b CR1 #3 
06:33 
Fab8b CR1 #4 
12:25 
252681710275 
Fab9b CR1 #1 
19:30 
Fab9b CR1 #2 
01:27 
Fab9b CR1 #3 
07:27 
Fab9b CR1 #4 
13:26 
252681710276 
Fab7b CR1 #5 
17:24 
Fab8b CR1 #5 
18:33 
Fab1b CR1 #5 
16:19 
Fab4b CR1 #5 
16:26 
Table 2.12: Hybridisation slide set up. 
2.16.7 Washing 
 
The following was carried out by Dr Giselda Bucca. Prior to use, 2ml of Triton X-102 (10%) 
was added to both the gene expression wash buffer 1 and gene expression wash buffer 2 to 
give a final concentration of 0.005%. The buffers were inverted multiple times to ensure 
thorough mixing. All washing glassware was washed with acetonitrile before first time use; 
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before every successive wash, the glassware, racks and stir bars were cleaned thoroughly 
with ultrapure water.   
Three glass slide staining dishes were prepared for washing the microarray slides. Dishes 1 
and 2 contained gene expression wash buffer 1. Dish 3 was filled with the pre-warmed gene 
expression wash buffer 2 just prior to use. One at a time, a hybridization chamber was 
removed from the incubator. Ensuring the slides remained together, the chamber was 
disassembled and the slides, handled only from the barcode, were placed into dish 1. Only 
when the slides were completely submerged in the wash buffer were they separated using 
tweezers. The microarray slide was then quickly placed into the staining rack in dish 2 as 
quickly as possible. This process was repeated on each of the microarray slides that were 
undergoing hybridization.  
Slides were washed for one minute in gene expression wash buffer 1, which was being 
stirred by a stirrer on setting 4. The pre-warmed gene expression wash buffer 2 was added 
to dish 3, and slide rack quickly transferred from dish 2 to 3. The slides were again washed 
for one minute with the stirrer set to setting 4. 
The slide rack was slowly removed at an angle to get rid of liquid and any excess was 
removed by dabbing slides on a clean tissue. The slides were put into a slide holder and 
covered with an ozone-barrier slide cover (Agilent Technologies). 
2.16.8 Scanning microarray slides 
 
The Agilent scanner C was turned on to warm up. Before scanning, destination folders for 
the data were set up and the program settings entered (Table 2.13). 
Settings 
 
Profile AgilentHD_GX_1color 
 
 
Dye channel G (green) 
 
 
Scan Region  Agilent HD (61 x 21.6mm) 
 
 
Scan Resolution 5µm 
 
 
Tiff file dynamic range 20 bit 
 
 
Green PMT gain 100% 
 
 
End slot 3 
   Start slot 1   
Table 2.13:  Scanner C settings. 
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Once the slides had been washed, they were placed into the carousel in the positions 
named and scanned. Data was then extracted using the Agilent Feature Extraction Software 
(Agilent Technologies). 
2.17 Data Analysis and Statistics 
2.17.1 Dim light melatonin onset 
 
The dim light melatonin onset (DLMO) is a well established estimate of phase of the human 
SCN clock (Arendt 2010). To align peripheral rhythms to the endogenous circadian phase 
values are expressed relative to the DLMO for each participant; this was done for each 
constant routine. Calculations for the DLMO were carried out by Dr Sophie Wehrens. The 
minimum melatonin concentration was calculated by averaging the first 10 samples taken 
during the biological day. The maximum melatonin concentration was calculated by 
averaging the 3 highest consecutive concentrations. The range of the calculated baseline 
and highest concentration was calculated and the 25% concentration threshold was 
determined by dividing the range by 4 and adding this to the averaged minimum 
concentration value. The DLMO time was determined by selecting the time point before and 
after this concentration was reached, calculating the change in minutes of melatonin 
concentration and then determining the time taken to reach the desired concentration. This 
time was set as zero, and time of samples expressed as hours before (negative) or after 
(positive) the DLMO. 
2.17.2 Food pulse trial 
 
The participant demographics such as age, BMI, sleep and wake times, were separated by 
food pulse group and a one way analysis of variance (ANOVA) applied to check for 
significant differences; the significance level was set at 5% for all tests unless otherwise 
stated.  
To compare the efficacy of the pre-study protocol and the effect of the control protocol on 
measures, data from all 27 participants were grouped. For melatonin, data were plotted 
relative to clock time where the time of sampling was averaged between the participants. A 
locally weighted least squares (LOWESS) curve on a fine setting was applied to the 
melatonin data, using GraphPad Prism 6 (GraphPad Software Inc, La Jolla, California, USA). 
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LOWESS is a smoothing tool for generating a curve and was used as has been previously 
described (Revell et al. 2012). In addition, the individual timing of DLMO underwent a pair-
wise comparison and a student’s paired t-test was applied.  
For all other measures, the data were normalised by z-scoring raw values (Equation 2.8). 
The data were also aligned to each individual’s DLMO and grouped into 2-hour time bins. As 
a result of the aligning process, some of the time bins did not have a full dataset within 
them. When data from all of the participants were plotted together, time bins which 
contained data from less than half of the participants were excluded. These were typically 
the time bins relating to the time of the first and last samples. A linear mixed effects model 
(LMEN) that conducted a two-way repeated measures ANOVA was applied to all of the data, 
using the program RStudio (RStudio, Inc., Boston, Massachusetts, USA). The LMEM-ANOVA 
identified if there was a significant effect of time, constant routine and time x constant 
routine interaction.   
          
   
 
 
Equation 2.8: Z-score calculation. X is the sample value, µ represents the mean of the dataset, and σ is the standard 
deviation of the dataset. Z score is expressed as a value around the mean, which is set to zero. A positive value indicates 
the sample was above the mean and a negative value indicates the sample was below the mean. 
 
To look at the effect of each food pulse on measures, participants were separated into their 
food pulse group. Data were aligned to each individual’s DLMO and grouped into 2-hour 
time bins. Due to the aligning process, time bins which contained data from only one 
participant were excluded. A 2 way LMEN-ANOVA was also applied to this data. 
To the raw and z-scored individual and grouped data, a cosinor curve (Equation 2.9) was 
applied assessed for a significant fit. In GraphPad Prism 6 (GraphPad Software Inc), a 
comparison between the cosinor curve and a horizontal line was done using the extra sum-
of-squares F test. If the p value was less than 0.05, the data fitted a cosine model better 
than a straight line, and was deemed to be rhythmic. 
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) 
Equation 2.9: Cosinor curve equation for determination of circadian rhythm. The mesor is the mean level of the cosinor 
curve, amplitude is half of the range of the oscillation and acrophase is the time of peak level of the cosinor. A period 
length of 24 hours was chosen when assessing the individual data and for the grouped data the period below 30 hours that 
gave the best fit was used; this was determined by GraphPad Prism 6 (GraphPad Software Inc). 
 
For the individual PER3 whole blood relative mRNA expression and the food pulse grouped 
data, the significance level was relaxed to 10% to allow for the estimation of phase; in these 
cases the curve is shown by a dashed line. This was done in order to allow for phase 
assessment of the grouped data and the production of a phase response curve for the 
individual PER3 data. For remaining food pulse groups with no significant cosine curve, the 
acrophases were estimated one of two ways; using the predicted phase if a cosine curve fit 
was accepted as significant or using the time of the maximum mean concentration. For the 
predicted cosine curve fit, this acrophase was accepted when the p-value was less than 
0.12. When the p value was larger than 0.12, an estimation using the maximum mean 
concentration was used; all participants needed to be in that time bin for the value to be 
accepted. 
Phase shifts for either the control session or the food pulse session were determined by 
subtracting the acrophase of the second constant routine from the acrophase of the first 
constant routine. In order to calculate the net phase shift, the phase shift of the control 
session was subtracted from the phase shift of the food pulse session. 
In order to construct a PRC, the net phase shift observed in an individual’s timing of DLMO 
or PER3 relative gene expression acrophase was plotted against the time the participant 
received the food pulse relative to their DLMO (Burgess et al. 2008; Burgess et al. 2010; 
Revell et al. 2012).  The net phase shifts were also grouped by food pulse and double 
plotted.  
2.17.3 Food delay trial 
 
Data were plotted relative to clock time, each individual’s DLMO and hours after wake. Data 
were grouped into time bins, the sizes relative to the sampling frequency for that 
parameter; 1 hour for melatonin, cortisol and subjective measures, 2 hours for blood gene 
expression, plasma glucose, TAG and NEFAs and insulin, and 4 hours for adipose gene 
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expression. The time bin sizes were selected after data had been plotted in multiple sized 
time bins to ensure the final results of the data were not affected. 
To the grouped mean melatonin and cortisol profiles, a LOWESS curve was applied, as 
described in section 2.17.2. In addition, data were also Z-scored (Equation 2.8) to align on 
the y-axis. A cosinor curve (Equation 2.9) was applied, with the period adjusted to 24.2 
hours. The data were assessed for significant fit in the way described in section 2.16.2, but 
only to a significance level of 5%. Where a significant fit was present the acrophase was 
calculated, and phase shifts were determined by subtracting the acrophase of the second 
constant routine from the first.  
When a measure was highly circadian at the individual level, a pair-wise comparison of the 
DLMO timing or acrophase was conducted. On the pair-wise data, a student’s paired t-test 
was conducted. For melatonin and cortisol, a two-tailed t-test was conducted, whereas for 
adipose PER2 and PER3 mRNA relative expression, a one-tailed t-test was conducted as it 
was hypothesised that a delay in meal timing would delay peripheral clock rhythms. In 
addition, a student’s two-tailed t-test was conducted on the pair-wise mean plasma glucose 
concentration for each individual between the first and second constant routine. 
Two-way repeated measures analysis of variance (2w-ANOVA) was conducted on the mean 
grouped data to determine if the delayed food caused an overall difference to the data. Due 
to the aligning process the first and last 2-hour time bins only contained data from a couple 
of participants and so were excluded from the analysis.   
For the grouped whole blood gene expression data, a LMEM ANOVA in RStudio (RStudio, 
Inc.) was used to conduct repeated measures ANOVA; this was because the outlier cleaning 
method would have resulted in some missing data values. In addition, for the whole blood 
GR expression data a periodogram analysis was conducted in GraphPad Prism 6 (GraphPad 
Software Inc.) with periods ranging between 8 and 30 hours, at 0.1-hour increments. The 
goodness of fit (R2) for each cosinor was multiplied by (1 – p value) to produce a 
periodogram showing the best fit. 
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2.17.4 Microarray data analysis 
 
Microarray data were deposited in the Gene Expression Omnibus dataset (accession 
number GSE87761). The processing of the data was done by Dr Carla Möller-Levet using the 
R Bioconductor package Limma. Log2 values were quantile-normalised and non-control 
replicates probes, together with their corresponding flags were averaged.  
Two models were applied to the transcriptome data to identify circadian probes. A linear 
form of a cosinor curve was fitted to the combined transcript data from all 7 participants at 
once; this was classed as the single fit model approach. The data were aligned by sample 
time and to be identified as circadian, the curve needed a R2 greater than 0.8 and the 
amplitude had to have a 95% confidence interval that did not cross zero.  
In addition to the single fit model, an individual fit approach was applied where the linear 
form of a cosine curve was applied to the individual transcript data for each suitable subject. 
Data from 2 of the 7 participants were excluded from the individual fit analysis; for the first, 
one sample representing one time point in one individual did not yield adequate RNA for 
analysis and the second had one sample with high background in the microarray scan. As 
with the single fit model, the R2 needed to be above 0.8 and the amplitude had a 95% 
confidence interval that did not cross zero. To be considered circadian in the final analysis, 
probes had to fulfil the dual criteria of being circadian in at least 3 participants under the 
individual fit model and circadian under the single fit model. 
Probes that had been identified as circadian were further analysed. Probes identified as 
circadian in 5 people under the individual fit model, circadian in the single fit model and 
circadian under the dual criteria all underwent gene ontology enrichment analysis and Kyoto 
encyclopaedia of genes and genomes (KEGG) enrichment (described below). The dual 
criteria probes underwent further analysis and unsupervised clustering was conducted 
which revealed 4 distinct clusters. Clusters were analysed either individually, together based 
on peak time or together as an evening or morning peaking cluster. Only data from the 
evening and morning peaking clusters are shown. The data were aligned relative to the 
average DLMO time. 
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Gene ontology enrichment analysis was conducted using WebGestalt (Zhang et al. 2005; 
Wang et al. 2013)(www.webgestalt.org). The species was set to Homo sapiens and gene 
symbols were used for the gene ID type. The reference gene set for the enrichment analysis 
was hsapiens_agilent_wholegenome_4x44k_v1. Gene ontology analysis was selected and 
other conditions kept on default. An enriched gene ontology category was only considered 
during analysis when it had an adjusted p value of less than 0.05, when using the Benjamini 
and Hochberg method (Benjamini & Hochberg 1995) to adjust for multiple testing. In 
addition, enrichment analysis using the KEGG pathway setting on WebGestalt was also used.  
Protein-protein interactions were assessed using the online database, STRING (Szklarczyk et 
al. 2015) (www.string-db.org). The gene IDs from each cluster were entered under a 
multiple protein search. Default settings were used to generate interactions and a minimum 
interaction score of 0.400, the score was the sum of the known and predicted interactions, 
was used as a threshold for an interaction (Szklarczyk et al. 2015). The connecting lines in 
the figures indicated the source of evidence for the interaction. 
The circadian probes were compared to other transcriptomics dataset to look for common 
circadian probes. From the online database, CircaDB (Pizarro et al. 2013) 
(www.circadb.hogeneschlab.org), the dataset Mouse 1. OST White Adipose (Affymetrix) was 
assessed. Circadian probes from the animal dataset were determined by using the default 
settings of the JTK Q-value probability filter. Data from human whole blood transcriptomics 
experiments conducted at Surrey (Möller-Levet et al. 2013; Archer et al. 2014) were also 
assessed to look for common circadian probes across human tissues.  
 
 
 
 
 
 
 
 
Discrete Food Pulses Given in an Ultradian Protocol Phase Shift Peripheral Circadian Rhythms 
86 
 
3 DISCRETE FOOD PULSES GIVEN IN AN 
ULTRADIAN PROTOCOL PHASE SHIFT 
PERIPHERAL CIRCADIAN RHYTHMS 
 
3.1 Introduction 
 
The best characterised zeitgeber to humans is light, which mediates its effects via the 
central pacemaker, the SCN (Czeisler et al. 1989; Lockley et al. 1997; Thapan et al. 2001; 
Brainard et al. 2001; Khalsa et al. 2003;). The impact that non-photic zeitgebers have on the 
human circadian system, especially on peripheral clock rhythms, is poorly understood. 
Phase response curves (PRCs) to exogenous melatonin (Lewy et al. 1992; Middleton et al. 
1997; Burgess et al. 2008; Burgess et al. 2010) as well as to exercise (Buxton et al. 2003) 
have been produced in humans. However, animal studies have shown that restricting the 
availability of food to a certain time window can phase shift peripheral clock rhythms 
without altering the phase of the SCN, as long as calories are ad libitum and not restricted 
(Damiola et al. 2000; Stokkan et al. 2001). However, whether food acts as a zeitgeber to 
peripheral clocks in humans is poorly understood. 
The aim of this study was to determine if food acts as a zeitgeber to the human circadian 
system by producing a PRC. The hypothesis was that food would act as a zeitgeber to 
peripheral clocks in humans and a PRC would be similar to other non-photic zeitgebers, not 
light, in terms of phase advances and phase delays. Furthermore, whilst maintaining a 
normocaloric diet, the phase of the SCN would remain unchanged whilst the phase of 
peripheral rhythms would be affected by food pulses. 
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3.2 Methods 
 
Twenty-seven healthy, male participants were recruited to undertake a within-subject 
counterbalanced controlled laboratory study. Participants underwent two 6-day controlled 
laboratory sessions, consisting of the control session and food pulse session (see section 
2.3.1 for details). Following a strict pre-study protocol, where sleep/wake and meal timing 
was regulated (see section 2.2.1), participants entered the SCRC for a habituation night. 
Participants then underwent a 25-hour constant routine to assess the phase of rhythms at 
baseline. Following the constant routine, participants maintained 3 days of a 4-hour 
ultradian sleep/wake and light/dark cycle. In the control session, participants received 
isocaloric meals every 2 hours across the whole laboratory period. For the food pulse 
session, participants still received meals every 2 hours but, during the ultradian protocol, 
one meal consisted of 50% of the participant’s daily caloric need and could have been given 
at 1 of 6 times; the meal would have been given at the same selected time over the 3 days. 
Participants then underwent a second 25-hour constant routine to determine if phase shifts 
had occurred to rhythms. 
Saliva samples were taken to assess melatonin concentration, as described in section 2.13.1. 
Plasma samples were assessed for glucose, TAG, NEFA and leptin concentration, as 
described in sections 2.11 and 2.15. RNA expression in whole blood of core clock 
components, BMAL1, PER3 and REVERB-β, and GR was conducted as detailed in section 
2.10. 
3.3 Results 
3.3.1 Participant demographics 
 
Twenty-seven participants were separated into one of six food pulse groups. Allocation was 
based on BMI, age and sleep-time to ensure that groups were matched. These measures, 
along with Munich chronotype sleep and wake times, Horne-Östberg score, Pittsburgh Sleep 
Quality Index, Beck Depression Inventory, Epworth Sleepiness Scale and pre-study wake 
time, were compared between groups using a one-way analysis of variance (ANOVA). No 
significant differences (p>0.05) were observed between the food pulse groups for any of the 
participant demographics (Table 3.1). 
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Food Pulse Group 
 
00:40 04:40 08:40 12:40 16:40 20:40 
N 4 5 4 4 5 5 
Age (years ± SEM) 22.5 ± 1.8 24.6 ± 2.1 22.8 ± 1.5 22.3 ± 1.0 24.0 ± 1.8 22.6 ± 1.5 
BMI (kg/m2 ± SEM) 23.7 ± 1.4 24.9 ± 1.0 24.9 ± 0.9 24.7 ± 1.3 24.1 ± 0.9 24.0 ± 1.6 
Munich Chronotype 
      
Sleep Time (hours ± SEM) 
23.25 ± 
0.5 
23.35  ± 
0.2 
23.13  ± 
0.7 
23.88  ± 
0.1 
22.90  ± 
0.6 
24.00  ± 
0.4 
Wake Time (hours ± SEM) 
7.75  ± 
0.5 
7.70  ± 
0.4 
7.38  ± 
0.4 
7.88  ± 
0.3 
8.22  ± 
0.5 
7.88  ± 
0.7 
Horne-Östberg  
(score ± SEM) 
46.8  ± 
0.9 
54.4  ± 
1.0 
53.5  ± 
3.6 
48.8  ± 
3.6 
51.6  ± 
4.7 
52.6  ± 
5.4 
Pittsburgh Sleep Quality 
Index (score ± SEM) 
3.3 ± 0.9 2.4  ± 1.0 3.3  ± 0.3 4.0  ± 0.7 2.2  ± 0.7 2.8  ± 0.6 
Beck Depression Inventory 
(score ± SEM) 
1.3  ± 0.8 1.4  ± 1.4 2.3  ± 1.6 0.8  ± 0.8 2.2  ± 1.1 0.6  ± 0.4 
Epworth Sleepiness Scale 
(score ± SEM) 
5.0 ± 1.1 4.2 ± 1.4 4.5 ± 1.0 3.5 ± 1.0 3.8 ± 1.41 4.4 ± 0.7 
Pre-study sleep time 
(hours ± SEM) 
23.75 ± 
0.6 
23.70 ± 
0.5 
23.38 ± 
0.2 
23.75 ± 
0.1 
23.70 ± 
0.4 
23.50 ± 
0.3 
Pre-study wake time 
(hours ± SEM) 
7.75 ± 0.6 7.70 ± 0.5 7.69 ± 0.3 8.13 ± 0.2 7.80 ± 0.3 7.60 ± 0.4 
Table 3.1: Participant demographics were not significantly different between the food pulse groups. One way analysis of 
variance (ANOVA) revealed no significant differences for any of the measures between the food pulse group (p>0.05). 
 
3.3.2 Pre-study protocol assessment 
 
To assess the efficacy of the pre-study protocol on maintaining the phase of rhythms 
between the two trial sessions, the first constant routine from both the control and food 
pulse sessions were compared. Saliva melatonin data from all participants was grouped by 
clock time (Figure 3.1A) and melatonin profiles were smoothed using the locally weighted 
least square (LOWESS) curve on the fine setting. A 2-way repeated measures ANOVA 
revealed a significant effect of time (F29,754 = 43.79, p<0.0001), but no significant effect of 
session (F1,26 = 2.06, p>0.05) or session x time interaction (F29,754 = 0.79, p>0.05). The timing 
of the 25% dim light melatonin onset (DLMO) for each participant was compared (Figure 
3.1B) and no significant difference was found in the DLMO timing between the two sessions 
(student’s paired t-test, p>0.05). The mean time for the 25% DLMO was 22.20 ± 0.25 (mean 
± SEM) and 22.28 ± 0.22 decimal time for first constant routine of the control and food pulse 
session, respectively. 
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Figure 3.1: Pre-study protocol resulted in no significant difference in mean grouped saliva melatonin profile (A) or 
individual timing of 25% dim light melatonin onset (B) between the first constant routine from both the control and food 
pulse session. Saliva melatonin values (A, pg/ml) from all participants were grouped by clock time and a locally weighted 
least squares (LOWESS) curve on a fine setting was applied; data were expressed as mean ± SEM. A 2-way repeated 
measures ANOVA was conducted on the grouped mean data and a significant effect of time (F29,754 = 43.79, p<0.0001), but 
no significant effect of session (F1,26 = 2.06, p>0.05) or session x time interaction (F29,754 = 0.79, p>0.05) was found. 
Assessment of individual saliva melatonin profiles allowed for calculation of the 25% DLMO, and the timing of this 
exhibited no significant difference between the two sessions (student’s paired t-test, p>0.05). 
 
 
3.3.2.1 Pre-study assessment of plasma glucose, NEFA, TAG and leptin  
 
Following saliva melatonin assessment, data from all participants were aligned to their 
individual 25% DLMO times and grouped into 2-hour time bins. A cosine curve was fitted to 
the grouped data where the best fit period was determined by the model; the only 
constraint was that the period could not be more than 30 hours. The mean grouped plasma 
glucose concentrations exhibited rhythmicity in both constant routines as determined by a 
significant cosinor curve fit (Figure 3.2, cosinor non-linear regression (CNLR), p<0.05); so too 
did the mean grouped plasma NEFA and TAG concentrations (Figure 3.2). For the mean 
grouped plasma leptin concentrations, significant cosinor curve fits were only observed for 
the normalised z-scored data (Figure 3.2). 
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Figure 3.2: Pre-study protocol resulted in minimal phase differences between the first constant routine from the control 
and food pulse session for plasma glucose, NEFA, TAG or leptin rhythms. Grouped plasma glucose concentrations, plasma 
NEFA concentrations, plasma TAG concentrations (left, mmol/L and right, z-score) and plasma leptin concentrations (left, 
ng/ml and right, z-score) from the first constant routine of the control and food pulse session were assessed. All measures, 
apart from raw leptin concentration had significant rhythms in concentration level (cosinor non-linear regression (CNLR), 
p<0.05). Phase differences of less than 1 hour were observed for all measures apart from z-scored TAG. A linear mixed 
effect model ANOVA (LMEM-ANOVA) identified a significant effect of time for all measures (p<0.05), a significant effect of 
session for NEFA mmol/L and leptin ng/ml (p<0.05, other measures p>0.05) and no significant time x session interaction, 
apart from z-scored TAG (p>0.05, TAG z-score p<0.05). Data were grouped into 2-hour time bins relative to the 25% DLMO 
and are expressed as mean ± SEM. 
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A comparison of the phase of the first constant routine from the control and the food pulse 
session revealed phase differences of less than an hour in all cases except for normalised z-
scored TAG (Figure 3.2); a summary of the acrophases, period, goodness of fit (R2) and 
phase shifts can be seen in Table 3.2. Furthermore, the period of plasma glucose and leptin 
rhythms were the same between the sessions, whilst plasma TAG had differences in period 
of less than an hour. In contrast, plasma NEFA had a shorter period by approximately 3 
hours in the food pulse session compared to the control session. 
 
Measure 
Control Session Food Pulse Session  
Acrophase 
(Time 
relative to 
25% DLMO 
± SE) 
Period 
(Hours ± 
SE) 
R
2
 of 
Curve 
Acrophase 
(Time 
relative to 
25% DLMO 
± SE) 
Period 
(Hours ± 
SE) 
R
2
 of 
Curve 
Phase 
difference 
(Hours, 
control 
session – 
food pulse 
session) 
Glucose 
mmol/L 3.98±0.79 ~30 0.14 3.37±0.8 ~30 0.11 0.61 
mmol/l, 
z-score 
4.27±0.51 ~30 0.29 4.20±0.51 ~30 0.30 0.07 
NEFA 
mmol/L -3.53±0.96 ~30 0.06 -4.06±0.60 26.8±3.2 0.13 0.53 
mmol/l, 
z-score 
-3.82±0.56 ~30 0.16 -4.31±0.45 27.1±2.3 0.22 0.49 
TAG 
mmol/L 5.16±0.90 28.2±3.0 0.13 4.26±1.04 29.0±4.3 0.09 0.9 
mmol/l, 
z-score 
5.13±0.32 28.4±1.1 0.54 3.58±0.31 27.9±1.3 0.44 1.55 
Leptin 
ng/ml        
ng/ml, 
z-score 
6.35±0.76 ~30 0.33 5.61±0.74 ~30 0.29 0.74 
Table 3.2: Summary of the acrophase times, estimated period, goodness of fit (R
2
) and phase difference between the 
first constant routine of the control and food pulse session for plasma glucose, NEFA, TAG and leptin. The period of the 
cosine curve was determined by the model and had the constraint that the period could not be more than 30 hours. 
Periods identified as ~30 hours reached the constraint set. The phase shift was calculated by subtracting the acrophase of 
the food pulse constant routine from the control constant routine. SE, standard error. 
 
 
A 2-way linear mixed effects model ANOVA (LMEM-ANOVA) was conducted on all data to 
determine if there was a significant effect of time, session and time x session interaction. 
For plasma glucose, NEFA, TAG and leptin, there was a significant effect of time in all cases 
(glucose - mmol/L: F14,643 = 20.29, z-score F14,669 = 24.30; NEFA - mmol/L: F14,643 = 10.08, z-
score F14,669 = 13.47; TAG - mmol/L: F14,643 = 28.89, z-score F14,669 = 56.24; leptin – ng/ml: 
F12,591 = 9.52, z-score F14,619 = 22.97, all p<0.05). When assessing session, all measures apart 
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from raw plasma NEFA and leptin concentrations, had no significant effect of session 
(glucose - mmol/L: F1,643 = 3.70, z-score F1,669 = 0.06; NEFA - z-score F1,669 = 0.13; TAG - 
mmol/L: F1,643 = 0.81, z-score F1,669 = 0.44; leptin - z-score F1,619 = 0.08, all p>0.05; NEFA - 
mmol/L: F14,643 = 10.08 and leptin – ng/ml: F1,591 = 17.13, p<0.05). Only normalised plasma 
TAG had a significant time x session interaction (glucose - mmol/L: F14,643 = 1.07, z-score 
F14,669 = 1.31; NEFA - mmol/L: F14,643 = 0.86, z-score F14,669 = 0.98; TAG - mmol/L: F14,643 = 
0.73; leptin – ng/ml: F12,591 = 0.24, z-score F13,619 = 0.36, all p>0.05; TAG – z-score F14,669 = 
2.22, p<0.05). 
3.3.2.2 Pre-study assessment of whole blood relative mRNA expression of 
BMAL1, PER3, REVERB-β and GR 
 
In addition to plasma glucose, NEFA, TAG and leptin, the relative mRNA expression of 
BMAL1, PER3, REVERB-β and GR in whole blood was assessed (Figure 3.3). Data from all 
participants were aligned to their individual DLMO times and grouped into 2-hour time bins. 
A cosine curve was fitted to the grouped data where the best fit period was determined by 
the model; the only constraint was that the period could not be more than 30 hours. BMAL1 
relative mRNA expression only had significant rhythms for the normalised z-scored data 
(Figure 3.3 - right, CNLR, p<0.05). The mean grouped PER3 relative mRNA expression data 
exhibited circadian rhythms for both constant routines, as did the mean grouped REVERB-β 
relative mRNA expression data (Figure 3.3, CNLR p<0.05). For the mean grouped GR relative 
mRNA expression data, a significant cosinor curve fit was only present for the normalised z-
scored data (Figure 3.3, CNLR p<0.05). 
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Figure 3.3: Pre-study protocol resulted in no phase difference between the first constant routine from the control and 
food pulse session for PER3 and REVERB-β relative mRNA expression, whilst BMAL1 relative mRNA expression had a 2.4-
hour phase difference. Grouped whole blood BMAL1, PER3, REVERB-β and GR relative mRNA expression (Left, 2
-δδCT
 and 
right, z-scored) from the first constant routine of the control and food pulse session were assessed. PER3, REVERB-β, 
normalised BMAL1 and GR relative mRNA expression had significant rhythms (CNLR, p<0.05). Phase differences of less than 
1 hour were observed for PER3, REVERB-β, and GR, whilst BMAL1 had a 2.4-hour phase difference between the two 
sessions. A LMEM-ANOVA identified a significant effect of time for all measures (p<0.05) apart from BMAL1 relative mRNA 
expression (left, p>0.05). A significant effect of session for PER3 relative mRNA expression was found (PER3 p<0.05, all 
other measures p>0.05) and no significant time x session interaction was found for any measure (p>0.05). Data were 
grouped into 2-hour time bins relative to the 25% DLMO and are expressed as mean ± SEM. 
Discrete Food Pulses Given in an Ultradian Protocol Phase Shift Peripheral Circadian Rhythms 
94 
 
A 2-way LMEM-ANOVA was conducted and there was a significant effect of time in all cases 
except for raw BMAL1 relative mRNA expression (BMAL1 - z-score F14,596 = 2.70; PER3 – 
relative expression F14,568 = 26.35, z-score F14,594 = 55.17; REVERB-β – relative expression 
F14,570 = 11.92, z-score F14,595 = 24.55; GR – relative expression F14,557 = 3.12, z-score F14,583 = 
4.79; all p<0.05; BMAL1 – relative expression F14,571 = 0.90, p>0.05). All measures, apart from 
raw PER3 relative mRNA expression, had no significant effect of session (BMAL1 – relative 
expression F1,571 = 0.09,  z-score F1,596 = 0.23; PER3 – z-score: F1,594 = 1.09; REVERB-β – 
relative expression F1,571 = 1.97, z-score F1,595 = 0.002; GR – relative expression F1,559 = 0.81, 
z-score F1,583 = 0.06; all p>0.05; PER3 – relative expression: F1,569 = 5.12, p<0.05). There was 
no significant time x session interaction in any relative mRNA expression measure (BMAL1 – 
relative expression F13,570 = 0.67,  z-score F13,596 = 1.30; PER3 – relative expression  F13,568 = 
0.56, z-score: F13,594 = 1.27; REVERB-β – relative expression F13,570 = 0.28, z-score F13,595 = 
0.83; GR – relative expression F13,557 = 0.45, z-score F13,583 = 0.83; all p>0.05).  
The phase of BMAL1 relative mRNA expression showed the largest difference between the 
two sessions, with a phase difference of 2.36 hours; no significant time x session effect was 
found in the LMEM-ANOVA. In contrast, the phase difference between sessions for the PER3 
and REVERB-β relative mRNA expression were similar to that of plasma glucose, NEFA, TAG 
and leptin, as the differences were less than an hour. Table 3.3 summarises the acrophases, 
period, R2 and phase differences of the whole blood relative mRNA expression. Grouped 
PER3 and REVERB-β relative mRNA expression had periods close to 24 hours whilst BMAL1 
relative mRNA expression had a longer period closer to 30 hours. In contrast, the period for 
GR relative mRNA expression was identified as ultradian. Note that the phase difference 
between the two sessions for GR relative mRNA expression was calculated using the time of 
the first peak. 
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Measure 
Control Session Food Pulse Session  
Acrophase 
(Time 
relative to 
25% DLMO 
± SE) 
Period 
(Hours ± 
SE) 
R
2
 of 
Curve 
Acrophase 
(Time 
relative to 
25% DLMO 
± SE) 
Period 
(Hours ± 
SE) 
R
2
 of 
Curve 
Phase 
difference 
(Hours, 
control 
session – 
food pulse 
session) 
BMAL1 
Relative 
expression        
 z-score -2.16±0.99 ~30 0.05 -4.52±1.14 29.0±7.9 0.05 2.36 
PER3 
Relative 
expression 5.14±1.74 22.2±1.3 0.16 4.57±0.43 21.3±0.9 0.22 0.57 
z-score 5.16±0.84 22.8±0.6 0.49 4.43±0.21 21.2±0.5 0.54 0.73 
REVERB-β 
Relative 
expression 2.29±0.58 23.3±2.1 0.13 2.28±0.58 22.3±1.8 0.12 0.01 
z-score 2.24±0.35 24.2±1.4 0.30 1.99±0.31 22.1±1.0 0.32 0.25 
GR 
Relative 
expression        
z-score -6.91±0.42 10.8±0.7 0.06 -7.11±0.38 11.2±0.7 0.07 0.20 
Table 3.3: Summary of the acrophase times, estimated period, goodness of fit (R
2
) and phase difference between the 
first constant routine of the control and food pulse session for whole blood relative mRNA expression of BMAL1, PER3, 
REVERB-β and GR. The period of the cosine curve was determined by the model and had the constraint that the period 
could not be more than 30 hours. Periods identified as ~30 hours reached the constraint set. The phase shift was calculated 
by subtracting the acrophase of the food pulse constant routine from the control constant routine. SE, standard error. 
 
3.3.3 Control session caused a significant difference in melatonin timing and 
large phase differences in peripheral circadian rhythms 
 
The effect that the 3-day ultradian rhythm protocol had on the phase, period and amplitude 
of rhythms, without a food pulse, was determined by the control session. By assessing the 
phase between the first and second constant routine of the control session, the combined 
effect of both a 4-hour sleep/wake and light/dark cycle, and 2-hourly meals on rhythms 
could be discovered.  
Saliva melatonin data from all participants was grouped by clock time (Figure 3.4A) and 
melatonin profiles were smoothed using the LOWESS curve on the fine setting. A 2-way 
LMEM-ANOVA revealed a significant effect of time (F32,1509 = 65.31, p<0.05), no significant 
effect of constant routine (F1,1509 = 0.06) and a significant effect of time x constant routine 
interaction (F26,1509 = 1.64, p<0.05). 
The individual timing of the 25% DLMO for all participants was compared (Figure 3.4B) and a 
significant difference was found in the 25% DLMO between the two constant routines 
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(student’s paired t-test, p<0.05). The mean time for the 25% DLMO was 22.20 ± 0.25 and 
22.98 ± 0.31 decimal time for the first and second constant routine, respectively. This 
indicated that there was a phase delay of 0.78 hours in melatonin over the course of the 
session. This suggests that there was a phase delay on average of 0.26 hours each day and 
that melatonin had a tau of 24.26 hours. 
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Figure 3.4: Control session caused a significant difference in the timing of the 25% dim light melatonin onset. Saliva 
melatonin values (A, pg/ml) from all participants were grouped by clock time and a LOWESS curve on a fine setting was 
applied; data were expressed as mean ± SEM. A 2-way LMEM-ANOVA was conducted on the grouped mean data and found 
a significant effect of time (F32,1509 = 65.31, p<0.05), no significant effect of constant routine (F1,1509 = 0.06, p>0.05), and a 
significant time x constant routine interaction (F26,1509 = 1.64, p<0.05). Assessment of individual saliva melatonin profiles 
allowed for calculation of individual 25% DLMO, and the timing of this exhibited a significant phase delay of 0.78 hours 
between the first and second constant routine (student’s paired t-test,* denotes p<0.05 compared to baseline constant 
routine 1). 
 
3.3.3.1 Control session caused large changes to plasma glucose, NEFA and leptin, 
but not to plasma TAG 
 
As all participants underwent a control session, data from all 27 participants were aligned to 
their individual 25% DLMO times and grouped into 2-hour time bins. As previously, the 
mean grouped plasma glucose concentrations exhibited rhythmicity in both constant 
routines as determined by a significant cosinor curve fit (Figure 3.5, CNLR, p<0.05); so too 
did the mean grouped plasma TAG concentrations (Figure 3.5, CNLR, p<0.05). Mean plasma 
NEFA concentration had a significant rhythm for the first constant routine only for the raw 
data, but a significant rhythm for both constant routines when normalised (Figure 3.5, CNLR, 
p<0.05). For the mean grouped plasma leptin concentrations, significant cosinor curve fits 
were only observed for the normalised z-scored data (Figure 3.5, right panel, CNLR, p<0.05). 
Large phase differences as a result of the 3-day ultradian rhythm protocol were seen for 
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plasma glucose, plasma NEFA and plasma leptin concentrations. A summary of the 
calculated acrophases, period, R2 and phase shift of rhythms are listed in Table 3.4.  
Mean grouped plasma glucose concentrations had a relative phase delay of almost 8 hours 
between the first and second constant routine over the whole session, with normalised 
values showing a delay of 9.4 hours (Figure 3.5, Table 3.4). Interestingly, in addition to the 
change in phase, the period of the rhythm was also affected with a shorter period observed 
in the second constant routine. A 2-way LMEM-ANOVA found a significant effect of time 
(mmol/L: F16,641 = 3.95, z-score F16,667 = 2.82, p<0.05), no effect of constant routine (mmol/L: 
F1,641 = 0.04, z-score F1,667 = 1.60, p>0.05), but a significant time x constant routine 
interaction (mmol/L: F14,641 = 8.19, z-score F14,667 = 9.89, p<0.05). 
Normalised mean grouped plasma NEFA concentrations also had a large phase shift with a 
phase advance of 7.76 hours in the rhythm between the first and second constant routine 
(Figure 3.5 – right, Table 3.4). The period of the NEFA rhythm did not change over the 
ultradian protocol, although period assessment was limited by both constant routines 
meeting the period constraint of 30 hours. A 2-way LMEM-ANOVA found a significant effect 
of time (mmol/L: F16,642 = 4.20, z-score F16,667 = 5.22, p<0.05), constant routine (mmol/L F1,642 
= 20.79, z-score F1,667 = 7.65, p<0.05), and time x constant routine interaction (mmol/L: 
F14,641 = 4.41, z-score F14,667 = 6.05, p<0.05).  
The significant effect of constant routine could relate to the lower overall plasma NEFA 
concentration in the second constant routine. Raw plasma NEFA concentration had a 
reduced mean in the second constant routine with values of 0.52 ± 0.01 (mean ± SEM) and 
0.43 ± 0.02 mmol/L for the first and second constant routine, respectively.  
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Figure 3.5: Control session caused large phase shifts in plasma glucose, NEFA and leptin, whilst no change was seen in 
TAG. Grouped plasma glucose, NEFA, TAG (left, mmol/L and right, z-scored) and leptin concentrations (left, ng/ml and 
right, z-scored) from the control session were assessed. All measures, apart from raw leptin concentration and the second 
constant routine from the raw NEFA concentration (left), had significant rhythms in concentration level (CNLR, p<0.05). An 
8-hour phase delay was observed in mean grouped plasma glucose concentration between the first and second constant 
routine of the control session. A phase advance of almost 8 hours was observed for the mean grouped plasma NEFA and a 
phase advance of 10.7 hours to normalised plasma leptin concentrations between the first and second constant routine of 
the control session. Mean grouped plasma TAG concentrations had phase shifts of less than an hour between the first and 
second constant routine of the control session. A LMEM-ANOVA found a significant effect of time for all measures (p<0.05) 
apart from raw plasma leptin concentrations (left, p>0.05). There was a significant effect of constant routine for plasma 
NEFA (left and right) plasma TAG (left) and plasma leptin (left) (p<0.05, all other measures p>0.05) and there was a 
significant time x constant routine interaction for all measures (p<0.05). Data were grouped into 2-hour time bins relative 
to the 25% DLMO and are expressed as mean ± SEM. 
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Measure 
Constant 
Routine 1 
Acrophase 
(Time 
relative to 
25% DLMO ± 
SE) 
Period 
(Hours ± 
SE) 
R
2 
of 
curve 
Constant 
Routine 2 
Acrophase 
(Time 
relative to 
25% DLMO ± 
SE) 
Period  
(Hours ± 
SE) 
R
2 
of 
curve 
Phase 
shift 
(Hours, 
CR1-
CR2) 
Estimated 
change to 
period 
per day 
(Hours) 
Glucose 
mmol/L 4.21±0.78 ~30 0.13 12.00±1.30 21.5±5.1 0.02 -7.79 2.83 
mmol/L, 
z-score 
4.30±0.48 ~30 0.29 13.70±0.69 25.4±5.0 0.09 -9.4 1.53 
NEFA 
mmol/L -3.52±0.94 ~30 0.06 
     
mmol/L, 
z-score 
-3.75±0.54 ~30 0.18 -11.51±0.93 ~30 0.06 7.76 
 
TAG 
mmol/L 5.05±0.80 27.8±2.7 0.12 4.48±1.04 20.7±2.4 0.03 0.57 2.37 
mmol/L, 
z-score 
5.04±0.28 28.1±1.0 0.54 4.35±0.33 20.2±0.8 0.25 0.69 2.63 
Leptin 
mmol/L 
        
mmol/L, 
z-score 
6.35±0.76 ~30 0.33 -4.31±1.02 21.9±2.4 0.05 10.66 2.7 
Table 3.4: Summary of the acrophase times, period, goodness of fit, phase shift between the first and second constant 
routine of the control session and estimated change to period per day for plasma glucose, NEFA, TAG and leptin 
concentrations. The phase shift was calculated by subtracting the acrophase of the second constant routine from the first 
constant routine. The period of the cosine curve was determined by the model and had the constraint that the period 
could not be more than 30 hours. Periods identified as ~30 hours reached the constraint set. The estimated change to 
period per day was calculated by dividing the difference between the first and second constant routine period by the 
number of ultradian days (3 days). SE, standard error.  
 
Similarly to plasma NEFA, z-scored mean group plasma leptin concentrations also had a 
phase advance to their rhythms of 10.66 hours between the first and second constant 
routine (Figure 3.5 - right). There was also a shortening of the period from ~30 hours to 21.9 
± 2.4 hours in the second constant routine, similar to the plasma glucose rhythm. A 2-way 
LMEM-ANOVA revealed a significant effect of time for the normalised data only (z-score 
F15,618 = 3.04, p<0.05; ng/ml: F15,592 = 1.50, p>0.05), a significant effect of constant routine 
for raw data (ng/ml F1,592 = 45.83, p<0.05; z-score F1,618 = 0.21, all p>0.05), and a significant 
effect of time x constant routine interaction for both (ng/ml F13,592 = 3.60, z-score F13,618 = 
8.73, p<0.05). Leptin had an increase in mean concentration in the second constant routine 
as values were 4.91 ± 0.09 and 5.57 ± 0.08 ng/ml for the first and second constant routine, 
respectively. 
In contrast to plasma glucose, NEFA and leptin, mean plasma TAG concentrations exhibited 
a minimal phase difference in rhythms as a result of the protocol (Figure 3.5). There was a 
phase delay of 0.57 hours to the rhythm between the first and second constant routine 
Discrete Food Pulses Given in an Ultradian Protocol Phase Shift Peripheral Circadian Rhythms 
100 
 
(Figure 3.5 – left, Table 3.4). The z-scored mean group plasma TAG data had a similar phase 
delay of 0.69 hours (Figure 3.5 – right, Table 3.4). Although the phase shift was minimal, the 
period of the plasma TAG rhythm was shorter in the second constant routine following the 
ultradian protocol. 
A 2-way LMEM-ANOVA found a significant effect of time (mmol/L: F16,641 = 15.38, z-score 
F16,667 = 28.76, p<0.05), a significant effect of constant routine for raw data (mmol/L F1,641 = 
19.94, p<0.05; z-score F1,667 = 1.50, p>0.05), and a significant effect of time x constant 
routine interaction (mmol/L: F14,641 = 3.96, z-score F14,667 = 3.98, p<0.05). Plasma TAG had a 
reduction in the mesor and amplitude of the second constant routine, where the mesor 
values were 1.16 ± 0.02 (mesor ± standard error (SE)) and 1.07 ± 0.02 mmol/L and the 
amplitude values were 0.18 ± 0.03 and 0.08 ± 0.02 mmol/L for the first and second constant 
routine, respectively (Figure 3.5 - left).  
3.3.3.2 Control session resulted in minimal changes to whole blood relative 
mRNA expression of BMAL1, PER3, REVERB-β and GR 
 
The relative mRNA expression data from whole blood for BMAL1, PER3 and REVERB-β did 
not have large phase differences as a result of the 3-day ultradian protocol. The mean 
grouped z-scored BMAL1 relative mRNA expression data exhibited rhythmicity in both 
constant routines as determined by a significant cosinor curve fit (Figure 3.6 - right, CNLR, 
p<0.05). The mean grouped PER3 relative mRNA expression data exhibited circadian 
rhythms for both constant routines, as did the mean grouped REVERB-β relative mRNA 
expression data (Figure 3.6, CNLR p<0.05). For the mean grouped z-scored GR relative mRNA 
expression data, a significant cosinor curve fit was only seen for the first constant routine 
and this had an ultradian period (Figure 3.6, CNLR p<0.05). 
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Figure 3.6: Control protocol did not cause a phase shift in gene expression in whole blood. Grouped whole blood BMAL1, 
PER3, REVERB-β and GR relative mRNA concentrations (left, 2
-δδCT
 and right, z-scored) from the control protocol were 
assessed. PER3, REVERB-β, normalised BMAL1 (right) and the first constant routine of the control protocol for GR had 
significant rhythms (CNLR, p<0.05). Phase advance of less than 1 hour were observed for PER3 and REVERB-β (left), whilst a 
phase advance of almost 2 hours was found for normalised BMAL1 relative mRNA expression (right). A phase comparison 
of GR could not be calculated, but did exhibit an ultradian period. A LMEM-ANOVA revealed a significant effect of time for 
all measures (p<0.05) apart from BMAL1 and GR relative mRNA expression (left, p>0.05). There was a significant effect of 
constant routine for the relative mRNA expression of all genes (left, p<0.05), but not for the normalised data (right, 
p>0.05). There was no significant time x constant routine interaction for any measure (p>0.05). Data were grouped into 2-
hour time bins relative to the 25% DLMO and are expressed as mean ± SEM. 
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Of all the genes, the largest phase difference was seen for the z-scored mean grouped 
BMAL1 relative mRNA expression; a summary of the acrophases, period R2, phase shifts and 
estimated daily change to period can be seen in Table 3.5. BMAL1 exhibited a phase 
advance of 1.78 hours (Figure 3.6 - right) and there was a shortening of the period after the 
ultradian protocol. A 2-way LMEM-ANOVA identified a significant effect of time only for the 
normalised data (z-score F15,602 = 2.72, p<0.05; relative expression F15,577 = 1.20, p>0.05), a 
significant effect of constant routine for raw data (relative expression F1,578 = 4.83, p<0.05; z-
score F1,602 = 2.88 x 10
-7, p>0.05) and no significant time x constant routine interaction 
(relative expression F13,577 = 3.96, z-score F13,602 = 0.98, p>0.05). The mean BMAL1 relative 
expression increased in concentration slightly from 1.83 ± 0.02 to 1.90 ± 0.02 2-δδCT between 
the first and second constant routine (Figure 3.6 – left). 
PER3 relative mRNA expression had a phase advance of 0.68 hours for relative expression 
(Figure 3.6 – left) and a phase advance of 0.67 hours for normalised z-scored data between 
the first and second constant routine. However, there was minimal change to the period of 
the rhythm as a result of the ultradian protocol. A 2-way LMEM-ANOVA revealed a 
significant effect of time (relative expression F15,576 = 23.94, z-score F15,602 = 50.12, p<0.05), a 
significant effect of constant routine for raw data (relative expression F1,577 = 25.34, p<0.05; 
z-score F1,602 = 0.19, p>0.05) and no significant time x constant routine interaction (relative 
expression F13,576 = 0.79, z-score F13,602 = 1.55, p>0.05). Similarly to the biochemical data, 
there was a reduction in the mesor and amplitude of the rhythm in the second constant 
routine where the mesor values were 1.69 ± 0.04 and 1.48 ± 0.04 2-δδCT and the amplitude 
values were 0.47 ± 0.06 and 0.42 ± 0.05 2-δδCT for the first and second constant routine, 
respectively (Figure 3.6). 
The smallest shift in rhythms over the course of the session was to REVERB-β relative mRNA 
expression. Both the raw and z-scored data had a phase delay of approximately 0.4 hours 
due to the ultradian protocol. A 2-way LMEM-ANOVA found a significant effect of time 
(relative expression F15,577 = 9.21, z-score F15,602 = 19.69, p<0.05), a significant effect of 
constant routine for raw data (relative expression F1,579 = 7.12, p<0.05; z-score F1,602 = 0.32, 
p>0.05) and no significant time x constant routine interaction (relative expression F13,577 = 
0.73, z-score F13,602 = 1.18, p>0.05). Similar to PER3, REVERB-β had a reduction in mesor 
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(1.96 ± 0.05 and 1.77 ± 0.05 2-δδCT) and amplitude (0.43 ± 0.06 and 0.38 ± 0.05 2-δδCT) 
between the first and second constant routine, respectively. 
Although phase shifts could not be assessed for GR relative mRNA expression a 2-way 
LMEM-ANOVA found a significant effect of time for normalised z-scored data only (z-score 
F15,602 = 50.12, p<0.05; relative expression F15,576 = 23.94, p>0.05), a significant effect of 
constant routine for raw data (relative expression F1,577 = 25.34, p<0.05; z-score F1,602 = 0.19, 
p>0.05) and no significant time x constant routine interaction (relative expression F13,576 = 
0.79, z-score F13,602 = 1.55, p>0.05). The mean GR relative expression decreased from 1.90 ± 
0.04 in the first constant routine to 1.75 ± 0.03 2-δδCT in the second constant routine. 
Measure 
Constant 
Routine 1  
Acrophase 
(Time 
relative to 
25% DLMO ± 
SE) 
Period 
(Hours ± 
SE) 
R
2 
of 
curve 
Constant 
Routine 2 
Acrophase 
(Time 
relative to 
25% DLMO ± 
SE) 
Period  
(Hours ± 
SE) 
R
2 
of 
curve 
Phase 
shift 
(Hours, 
CR1-
CR2) 
Estimated 
change to 
period per 
day 
(Hours) 
BMAL1 
Relative 
expression 
                
z-score -2.16±0.99 ~30 0.05 -3.94±1.56 27.5±6.2 0.04 1.78 0.83 
PER3 
Relative 
expression 
5.14±1.74 22.2±1.3 0.16 4.46±1.33 22.3±1.4 0.19 0.68 -0.03 
z-score 5.16±0.84 22.8±0.6 0.49 4.49±0.20 22.4±0.6 0.54 0.67 0.13 
REVERB-β 
Relative 
expression 
2.29±0.58 23.3±2.1 0.13 1.85±0.47 21.6±2.3 0.16 0.44 0.57 
z-score 2.24±0.35 24.2±1.4 0.30 1.83±0.31 22.6±1.8 0.32 0.41 0.53 
GR 
Relative 
expression         
z-score -6.91±0.42 10.82±0.69 0.06 
     
Table 3.5: Summary of the acrophase times, period, goodness of fit, phase shift between the first and second constant 
routine of the control session and estimated change to period per day for whole blood relative mRNA expression of 
BMAL1, PER3, REVERB-β and GR. The phase shift was calculated by subtracting the acrophase of the second constant 
routine from the first constant routine. The period of the cosine curve was determined by the model and had the 
constraint that the period could not be more than 30 hours. Periods identified as ~30 hours reached the constraint set. The 
estimated change to period per day was calculated by dividing the difference between the first and second constant 
routine period by the number of ultradian days (3 days).  SE, standard error.  
3.3.4 Prevalence of circadian rhythms at the individual level 
To construct a PRC, the phase of rhythms must be determined in both the control and the 
food pulse session. All individual data were assessed for the presence of a significant 
circadian rhythm and the summary tables of significant rhythms for the control (Table 3.6) 
and food pulse (Table 3.7) session are shown. A cosine curve with a set period of 24 hours 
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was compared to a simple model of a horizontal line and a p value was produced. A 
significant circadian rhythm was identified when the p value was less than 0.05. Apart from 
melatonin, which was circadian in all participants, no other measure was circadian in all 
individuals and the prevalence of circadian rhythmicity varied between the different 
measures assessed.  
For the control session (Table 3.6), the measure with the highest prevalence of significant 
circadian rhythms at the individual level, aside from melatonin, was whole blood PER3 
relative mRNA expression in the second constant routine; this was circadian in 88.9% of 
individuals. This was followed by plasma TAG in the first constant routine which was 
circadian in 77.8% of individuals (Table 3.6). An average of rhythmicity between both 
constant routines revealed that PER3 was the most circadian measure as it was rhythmic 
79.6% of the time (Table 3.6). The measure with the lowest prevalence of significant 
circadian rhythms at the individual level was plasma NEFA concentration in the second 
constant routine, which was circadian in just 1 individual (3.7%). However, the measure with 
the lowest average rhythmicity was whole blood GR relative mRNA expression which was 
circadian 9.3% of the time (Table 3.6). Within the control session, the individuals with the 
highest prevalence of circadian rhythms were FAB15, FAB18 and FAB0150 as 62.5% of their 
measures showed a significant circadian rhythm. The individual with the lowest prevalence 
of rhythms was FAB24 as only 12.5% of their measures showed a significant circadian 
rhythm (Table 3.6).  
For the food pulse session, there was a lower global circadian rhythmicity, as plasma TAG 
had the highest prevalence of rhythms at the individual level during the first constant 
routine and was circadian in only 77.8% of individuals (Table 3.7). There were also measures 
that had no circadian rhythmicity at the individual level, which were whole blood GR relative 
mRNA expression and plasma NEFA concentration, both in the second constant routine 
(Table 3.7). However, although overall there was a reduction in the prevalence of circadian 
rhythms across measures, at the individual level the rhythmicity of some participants 
increased with FAB23 and FAB0150 having 68.8% of their measures rhythmic (Table 3.7). 
FAB24 still had the lowest prevalence of rhythms but there was an increase in their overall 
rhythmicity as now 18.8% of their measures had a significant circadian rhythm (Table 3.7).  
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3.3.5 Net phase shifts of the dim light melatonin onset revealed no clear effect of 
the timing of food pulse on the direction and magnitude of phase shift 
 
The timing of the 25% DLMO was calculated in each individual and for all constant routines, 
in order to construct a PRC of the 25% DLMO to food pulse. The net phase shift was 
calculated by subtracting the shift in the control session (constant routine 1 – constant 
routine 2), from the shift in the food pulse session (constant routine 1 – constant routine 2). 
A positive value indicated a net phase advanced and a negative value indicated a net phase 
delay. The net shift was aligned to the time of the food pulse relative to the individual’s time 
of the 25% DLMO from the first constant routine of the food pulse session. The net shift for 
all participants 25% DLMO can be viewed in Figure 3.7A.  
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Figure 3.7: A phase response curve of the net phase shift of the timing of the 25% DLMO to a food pulse revealed no 
clear direction or magnitude of phase shift in response to each food pulse. (A) The net phase shift of the timing of the 
25% DLMO did not have a clear phase response curve to food pulse timing. (B) The average phase shift for each food pulse 
was double plotted to the time of the food pulse relative to the average DLMO of the group. No phase response curve was 
generated on the group data, but the largest phase shift was seen when food was administered shortly after the 25% 
DLMO. Grouped data were plotted as mean ± SEM. 
 
A PRC was generated from the individual net shift (Figure 3.7A) but revealed no clear 
magnitude or direction of phase shift as a result of each food pulse. The PRC did not have a 
clear fit for a dual harmonic sine function. The largest phase advance across the protocol 
was 1.82 hours, whilst the largest phase delay was 1.87 hours; both of these shifts were 
within the same food pulse group. The net shift data were then grouped by food pulse time 
and double plotted (Figure 3.7B). Each food pulse group was aligned to the average 25% 
DLMO of that food pulse group and the average net shift was plotted (Figure 3.7B). The 
largest shift was a 1-hour advance to the timing of the 25% DLMO when the food pulse was 
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administered around the time of the DLMO (Figure 3.7B); this was the 00:40 food pulse. The 
other food pulse groups caused little change to the timing of the DLMO. 
3.3.6 Effect of food pulse on glucose rhythms 
 
For phase assessment of plasma glucose concentration, data were grouped into food pulse 
groups as there had not been a high incidence of circadian rhythms at the individual level. 
Instead of using the grouped control session data (all 27 participants), the control session 
used was the one that corresponded with each food pulse group (i.e. the control session 
data for participants who underwent the 00:40 food pulse was the control session for that 
food pulse group). Phase shift calculations were done for each food pulse group for both the 
control and food pulse session. Data were aligned to each participant’s individual 25% 
DLMO and grouped into 2-hour time bins, and both raw data (Figure 3.8) and z-scored data 
(Figure 3.9) were plotted. A cosine curve was applied to the data where the best fit period 
was determined by the model, and the period had to be less than 30 hours. 
For the raw data, few sessions had significant cosine curve fits to allow for phase 
assessment (Figure 3.8). Due to this, all subsequent phase comparisons were made on the z-
scored data which had a higher prevalence of significant circadian rhythms (Figure 3.9). To 
give the best estimate of phase for data which did not have a significant circadian rhythm 
when p<0.05, the significance level was relaxed to 0.1 and if this still did not yield a 
significant rhythm, a visual estimation of phase based on the point of maximum value was 
also made. Arrows on the graphs indicate the estimated time of acrophase where a cosinor 
curve is not present. 
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Figure 3.8: Plasma glucose concentrations were separated by food pulse group and split into the control session (left) 
and food pulse session (right). Mean grouped plasma glucose concentrations (mmol/L) from the control (left) and food 
pulse session (right) were assessed. Data were separated by time of food pulse, which was given at either 00:40, 04:40, 
08:40, 12:40, 16:40 and 20:40. Significant rhythms were determined by CNLR and depicted by the presence of a cosine 
curve (solid lines: p<0.05, dashed line: p<0.1 but >0.05). Data were grouped into 2-hour time bins relative to the 25% 
DLMO and are expressed as mean ± SEM. 
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Figure 3.9: Z-scored plasma glucose concentrations rhythms had differences in phase when separated by food pulse 
group and split into the control session (left) and food pulse session (right). Mean grouped plasma glucose concentrations 
(z-scored) from the control (left) and food pulse session (right) were assessed. Data were separated by time of food pulse, 
which was given at either 00:40, 04:40, 08:40, 12:40, 16:40 and 20:40. Significant rhythms were determined by CNLR and 
depicted by the presence of a cosine curve (solid lines: p<0.05, dashed line: p<0.1 but >0.05). Arrows indicated the timing 
of the estimated peak concentration where a significant cosinor curve was not present. Timing of plasma glucose rhythms 
were most affected by food pulses given in the evening (16:40 and 20:40). Data were grouped into 2-hour time bins 
relative to the 25% DLMO and are expressed as mean ± SEM. 
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A summary of the acrophases, both calculated and estimated, periods and the phase shifts 
for each food pulse can be view in Table 3.8. When a food pulse was administered at 16:40 
and 20:40 (Figure 3.9) a large net phase shift was seen in plasma glucose rhythms. For the 
16:40 food pulse group, the control session caused a phase delay of 5.48 hours over the 
session. For the food pulse session, a phase delay of only 0.09 hours was seen. When the 
net phase shift was calculated, by subtracting the control phase shift from the food pulse 
shift, there was an overall phase advance of 5.57 hours to the glucose rhythm as a result of 
the food pulse at 16:40. Interestingly, the control session had a shortening of the period in 
the second constant routine (from 29.0 ± 3.2 hours to 19.8 ± 3.0 hours), whereas the food 
pulse at 16:40 appeared to maintain both the phase and the period length of the glucose 
rhythm. 
A 2-way LMEM-ANOVA showed a significant effect of time for the food pulse session (food 
pulse F14,102 = 2.64, p<0.05; control F15,100 = 1.29, p>0.05), no effect of constant routine 
(control F1,100 = 0.01, food pulse F1,102 = 0.18, p>0.05) and a significant time x constant 
routine interaction for the control session, but not the food pulse (control F12,100 = 3.55, 
p<0.05; food pulse F12,102 = 0.75, p>0.05). This suggests that the difference between the two 
constant routines was greater in the control session than in the food pulse, which would be 
in line with the phase differences observed. 
Similarly, the control session of the 20:40 food pulse group resulted in a phase delay of 9.67 
hours across the session, whilst the food pulse session had a smaller phase delay of 2.92 
hours. The net phase shift was an advance of 6.75 hours when a food pulse was given at 
20:40. Although there was a reduction in the period in the second constant routine of both 
sessions, the food pulse reduced the magnitude of this (Table 3.8).  
A 2-way LMEM-ANOVA indicated that there was a significant effect of time for the food 
pulse session (food pulse F15,101 = 3.90, p<0.05; control F12,102 = 5.88, p>0.05), no effect of 
constant routine in either session (control F1,102 = 0.06, food pulse F1,101 = 0.67, p>0.05) and 
a significant time x constant routine interaction for the control session, but not the food 
pulse session (control F12,102 = 5.88, p<0.05; food pulse F12,101 = 0.905, p>0.05). As above, this 
suggests that the constant routines had a larger phase difference in the control session than 
in the food pulse session. 
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    Food Pulse Group 
    00:40 04:40 08:40 12:40 16:40 20:40 
C
o
n
tr
o
l 
Constant 
Routine 1 
Acrophase 
(Time relative 
to the 25% 
DLMO ± SEM) 
5.00* 
4.11 ± 
1.18 
4.00 ± 
1.84 
2.86  ± 
0.92 
4.64  ± 
0.75 
3.88  ± 
0.73 
Period of CR1 
(Hours ± SE)  
~30 ~30 ~30 29.0  ± 3.2 ~30 
Constant 
Routine 2 
Acrophase 
(Time relative 
to the 25% 
DLMO ± SEM) 
12.33 ± 
0.52 
3.00* 
-11.00* 
(24) 
16.29  ± 
0.85 
10.12  ± 
1.20 
13.55  ± 
1.23 
Period of CR2 
(Hours ± SE) 
21.8 ± 2.3 
  
29.0  ± 7.1 19.8  ± 3.0 19.4  ± 2.9 
Phase Shift 
(CR1-CR2) 
(Hours) 
-7.33 1.11 -9.00 -13.43 -5.48 -9.67 
Fo
o
d
 P
u
ls
e
 
Constant 
Routine 1 
Acrophase 
(Time relative 
to the 25% 
DLMO ± SEM) 
6.06 ± 
2.48 
3.46 ± 
1.73 
4.14 ± 
1.03 
2.89  ± 
0.76 
4.76  ± 
1.20 
4.31  ± 
0.94 
Period of CR1 
(Hours ± SE) 
~30 ~30 ~30 26.9  ± 3.3 ~30 ~30 
Constant 
Routine 2 
Acrophase 
(Time relative 
to the 25% 
DLMO ± SEM) 
9.55 ± 
0.52 
11.31 ± 
0.68 
11.00* 
13.54  ± 
1.25 
4.67  ± 
1.46 
7.23  ± 
1.02 
Period of CR2 
(Hours ± SE) 
19.8 ± 1.6 21.0 ± 2.7 
 
18.5  ± 2.6 
30.0  ± 
10.7 
23.5  ± 2.3 
Phase Shift 
(CR1-CR2) 
(Hours) 
-3.49 -7.85 -6.86 -10.65 0.09 -2.92 
  
Net Phase 
Shift (Pulse - 
Control) 
(Hours) 
3.84 -8.96 2.14 2.78 5.57 6.75 
Table 3.8: Summary of plasma glucose acrophases, periods and phase shifts from the control and food pulse session of 
each food pulse group. The phase shift for each session and the net phase shift for each food pulse group are shown. The 
asterisks (*) denotes an estimated acrophase as a significant cosinor curve was not present for that constant routine. 
Negative phase shifts indicate a phase delay and positive phase shifts indicate a phase advance. The period of the cosine 
curve was determined by the model and had the constraint that the period could not be more than 30 hours. Periods 
identified as ~30 hours reached the constraint set. SE, standard error. 
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For the remaining food pulse groups where a significant cosinor fit was not present (p<0.1), 
the acrophases for glucose were estimated using either the time of the maximum mean 
concentration or from a cosinor curve which was just short of the 0.1 significance level cut 
off (e.g. 0.12). The maximum mean also needed to be from a time bin which contained data 
from all participants to reduce bias from low sampling. Please note that 24 hours was added 
to the estimated phase for the second constant routine of the control session of the 08:40 
group to be in line with the timing of other phases; this value (13 hours relative to the 
DLMO) was used for the phase calculations. From this, the phase shift was compared within 
the control and food pulse session and results are shown in Figure 3.10. When food pulses 
were given at 08:40 and 12:40, the phase shift was similar between the control and food 
pulse session; this indicated that the protocol, rather than the time of the food pulse had 
greater effect. For the 16:40 and 20:40 food pulse groups, the phase shift differed between 
the control and food pulse session, indicating that the time of the food had a greater impact 
than the protocol. The phase shift seen for the control session of the 04:40 food pulse group 
showed a slight phase advanced, contrary to all other control sessions which showed a 
substantial delay.  
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Figure 3.10: Phase shifts observed over the course of a 3-day ultradian routine in z-scored plasma glucose concentrations 
for the control (white) and food pulse (black) sessions for each food pulse group. Phase was either from a significant 
cosinor curve fit, estimated by a significant cosinor curve fit or by the time of maximum glucose concentration. A negative 
value indicates a phase delay to the timing of rhythms whilst a positive value indicates a phase advance. 
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3.3.7 Effect of food pulse on plasma NEFA and leptin rhythms 
 
Assessment of the control protocol showed large phase shifts in plasma NEFA rhythms. 
However, at the individual level there was not a high incidence of significant circadian 
rhythms for plasma NEFA (Table 3.6 and Table 3.7, control session: 26% - constant routine 1, 
3.7% - constant routine 2; food pulse session: 37% - constant routine 1, 0% - constant 
routine 2). Due to this, the phase shifting effect of food pulses on plasma NEFA rhythms was 
assessed at the group level, using the normalised z-scored plasma NEFA concentrations 
(Figure 3.11). Raw plasma NEFA data separated by food pulse groups can be seen in 
Appendix 3.1.  
The normalised z-scored plasma NEFA concentrations had significant rhythms for all bar one 
of the first constant routines for both the control and food pulse session, but few significant 
circadian rhythms for the second constant routine (Figure 3.11); this is consistent with the 
higher prevalence of individual rhythms for the first constant routine (Table 3.6 and 3.7). 
Similar to assessment of the efficacy of the pre-study protocol, the timing of the acrophase 
of the first constant routine between the control and food pulse sessions for the 6 food 
pulse groups had no significant difference in timing (student’s paired t-test, p>0.05, data not 
shown).  
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Figure 3.11: Z-scored plasma NEFA concentrations rhythms were separated by food pulse group and split into the control 
session (left) and food pulse session (right). Mean grouped plasma NEFA concentrations (z-scored) from the control (left) 
and food pulse session (right) were assessed. Data were separated by time of food pulse, which was given at either 00:40, 
04:40, 08:40, 12:40, 16:40 and 20:40. Significant rhythms were determined by CNLR and depicted by the presence of a 
cosine curve (solid lines: p<0.05, dashed line: p<0.1 but >0.05). Data were grouped into 2-hour time bins relative to the 
25% DLMO and are expressed as mean ± SEM. 
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Due to a higher prevalence of ultradian rhythms, phase assessment of NEFA rhythms was 
restricted to the sessions that had a significant rhythm for both constant routines. The 
control session of the 12:40 food pulse group (Figure 3.11, left), had a reduction in the 
period from 27.2 ± 6.1 to 10.8 ± 0.7 hours for the first and second constant routine, 
respectively. A 2-way LMEM-ANOVA revealed a significant effect of time (F15,73 =1.91, 
p<0.05) but no significant effect of constant routine (F1,73 = 0.54, p>0.05) or time x constant 
routine interaction (F14,73 = 1.60, p>0.05). For the food pulse session (Figure 3.11, right), 
there was a phase advance of 2.37 hours. Interestingly, the food pulse resulted in a 
lengthening of the period from 19.2 ± 1.8 to ~30 hours for the first and second constant 
routine, respectively. A 2-way LMEM-ANOVA of the food pulse session found a significant 
effect of time (F15,75 = 3.01, p<0.05), no effect of constant routine (F1,75 = 0.02, p>0.05) and a 
significant time x constant routine interaction (F12,75 = 2.07, p<0.05).  
For the remainder of the food pulse sessions, the effect of the food pulse on the phase and 
period of the NEFA rhythms differed. The food pulse session of the 04:40 group had a phase 
delay of 11.95 hours between the first and second constant routine (Figure 3.11), yet the 
period was mostly maintained. A 2-way LMEM-ANOVA of the food pulse session revealed a 
significant effect of time (F14,102 = 2.06, p<0.05), no effect of constant routine (F1,101 = 0.66, 
p>0.05) and a significant time x constant routine interaction (F12,102 = 5.82, p<0.05). The 
significant time x constant routine interaction was in keeping with the large phase change 
observed in the rhythms. 
For the 16:40 food pulse session, there was a moderate phase delay of 6.64 hours to the 
rhythm but there was a far greater effect on period, with a shortening after the food pulse 
intervention. The period went from ~30 hours for the first constant routine down to 14.4 ± 
1.4 hours for the second constant routine. A 2-way LMEM-ANOVA found a significant effect 
of time (F14,102 = 4.15, p<0.05), no effect of constant routine (F1,102 = 0.26, p>0.05) and a 
significant time x constant routine interaction (F12,102 = 2.86, p<0.05).  
In contrast, the 20:40 food pulse session had a small phase advance of 3.57 hours and a 
lengthening of the period from 26.0 ± 5.0 to ~30 hours for the first and second constant 
routine, respectively. A 2-way LMEM-ANOVA found a significant effect of time (F15,101 = 2.83, 
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p<0.05), no significant effect of constant routine (F1,101 = 0.00, p>0.05) or time x constant 
routine interaction (F12,101 = 1.17, p>0.05). 
The raw plasma leptin concentrations had no significant rhythms when separated into the 
control and food pulse sessions for each food pulse group (Appendix 3.2). Due to this, the 
normalised z-scored data were used to determine phase to help overcome the variation 
between individuals (Figure 3.12). Where a constant routine did not have a significant 
rhythm, the phase was estimated as described in section 3.3.6. The majority of non-
significant plasma leptin rhythms were in the control session (Figure 3.12, left).  
A summary of the acrophases, both calculated and estimated, periods and the phase shifts 
for z-scored plasma leptin can be viewed in Table 3.9. The largest net phase delays for 
plasma leptin rhythms were seen in the evening food pulse groups of 16:40 and 20:40 
(Figure 3.12). For the 16:40 food pulse group, the phase advance in plasma leptin rhythms 
for the control session was estimated to be 13.99 hours. For the food pulse session a phase 
advance of 6.25 hours was seen indicating a net phase delay of 7.74 hours to leptin rhythms 
when a food pulse was administered at 16:40. A 2-way LMEM-ANOVA found a significant 
effect of time (control F14,92 = 2.77, food pulse F13,94 = 2.05, p<0.05), no effect of constant 
routine (control F1,92 = 0.19, food pulse F1,94 = 0.78, p>0.05) and a significant time x constant 
routine interaction for the control session only (control F12,92 = 4.16, p<0.05; food pulse F11,94 
= 0.81, p>0.05). 
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Figure 3.12: Z-scored plasma leptin concentrations rhythms were separated by food pulse group and split into the 
control session (left) and food pulse session (right). Mean grouped plasma leptin concentrations (z-scored) from the 
control (left) and food pulse session (right) were assessed. Data were separated by time of food pulse, which was given at 
either 00:40, 04:40, 08:40, 12:40, 16:40 and 20:40. Significant rhythms were determined by CNLR and depicted by the 
presence of a cosine curve (solid lines: p<0.05, dashed line: p<0.1 but >0.05). Arrows indicated the timing of the estimated 
peak concentration where a significant cosinor curve was not present. Data were grouped into 2-hour time bins relative to 
the 25% DLMO and are expressed as mean ± SEM. 
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Food Pulse Group 
  
00:40 04:40 08:40 12:40 16:40 20:40 
C
o
n
tr
o
l 
Constant 
Routine 1 
Acrophase 
(Time relative 
to the 25% 
DLMO ± SEM) 
5.05 ± 
1.32 
6.34 ± 
1.54 
4.58 ± 
2.48 
5.61 ± 
1.36 
6.99 ± 
3.84 
9.00* 
Period of CR1 
(Hours ± SE) 
28.4 ± 4.8 ~30 ~30 ~30 ~30 
 
Constant 
Routine 2 
Acrophase 
(Time relative 
to the 25% 
DLMO ± SEM) 
-3.00* -5.00* 
-4.87 ± 
0.81 
3.00* -7.00* 
-4.00 ± 
1.37 
Period of CR2 
(Hours ± SE)   
20.4 ± 1.8 
  
23.0 ± 3.3 
Phase Shift 
(CR1-CR2) 
(Hours) 
2.05 11.34 9.45 2.61 13.99 13.00 
Fo
o
d
 P
u
ls
e
 
Constant 
Routine 1 
Acrophase 
(Time relative 
to the 25% 
DLMO ± SEM) 
6.50 ± 
2.92 
5.53 ± 
1.45 
2.04 ± 
0.93 
7.00* 
5.25 ± 
2.04 
6.63 ± 
0.97 
Period of CR1 
(Hours ± SE) 
~30 ~30 ~30 
 
~30 ~30 
Constant 
Routine 2 
Acrophase 
(Time relative 
to the 25% 
DLMO ± SEM) 
-3.50 ± 
1.75 
-7.36 ± 
1.51 
-4.29 ± 
0.41 
-3.00* -1.00* 
-2.05 ± 
1.09 
Period of CR2 
(Hours ± SE) 
~30 ~30 25.0 ± 1.5 
  
19.4 ± 2.7 
Phase Shift 
(CR1-CR2) 
(Hours) 
10.00 12.89 6.33 10.00 6.25 8.68 
 
Net Phase Shift 
(Pulse - 
Control) 
(Hours) 
7.95 1.55 -3.12 7.39 -7.74 -4.32 
Table 3.9: Summary of plasma leptin acrophases, periods and phase shifts from the control and food pulse session of 
each food pulse group. The phase shift for each session and the net phase shift for each food pulse group are shown. The 
asterisks (*) denotes an estimated acrophase as a significant cosinor curve was not present for that constant routine. 
Negative phase shifts indicate a phase delay and positive phase shifts indicate a phase advance. The period of the cosine 
curve was determined by the model and had the constraint that the period could not be more than 30 hours. Periods 
identified as ~30 hours reached the constraint set. SE, standard error. 
Similarly, the 20:40 food pulse group produced an estimated phase advance of 13.00 hours 
for the control session and a phase advance of 8.68 hours for the food pulse session; this 
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meant a net phase delay of 4.32 hours to leptin rhythms when a food pulse was 
administered at 20:40. A 2-way LMEM-ANOVA found a significant effect of time for the food 
pulse session (food pulse F14,93 = 2.36, p<0.05; control F14,92 = 0.99, p>0.05), no effect of 
constant routine (control F1,92 = 0.03, food pulse F1,93 = 0.53, p>0.05) and a time x constant 
routine interaction for the food pulse session only (food pulse F11,93 = 4.37, p<0.05; control 
F12,92 = 1.74, p>0.05). 
The smallest net phase shifts to plasma leptin rhythms were observed when food pulses 
were administered at 04:40 (Figure 3.12). The phase shift observed in the control session 
was similar to that of the food pulse session, indicating that the protocol rather than the 
food pulse had the largest effect. The net phase shift was 1.55 hours for the 04:40 food 
pulse. A 2-way LMEM-ANOVA found no significant effect of time (04:40 – control F13,94 = 
1.63, food pulse F14,93 = 0.86, p>0.05), no effect of constant routine (04:40 – control F1,94 = 
0.39, food pulse F1,93 = 0.01, p>0.05) and a significant time x constant routine interaction 
(04:40 – control F11,94 = 2.79, food pulse F11,93 = 6.94, p<0.05). The phase shifts of the control 
and food pulse session for each food pulse group are shown in Figure 3.13. 
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Figure 3.13: Phase shifts observed over the course of a 3-day ultradian routine in z-scored plasma leptin concentrations 
for the control (white) and food pulse (black) sessions for each food pulse group. Phase was either from a significant 
cosinor curve fit, estimated by a significant cosinor curve fit or by the time of maximum glucose concentration. A positive 
value indicates a phase advance. 
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3.3.8 Effect of food pulse on triglyceride rhythms 
 
When assessing the effect of the control session on plasma TAG, a minimal phase delay of 
less than 0.7 hours was observed in rhythms. In addition, plasma TAG concentrations were 
found to be rhythmic at the individual level. However, as less than half of the participants  
(N = 10) has a significant cosinor curve fit (p<0.1) in all 4 constant routines, the data were 
separated into food pulse group in order to determine phase. Data were aligned to each 
individual’s 25% DLMO and grouped into 2-hour time bins. 
Plasma TAG concentrations were found to have significant circadian rhythms (CNLR p<0.05) 
in both the raw data (Appendix 3.3) and when z-scored (Figure 3.14). For phase assessment, 
the rhythms from the normalised z-scored plasma TAG data were used. All constant routines 
had a significant circadian rhythm (Figure 3.14). 
A summary of the acrophases, periods and phase shifts for each session and food pulse 
group can be viewed in Table 3.10. The largest phase shift in plasma TAG rhythms was seen 
for the 08:40 food pulse group (Figure 3.14) with a net phase delay of 7.17 hours to plasma 
TAG rhythms. The next largest phase shift was seen in the food pulse given 12 hours later at 
20:40 with a net phase delay of 4.57 hours The smallest net phase shift was seen when the 
food pulse was given at in the middle of the day at 12:40, as a delay of only 1.23 hours was 
observed to plasma TAG rhythms. The phase shifts of the control and food pulse session for 
each food pulse group are shown in Figure 3.15. 
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Figure 3.14: Z-scored plasma TAG concentrations rhythms had differences in phase when separated by food pulse group 
and split into the control session (left) and food pulse session (right). Mean grouped plasma TAG concentrations (z-
scored) from the control (left) and food pulse session (right) were assessed. Data were separated by time of food pulse, 
which was given at either 00:40, 04:40, 08:40, 12:40, 16:40 and 20:40. Significant circadian rhythms were determined by 
CNLR and depicted by the presence of a cosine curve (p<0.05). Timing of plasma TAG rhythms were most affected by food 
pulses given in the morning or evening (08:40 and 20:40). Data were grouped into 2-hour time bins relative to the 25% 
DLMO and are expressed as mean ± SEM. 
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    Food Pulse Group 
    00:40 04:40 08:40 12:40 16:40 20:40 
C
o
n
tr
o
l 
Constant 
Routine 1 
Acrophase 
(Time relative 
to the 25% 
DLMO ± SEM) 
4.84 ± 
0.80 
3.89 ± 
0.70 
7.10 ± 
11.69 
6.80 ± 
17.11 
4.28 ± 
0.54 
4.77 ± 
0.63 
Period of CR1 
(Hours ± SE) 
~30 30.0 ± 3.5 29.3 ± 2.2 ~30 26.6 ± 1.9 ~30 
Constant 
Routine 2 
Acrophase 
(Time relative 
to the 25% 
DLMO ± SEM) 
2.95 ± 
0.67 
6.26 ± 
0.99 
3.42 ± 
0.63 
5.28 ± 
1.20 
5.00 ± 
1.84 
4.07 ± 
0.69 
Period of CR2 
(Hours ± SE) 
18.5 ± 1.5 16.3 ± 2.0 20.7 ± 1.4 25.7 ± 2.6 18.4 ± 1.1 20.8 ± 1.9 
Phase Shift 
(CR1-CR2) 
(Hours) 
1.89 -2.37 3.68 1.52 -0.72 0.70 
Fo
o
d
 P
u
ls
e
 
Constant 
Routine 1 
Acrophase 
(Time relative 
to the 25% 
DLMO ± SEM) 
3.15 ± 
0.51 
3.61 ± 
0.58 
3.97 ± 
1.22 
4.99 ± 
0.85 
4.16 ± 
0.87 
2.15 ± 
0.59 
Period of CR1 
(Hours ± SE) 
26.2 ± 1.9 ~30 27.0 ± 4.5 28.6 ± 2.9 26.0 ± 3.0 27.0 ± 3.1 
Constant 
Routine 2 
Acrophase 
(Time relative 
to the 25% 
DLMO ± SEM) 
4.40 ± 
0.65 
4.26 ± 
0.41 
7.46 ± 
0.49 
4.70 ± 
7.40 
1.75 ± 
0.71 
6.02 ± 
0.58 
Period of CR2 
(Hours ± SE) 
~30 23.9 ± 1.4 20.6 ± 1.1 27.9 ± 3.8 ~30 25.4 ± 1.9 
Phase Shift 
(CR1-CR2) 
(Hours) 
-1.25 -0.65 -3.49 0.29 2.41 -3.87 
  
Net Phase 
Shift (Pulse - 
Control) 
(Hours) 
-3.14 1.72 -7.17 -1.23 3.13 -4.57 
Table 3.10: Summary of plasma TAG acrophases, periods and phase shifts from the control and food pulse session of 
each food pulse group. The phase shift for each session and the net phase shift for each food pulse group are shown. The 
asterisks (*) denotes an estimated acrophase as a significant cosinor curve was not present for that constant routine. 
Negative phase shifts indicate a phase delay and positive phase shifts indicate a phase advance. The period of the cosine 
curve was determined by the model and had the constraint that the period could not be more than 30 hours. Periods 
identified as ~30 hours reached the constraint set. SE, standard error. 
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Figure 3.15: Phase shifts observed over the course of a 3-day ultradian routine in z-scored plasma TAG concentrations 
for the control (white) and food pulse (black) sessions for each food pulse group. Phase was either from a significant 
cosinor curve fit or estimated by a significant cosinor curve fit. A negative value indicates a phase delay to the timing of 
rhythms whilst a positive value indicates a phase advance. 
 
A 2-way LMEM-ANOVA was conducted on all food pulse groups and there was a significant 
effect of time (p<0.05) and no significant effect of constant routine for all groups (p>0.05); 
for F values see Table 3.11. For the time x constant routine interaction, there was a 
significant effect in for both sessions of the food pulse groups 04:40 and 08:40 (p<0.05). In 
contrast, food pulse groups 12:40 and 16:40 food pulse group had no significant time x 
constant routine interaction (p>0.05). Food pulse group 00:40 had a significant time x 
constant routine interaction for the control session only (p<0.05), whilst food pulse group 
20:40 had a significant time x constant routine interaction for the food pulse session only 
(p<0.05). 
 
 
Session Time Constant Routine Time x Constant Routine 
00:40 
Control F13,76 = 5.16† F1,76 = 0.44 F13,76 = 2.06† 
Food Pulse F15,75 = 12.32† F1,75 = 0.005 F12,75 = 1.13 
04:40 
Control F13,102 = 4.63† F1,102 = 0.21 F12,102 = 2.86† 
Food Pulse F14,102 = 14.32† F1,102 = 0.37 F12,102 = 2.04† 
08:40 
Control F15,74 = 8.04† F1,74 = 0.01 F12,74 = 2.21† 
Food Pulse F15,74 = 4.52† F1,74 = 0.08 F12,74 = 2.89† 
12:40 
Control F15,73 = 7.76† F1,73 = 0.02 F14,73 = 1.05 
Food Pulse F15,75 = 8.11† F1,75 = 0.008 F12,75 = 1.07 
16:40 
Control F15,100 = 10.85† F1,100 = 0.01 F12,100 = 1.19 
Food Pulse F14,102 = 4.73† F1,102 = 0.001 F12,102 = 0.84 
20:40 
Control F14,102 = 6.82† F1,102 = 8.18 x 10
-6 F12,102 = 1.37 
Food Pulse F15,101 = 7.03† F1,101 = 0.02 F12,101 = 1.94† 
Table 3.11: Z-scored plasma TAG 2-way LMEM-ANOVA F values. † indicates a p<0.05. 
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3.3.9 Effect of food pulse on whole blood mRNA expression of core clock genes 
 
Assessment of the relative mRNA expression of BMAL1 did not show a high prevalence of 
significant circadian rhythms at the individual level (Table 3.6 and Table 3.7), nor when 
grouped by food pulse (Appendix 3.4 and Appendix 3.5). Due to the lack of significant 
individual rhythms, there is a greater variation at each time point, increasing the likelihood 
of inaccurate phase estimation. Therefore, phase assessment on BMAL1 relative expression 
was not carried out.  
As the most rhythmic peripheral measure was whole blood PER3 relative mRNA expression 
(Table 3.6 and Table 3.7), a PRC was generated using the individual phase shift data. As 
many participants had a significant cosine curve fit when the period was set to 24 hours in 3 
out of 4 constant routines, the p value cut off was relaxed to 0.1; this increased the number 
of participants for assessment from 9 to 15. As with the net phase shift of the DLMO timing, 
a PRC for individual shifts for PER3 was generated but did not show a clear direction or 
magnitude in the phase shifts in response to each food pulse (Figure 3.16A); it also did not 
have a clear fit for a dual harmonic function. The largest phase advance was 4.59 hours, 
whilst the largest phase delay was -5.60 hours. When the net phase shift data was grouped 
by food pulse, minimal phase advances were seen to the rhythms (Figure 3.16B). The 
majority of the net phase shifts were phase delays with maximal delay of 2.29 hours when 
the food pulse was administered at 16:40. 
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Figure 3.16: A phase response curve of the net shift of the timing of PER3 relative mRNA expression to food pulse 
revealed no clear direction or magnitude of phase shift in response to each food pulse. (A) The net phase shift of the 
timing of PER3 relative mRNA expression did not have a clear phase response curve to food pulse timing. (B) The average 
phase shift for each food pulse was double plotted to the time of the food pulse relative to the average DLMO of the 
group. No phase response curve was generated on the group data, but the largest net phase shift was seen when food was 
administered prior to the 25% DLMO. 
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Although a PRC was attempted with the individual PER3 relative mRNA expression, the 
grouped data was also revealing (Figure 3.17, 2-δδCT). A 2-way LMEM-ANOVA found a 
significant effect of time for all sessions (p<0.05) and no significant time x constant routine 
interaction (p>0.05); see Table 3.12 for F values. There was a significant effect of constant 
routine in both sessions of the 12:40 and 20:40 food pulse groups (p<0.05). This coincided 
with a reduction in the mesor (12:40 – control 1.72 ± 0.09 and 1.58 ± 0.08 2-δδCT, food pulse 
1.97 ± 0.11 and 1.59 ± 0.09 2-δδCT; 20:40 – control 1.84 ± 0.09 and 1.26 ± 0.06 2-δδCT, food 
pulse 1.61 ± 0.10 and 1.38 ± 0.06 2-δδCT, for the first and second constant routine, 
respectively) and amplitude for the second constant routine of both sessions (12:40 – 
control 0.53 ± 0.13 and 0.47 ± 0.11 2-δδCT, food pulse 0.75 ± 0.16 and 0.43 ± 0.12 2-δδCT; 20:40 
– control 0.60 ± 0.13 and 0.41 ± 0.09 2-δδCT, food pulse 0.60 ± 0.14 and 0.48 ± 0.08 2-δδCT, for 
the first and second constant routine, respectively).  
A reduction in mesor (1.77 ± 0.09 and 1.62 ± 0.10 2-δδCT)  and amplitude (0.51 ± 0.13 and 
0.39 ± 0.13 2-δδCT) was also evident for the control session of the 16:40 food pulse group and 
this also had a significant effect of constant routine in the 2-way LMEM-ANOVA (p<0.05). 
Interestingly, the food pulse session of the 00:40 food pulse group had an increase in mesor 
(1.17 ± 0.05 and 1.73 ± 0.09 2-δδCT) and amplitude (0.33 ± 0.07 and 0.35 ± 0.14 2-δδCT) in the 
second constant routine (Figure 3.17 - right); this also had a significant effect of constant 
routine (p<0.05). There was no change in the mesor or amplitude for either session in the 
08:40 food pulse group (Figure 3.17) (2-way LMEM-ANOVA, constant routine, p>0.05).  
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Figure 3.17: Whole blood PER3 relative mRNA expression (2
-δδCT
) rhythms had little difference in phase, but differences 
in amplitude, when separated by food pulse group and split into the control session (left) and food pulse session (right). 
Mean grouped whole blood PER3 relative mRNA expression (2
-δδCT
) from the control (left) and food pulse session (right) 
were assessed. Data were separated by time of food pulse, which was given at either 00:40, 04:40, 08:40, 12:40, 16:40 and 
20:40. Significant circadian rhythms were determined by CNLR and depicted by the presence of a cosine curve (solid lines: 
p<0.05, dashed line: p<0.1 but >0.05). Data were grouped into 2-hour time bins relative to the 25% DLMO and are 
expressed as mean ± SEM. 
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Session Time Constant Routine Time x Constant Routine 
00:40 
Control F13,66 = 9.14† F1,66 = 0.58 F11,66 = 0.68 
Food Pulse F14,57 = 3.13† F1,57 = 39.14† F11,57 = 0.96 
04:40 
Control F13,86 = 2.91† F1,86 = 5.77† F11,86 = 0.36 
Food Pulse F14,84 = 2.94† F1,84 = 1.53 F11,84 = 0.38 
08:40 
Control F13,64 = 5.00† F1,64 = 3.58 F11,64 = 0.53 
Food Pulse F13,59 = 3.67† F1,59 = 1.58 F11,59 = 0.51 
12:40 
Control F14,63 = 7.92† F1,63 = 4.92† F12,63 = 0.61 
Food Pulse F13,60 = 10.04† F1,60 = 16.27† F12,60 = 1.40 
16:40 
Control F14,83 = 3.86† F1,83 = 4.67† F12,83 = 0.43 
Food Pulse F13,88 = 7.22† F1,88 = 0.20 F11,88 = 1.30 
20:40 
Control F14,87 = 4.60† F1,87 = 22.94† F12,87 = 0.39 
Food Pulse F14,87 = 8.98† F1,87 = 8.28† F11,87 = 0.55 
Table 3.12: PER3 relative mRNA expression 2-way LMEM-ANOVA F values. † indicates a p<0.05. 
 
In addition to the differences in amplitude, the PER3 relative mRNA expression z scored data 
revealed that the largest net phase shifts were in the 00:40, 16:40 and 20:40 food pulse 
groups (Figure 3.18). A summary of acrophases, period and phase shifts can be seen in and 
Table 3.13. A net phase delay of 1.40, 1.93 and 1.48 hours was seen in z-scored PER3 
relative mRNA expression when a food pulse was administered at 00:40, 16:40 and 20:40, 
respectively. The smallest net phase shift observed in PER3 relative mRNA expression 
rhythms was for the 04:40 food pulse group, where the net phase advance was 0.82 hours 
(Figure 3.18). The phase shifts of the control and food pulse session for each food pulse 
group are shown in Figure 3.19. 
A 2-way LMEM-ANOVA was carried out on all food pulse groups and a significant effect was 
found for time (p<0.05) but no significant effect was seen for constant routine (p>0.05) or a 
time x constant routine interaction (p>0.05); see Table 3.14 for F values. 
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Figure 3.18: Z-scored whole blood PER3 relative mRNA expression rhythms had little difference in phase when separated 
by food pulse group and split into the control session (left) and food pulse session (right). Mean grouped whole blood 
PER3 relative mRNA expression (z-scored) from the control (left) and food pulse session (right) were assessed. Data were 
separated by time of food pulse, which was given at either 00:40, 04:40, 08:40, 12:40, 16:40 and 20:40. Significant 
circadian rhythms were determined by CNLR and depicted by the presence of a cosine curve (p<0.05). Data were grouped 
into 2-hour time bins relative to the 25% DLMO and are expressed as mean ± SEM. 
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    Food Pulse Group 
    00:40 04:40 08:40 12:40 16:40 20:40 
C
o
n
tr
o
l 
Constant 
Routine 1 
Acrophase 
(Time relative 
to the 25% 
DLMO ± SEM) 
4.84 ± 
1.36 
4.88 ± 
1.01 
3.79 ± 
0.60 
5.87 ± 
0.73 
5.79 ± 
3.89 
5.78 ± 
0.44 
Period of CR1 
(Hours ± SE) 
21.2 ± 1.0 23.5 ± 2.4 22.9 ± 1.5 24.9 ± 1.6 22.3 ± 1.8 22.9 ± 1.2 
Constant 
Routine 2 
Acrophase 
(Time relative 
to the 25% 
DLMO ± SEM) 
5.33 ± 
1.13 
4.36 ± 
0.45 
3.48 ± 
0.49 
4.45 ± 
0.46 
4.43 ± 
0.85 
4.72 ± 
0.33 
Period of CR2 
(Hours ± SE) 
23.3 ± 1.2 21.5 ± 1.3 22.5 ± 1.7 22.8 ± 1.2 22.7 ± 3.6 20.6 ± 1.0 
Phase Shift 
(CR1-CR2) 
(Hours) 
-0.49 0.52 0.31 1.42 1.36 1.06 
Fo
o
d
 P
u
ls
e
 
Constant 
Routine 1 
Acrophase 
(Time relative 
to the 25% 
DLMO ± SEM) 
5.63 ± 
0.46 
5.07 ± 
1.08 
3.42 ± 
0.47 
4.63 ± 
31.6 
3.48 ± 
0.45 
4.76 ± 
0.43 
Period of CR1 
(Hours ± SE) 
21.9 ± 1.6 20.6 ± 1.4 21.5 ± 1.1 21.4 ± 1.1 20.6 ± 1.1 22.6 ± 1.0 
Constant 
Routine 2 
Acrophase 
(Time relative 
to the 25% 
DLMO ± SEM) 
7.52 ± 
1.03 
3.73 ± 
0.95 
4.30 ± 
0.77 
4.47 ± 
0.53 
4.05 ± 
0.58 
5.18 ± 
3.14 
Period of CR2 
(Hours ± SE) 
22.8 ± 2.8 20.2 ± 2.7 27.0 ± 3.5 22.3 ± 1.3 21.3 ± 2.2 21.8 ± 1.0 
Phase Shift 
(CR1-CR2) 
(Hours) 
-1.89 1.34 -0.88 0.16 -0.57 -0.42 
  
Net Phase 
Shift (Pulse - 
Control) 
(Hours) 
-1.40 0.82 -1.19 -1.26 -1.93 -1.48 
Table 3.13: Summary of z-scored whole blood PER3 relative mRNA expression acrophases, periods and phase shifts from 
the control and food pulse session of each food pulse group. The phase shift for each session and the net phase shift for 
each food pulse group are shown. Negative phase shifts indicate a phase delay and positive phase shifts indicate a phase 
advance. The period of the cosine curve was determined by the model and had the constraint that the period could not be 
more than 30 hours. SE, standard error. 
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Figure 3.19: Phase shifts observed over the course of a 3-day ultradian routine in z-scored whole blood PER3 relative 
mRNA expression for the control (white) and food pulse (black) sessions for each food pulse group. Phase was from a 
significant cosinor curve fit. A negative value indicates a phase delay to the timing of rhythms whilst a positive value 
indicates a phase advance. 
 
 
Session Time Constant Routine Time x Constant Routine 
00:40 
Control F13,69 = 19.10† F1,69 = 0.008 F11,69 = 1.44 
Food Pulse F14,60 = 4.70† F1,60 = 0.006 F11,60 = 1.48 
04:40 
Control F13,90 = 6.15† F1,90 = 0.01 F11,90 = 0.40 
Food Pulse F14,88 = 3.98† F1,88 = 0.002 F11,88 = 0.64 
08:40 
Control F13,67 = 13.93† F1,67 = 0.04 F11,67 = 1.17 
Food Pulse F13,62 = 12.19† F1,62 = 0.43 F11,62 = 1.49 
12:40 
Control F14,66 = 15.51† F1,66 = 0.006 F12,66 = 1.16 
Food Pulse F13,63 = 16.52† F1,63 = 0.0003 F12,63 = 1.08 
16:40 
Control F14,87 = 4.78† F1,87 = 0.10 F12,87 = 0.72 
Food Pulse F13,92 = 9.49† F1,92 = 0.22 F11,92 = 1.71 
20:40 
Control F14,91 = 15.97† F1,91 = 0.27 F12,91 = 0.70 
Food Pulse F14,91 = 15.70† F1,91 = 0.42 F11,91 = 0.47 
Table 3.14: PER3 z-scored relative mRNA expression 2-way LMEM-ANOVA F values. † indicates a p<0.05. 
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For REVERB-β relative mRNA expression, there were many significant circadian rhythms for 
the raw data (Figure 3.20, CNLR, p<0.05). A 2-way LMEM-ANOVA found a significant effect 
of time for all food pulse groups (p<0.05) apart from the control session of the 16:40 food 
pulse group and the food pulse session of the 00:40 and 20:40 group (p>0.05); see Table 
3.15 for a summary of the F values. There was a significant effect of constant routine for 
both sessions of the 04:40 food pulse group, the control session of the 16:40 and 20:40 food 
pulse groups and the food pulse session of the 00:40 and 12:40 group (p<0.05). No 
significant time x constant routine interaction was seen for any group (p>0.05). 
To be consistent with other datasets, the phase assessment was carried out in the z-scored 
data (Figure 3.21). A summary of the acrophases, period and the phase shifts can be seen in 
Table 3.16. Interestingly, the smallest net phase shift to REVERB-β relative mRNA expression 
was an advance of 0.02 hours in the 04:40 food pulse group, the same food pulse time that 
gave the smallest net phase shift in PER3 relative mRNA rhythms (Figure 3.18 and Figure 
3.21). The largest net phase advance of 3.28 hours for REVERB-β relative mRNA expression 
rhythms was when the food pulse was administered at 12:40. The largest net phase delay 
was 2.09 hours when the food pulse was administered at 08:40. The phase shifts of the 
control and food pulse session for each food pulse group are shown in Figure 3.22. 
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Figure 3.20: Whole blood REVERB-β relative mRNA expression (2
-δδCT
) rhythms had little difference in phase, but 
differences in amplitude, when separated by food pulse group and split into the control session (left) and food pulse 
session (right). Mean grouped whole blood REVERB-β relative mRNA expression (2
-δδCT
) from the control (left) and food 
pulse session (right) were assessed. Data were separated by time of food pulse, which was given at either 00:40, 04:40, 
08:40, 12:40, 16:40 and 20:40. Significant circadian rhythms were determined by CNLR and depicted by the presence of a 
cosine curve (solid lines: p<0.05, dashed line: p<0.1 but >0.05). Data were grouped into 2-hour time bins relative to the 
25% DLMO and are expressed as mean ± SEM. 
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Session Time Constant Routine Time x Constant Routine 
00:40 
Control F13,66 = 2.77† F1,66 = 1.54 F11,66 = 0.51 
Food Pulse F14,57 = 1.16 F1,57 = 18.13† F11,57 = 0.94 
04:40 
Control F13,86 = 2.12† F1,86 = 5.93† F11,86 = 0.80 
Food Pulse F14,84 = 2.04† F1,84 = 7.30† F11,84 = 0.92 
08:40 
Control F13,64 = 2.56† F1,64 = 3.13 F11,64 = 0.46 
Food Pulse F13,59 = 2.08† F1,59 = 2.71 F11,59 = 1.38 
12:40 
Control F14,63 = 2.05† F1,63 = 0.005 F12,63 = 0.64 
Food Pulse F13,61 = 3.56† F1,61 = 5.67† F12,61 = 1.07 
16:40 
Control F14,83 = 1.34 F1,84 = 5.21† F12,83 = 0.77 
Food Pulse F13,88 = 3.01† F1,88 = 3.02 F11,88 = 1.07 
20:40 
Control F14,87 = 3.21† F1,87 = 13.37† F12,87 = 0.70 
Food Pulse F14,87 = 1.66 F1,87 = 0.99 F11,87 = 0.77 
Table 3.15: REVERB-β relative mRNA expression 2-way LMEM-ANOVA F values. † indicates a p<0.05. 
 
A 2-way LMEM-ANOVA was carried out on all food pulse groups and a significant effect was 
found for time for all groups apart from the control session from the 16:40 food pulse 
(p<0.05). There was no significant effect of constant routine for all food pulse groups 
(p>0.05) and no significant time x constant routine interaction for the food pulse groups 
(p>0.05) apart from the food pulse session of the 08:40 food pulse session (p<0.05); see 
Table 3.17 for F values. 
Whole blood GR relative mRNA expression did not have a high incidence of significant 
circadian rhythms at the individual level (Table 3.6 and Table 3.7) or at the grouped level 
when separated into food pulse groups (Appendix 3.6 and Appendix 3.7). GR relative mRNA 
expression was selected as a target due to the rhythmic nature of its ligand, cortisol, as well 
as the involvement that cortisol has on food entrainment in rodents. These results indicate 
that relative mRNA expression of GR is not circadian in whole blood in our data set and 
phase assessment would not be accurate. Therefore, no further analysis was conducted to 
determine the phase shifting effect that food has on its rhythm. 
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Figure 3.21: Z-scored whole blood REVERB-β relative mRNA expression rhythms had little difference in phase when 
separated by food pulse group and split into the control session (left) and food pulse session (right). Mean grouped 
whole blood PER3 relative mRNA expression (z-scored) from the control (left) and food pulse session (right) were assessed. 
Data were separated by time of food pulse, which was given at either 00:40, 04:40, 08:40, 12:40, 16:40 and 20:40. 
Significant circadian rhythms were determined by CNLR and depicted by the presence of a cosine curve (p<0.05). Data 
were grouped into 2-hour time bins relative to the 25% DLMO and are expressed as mean ± SEM. 
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    Food Pulse Group 
    00:40 04:40 08:40 12:40 16:40 20:40 
C
o
n
tr
o
l 
Constant 
Routine 1 
Acrophase 
(Time relative 
to the 25% 
DLMO ± SEM) 
2.79 ± 
0.78 
1.83 ± 
0.69 
1.62 ± 
0.61 
1.78 ± 
0.96 
3.00* 
2.46 ± 
0.71 
Period of CR1 
(Hours ± SE) 
24.1 ± 2.8 23.3 ± 2.5 20.6 ± 1.6 27.3 ± 4.3 
 
26.4 ± 3.8 
Constant 
Routine 2 
Acrophase 
(Time relative 
to the 25% 
DLMO ± SEM) 
2.99 ± 
0.74 
0.56 ± 
0.55 
1.13 ± 
0.57 
3.44 ± 
1.15 
1.52 ± 
0.65 
2.42 ± 
0.47 
Period of CR2 
(Hours ± SE) 
20.8 ± 2.5 23.9 ± 3.9 21.3 ± 2.8 21.2 ± 3.0 ~30 20.5 ± 2.0 
Phase Shift 
(CR1-CR2) 
(Hours) 
-0.20 1.27 0.49 -1.66 1.48 0.04 
Fo
o
d
 P
u
ls
e
 
Constant 
Routine 1 
Acrophase 
(Time relative 
to the 25% 
DLMO ± SEM) 
3.09 ± 
1.10 
2.89 ± 
0.71 
1.09 ± 
0.71 
2.86 ± 
0.59 
0.68 ± 
0.65 
1.84 ± 
1.01 
Period of CR1 
(Hours ± SE) 
24.1 ± 3.5 22.2 ± 2.0 23.3 ± 3.2 20.8 ± 1.4 19.4 ± 2.0 25.0 ± 5.1 
Constant 
Routine 2 
Acrophase 
(Time relative 
to the 25% 
DLMO ± SEM) 
1.00* 
1.60 ± 
0.63 
2.69 ± 
0.73 
1.24 ± 
0.78 
0.57 ± 
0.82 
3.41 ± 
0.64 
Period of CR2 
(Hours ± SE)  
18.8 ± 2.0 24.4 ± 3.7 23.3 ± 3.5 17.1 ± 2.0 25.4 ± 3.6 
Phase Shift 
(CR1-CR2) 
(Hours) 
2.09 1.29 -1.60 1.62 0.11 -1.57 
  
Net Phase 
Shift (Pulse - 
Control) 
(Hours) 
2.29 0.02 -2.09 3.28 -1.37 -1.61 
Table 3.16: Summary of whole blood REVERB-β relative mRNA expression acrophases, periods and phase shifts from the 
control and food pulse session of each food pulse group. The phase shift for each session and the net phase shift for each 
food pulse group are shown. The asterisks (*) denotes an estimated acrophase as a significant cosinor curve was not 
present for that constant routine. Negative phase shifts indicate a phase delay and positive phase shifts indicate a phase 
advance. The period of the cosine curve was determined by the model and had the constraint that the period could not be 
more than 30 hours. Periods identified as ~30 hours reached the constraint set. SE, standard error. 
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Figure 3.22: Phase shifts observed over the course of a 3-day ultradian routine in z-scored whole blood REVERB-β 
relative mRNA expression for the control (white) and food pulse (black) sessions for each food pulse group. Phase was 
either from a significant cosinor curve fit, estimated by a significant cosinor curve fit or by the or by the time of maximum 
REVERB-β expression. A negative value indicates a phase delay to the timing of rhythms whilst a positive value indicates a 
phase advance. 
 
 
 
 
Session Time Constant Routine Time x Constant Routine 
00:40 
Control F13,69 = 3.88† F1,69 = 0.06 F11,69 = 0.69 
Food Pulse F14,60 = 2.25† F1,60 = 0.04 F11,60 = 1.07 
04:40 
Control F13,90 = 8.56† F1,90 = 0.07 F11,90 = 1.55 
Food Pulse F14,88 = 4.85† F1,88 = 0.26 F11,88 = 1.02 
08:40 
Control F13,67 = 6.89† F1,67 = 0.08 F11,67 = 0.52 
Food Pulse F13,62 = 7.00† F1,62 = 0.03 F11,62 = 2.32† 
12:40 
Control F14,66 = 3.66† F1,66 = 0.10 F12,66 = 0.96 
Food Pulse F13,64 = 4.93† F1,64 = 0.04 F12,64 = 1.12 
16:40 
Control F14,87 = 1.70 F1,87 = 0.03 F12,87 = 0.91 
Food Pulse F13,92 = 4.29† F1,92 = 0.93 F11,92 = 1.35 
20:40 
Control F14,91 = 6.34† F1,91 = 0.005 F12,91 = 1.01 
Food Pulse F14,91 = 4.41† F1,91 = 0.03 F11,91 = 1.00 
Table 3.17: REVERB-β z-scored relative mRNA expression 2-way LMEM-ANOVA F values. † indicates a p<0.05. 
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To summarise the effect of food pulses on the phase of circadian rhythms, the net phase 
shift from the more circadian measures have been plotted (Figure 3.23). The largest phase 
shifts for plasma glucose and leptin occurred when food pulses were administered in the 
evening, whilst plasma TAG had the largest phase shift when food was given at 08:40 and 
20:40 (Figure 3.23A). In contrast, the net phase shifts seen in whole blood PER3 and 
REVERB-β relative mRNA expression were far smaller and were less affected by food pulses 
(Figure 3.23B). 
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Figure 3.23: Summary of the net phase shifts seen for biochemical markers (A) and gene expression (B) measures that 
were circadian at the group level against the time of the food pulse. 
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3.4 Discussion 
 
This study identified the impact of a three-pulse food pulse on the human circadian system 
when food was administered at different times over the circadian phase. During the control 
session, where 2-hourly isocaloric snacks were given under a 4-hour ultradian routine, a 
significant phase delay was seen for the marker of central phase, the timing of the 25% 
DLMO. Large phase shifts were seen in plasma glucose, leptin and NEFA rhythms, but 
minimal changes were seen in plasma TAG and whole blood relative mRNA expression 
rhythms. In addition, the control session caused changes to the period of rhythms and 
significant reductions in the mesor and amplitude of rhythms over the course of the 
protocol. 
PRCs were generated for the individual net phase shifts of saliva melatonin and whole blood 
PER3 relative mRNA expression, but no clear direction or magnitude was seen to the phase 
shifts in response to a large food pulse. The largest magnitude phase shifts were seen in 
grouped plasma glucose and leptin rhythms, whilst smaller phase shifts were seen for the 
robustly circadian plasma TAG and whole blood PER3 and REVERB-β relative mRNA 
expression rhythms. Overall, the results indicated that the response to a food pulse differs 
between tissues and measures, highlighting the differential effect that meal timing has on 
the human circadian system.  
3.4.1 Participants 
 
The inclusion criteria for this study ensured that individuals who may have had extreme 
diurnal preference or undergone periods of circadian desynchrony were not selected for the 
study. This would minimise the phase of entrainment between individuals and variation 
within and between the food pulse groups. There were no significant differences between 
age, BMI, sleep time, wake time or the validated questionnaires responses between the 
participants of the food pulse groups. This indicated that each food pulse group was well 
matched for chronotype, circadian phase and metabolic profile. 
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3.4.2 Efficacy of the pre-study protocol 
 
This study was a within-subject counterbalanced design, used in previous human phase 
response curve experiments (Burgess et al. 2008; Burgess et al. 2010; Revell et al. 2012), and 
the pre-study protocol was important to minimise variation within individuals and between 
sessions. As with previous human chronobiology studies, participants were required to 
maintain a strict sleep/wake schedule during the pre-study protocol (Shea et al. 2005; 
Scheer et al. 2009; Burgess et al. 2010; Wehrens et al. 2010; Otway et al. 2011; Revell et al. 
2012; Davies et al. 2014). Assessment of melatonin in the first constant routine from both 
sessions revealed that there were no significant differences in the timing of the 25% DLMO, 
indicating that the strict sleep/wake and light exposure schedule helped to maintain 
circadian phase.  
Differently to previous studies cited using this ultradian protocol, the timing of meals was 
regulated to specific time windows and the food and amount consumed was noted down in 
diet diaries. The diet diary from their first pre-study protocol session was photocopied to be 
followed for their second pre-study protocol session. Furthermore, 3 days prior to the study 
participants were given food by the study team, similar to other experiments (McHill et al. 
2014). Assessment of the biochemical molecules, glucose and NEFA, and the appetite 
hormone leptin showed phase differences of less than 1 hour between the two sessions; for 
glucose the phase difference was only 0.07 hours. Importantly, the period of plasma glucose 
and leptin rhythms was also maintained between the two sessions; NEFA had period 
differences of approximately 3 hours. For z-scored plasma TAG concentration there was a 
phase difference of 1.55 hours, but the period of the rhythms was consistent between the 
two sessions. These small differences indicate that both the meal timing and the replication 
of the diet in the pre-study protocol minimised differences to these key biological 
molecules. This is important for the interpretation of how the food pulse affects the human 
circadian system. 
Of the genes measured in whole blood, the only gene to show a phase difference of more 
than an hour was BMAL1 relative mRNA expression. However, a 2-way LMEM-ANOVA did 
not show a significant time x session interaction suggesting that the phase difference was 
not a significant source of variation. Possible reasons for this phase advance between the 
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two sessions may be due to the large individual variation seen for BMAL1 relative mRNA 
expression (Archer et al. 2008; Lech et al. 2016). Such variation will impact on the fit of a 
rhythm and therefore the phase assessment. However, the period of all whole blood 
relative mRNA expression rhythms was the same between the two sessions. This further 
indicates that the pre-study protocol maintained the phase and period of the rhythms 
measured, and subsequent differences in phase would not be a result of different session. 
3.4.3 Effect of control session on rhythms 
 
A comparison of the first and second constant routines from the control protocol revealed 
marked phase and period differences for certain measures. Assessment of the 25% DLMO 
found a significant phase delay of 0.78 hours in the central clock due to the protocol. This 
indicated that on average, melatonin phase was delayed by 0.26 hours per day. As the 
ultradian protocol aimed to be outside the range of entrainment, the delay in melatonin 
was expected as the protocol is believed to induce free-running rhythms similar to forced 
desynchrony protocols (Burgess & Eastman 2008). The average human tau is approximately 
24.18 ± 0.04 hours (Czeisler et al. 1999), as assessed using melatonin, cortisol and core body 
temperature, and indicates that a rhythm that is free-running will have a daily delay in the 
timing of the rhythm as the period is more than 24 hours. Using this protocol, it has been 
previously reported that the average tau was 24.22 hours (Burgess & Eastman 2008) and 
the results reported here indicate an average tau of 24.26 hours, suggesting reproducibility 
in estimating human tau from this protocol. 
Some rhythms shifted a similar magnitude to that seen in the central clock, whilst others 
rhythms shifted a much larger magnitude over the course of the session. Plasma TAG 
concentrations had a phase advance of 0.6 hours in the control protocol which was similar 
in magnitude to saliva melatonin. However, there was a shortening of the period of plasma 
TAG rhythms after the ultradian routine, indicating that although the phase was maintained, 
the rhythm was affected. Plasma TAG concentrations in this study were found to rise around 
the time of the 25% DLMO and peak in the early morning. This is similar to rhythms of TAG 
seen in other constant routine studies (Morgan et al. 1998; Chua et al. 2013).  
The relative mRNA expression of the core clock genes PER3 and REVERB-β also had phase 
shifts of a similar magnitude to the central clock over the course of the session. PER3 
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relative mRNA expression in whole blood has been shown to phase shift after exposure to 
blue light (Ackermann et al. 2009), and the phase of PER3 is known to correlate with the 
timing of melatonin (Archer et al. 2008) suggesting that this could be a SCN-clock driven 
rhythm. Further to this, the period of the whole blood PER3 relative mRNA rhythm was 
close to 24 hours (~22 hours) and was maintained after the ultradian protocol, suggestive of 
input from the central clock.  
Plasma glucose concentration rhythms showed the largest phase delay, with 7.8 hours for 
raw data and 9.4 hours for z-scored data, as a result of the control session. Due to the large 
difference in magnitude with the phase shift seen in the central clock over the course of the 
session, it is clear that this shift was being driven by mechanisms outside of the SCN central 
clock; the protocol caused the uncoupling of the central clock to some peripheral rhythms. 
This uncoupling is further emphasised by a change to the period of the plasma glucose 
rhythm, with a shortening occurring after the ultradian protocol; this is in contrast to the 
PER3 period. 
A large shift in glucose rhythms and period has not been previously observed under these 
conditions before. Previous studies using this ultradian protocol were not assessing glucose 
rhythms and did not regulate meal timing or calorific intake (Burgess et al. 2008; Burgess et 
al. 2010; Revell et al. 2012). Studies using forced desynchrony protocols found changes in 
glucose homeostasis and altered postprandial responses when food was consumed under 
circadian misalignment (Morgan et al. 1998; Lund et al. 2001; Scheer et al. 2009; Buxton et 
al. 2012). However, a key difference between the studies is that this study gave isocaloric 
snacks at 2-hourly intervals throughout the study, whilst others gave a few meals at the 
same time relative to wake; this is in part because this study used a constant routine 
protocol as opposed to a forced desynchrony protocol. Therefore, this shift in glucose may 
be due to the meal frequency and sustained post-absorptive state across the circadian cycle. 
Plasma NEFA had a 7.8 hour phase advance to its rhythm with the acrophase of the first 
constant routine being in the early evening at -3.75 ± 0.54 hours relative to the 25% DLMO. 
In contrast to plasma glucose, the period of the NEFA rhythm was unchanged by the 
ultradian protocol and remained at ~30 hours. However, as only one 24-hour cycle of data 
was collected, the accuracy of estimating changes to periods of more than 30 hours is 
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limited. Although NEFA is thought to have diurnal variation with increases at night, there 
has not been a consistently reported circadian rhythm or acrophase in the literature 
(Morgan et al. 1998). This could in part be because the concentration of plasma NEFA is 
affected by many factors, such as insulin, which suppresses the hydrolysis of TAG into NEFA, 
and NEFA utilisation by peripheral organs such as muscle (Frayn et al. 1996). This could 
result in more variability in NEFA concentration and make it harder to assign a phase. As 
with glucose, NEFA has not been assessed under such conditions but is known to be affected 
by meal timing (Fielding et al. 1996; Frayn et al. 1996). The advance in the rhythm from the 
control session may also be due to the meal frequency. 
Plasma leptin also had a phase advance to rhythms, with a shift of 10.7 hours during the 
control session. Similarly to glucose, plasma leptin had a shorter period following the 
ultradian protocol, suggesting that this too was a food entrained rhythm. The first constant 
routine had a rise in leptin rhythms beginning at the 25% DLMO and a peak in the early 
morning at 6.35 ± 0.76 hours relative to the 25% DLMO. There have been contradictions 
within the literature for the timing of the acrophase, with a constant routine analysis 
showing a peak around the time of wake (Shea et al. 2005) whilst constant enteral nutrition 
resulted in a peak at night (Simon et al. 1998); our reported peak for leptin is earlier than in 
other constant routines (Shea et al. 2005).  
Plasma leptin rhythms are known to be affected by the circadian clock (Shea et al. 2005), 
meal timing (Schoeller et al. 1997) and sleep (Simon et al. 1998). Studies that assessed meal 
timing on plasma leptin rhythms gave a few distinct meals over the wake period and not at 
2-hourly intervals across the day as seen in this study. One forced desynchrony study did not 
identify a significant circadian rhythm in plasma leptin levels, but did report a decrease in 
concentration when individuals’ sleep/wake and circadian clock were misaligned (Scheer et 
al. 2009). The cause of the large phase shift for leptin is likely to be a combination of both 
the meal frequency and the alteration of the sleep/wake cycle. 
Although meal frequency in a constant routine is thought to unmask the effect of larger 
meals on the circadian system (Duffy & Dijk 2002), maintaining this meal frequency across 
multiple days has not been assessed. Having multiple small meals may result in a sustained 
post absorptive state and removes a large period of fasting. Days of multiple meals in an 
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ultradian routine may result in the free-running of food entrained rhythms, perhaps due to 
the reduced amplitude of the feeding and fasting state. These results show that frequent 
meals in an ultradian routine outside the range of entrainment uncouple food driven 
rhythms from SCN-driven rhythms. Further investigation is needed to assess how the 
hormones regulating glucose homeostasis and glucose uptake by tissues may differ under 
periods of high meal frequency.  
A significant reduction was seen in the mesor and amplitude over the course of the session 
for all rhythms, apart from plasma glucose and leptin, as indicated by a significant effect of 
constant routine in the 2-way LMEM-ANOVA. This indicated that the ultradian routine 
attenuated circadian rhythms. This again could be due to the lack of a clear feeding and 
fasting rhythm and the circadian disruption over multiple days. Prior to the session, 
participants had a strict sleep/wake cycle and had to eat within certain time windows, 
enhancing their circadian resonance going into the first constant routine.  
3.4.4 Effect of food pulse on rhythms 
 
The overall aim of this study was to construct PRCs on central and peripheral circadian 
rhythms in response to food pulses. The hypothesis was that similar to other non-photic 
zeitgebers, such as exogenous melatonin and exercise, a pulse given before the DLMO 
would cause a phase advance to rhythms, whilst a food pulse after would cause a phase 
delay to rhythms (Mistlberger & Skene 2005; Burgess et al. 2008; Burgess et al. 2010). 
Furthermore, it was hypothesised that meal timing would affect the phase of peripheral, but 
not central, circadian clocks similar to the work seen in rodents with ad libitum food 
quantity (Damiola et al. 2000).  
An attempt to construct a PRC of both 25% DLMO and PER3 relative mRNA expression was 
found to not fit a dual harmonic sine function, indicating that food pulses did not have 
consistent effects on rhythms. This is perhaps expected as it was hypothesised that food 
pulses would cause phase shifts to peripheral, but not central, clocks. The food pulse that 
resulted in the largest net phase shift to the timing of the 25% DLMO was 00:40 as it caused 
an average phase advance of 0.86 hours over the session, or an average shift of 0.29 hours a 
day. Compared with the non-photic zeitgeber, exercise, which found phase changes in 
melatonin onset of around an hour in response to a single 1 hour bout of high intensity 
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exercise (Buxton et al. 2003), the phase change in melatonin as a result of food pulses is 
smaller. Furthermore, the direction of the phase shift at night is the opposite as night time 
exercise caused a delay in melatonin onset, whilst a food pulse at 00:40 caused an advance 
(Buxton et al. 2003). This suggests that food may act differently to other non-photic 
zeitgebers.  
For PER3 relative mRNA expression, the majority of phase shifts were delays, indicating that 
there was a limited advance portion to the response of food. The largest delay was seen 
when the food pulse was given at 16:40 which would have been around the time of the 
usual trough for the PER3 relative mRNA expression. As it has been postulated that whole 
blood PER3 mRNA rhythms are SCN-driven, the lack of a clear PRC could again relate to the 
belief that meal timing would not affect the central clock under normocaloric conditions.    
For other measures, the number of significant circadian rhythms at the individual level was 
too low in order to attempt phase assessment and a PRC. Instead data were grouped by 
food pulse and the phase shift calculated at the group level. The largest magnitude shifts 
were seen for plasma glucose and leptin rhythms, two measures which are largely affected 
by meals and meal timing. Plasma TAG had moderate phase shifts whilst there were smaller 
shifts in PER3 and REVERB-β relative mRNA expression. 
Two food pulse times which caused large phase shifts to plasma glucose and leptin rhythms 
were at 16:40 and 20:40. The food pulse at 16:40 resulted in a net phase advance of 5.57 
and a phase delay of 7.74 hours to the glucose and leptin rhythms, respectively. The phase 
shift in the food pulse session for plasma glucose was small (0.09 hours) and the period of 
the rhythm was maintained, indicating that the repeated food pulse helped to maintain the 
synchrony of glucose rhythms and was therefore a zeitgeber. For plasma leptin, the phase 
shift for the food pulse session was larger (6.25 hours), in part due to estimating the phase, 
but there was no significant time x constant routine interaction. The 20:40 food pulse also 
maintained synchrony for plasma glucose but it had a phase delay to the rhythms during the 
food pulse session (-2.92 hours), resulting in a net phase shift of 6.75 hours. Plasma leptin 
had a phase advance for the food pulse session of 8.68 hours, and a net phase delay of 4.32 
hours.  
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A potential reason for the effect seen at these food pulse times could be that the pulse 
coincides with the usual rise of the glucose and leptin rhythm. It is known that consumption 
of a meal later at night increases the postprandial concentration and area under the curve 
than eating the same meal earlier in the day (Morgan et al. 2003). Therefore a food pulse at 
these times would result in prolonged levels in the blood, and perhaps impacts on 
regulatory measures. One way in which this could be investigated would be to assess insulin 
and glucagon, two key hormones in glucose and leptin regulation, for their timing and 
concentration as a result of the food pulse.  
The difference in the direction of the phase shift seen for glucose and leptin rhythms may 
also relate to levels in plasma being regulated by different clocks. For plasma glucose 
concentration, the liver plays an important role in maintaining homeostasis and is also the 
main site for gluconeogenesis in the body. The liver clock has been shown to impact glucose 
homeostasis (Lamia et al. 2008), and may be regulating the glucose rhythms in response to 
the food pulses. The adipose clock has been found to regulate leptin expression and 
production in mice (Kettner et al. 2015). To determine if the delays were being mediated by 
the adipose clock, leptin mRNA expression in this tissue could be examined.  
For plasma TAG, the food pulse that gave the biggest net phase shift was at 08:40 with a 
phase delay of 7.17 hours. In addition, a pulse at 20:40 caused a net phase delay of 4.57 
hours, with the phase shift in the food pulse session alone being -3.87 hours. As the food 
pulse times are around the start and end of biological night, which is when plasma TAG is 
known to rise in concentration, it may have been thought that the direction of phase shift 
would be different, with one pulse causing and advance and one a delay (Burgess et al. 
2008). However, both food pulses showed a delay, indicating that although food can act as a 
zeitgeber, it does not follow a traditional PRC profile.  
Plasma TAG concentration will be made of both dietary TAG and those which are 
endogenously synthesised and released by the liver (Bruinstroop et al. 2014). The circadian 
rhythm of plasma TAG has not been assessed under fasting condition in humans, which 
would help to highlight the relative contribution of dietary TAG sources from endogenous 
sources in generating the circadian rhythm. Therefore, it is difficult to determine whether 
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the phase shifts seen in the plasma TAG rhythms are from a change to the synthesis and 
release of TAG from the liver, or from a change in the absorption of dietary lipids.  
Interestingly, for whole blood PER3 and REVERB-β mRNA expression, the food pulse time 
that caused almost no effect to the timing of rhythms was at 04:40. As the circadian system 
responds differently to zeitgebers across the circadian phase to allow for entrainment, this 
food pulse group shows that these rhythms are resistant to phase changes from food given 
around the time of the acrophase. For plasma glucose, leptin and TAG the food pulse that 
resulted in the period of unresponsiveness differed for each measure with the smallest net 
phase shifts occurring when food pulses were given at 08:40, 04:40 and 12:40 for plasma 
glucose, leptin and TAG, respectively. These differences could relate to the underlying 
timing of the rhythm as well as how the clocks that regulate the rhythms respond to the 
food pulse.     
These results highlight that food can act as a zeitgeber to the human circadian system but 
that there is a differential response of tissues and rhythms to it. Furthermore, the response 
to food by tissues and rhythms does not appear to follow a traditional PRC seen in other 
non-photic zeitgebers. The exact mechanisms behind these results require further 
investigation. 
3.4.5 Limitations of human and animal data 
 
Although food has been shown to be a powerful zeitgeber to peripheral molecular clock 
rhythms in rodents, our results have shown a greater effect on plasma glucose and leptin, 
but small effects on the phase of molecular rhythms. The within-subject counterbalanced 
design was a positive when assessing food as a zeitgeber, as every participant was their own 
control and this reduced the variation in how an individual would respond to and 
metabolise food. Furthermore, when separated into food pulse groups, the within-subject 
counterbalanced design meant each group had its own control session so baseline circadian 
measurements were paired with the food pulse data. The pre-study protocol was shown to 
be successful in maintaining the phase of rhythms between the two sessions, further 
reducing variations. 
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One important limitation in the study design was that this was a 3-pulse protocol. 
Traditional PRC are generated by single exposure to a zeitgeber over one cycle, before 
rhythms are re-measured (Burgess et al. 2008). Here, there was repeated exposure to the 
food pulse as participants were given it over 3 days instead of one (Burgess et al. 2008; 
Burgess et al. 2010; Revell et al. 2012). An issue with the repeated exposures is that 
although the food pulse would be given at the same clock time, if phase shifting was 
occurring with every cycle, as would be expected of a zeitgeber, the food pulse would be 
given at a slightly different circadian time across the cycle. This study design also makes it 
difficult to determine if the kinetics of the phase shift are the same across the 3 days. 
Although the assumption has been made that the phase shift was the same across all three 
days, this may not be the case. A single pulse and 2-pulse protocol, where the food pulse is 
applied to one or two cycles before circadian rhythms are measured could be carried out to 
determine the kinetics; this would be especially informative for plasma glucose rhythms.  
One of the largest differences and limitations of our study with the initial animal work was 
the restriction of food. The animal studies restricted ad libitum food consumption either to 
12 hours (Damiola et al. 2000) or to just 4 hours (Stokkan et al. 2001) during the normal rest 
phase. In doing so, there was a greater period of fasting and as rodents cannot survive 
starvation for as long as humans (Scheer et al. 2009), this may present as a stronger 
zeitgeber. In our study, the food pulse was not the only time a participant received calories 
as they still received meals, albeit very small, every 2 hours. Therefore even in the food 
pulse, there was not a period of complete fasting, indicating that interventions in animal 
studies were far more extreme.  
Another limitation of this human study was that the size of the food pulse administered only 
represented 50% of all the necessary calories. As animal studies restricted all food 
consumption to one window of time, their food pulse would be 100% of calories but over a 
longer period (Damiola et al. 2000; Stokkan et al. 2001). Therefore, the zeitgeber strength of 
our food pulse may have been weaker than food restriction in rodents (Roenneberg & 
Merrow 2007). Due to the time restriction of all meals being consumed within 30 minutes 
for consistency, a larger food pulse would be difficult to consume due to the physical size of 
the meal; this would risk emesis of food whilst also making the participant uncomfortable. A 
consideration could have been to increase the food pulse to 55% of all required calories, as 
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this would be the majority of calories without increasing the size of the meal too 
dramatically. However, whether this small majority would have had a greater impact 
biologically remains to be seen. 
Although the diet could be changed to include a higher proportion of energy dense food, 
such as fat, to increase the calorie content of a pulse, this would not represent a realistic 
diet and the impact that food could have on the human circadian system under normal 
conditions. Furthermore, as high-fat diets are known to disrupt circadian rhythms in rodents 
(Kohsaka et al. 2007; Eckel-Mahan et al. 2013), it would be difficult to ascertain whether the 
effects were from food timing, or food composition. For an initial study into the zeitgeber 
effect of food on the human circadian system, a diet that was balanced in composition was 
vital, and the diet used here ensured that it was not too high in carbohydrates or fat. 
An alternative could have been to consume all calories in one 2.5-hour wake episode; 
however, an issue here would be whether it is the food pulse, or the long period of fasting, 
that is exerting the effect on the human circadian system. Furthermore, having such a large 
amount of time to consume food would also affect the rate of consumption between 
individuals, making food pulses variable between participants. A future investigation could 
be to determine how the duration as well as the timing of fasting affects the timing of 
circadian rhythms in humans. 
Further to the study design, a limitation was that only healthy, male participants were 
assessed. Males were chosen for this study to eliminate the variable of the female 
menstrual cycle, as this is thought to affect the melatonin rhythm (Baker & Driver 2007). 
This was important due to melatonin being used as a key marker of SCN phase in this study 
as well as the fact that the trial took place over two separate sessions. It is important to 
discover whether food is a zeitgeber in females, as well as if there are differences in the 
response of the circadian system to food. Furthermore, the impact that large food pulses 
may have on circadian rhythms in people with metabolic disorders is also of interest.  
It would also be of interest to study more hormones and regulators of appetite and 
metabolism. As the largest changes were seen to the timing of glucose and leptin rhythms, 
assessment of hormones such as insulin and glucagon would help to indicate the 
mechanism involved. 
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The results of this study show for the first time the impact that a large food pulse has on the 
phase of circadian rhythms in humans. Although a full PRC could not be generated for many 
measurements, the results clearly show that food pulses can have phase shifting effects on 
the human circadian system. Previous studies have only looked at whether the timing of 
food affects health outcomes, but these results show that meal timing has an effect on the 
timing of the circadian system. Of all the measures, plasma glucose and leptin rhythms were 
shown to be the most changed due to meal timing, especially by afternoon and evening 
pulses.  
Furthermore, this study also revealed that there is a large phase shifting effect on plasma 
glucose, leptin and NEFA rhythms when having 2-hourly isocaloric meals when under 
conditions outside the range of entrainment. Furthermore we revealed that there were 
alterations to the period of certain rhythms as a result of the ultradian protocol. We show 
for the first time that sustained meal frequency across the circadian phase whilst being 
under a light/dark and behavioural cycle outside the range of entrainment has a large effect 
on food driven rhythms, dissociating them from SCN-driven rhythms. 
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4 A FIVE-HOUR DELAY TO MEAL TIMING CAN 
REGULATE THE HUMAN CIRCADIAN SYSTEM 
4.1 Introduction 
 
Ensuring circadian synchrony between internal clocks and the external environment is 
important to health (Karlsson et al. 2001; Esquirol et al. 2009; De Bacquer et al. 2009; 
Arendt 2010). Identifying non-photic zeitgebers and their phase resetting effect on 
peripheral clock rhythms could provide an additional method for entrainment. Food is a 
non-photic zeitgeber in animals, especially when the food availability is restricted (Damiola 
et al. 2000; Stokkan et al. 2001) but it is unknown if food can be an effective zeitgeber in 
humans. Having already studied the role of a food pulse under free-running conditions (see 
chapter 3), understanding the relative effects that non-photic zeitgebers have under 
entrained light/dark conditions needs to be investigated. 
The aim for this study was to determine how a change in meal timing, but no change to the 
sleep/wake or light/dark schedule, would affect the circadian system. The hypothesis was 
that a 5-hour delay in meal timing would cause phase delays to peripheral clock rhythms 
whilst central rhythms remained synchronised to the light/dark cycle. 
4.2 Methods 
 
Ten healthy male participants were recruited to undertake a 13-day laboratory study to 
investigate whether a 5-hour delay to all meals would cause phase shifts to circadian 
rhythms (see section 2.3.2). Participants underwent 3 days with meals being timed at 0.5, 
5.5 and 10.5 hours after wake, before undergoing a 37-hour constant routine. During the 
constant routine, questionnaires were administered and samples were taken to assess the 
phase of circadian rhythms. Following this, participants underwent 6 days where all meals 
were delayed by 5 hours (timed at 5.5, 10.5 and 15.5 hours after wake) in the same 
light/dark and sleep/wake cycle and then underwent a second 37-hour constant routine to 
assess the phase of circadian rhythms following the food delay. 
Subjective assessment of hunger and sleepiness were assessed by validated questionnaires 
as outlined in section 2.5. Plasma samples were assessed for melatonin, cortisol, glucose, 
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TAG, NEFA and insulin concentration, as described in sections 2.13.2, 2.14, 2.11 and 2.12. 
RNA expression of core clock components, BMAL1, PER3, as well as auxiliary loop 
component REVERB-β, and GR, in whole blood and the addition of PER2 in adipose tissue 
were conducted as detailed in section 2.10. 
4.3 Results 
4.3.1 Participant demographics 
 
Participant demographics (Table 4.1) showed that they were young and healthy males, as 
assessed by BMI, percent body fat and biochemical screening (not shown), and showed no 
evidence of sleep disorders or depression as reported through validated questionnaires. As 
part of the inclusion criteria, they had not undertaken shift work in the 6 months prior to 
the study and had also not crossed more than 2 time zones in the month prior to the study. 
 
  Participant Demographics Mean ± SEM   
 
Physiological Variables 
  
 
Age (years) 22.9 ± 1.3  
 
 
Body Mass Index (kg/m2) 23.1 ± 0.8  
 
 
Body Fat (%) 15.0 ± 1.9  
   Questionnaire Data     
 
Munich Chronotype 
  
 
Sleep Time (hours) 23.45 ± 0.2 
 
 
Wake Time (hours) 7.88 ± 0.2 
 
 
Horne-Östberg 49.4 ± 2.2 
 
 
Pittsburgh Sleep Quality Index 3.0 ± 0.3 
 
 
Beck Depression Inventory 1.8 ± 0.5 
 
 
Epworth Sleepiness Scale 4.0 ± 0.7 
   Ethnicity N   
 
White 
  
 
British 6 
 
 
Romanian 1 
 
 
South African 1 
 
 
African 1 
 
 
Mixed 
    White and Black Caribbean  1   
Table 4.1: Participant Demographics. Participants showed no evidence of sleep disorders and were healthy based on our 
measures of body mass index (kg/m
2
) and body fat percentage. 
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4.3.2 Effect of meal timing on plasma melatonin and cortisol 
 
The timing of the DLMO, the gold standard phase marker for the central clock, was not 
significantly different after the delayed food intervention (Figure 4.1A, student’s two-tailed 
paired t-test, p>0.05). The average time for the 25% DLMO onset was 23.11 ± 0.31 (mean ± 
standard error of the mean (SEM)) and 23.28 ± 0.27 decimal time for the first and second 
constant routine, respectively. The mean group melatonin concentration profiles (Figure 
4.1B) were smoothed using the locally weighted least square (LOWESS) curve on the fine 
setting applied to it and also showed no changes to timing (two-way repeated measures 
ANOVA (2w-ANOVA), time F30,270 = 15.37, p<0.0001, food F1,9 = 2.33, p>0.05 and food x time 
interaction F30,270 = 1.20, p>0.05).  
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Figure 4.1: Individual dim light melatonin onset (A) and mean group plasma melatonin profile (B) showed no differences 
in timing after the delayed food intervention. A) The individual onset times are shown and there was no significant 
difference (student’s paired t-test, p>0.05) in the timing between the two constant routines. B) Grouped plasma melatonin 
had a locally weighted least squares (LOWESS) curve on a fine setting was applied and showed a significant effect of time 
(2w-ANOVA, F30,270 = 15.37, p<0.0001) but no effect of food (F1,9 = 2.33, p>0.05), or food x time interaction (F30,270 = 1.20, 
p>0.05). Data were aligned into 1-hour time bins with data expressed as mean ± SEM. 
 
Similar to the 25% DLMO, individual plasma cortisol acrophase showed no significant 
differences in timing after the delayed food intervention (Figure 4.2A, student’s two-tailed 
paired t-test, p>0.05). The average cortisol acrophase was 10.60 ± 0.45 and 10.89 ± 0.30 
decimal time for the first and second constant routine, respectively. The mean group 
cortisol concentration also had a LOWESS curve on a fine setting applied to it (Figure 4.2B) 
and showed no changes to timing (2w-ANOVA, time F30,270 = 17.13, p<0.0001, food F1,9 = 
1.94, p>0.05 and food x time interaction F30,270 = 1.12, p>0.05).  
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Figure 4.2: Individual cortisol acrophase (A) and mean group plasma cortisol profile (B) showed no differences in timing 
after the delayed food intervention. A) The individual acrophase times are shown and there was no significant difference 
(student’s paired two-tailed t-test, p>0.05) in the timing between the two constant routines. B) Grouped plasma cortisol 
had a LOWESS curve on a fine setting applied to the data and showed a significant effect of time (2w-ANOVA, F30,270 = 
17.13, p<0.0001) but no effect of food (F1,9 = 1.94, p>0.05), or food x time interaction (F30,270 = 1.12, p>0.05). Data were 
aligned into 1-hour time bins with data expressed as mean ± SEM. 
 
4.3.3 Effect of meal timing on subjective hunger and sleepiness 
 
Assessment of subjective hunger and sleepiness was done through the use of visual 
analogue scales (hunger, Figure 4.2, A and B) and the Karolinksa sleepiness scale (KSS, Figure 
4.3, C and D). Both measures showed a significant effect of time on the ratings (Figure 4.3, 
2w-ANOVA, F37,333 = 6.115 for hunger, F37,333 = 10.84 for KSS, both p<0.0001). However, 
there was no significant effect of the meal timing on the ratings (Figure 4.3, 2w-ANOVA, F1,9 
= 1.598 for hunger, F1,9 = 0.3633 for KSS, both p>0.05), or a significant food x time 
interaction (Figure 4.3, 2w-ANOVA, F37,333 = 1.031 for hunger, F37,333 = 1.138 for KSS, both 
p>0.05). Hunger decreased during biological night, the start of which is indicated by the 
DLMO (Figure 4.3, time zero, B) whilst sleepiness increased (Figure 4.3, time zero, D). 
Sleepiness decreased towards biological morning, but levels remained elevated due to the 
accumulated sleep debt. 
Assessment of other subjective measures relating to appetite, mood and alertness can be 
viewed in the appendix (Appendix 4.1-4.4). As subjective hunger levels decreased around 
the time of the DLMO, so too did the subjective desire for sweet, salty, fatty and savoury 
food (Appendix 4.3, A-D); the subjective measure for ‘can eat’ was also similar to subjective 
hunger (Appendix 4.1E and 5.3E). Subjective fullness (Appendix 4.1F and 4.3F) rose over the 
course of both constant routines, whilst subjective thirst values (Appendix 4.1G and 4.3G) 
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were more consistent and remained between a range of 23.3% and 16.7% for the first and 
second constant routine, respectively. 
Mood and alertness questionnaires revealed the alert score (Appendix 4.2A and 4.4A) had a 
profile similar to that of the KSS, whilst the assessment of mood (calm, cheerful and 
depressed, Appendix 4.2 and 4.4, B-D) did not exhibit large variation over the course of the 
constant routines.  
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Figure 4.3: Subjective ratings for hunger and sleepiness using validated visual analogue scales (hunger) and Karolinska 
sleepiness scales showed significant differences in their temporal profiles between the constant routines. Subjective 
hunger (A and B) and sleepiness (C and D) both showed a significant effect of time (2w-ANOVA, F37,333 = 6.115, hunger ; 
F37,333 = 10.84, KSS; both p<0.0001) on rating, but no significant effect of food (F1,9 = 1.598, hunger ; F1,9 = 0.3633, KSS, both 
p>0.05) or food x time interaction (F37,333 = 1.031, hunger ; F37,333 = 1.138, KSS  both p>0.05). Data is aligned to 1-hour time 
bins of time after wake (A and C) or time relative to the DLMO (B and D). Data expressed as mean ± SEM.  
 
4.3.4  Effect of meal timing on plasma glucose 
 
Plasma glucose concentration was assessed at 2-hour intervals during the constant routines 
(Figure 4.4). The mean group concentration exhibited circadian rhythmicity in both constant 
routines as determined by a significant cosinor curve fit (cosinor non-linear regression 
(CNLR), p<0.05). A 2w-ANOVA of absolute concentration found a significant effect of time 
(F15,135 = 3.018, p<0.05), food (F1,9 = 29.42, p<0.05) and food x time interaction (F15,35 = 
4.956, p<0.0001). The acrophase of the absolute glucose concentration rhythms were 14.1 ± 
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1.24 (mean ± SE) and 19.9 ± 0.66 hours after wake for the first and second constant routine, 
respectively (Figure 4.4A), indicating a phase delay of 5.8 hours. This was similar to data 
aligned by the DLMO, where the acrophase occurred at -2.0 ± 1.06 and 3.9 ± 0.76 hours 
relative to the DLMO in constant routines 1 and 2, respectively (Figure 4.4B). 
For the z-scored data the acrophases were 13.89 ± 0.88 and 19.85 ± 0.45 hours after wake 
for the first and second constant routine, respectively (Figure 4.4C). This gave a phase delay 
of 5.96 hours which was similar to absolute values. When data were aligned to the DLMO 
the acrophases were -1.99 ± 0.76 and 3.84 ± 0.51 hours relative to the DLMO for the first 
and second constant routine, respectively (Figure 4.4D), giving a phase delay of 5.83 hours. 
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Figure 4.4: Glucose rhythms showed a delay in timing as a result of the delayed meal timing intervention. Plasma glucose 
concentration (mmol/L, top and z scored, bottom) showed significant circadian rhythms for both constant routines (cosinor 
non-linear regression (CNLR), p<0.05, R
2
 listed for each significant curve). There was a delay in the timing of the glucose 
rhythms (2w-ANOVA, p<0.05 for food (F1,9 = 29.42), time (F15,135 = 3.018) and food x time interaction (F15,135 = 4.956)) by 5.8 
hours. Plasma glucose concentration was grouped into 2-hour time bins of either time after wake (left panels) or relative to 
the DLMO (right panels). Data expressed as mean ± SEM.  
 
The significant effect of food in the 2w-ANOVA indicated a significant difference in glucose 
concentration. The mean cycle concentration for glucose in each individual participant was 
assessed and found to be significantly decreased after the delayed food intervention (Figure 
4.5A, student’s two-tailed paired t-test, p<0.05) with an average concentration of 5.72 ± 
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0.11 (mean ± SEM) and 5.45 ± 0.11 mmol/L for the first and second constant routine, 
respectively. 
Crucially, this significant decrease was not a result of assay drift, as no significant differences 
were found in the concentration of the quality controls (Figure 4.5, B and C, student’s two-
tailed paired t-test, p>0.05). The low quality control had an average concentration of 5.6 ± 
0.13 (mean ± SEM) at the start and 5.6 ± 0.13 mmol/L at the end of the run, whilst the high 
quality control had an average concentration of 13.34 ± 0.30 and 13.52 ± 0.28 mmol/L at the 
start and end of the run, respectively. 
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Figure 4.5: Mean glucose concentration was significantly lower after the delayed food intervention. A) Mean cycle 
glucose concentration for each participant was found to be significantly decreased after the delayed food intervention. No 
evidence of assay drift was discovered as the quality control concentrations did not show a significant difference from the 
start to the end of the run (B and C, student’s two-tailed paired t-test, p>0.05). B-C data expressed as mean ± SEM. 
Student’s two-tailed paired t-test, * denotes p<0.05 compared with control. 
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4.3.5 Effect of meal timing on plasma insulin 
 
To determine if insulin secretion was responsible for the shift in phase observed in glucose, 
plasma insulin concentration was assessed. Significant circadian rhythms in the mean group 
data were only present during the second constant routine after the delayed food 
intervention when plotted relative to time after wake (Figure 4.6, A and C, CNLR, p<0.05) or 
the DLMO (Figure 4.6, B and D, CNLR, p<0.05). The acrophase of insulin in the second 
constant routine was 4.53 ± 1.27 (mean ± SE) hours relative to wake and 12.27 ± 1.21 hours 
relative to the DLMO. 
A 2w-ANOVA on the absolute concentrations (Figure 4.6, A and B) revealed a significant 
effect of time (F15,135 = 3.094, p<0.05) but no significant effect of food (F1,9 = 5.068, p>0.05), 
or food x time interaction (F15,135 = 0.8426, p>0.05).  
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Figure 4.6: Plasma insulin concentration did not show a difference in timing after the delayed food intervention. Plasma 
insulin concentration (pM, A and B, and z scored, C and D) showed significant circadian rhythms only for the second 
constant routine (CNLR, p<0.05, R
2
 listed for each significant curve), following the delayed food intervention. There was a 
significant effect of time (2w-ANOVA, F15,135 = 3.094, p<0.05) but no effect of food (F1,9 = 5.068, p>0.05), or food x time 
interaction (F15,135 = 0.8426, p>0.05). Plasma insulin concentration was grouped into 2-hour time bins of either time after 
wake (A and C) or relative to the DLMO (B and D). Data expressed as mean ± SEM. 
 
A Five-Hour Delay to Meal Timing Can Regulate the Human Circadian System 
159 
 
4.3.6 Effect of meal timing on plasma triglycerides 
 
Plasma TAG concentrations were assessed and mean group concentrations exhibited 
significant circadian rhythms for both constant routines (Figure 4.7, CNLR, p<0.05). A 2w-
ANOVA on absolute concentrations showed a significant effect of time (F15,135 = 22.65, 
p<0.05) but no effect of food (F1,9 = 0.01, p>0.05) nor food x time interaction (F15,135 = 1.57, 
p>0.05). The acrophase for absolute plasma TAG concentration rhythms were 22.12 ± 0.96 
and 22.61 ± 0.87 hours after wake (Figure 4.7A), and 6.02 ± 0.40 and 6.30 ± 0.34 hours after 
the DLMO (Figure 4.7B) first and second constant routine, respectively. For the z-scored 
data the acrophases were 22.03 ± 0.39 and 22.62 ± 0.32 hours after wake for the first and 
second constant routine, respectively (Figure 4.7C). When data were aligned to the DLMO 
the acrophases were 6.03 ± 0.40 and 6.30 ± 0.34 hours relative to the DLMO for the first and 
second constant routine, respectively (Figure 4.7D). 
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Figure 4.7: Plasma triglyceride concentration showed no difference in timing after the delayed food intervention. Plasma 
triglyceride concentration (mmol/L, A and B and z scored, C and D) showed significant circadian rhythms for both constant 
routines (CNLR, p<0.05, R
2
 listed for each significant curve). There was a significant effect of time (2w-ANOVA, F15,135 = 
22.65, p<0.05) but no effect of food (F1,9 = 0.01, p>0.05), or food x time interaction (F15,135 = 1.57 , p>0.05). Plasma 
triglyceride concentration was grouped into 2-hour time bins of either time after wake (A and C) or relative to the DLMO (B 
and D). Data expressed as mean ± SEM. 
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In addition to TAG, NEFA concentrations were assessed and found to only have a significant 
circadian rhythm for the second constant routine following the delayed food intervention 
(Figure 4.8, CNLR, p<0.05), except for raw data plotted relative to the DLMO (Figure 4.8B, 
CNLR, p>0.05). A 2w-ANOVA on absolute concentrations revealed a significant effect of time 
(F15,135 = 3.67, p<0.05) and food (F1,9 = 13.29, p<0.05), but not a food x time interaction 
(F15,135 = 1.455, p>0.05). The acrophase for the z-scored plasma NEFA rhythms were 19.75 ± 
3.87 hours after wake (Figure 4.8C), and 4.99 ± 0.74 hours after the DLMO (Figure 4.8D), 
both for the second constant routine only. 
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Figure 4.8: Plasma non-esterified fatty acid (NEFA) concentration did not show a difference in timing after the delayed 
food intervention. Plasma NEFA concentration (mmol/L, A and B and z scored, C and D) showed significant circadian 
rhythms for the second constant routine only (CNLR, p<0.05, R
2
 listed for each significant curve), following the delayed 
food intervention, except for raw data (mmol/L) plotted relative to DLMO (B) which did not have any significant circadian 
rhythms (CNLR, p>0.05). There was a significant effect of time (2w-ANOVA, F15,135 = 3.67, p<0.05) and food (F1,9 = 13.29, 
p<0.05) but no significant food x time interaction (F15,135 = 1.46, p>0.05). Plasma NEFA concentration was grouped into 2-
hour time bins of either time after wake (A and C) or relative to the DLMO (B and D). Data expressed as mean ± SEM. 
 
 
 
 
A Five-Hour Delay to Meal Timing Can Regulate the Human Circadian System 
161 
 
4.3.7 Effect of meal timing on gene expression in whole blood 
 
Due to the close link of metabolism and the molecular clock, qPCR for core clock genes and 
mediators of entrainment were analysed in whole blood. The positive arm transcription 
factor, BMAL1 was assessed and found to only have a significant cosinor rhythm in the first 
constant routine, under early meal conditions when data were z-scored (Figure 4.9, C and D, 
CNLR, p<0.05). A linear mixed effects model ANOVA (LMEM-ANOVA) on relative expression 
values showed no significant effect of time (F12,205 = 1.52, p>0.05), food (F1,205 = 0.34, 
p>0.05)  or food x time interaction (F12,205 = 0.31, p>0.05). The LMEM-ANOVA was used to 
conduct repeated measures ANOVA which could overcome the missing data values as a 
result of the data cleaning method used on the qPCR data. The acrophase of the early meal 
condition was 13.77 ± 1.32 hours after wake (Figure 4.9C) or -1.93 ± 1.28 hours relative to 
the DLMO (Figure 4.9D). 
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Figure 4.9: Whole blood BMAL1 relative mRNA expression showed no difference in timing after the delayed food 
intervention. The relative mRNA expression of BMAL1 showed no significant circadian rhythms (2
-δδCT
, top panels, CNLR, 
p>0.05) when aligned to time after wake (A) and time relative to DLMO (B). When values were normalised via z-scoring (C 
and D) circadian rhythms were evident (CNLR, p<0.05, R
2
 listed for each significant curve) only for the early meal condition. 
There was no significant effect of time (linear mixed effects model ANOVA (LMEM-ANOVA), F12,205 = 1.52, p>0.05), food 
(F1,205 = 0.34, p>0.05) or food x time interaction (F12,205 = 0.31, p>0.05) for the relative expression data, but there was a 
significant effect of time for the z-scored data (F12,214 = 3.52, p<0.05) . Data were aligned to 2-hour time bins of either time 
after wake (A and C) or to the DLMO (B and D) and expressed as mean ± SEM. 
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Analysis of the negative arm transcription factor, PER3 showed significant cosinor rhythms 
for both constant routines (Figure 4.10, CNLR, p<0.05). A LMEM-ANOVA on relative 
expression values showed a significant effect of time (F12,205 = 17.00, p<0.05) and food (F1,205 
= 23.20, p<0.05), but no significant food x time interaction (F12,205 = 0.67, p>0.05). The 
acrophases for PER3 relative mRNA expression were 20.73 ± 0.50 and 20.79 ± 0.58 hours 
after wake (Figure 4.10A), which was antiphasic to BMAL1 acrophase, and 5.11 ± 0.48 and 
4.97 ± 0.57 hours relative to the DLMO (Figure 4.10B) for the first and second constant 
routine, respectively. The acrophases for z-scored PER3 relative mRNA expression were 
20.97 ± 0.26 and 20.91 ± 0.27 hours after wake (Figure 4.10B) and 5.24 ± 0.23 and 5.01 ± 
0.25 hours relative to the DLMO (Figure 4.10D) for the first and second constant routine, 
respectively. There was no difference in the phase of the PER3 rhythm after the delayed 
food intervention. 
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Figure 4.10: Whole blood PER3 relative mRNA expression showed no difference in timing after the delayed food 
intervention. The relative expression of PER3 in whole blood (2
-δδCT
, A and B and z-scored, C and D) exhibited significant 
circadian rhythms for both constant routines (CNLR, p<0.05, R
2
 listed for each significant curve). There was a significant 
effect of time (LMEM-ANOVA, F12,205 = 17.00, <0.05) and food (F1,205 = 23.20, p<0.05) but no significant food x time 
interaction (F12,205 = 0.67, p>0.05). Data were aligned to 2-hour time bins of either time after wake (A and C) or to the 
DLMO (B and D) and expressed as mean ± SEM. 
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Analysis of the auxiliary loop clock gene, REVERB-β, showed significant cosinor rhythms for 
both constant routines (Figure 4.11, CNLR, p<0.05). A LMEM-ANOVA on relative mRNA 
expression values showed a significant effect of time (F12,205 = 10.60, p<0.05) and food (F1,205 
= 30.95, p<0.05), but no significant food x time interaction (F12,205 = 1.38, p>0.05). The 
acrophases for REVERB-β relative mRNA expression were 17.35 ± 0.70 and 17.86 ± 0.60 
hours after wake (Figure 4.11A), and 1.76 ± 0.71 and 2.11 ± 0.63 hours relative to the DLMO 
(Figure 4.11B) for the first and second constant routine, respectively. For the z-scored data, 
the acrophases were 17.57 ± 0.44 and 17.98 ± 0.60 hours after wake (Figure 4.11C), and 
1.75 ± 0.45 and 2.17 ± 0.42 hours relative to the DLMO (Figure 4.11D) for the first and 
second constant routine, respectively. There was no difference in the phase of the REVERB-
β rhythm after the delayed food intervention. 
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Figure 4.11: Whole blood REVERB-β relative mRNA expression showed no difference in timing after the delayed food 
intervention. The relative expression of REVERB-β in whole blood (2
-δδCT
, A and B and z-scored, C and D) exhibited 
significant circadian rhythms for both constant routines (CNLR, p<0.05, R
2
 listed for each significant curve). There was a 
significant effect of time (LMEM-ANOVA, F12,205 = 10.60, p<0.05) and food (F1,205 = 30.95, p<0.05) but no significant food x 
time interaction (F12,205 = 1.38, p>0.05). Data were aligned to 2-hour time bins of either time after wake (A and C) or to the 
DLMO (B and D) and expressed as mean ± SEM. 
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Analysis of GR mRNA showed no significant cosinor rhythms for either constant routine 
(Figure 4.12, CNLR, p>0.05). A LMEM-ANOVA on relative mRNA expression values showed a 
significant effect of time (F12,205 = 2.11, p<0.05) and food (F1,205 = 23.77, p<0.05), but no 
significant food x time interaction (F12,205 = 0.92, p>0.05). Due to the significant effect of 
time but lack of cosinor fit, a period analysis was conducted on the z-scored GR data (Figure 
4.13). The best fits were found at periods 15.0 and 12.9 hours for the first and second 
constant routine, respectively, when plotted to time after wake (Figure 4.13A) and 15.6 and 
12.7 hours for the first and second constant routine, respectively, when plotted to the 
DLMO (Figure 4.13B). 
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Figure 4.12: Whole blood GR relative mRNA expression showed no circadian rhythmicity or difference in timing after the 
delayed food intervention. No significant circadian rhythms were observed in the gene expression levels, as depicted by a 
lack of cosinor curve (CNLR, p>0.05). There was a significant effect of time (LMEM-ANOVA, F12,205 = 2.11, p<0.05) and food 
(F1,205 = 23.77, p<0.05) but no significant food x time interaction (F12,205 = 0.92, p>0.05). Data were aligned to 2-hour time 
bins of either time after wake (A and C) or to DLMO (B and D) and expressed as mean ± SEM. 
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Figure 4.13: Periodogram analysis of whole blood GR relative mRNA expression showed a strong correlation for an 
ultradian period in rhythmicity. A) Shows the period signal analysis for data plotted against time after wake and B) shows 
the period signal for data plotted against DLMO. 
 
4.3.8 Effect of meal timing on gene expression in adipose tissue 
 
In addition to blood, serial subcutaneous adipose biopsies were taken from 7 of the 10 
participants during the constant routines. Analysis of mean group PER2 relative mRNA 
expression showed significant cosinor rhythms for both constant routines (Figure 4.14, 
CNLR, p<0.05). A 2w-ANOVA on relative mRNA expression values revealed a significant 
effect of time (F4,24 = 40.6, p<0.0001), food (F1,6 = 28.39, p<0.05) and time x food interaction 
(F4,24 = 3.66, p<0.05). The acrophases for PER2 were 1.22 ± 0.54 and 1.93 ± 0.52 hours after 
wake (Figure 4.14, A and C), indicating that a phase delay of 0.71 hours had occurred. When 
aligned to the DLMO, the acrophase times were 9.42 ± 0.54 and 10.13 ± 0.52 hours relative 
to the DLMO (Figure 4.14, B and D) and had a phase delay of 0.71 hours. 
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Figure 4.14: Adipose PER2 relative mRNA expression showed a difference in timing after the delayed food intervention. 
The relative mRNA expression of PER2 in adipose (2
-δδCT
, A and B and z-scored, C and D) exhibited significant circadian 
rhythms for both constant routines (CNLR, p<0.05, R
2
 listed for each significant curve). There was a significant effect of 
time (2w-ANOVA, F4,24 = 40.60, p<0.0001), food (2w-ANOVA, F1,6 = 28.39, p<0.05) and time x food interaction (2w-ANOVA, 
F4,24 = 3.66, p<0.05). A delay of approximately an hour (0.78 hours) was seen in timing after the delayed food intervention. 
Data were aligned to 4-hour time bins of either time after wake (A and C) or relative to DLMO (B and D). Data were 
expressed as mean ± SEM. 
 
 
Analysis of mean group PER3 relative mRNA expression showed significant cosinor rhythms 
for both constant routines (Figure 4.15, CNLR, p<0.05). A 2w-ANOVA on relative expression 
values revealed a significant effect of time (F4,24 = 29.9, p<0.0001) but no significant effect of 
food (F1,6 = 0.57, p>0.05) and time x food interaction (F4,24 = 1.32, p>0.05). The acrophases 
for PER3 were 0.34 ± 0.42 and 1.28 ± 0.46 hours after wake (Figure 4.15, A and C). This 
showed a phase delay of 0.94 hours, a similar amount to PER2. When aligned to the DLMO, 
the acrophase times were 8.54 ± 0.42 and 9.48 ± 0.46 hours relative to the DLMO (Figure 
4.15, B and D), also indicating a phase delay of 0.94 hours. 
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Figure 4.15: Adipose PER3 relative mRNA expression showed no difference in timing after the delayed food intervention. 
The relative expression of PER3 in adipose (2
-δδCT
, A and B and z-scored, C and D) exhibited significant circadian rhythms for 
both constant routines (CNLR, p<0.05, R
2
 listed for each significant curve). There was a significant effect of time (2w-
ANOVA, F4,24 = 29.9, p<0.0001) but not for food (2w-ANOVA, F1,6 = 0.57, p>0.05) or time x food interaction (2w-ANOVA, 
F4,24 = 1.32, p>0.05). Data were aligned to 4-hour time bins of either time after wake (A and C) or relative to DLMO (B and 
D). Data were expressed as mean ± SEM. 
 
When observing the phase of PER2 and PER3 adipose relative mRNA expression at the 
individual level, significant differences were observed in the timing of these rhythms 
following the delayed feeding intervention (Figure 4.16). For PER2 relative mRNA 
expression, the mean individual acrophases were 2.22 ± 0.42 (mean ± SEM) and 3.24 ± 0.36 
hours after wake for the first and second constant routine, respectively (Figure 4.16A). This 
had a significant difference of -1.02 hours between the first and second constant routine 
(Figure 4.16A, student’s one-tailed paired t-test, p<0.05). For the individual PER2 relative 
mRNA expression acrophases relative to the DLMO, the means were 10.72 ± 0.30 and 11.69 
± 0.20 hours relative to the DLMO for the first and second constant routine, respectively 
(Figure 4.16C). This had a significant difference of -0.97 hours between the first and second 
constant routine, respectively (Figure 4.16C, student’s one-tailed paired t-test, p<0.05).  
For PER3 relative mRNA expression, a significant difference was only observed for the 
individual acrophases calculated as hours after wake (Figure 4.16B). The means were 1.62 ± 
0.41 and 2.65 ± 0.26 hours relative to wake for the first and second constant routine, 
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respectively; a significant shift of -1.03 hours was observed after the delayed feeding 
intervention (Figure 4.16C, student’s one-tailed paired t-test, p<0.05). For the individual 
PER3 relative mRNA expression calculated relative to the timing of the DLMO, the difference 
in the mean between the first and second constant routine was approaching significance 
(Figure 4.16D, student’s one-tailed paired t-test, p=0.06). 
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Figure 4.16: PER2 and PER3 relative mRNA expression showed significant differences in the timing of individual 
acrophases of approximately an hour following the delayed meal intervention. The individual acrophases for both PER2 
and PER3 relative mRNA expression were calculated relative to hours after wake (PER2 - A and PER3 - B) and hours relative 
to the DLMO (PER2 - C and PER3 - D). Student’s one-tailed paired t-test, * denotes p<0.05 compared with control. 
Analysis of mean group BMAL1 relative mRNA expression in adipose tissue showed 
significant cosinor rhythms for both constant routines (Figure 4.17, CNLR, p<0.05). A 2w-
ANOVA revealed a significant effect of time (F4,24 = 11.49, p<0.0001), but no effect of food 
(F1,6 = 1.00, p>0.05) or time x food interaction (F4,24 = 1.29, p>0.05).  
The acrophases for BMAL1 were 13.86 ± 0.74 and 14.93 ± 1.12 hours after wake for the first 
and second constant routine, respectively (Figure 4.17A), indicating a phase shift of -1.07 
hours. In addition, these acrophases were in antiphase to those of PER2 and PER3. However, 
when data was z-scored (Figure 4.17C) the acrophase times relative to time after wake were 
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14.30 ± 0. 24 hours and 14.75 ± 0.34 hours for the first and second constant routine, 
respectively; this reduced the phase shift to -0.45 hours. Similarly, when aligned relative to 
the DLMO, the relative mRNA expression data (Figure 4.17B) showed acrophase times of      
-2.05 ± 0.76 and -1.07 ± 1.12 hours for the first and second constant routine, respectively, 
and a phase shift of -0.98 hours, whereas the z-scored data aligned to DLMO (Figure 4.17D) 
had acrophase times of -1.70 ± 0.42 and -1.25 ± 0.34 hours relative to the DLMO for the first 
and second constant routines, respectively, and a reduced phase shift of -0.45 hours. 
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Figure 4.17: Adipose BMAL1 relative mRNA expression showed no difference in timing after the delayed food 
intervention. The relative mRNA expression of BMAL1 in adipose (2
-δδCT
, A and B and z-scored, C and D) exhibited 
significant circadian rhythms for both constant routines (CNLR, p<0.05, R
2
 listed for each significant curve). There was a 
significant effect of time (2w-ANOVA, F4,24 = 11.49, p<0.0001), but no effect of food (2w-ANOVA, F1,6 = 1.00, p>0.05) or 
time x food interaction (2w-ANOVA, F4,24 = 1.29, p>0.05). Data were aligned to 4-hour time bins of either time after wake 
(A and C) or relative to the DLMO (B and D). Data were expressed as mean ± SEM. 
 
Similarly to blood, analysis of mean group REVERB-β relative mRNA expression in adipose 
tissue showed significant cosinor rhythms for both constant routines (Figure 4.18, CNLR, 
p<0.05). A 2w-ANOVA showed a significant effect of time (F4,24 = 66.35, p<0.05), but no 
effect of food (F1,6 = 0.65, p>0.05) or time x food interaction (F4,24 = 0.82, p>0.05). The 
acrophases for REVERB-β were 22.78 ± 0.40 and 22.58 ± 0.59 hours after wake for the first 
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and second constant routine, respectively (Figure 4.18, A and C). The acrophases for 
REVERB-β were 6.77 ± 0.40 and 6.58 ± 0.59 hours relative to the DLMO for the first and 
second constant routine, respectively (Figure 4.18, B and D). 
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Figure 4.18: Adipose REVERB-β relative mRNA expression showed no difference in timing after the delayed food 
intervention. The relative mRNA expression of REVERB-β in adipose (2
-δδCT
, A and B and z-scored, C and D) exhibited 
significant circadian rhythms for both constant routines (CNLR, p<0.05, R
2
 listed for each significant curve). There was a 
significant effect of time (2w-ANOVA, F4,24 = 66.35, p<0.05), but no effect of food (2w-ANOVA, F1,6 = 0.65, p>0.05) or time x 
food interaction (2w-ANOVA, F4,24 = 0.82, p>0.05). Data were aligned to 4-hour time bins of either time after wake (A and 
C) or relative to the DLMO (B and D). Data were expressed as mean ± SEM. 
 
Analysis of mean group GR relative mRNA expression in adipose tissue only showed 
significant cosinor rhythms only for the second constant routine when data were z scored 
(Figure 4.19, CNLR, p<0.05). A 2w-ANOVA revealed a significant effect of time (F4,24 = 4.09, 
p<0.05), but no effect of food (F1,6 = 1.00, p>0.05) or time x food interaction (F4,24 = 0.69, 
p>0.05). The acrophases were -5.29 ± 1.34 hours after wake and 2.91 ± 1.34 hours relative 
to the DLMO for the second constant routine (Figure 4.19C and D). 
A Five-Hour Delay to Meal Timing Can Regulate the Human Circadian System 
171 
 
5 1 0 1 5 2 0 2 5 3 0 3 5 4 0
0
5
1 0
1 5
R
e
la
ti
v
e
 m
R
N
A
 e
x
p
r
e
s
s
io
n
(2
-

C
T
)
-1 0 -5 0 5 1 0 1 5 2 0
0
5
1 0
1 5
5 1 0 1 5 2 0 2 5 3 0 3 5 4 0
-1 .0
-0 .5
0 .0
0 .5
1 .0
1 .5
T im e  a fte r  w a k e  (4 h r  t im e  b in s )
R
e
la
ti
v
e
 m
R
N
A
 e
x
p
r
e
s
s
io
n
(2
-

C
T
, 
z
-s
c
o
r
e
)
-1 0 -5 0 5 1 0 1 5 2 0
-1 .0
-0 .5
0 .0
0 .5
1 .0
1 .5
T im e  re la tiv e  to  2 5 %  D L M O  (4 h r  t im e  b in )
A )
C o n s ta n t R o u tin e  1
D a y s  4 -5
C o n s ta n t R o u tin e  2
D a y s  1 2 -1 3
B )
C ) D )
R
2
= 0 .2 4 R
2
= 0 .2 4
Figure 4.19: Adipose GR relative mRNA expression showed no difference in timing after the delayed food intervention. 
The relative mRNA expression of GR in adipose (2
-δδCT
, A and B and z-scored, C and D) exhibited significant circadian 
rhythms only for the second constant routines when data was z scored (CNLR, p<0.05, R
2
 listed for each significant curve). 
There was a significant effect of time (2w-ANOVA, F4,24 = 4.09, p<0.05), but no effect of food (2w-ANOVA, F1,6 = 1.00, 
p>0.05) or time x food interaction (2w-ANOVA, F4,24 = 0.69, p>0.05). Data were aligned to 4-hour time bins of either time 
after wake (A and C) or relative to the DLMO (B and D). Data were expressed as mean ± SEM. 
 
A summary table of significant cosinor fits to individual data for all measures can be found in 
Table 4.2. The measure which was the most circadian at the individual level was PER3 
relative mRNA expression in whole blood (95%); this was followed by TAG (90%) and 
REVERB-β (70%) relative mRNA expression in whole blood. Interestingly, plasma glucose and 
plasma NEFA concentrations only showed significant circadian rhythms in the second 
constant routine at the individual level. The measures which were the least circadian were 
plasma insulin (10%) and GR relative mRNA expression in subcutaneous adipose tissue (7%).  
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4.4 Discussion 
 
This study revealed the effect of meal timing on the human circadian system whilst under 
the entrained conditions of a regular sleep/wake and light/dark cycle.  The results indicated 
that the biggest changes were to glucose homeostasis and to the phase of gene expression 
in a metabolic tissue, subcutaneous white adipose tissue.  
4.4.1 Subjective measures and markers of SCN phase 
 
The inclusion criteria ensured that the participants selected had no evidence of extreme 
diurnal preference or evidence of sleep disorders. The selected participants did not have an 
extreme chronotype, as assessed by the Horne-Östberg questionnaire which placed the 
majority (N=7) as intermediate type, and the remaining on the borders of moderate 
morning type (N=2) and moderate evening type (N=1). This helped to minimise the 
difference in the phase of entrainment between the participants. Further to the inclusion 
criteria, the pre-study entrainment protocol (see section 2.2.2) would also have minimised 
variation in phase of entrainment, as discussed in chapter 3. 
To determine how well tolerated the meal schedule was by participants and assess rhythms 
in subjective measures, validated questionnaires assessing hunger and sleepiness were 
given prior to each meal during both constant routines. Despite the difference in the timing 
of the preceding meal schedule, no significant difference was observed in hunger rating at 
the beginning of the constant routines. Concurrent with the literature, there was a 
significant temporal effect on subjective hunger (Scheer et al. 2013), with a peak in the 
evening and a decrease throughout the biological night. Sleepiness also increased over the 
course of the constant routines, and exhibited a rhythm with the largest values seen during 
the biological night (Dijk et al. 1992; Cajochen et al. 1999). No difference in sleepiness was 
observed at the start of the constant routine indicating no detectable changes in sleep as a 
result of the change to meal timing. Therefore, changes that may be seen were unlikely to 
be caused by differences in appetite or sleep. 
Melatonin was used to indicate the phase of the central pacemaker, the SCN. As 
hypothesised, no significant difference was observed in the timing of the DLMO, indicating 
that there had been no phase shift to this SCN-driven rhythm. This would be expected under 
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the presence of a fixed 24-hour light/dark cycle as light is the dominant zeitgeber for the 
SCN. In animals the SCN can phase shift under fixed light/dark cycles when exposed to a 
hypocaloric diet (Mendoza et al. 2005; Caldelas et al. 2005), so the lack of phase shift likely 
reflects successful use of the Schofield equation, which ensured participants were 
maintained on normocaloric diets. Plasma cortisol, another well validated SCN-driven 
rhythm, did not exhibit a significant difference in acrophase timing between the two 
constant routines. This further confirms that the phase of the SCN was not significantly 
altered by the change in meal timing. In addition, the lack of change to both melatonin and 
cortisol timing indicated that any subsequent changes observed in peripheral clock rhythms 
were not caused by a direct phase change in the SCN timing. 
4.4.2 Plasma glucose 
 
Plasma glucose concentrations exhibited circadian rhythms and a phase delay of 5.8 hours 
following the delayed meal intervention. As glucose concentration was measured under 
constant routine conditions, where participants received isocaloric hourly snacks, the 5.8-
hour delay was not an acute postprandial effect. In addition, sampling occurred after the 
minimum of an 8-hour sleep opportunity followed by 5 hours under constant conditions, 
further reducing the possibility of a postprandial effect; the postprandial absorptive state is 
thought to last for 2-4 hours after ingestion of a meal (Harvey & Ferrier 2011). This result 
indicated that meal timing was capable of phase shifting glucose rhythms. 
The literature has previously reported circadian rhythms in plasma glucose concentration, 
with conflicting acrophases stated. Studies previously done at Surrey have shown the 
acrophase of glucose to occur at night (Morgan et al. 1998) whereas others showed the 
plasma glucose acrophase occurring around the time of waking (Shea et al. 2005). The 
reported acrophase from the baseline constant routine was closer to the beginning of 
biological night, similar to the previous findings from Surrey. Possible discrepancies between 
the reported acrophases could be due to meal timing before sampling in each study, as 
neither group reported controlling for this prior to study commencement (Morgan et al. 
1998; Shea et al. 2005). As indicated from the results of this study, meal timing has a 
pronounced effect on the phase of the plasma glucose rhythm. A further possibility on the 
conflicting acrophase could be the impact of individual variation. Chua et al., reported that 
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plasma glucose at the group level did not display a rhythm, but at the individual level they 
saw rhythms which peaked in the evening and in the morning (Chua et al. 2013). Due to a 
lack of significant circadian rhythms at the individual level for glucose, it is difficult to 
determine the contribution individual variation may have had on the reported acrophase of 
the baseline glucose rhythm. 
When determining the cause of the phase shift in glucose, it was concluded that it was not 
caused by a detectable phase shift plasma concentration of in the hormone insulin. Insulin 
showed no significant time x food interaction (2w-ANOVA, F15,135 = 0.8426, p>0.05), 
indicating that despite a significant effect of time, the timing was not affected by the 
delayed meal intervention. Insulin release from the pancreas is under clock control as 
highlighted in mutation studies of Clock and Bmal1 in mouse pancreatic islet cells (Marcheva 
et al. 2010; Sadacca et al. 2011). As the participants had no evidence of metabolic disorders 
it can be assumed they had a functioning pancreatic clock. Therefore, the lack of a 
detectable phase shift of insulin in the results could also indicate that the phase of the 
pancreas clock was unaffected by the change in meal timing. 
The role of insulin is to clear glucose from the blood after a meal and to inhibit hepatic 
gluconeogenesis (Van Cauter et al. 1997). As no phase shift was seen in the insulin rhythm, 
the change seen to the glucose rhythm could have been caused by an alteration in the 
timing of hepatic gluconeogenesis and glucose export, not by a change to glucose clearance. 
The liver clock is known to be important in regulating glucose export during the fasting 
period, as liver specific Bma1l-/- mice showed hypoglycaemia during the fasting phase (Lamia 
et al. 2008). Due to a change in meal timing, and therefore the timing of fasting, the liver 
may have shifted gluconeogenesis and glucose export to cover the anticipated fasting 
period. The nadir of the glucose rhythms occurred shortly after the anticipated time of the 
first meal from the meal schedule participants were exposed to prior to the constant 
routine.  
A limitation with this conclusion is that glucagon, the hormone released during fasting 
(Harvey & Ferrier 2011), was not analysed and thus we cannot definitively conclude if 
gluconeogenesis and glucose release was the cause behind the phase shift to the glucose 
rhythm. In addition, serial sampling of the liver is difficult to do in humans, meaning that 
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changes to glucose metabolism and clock timing in this key metabolic tissue cannot be 
viewed directly. 
From our measurements, we cannot make any comments on changes to insulin sensitivity in 
tissues known to take up glucose, as a result of changes in meal timing. This too could 
impact glucose homeostasis and our result as clearance would be affected. The skeletal 
muscle clock in rodents has been shown to regulate insulin sensitive glucose uptake, as 
Bmal1-/- muscle specific knockout models saw a reduction in the glucose transporter 4, 
which is insulin sensitive  (Dyar et al. 2014). In humans, limited work has been carried out on 
skeletal muscle under circadian protocols, but gene expression and lipid content in people 
with differing metabolic profiles can be assessed (Goossens et al. 2016). Therefore, when 
assessing glucose homeostasis, skeletal muscle could be considered as another peripheral 
tissue for assessment, similar to the use of subcutaneous adipose tissue used in this study. 
As well as the phase shift observed in plasma glucose, the mean concentration of glucose 
was decreased after the delayed food intervention. This result conflicts with literature which 
shows that glucose tolerance decreases over the course of the day (Van Cauter et al. 1989; 
Van Cauter et al. 1997). Therefore, it could be expected that a late meal would result in a 
higher mean glucose concentration as clearance is reduced late in the day (Van Cauter et al. 
1989; Van Cauter et al. 1997). Although the reason for the decrease in mean concentration 
after late meals is unclear, one possible explanation for this could be an order effect of 
controlled laboratory conditions.  
As food intake was restricted to only the 3 meals, a lack of snacking as a result of the 
protocol may have improved glucose concentrations, as meal frequency is known to have an 
effect on health outcomes (Koopman et al. 2014). Additionally, the 3 meals would have 
given rise to clear periods of fasting and this is thought to improve glucose concentrations 
and tolerance in mice (Chaix et al. 2014). Moreover, the impact on daily glucose 
concentrations of consuming just enough calories for a prolonged period to sustain basal 
metabolic rate and level of activity has not been studied. A way in which an order effect 
could be determined is to either randomise the order in which participants received the 
meal schedule, or to have a group which remained on one meal schedule for the duration of 
the study to observe if the mean plasma glucose concentration was reduced. 
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In addition, larger amplitudes were observed in data from the second constant routine in 
plasma glucose and NEFA, PER3 and REVERB-β in whole blood, and BMAL1 in adipose tissue. 
For plasma NEFA and glucose, this could in part be explained by a greater prevalence of 
circadian rhythms at the individual level for the second constant routine. An increased 
occurrence of significant circadian rhythms for the second constant routine was also 
observed for plasma insulin, NEFA and the adipose GR relative mRNA expression. Although 
insulin and adipose GR relative mRNA expression did not have a high prevalence of rhythms 
at the individual level, a possible explanation for the occurrence could be circadian 
resonance. By enforcing a strict sleep/wake and light/dark cycle on the participants, there is 
a greater circadian resonance of endogenous rhythms to the environment within and 
between the individuals. As both desynchrony and sleep restriction are known to affect 
metabolism and rhythms (Scheer et al. 2009; Buxton et al. 2012; Morris et al. 2015), this 
could be a likely explanation for both the larger amplitudes and significant rhythms seen in 
the second constant routine.  
4.4.3 Plasma TAG and NEFA 
 
Assessment of plasma TAG concentration showed significant circadian rhythms, with a rise 
in levels during biological night and a peak in the early morning; this is concurrent with data 
in the literature (Morgan et al. 1998; Chua et al. 2013). Unlike the glucose rhythm, plasma 
TAG showed no phase shift in the timing of the rhythm as a result of the delayed meal 
intervention, indicating that mechanisms regulating TAG metabolism were not affected.  
There are two main sources of plasma TAG; the first is dietary which circulates in the plasma 
within chylomicrons, and the second source are those endogenously synthesised in the liver 
which circulate in very low density lipoproteins (Bruinstroop et al. 2014). Circulating TAG 
will be degraded by lipoprotein lipase (LPL) synthesised by adipocytes and skeletal muscle 
tissue, which will store and utilise TAGs, respectively (Harvey & Ferrier 2011; Gooley & Chua 
2014; Jha et al. 2015). In addition, there is tissue specific antiphasic activity of LPL in adipose 
tissue and skeletal muscle to favour uptake of dietary TAG by adipose during wake and 
activity, and endogenous TAG uptake by skeletal muscle during rest (Jha et al. 2015).  To 
release TAG, hormone sensitive lipase (HSL) in adipocytes will hydrolyse TAG to produce 
NEFAs and glycerol; insulin will inhibit the activity of HSL (Harvey & Ferrier 2011).  
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As the acrophase of both plasma TAG and NEFA concentrations occurred during the nadir of 
insulin, it could be presumed that the source of both NEFA and TAG are from endogenous 
sources, rather than dietary. To clarify this, the presence of apolipoprotein B-48, which is 
only found on chylomicrons (Schneeman et al. 1993), could be assessed to determine levels 
of circulating dietary TAG. Activity of HSL on adipose tissue could also be assessed to 
determine NEFA sources. Presuming that the circulating TAG were likely to be from the liver, 
the results indicated that the mechanisms regulating TAG synthesis and export in the liver 
were unaffected. Although the liver cannot be directly sampled, studies have found that 
REVERB-β is robustly circadian and also plays a role in lipid metabolism (Bugge et al. 2012; 
Cho et al. 2012; Laing et al. 2015). As the REVERB-β rhythms remained unchanged in blood 
and adipose tissue, it could reflect the response in the liver and explain the lack of shift 
observed in TAG rhythm. However, direct assessment of the liver clock would be needed to 
draw a clearer conclusion. 
The differential effect of meal timing on glucose and TAG rhythms may relate to the 
function of the metabolites. Glucose is the primary substrate for the brain; therefore the 
tight regulation of plasma glucose levels is important for the proper functioning of the 
organ, especially during fasting (Barclay et al. 2012). It could therefore be assumed that 
glucose, both concentrations and rhythms, need to be rapidly adjustable to cope with 
changes to nutritional status. Often, glucose seems to be the biochemical marker most 
affected by different manipulations to sleep timing, length and meal timing (Buxton et al. 
2012; Morris et al. 2015), whilst TAG are less affected (Morris et al. 2015). As TAGs are not 
readily used by the brain, its timing may take longer to adjust to changes. 
A potential effector of this differential effect on plasma glucose and TAG could be the 
autonomic nervous system. In rodents, both the liver and adipose tissue receive innervation 
from the autonomic nervous system which is influenced by the SCN (Kalsbeek et al. 2010). 
The SCN will mediate its effects via the paraventricular nucleus (PVN) that has many 
neuronal projections to the liver (Kalsbeek et al. 2010). The administration of different 
neuropeptides, such as neuropeptide Y and orexin, and denervation of the liver have 
resulted in differing effects on both hepatic glucose and TAG metabolism (Kalsbeek et al. 
2004; Kalsbeek et al. 2010; Bruinstroop et al. 2014). Therefore, neuronal input into the liver 
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via the SCN-controlled PVN could be differentially regulating glucose and TAG metabolism in 
the liver. 
4.4.4 Molecular clock components 
 
Both PER2 and PER3 mRNA rhythms were found to be phase shifted by approximately an 
hour in subcutaneous adipose tissue at the mean group level, and significantly at the 
individual level. BMAL1 relative mRNA expression was also found to be shifted in adipose 
tissue, but by around 30 minutes.  Although the phase shift was smaller than that seen in 
the glucose rhythm, this work indicates that meal timing can alter the timing of a known 
metabolic tissue (Khan et al. 2002; Otway et al. 2011). 
PER2 is involved in peripheral clock entrainment to timed feeding in mice (Feillet et al. 
2006). The phase shift viewed in the PERIOD genes indicates that they may also be a target 
in humans. Although glucocorticoids are known to entrain peripheral clocks (Balsalobre et 
al. 2000), cortisol did not exhibit a change in phase. Many metabolic sensors are known to 
interact with the molecular clock, and could be involved in causing the phase shift (Rutter et 
al. 2001; Hirota et al. 2002; Asher et al. 2008; Nakahata et al. 2008; Asher et al. 2010). 
However, it is important to note the limitation that a change in the mRNA expression does 
not necessarily translate to a change in protein levels and function, and the role of post 
transcriptional modifications has not been explored in this study. This is an important 
limitation as outputs of the adipose clock, such as NEFA, did not show a detectable change 
in rhythm. 
Gene expression in whole blood had no differences in timing for the genes which exhibited 
circadian rhythms. PER3 and REVERB-β had robust circadian rhythms, as previously reported 
in the literature (Archer et al. 2008; Laing et al. 2015). A lack of phase shift may well relate 
to the function of the tissue as, in animals, different tissues respond at different rates to 
zeitgebers (Damiola et al. 2000; Stokkan et al. 2001). Concurrent with the animal literature 
(Yamazaki et al. 2000; Yoo et al. 2004), the phase of PER3 differed between whole blood and 
subcutaneous adipose tissue; blood PER3 rhythms peak approximately 3 hours earlier than 
in adipose tissue. This was also seen with regards to the REVERB-β, with the acrophase 
being almost 5.5 hours earlier in blood compared with adipose tissue. However, the positive 
arm of the clock, as assessed through BMAL1 relative mRNA expression, did not see a 
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difference in phase between the two tissues. This could indicate that the dynamics of the 
clock differs between the two tissues, and could again relate to post-transcriptional 
modifications. However, the limited sampling resolution must also be considered as 
increased sampling may reveal a different acrophases for the adipose genes. 
BMAL1 in blood was only circadian for the first constant routine, and had a smaller R2 when 
compared with PER3 and REVERB-β in blood. Studies at Surrey have found that there was a 
greater variation in the phase and amplitudes of BMAL1 rhythms at the individual level in 
whole blood (Archer et al. 2008; Lech et al. 2016), which results in a low amplitude, or no 
rhythm at the group level. BMAL1 in adipose tissue had a significant circadian rhythm, but 
the phase shift calculated varied depending on the normalisation of the data. This 
discrepancy could arise from a low sampling frequency; 5 samples taken at 6-hourly 
intervals may not be able to accurately determine a phase shift as small as an hour. 
The relative mRNA expression of GR did not exhibit a circadian rhythm in blood, but 
periodogram analysis revealed an ultradian expression. Cortisol, the ligand for GR is known 
to have a pulsatile and circadian profile of release (Barclay et al. 2012). The action of 
glucocorticoids in rodents are thought to be regulated by the rhythmic expression of GR 
(Barclay et al. 2012). We show that two different peripheral tissues show a different 
rhythmic expression profile in relative mRNA expression of GR. In adipose, GR relative 
expression showed a circadian rhythm in the second constant routine, but the lack of 
rhythm in the first may relate to low sampling frequency. 
4.4.5 Study limitations 
 
There were some limitations in this study that potentially affected results and 
interpretations. Firstly, the study was only conducted in young, healthy men. Gender and 
age may affect the response to zeitgeber, as chronotype is known to be affected by both 
(Roenneberg et al. 2004). Another limitation is that all participants carried out the study 
with the early meal schedule first, followed by the delayed meal schedule. This therefore 
made it difficult to determine if the differences in the individual mean plasma glucose after 
the delayed meals were an effect of the treatment, or an order effect of being in controlled 
conditions for a sustained period of time. However, the effect of the meal schedule on the 
phase changes of rhythms persisted when plotted relative to the DLMO, a marker of 
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circadian phase, and therefore the phase changes seen were less likely to have been caused 
by an order effect. 
The macronutrient composition of the diet may also affect the strength of the zeitgeber, 
food. A human study showed how a high carbohydrate meal (75%) was capable of phase 
shifting core body temperature and heart rate (Kräuchi et al. 2002), whilst in animals, 
consuming high fat diets are known to affect molecular clock rhythms (Kohsaka et al. 2007; 
Eckel-Mahan et al. 2013). This study aimed to have meals with a macronutrient content that 
reflected free living individuals; 55% carbohydrate, 30% fat and 15% protein. This more 
balanced macronutrient composition may prevent the large changes seen in phase in other 
studies that had a higher proportion of energy dense macronutrients, but the diet and 
protocol used here provides more translational results to the real world. 
Further to the macronutrient composition, the caloric distribution of the meals may also 
play a role.  As this was the first study to look at how 3 meals, the traditional eating habit of 
people, and their timing would affect the human circadian system, all meals were kept 
isocaloric to remove another variable. A future study could determine how both meal timing 
and size of meal affects the human circadian system. Studies which have looked at meal 
timing of the main meal found later eaters lost less weight (Garaulet et al. 2013; Jakubowicz 
et al. 2013); however, circadian rhythms were not assessed. 
The results of this study clearly show that a change to meal timing, but no change to light 
exposure, sleep/wake cycle or macronutrient and caloric intake, could significantly phase 
shift peripheral clocks and rhythms whilst the central pacemaker remained locked to the 
light/dark cycle. Glucose rhythms, and therefore homeostasis, had the largest change with a 
5.8 hour delay as a result of the delayed meal intervention. In addition, core clock genes 
that have been implicated in mediating responses to timed feeding in animals were also 
phase shifted in a metabolic tissue. As seen in animal data (Damiola et al. 2000; Stokkan et 
al. 2001), there was a differential response to meal timing from different peripheral tissues, 
in this case adipose tissue and blood.  
These novel findings have not been previously reported in humans, with much work 
focussing on animals or only assessing how meal timing affects levels of biochemical 
markers, but not their circadian rhythmicity under controlled laboratory conditions. This 
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work highlights that food can act as a zeitgeber to peripheral clock rhythms and could 
provide an alternative method to entrain the circadian system in humans. Furthermore, this 
work looked at the strength of food as a zeitgeber under normal, entrained conditions 
whilst administering a diet that reflected a free living individual. This relatively subtle 
intervention still resulted in large significant changes, and it could be hypothesised that 
restricting the meal timing further, altering the macronutrient content of the diet and 
changing the proportion of calories in each meal would yield even greater results.  
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5 IDENTIFYING CIRCADIAN TRANSCRIPTS IN 
HUMAN SUBCUTANEOUS ADIPOSE TISSUE 
 
5.1 Introduction 
 
The molecular clock regulates the expression of clock controlled genes (CCG), indicating that 
elements of the transcriptome are under circadian regulation. Approximately 10% of the 
murine transcriptome is believed to be circadian in each tissue (Duffield 2003), and overall it 
is thought that around 43% of all murine genes are circadian in at least one tissue (Zhang et 
al. 2014). The tissue-specific circadian transcripts often relate to the function of the tissue 
and can reveal the role of the local tissue clock. Importantly, the murine circadian 
transcriptome is altered under different conditions, such as circadian misalignment (Barclay 
et al. 2012) or SCN lesioning (Reddy et al. 2007). Whilst the transcriptome has been studied 
extensively in animals for circadian regulation, less is known about which transcripts exhibit 
a circadian profile to their expression levels in humans.  
In humans, blood has been studied under various conditions and is thought to co-express 
genes found in other tissues (Liew et al. 2006; Mohr & Liew 2007). Similar to murine studies, 
approximately 10% of the human blood transcriptome is circadian (Möller-Levet et al. 2013), 
and the circadian profile of the transcriptome can also be altered under circadian 
misalignment (Archer et al. 2014). In addition to blood, the transcriptome of the human 
brain (Li et al. 2013) and hair follicles (Akashi et al. 2010) has also been assessed for 
circadian regulation and compared between control and circadian disrupted populations. 
However, compared with animals, few human tissues have been studied under controlled 
conditions using serial sampling to study the transcriptome. 
The aim of this study was to determine if the transcriptome of human subcutaneous 
adipose tissue was under circadian regulation. Few human tissues, especially ones with 
known metabolic activity, can be serially sampled, but a technique developed at Surrey 
(Otway et al. 2011) allowed for subcutaneous adipose tissue to be taken under constant 
routine conditions. 
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It was hypothesised that approximately 10% of the transcriptome in human subcutaneous 
adipose tissue would be under circadian control, as seen in other animal and human tissues 
(Duffield 2003; Möller-Levet et al. 2013; Archer et al. 2014; Laing et al. 2015). Within these 
circadian transcripts, there would be tissue-specific transcripts relating to the function of 
the tissue.   
5.2 Methods 
 
As part of the study examining the role of a non-photic zeitgeber under a fixed light/dark 
cycle (see chapter 4), adipose tissue was taken for microarray analysis. Ten healthy male 
participants were recruited for a 13-day laboratory study, where meals were timed at 0.5, 
5.5 and 10.5 hours after wake for 3 days (see section 2.3.2). Following these 3 days, 
participants underwent a 37-hour constant routine where 7 of the 10 participants had 
subcutaneous adipose tissue taken at 6-hourly intervals. This adipose tissue was then 
processed for microarray analysis. Only adipose taken from the first constant routine was 
assessed. 
Details of adipose tissue collection, RNA extraction, cRNA labelling, amplification, 
purification and hybridization can be found in section 2.3.2 (adipose collection) and 2.16 
(microarray protocol). On the array slide, additional custom probes targeting the canonical 
clock genes were present due to the interest of this project in circadian genes and rhythms. 
These custom probes were tiled across the clock genes to cover both introns and exons.  
The microarray data were deposited in the Gene Expression Omnibus dataset (accession 
number GSE87761). Two models were applied to the transcriptome data to identify 
circadian probes. Firstly, a linear form of a cosinor curve was fitted to the individual 
transcript data for each subject and secondly, a single model approach was applied where 
the cosine curve was fitted to the combined transcript data from all participants. In each 
case the goodness of fit (R2) needed to be more than 0.8 and the amplitude had a 95% 
confidence interval that did not cross zero. 
As one participant had one sample representing one time point that did yield adequate RNA 
for analysis, all of his samples were excluded from the individual fit model. In another 
participant, one sample was found to have a high background in the microarray scan so all 
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data from that participant were also excluded for the individual fit analysis. This meant that 
the analysis for the single fit model was carried out on all 7 participants whilst the individual 
fit model was carried out on samples from 5 participants. 
5.3 Results 
5.3.1 Defining and identifying circadian probes in subcutaneous adipose tissue 
5.3.1.1 Probes identified as circadian under an individual fit model 
 
The number of probes defined as circadian for each participant when the cosinor was fitted 
to individual transcript data can be seen in Table 5.1. There was individual variation in the 
percentage of circadian probes ranging from 25% to 42%, with a mean of 32.3%. The 
frequency of a probe being identified as circadian across the participants was then 
determined (Table 5.2). Only 1.5% of all probes were circadian in all 5 participants under the 
individual fit model, whilst 28% were not circadian in any individual. For a list of the probes 
that were circadian in all individuals see Appendix 5.1. 
 
 
Participant 
 
Fab1b Fab3b Fab4b Fab7b Fab8b 
Number of circadian 
probes 
12,935 14,222 12,403 17,240 10,423 
Percentage of total 
probes (41,619 total 
probes, %) 
31.08 34.17 29.80 41.42 25.04 
      
Table 5.1: Summary of the percentage of circadian transcripts in each individual. A linear form of a cosinor was fitted to 
individual data and deemed circadian when the goodness of fit was greater than 0.8 and the amplitude of the curve had a 
95% confidence interval that did not cross zero. 
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Circadian in 
participants 
(N) 
Number of 
probes 
Percentage of 
circadian probes 
(%) 
5 641 1.54 
4 3233 7.77 
3 7507 18.04 
2 9969 23.95 
1 8627 20.73 
0 11642 27.97 
Total 41,619 100 
Table 5.2: Summary of the prevalence of circadian probes in individuals when a linear form of a cosinor was fitted to the 
individual data. 
 
Probes were separated by phase into evening (336 probes) and morning peaking probes 
(305 probes). Due to the timing of sampling, this equated to 17:30 – 05:29 (-5.8 to 6.2 hours 
relative to DLMO) for evening peaking and 05:30 – 17:29 (6.21 to 18.21 hours relative to 
DLMO) for morning peaking probes. A histogram showing the frequency of peak times of 
the circadian probes can be seen in Figure 5.1. Gene ontology (GO) enrichment analyses 
were then carried out on the evening and morning peaking probes. GO allows for genes to 
be classified into groups based on their involvement in a particular biological process and 
molecular functions. GO enrichment analysis identifies biological processes and molecular 
functions that contained a significant number of genes from the dataset being assessed. A 
summary table of the biological processes that were enriched for circadian probes in this 
study can be viewed in Table 5.3.  
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Figure 5.1: The frequency of the peak time of probes identified as circadian in all five participants under the individual fit 
model showed a bimodal distribution. Peak times were put into 0.5-hour time bins. 
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Evening peaking probes were enriched in metabolic biological processes, such as nitrogen 
compound and organic cyclic compound metabolic processes (Table 5.3). For the morning 
peaking probes, enriched processes included circadian rhythms and rhythmic processes, as 
well as regulation of transcription (Table 5.3). The involvement of morning peaking probes 
in transcription was also seen for the enriched molecular functions (Table 5.4) as many 
significant functions were involved with DNA binding. Interestingly, evening peaking probes 
were only enriched for one molecular function which was binding (Table 5.4).   
 
Evening Peaking Process 
(336 probes) 
Adjusted 
p value 
Morning Peaking Process 
(305 probes) 
Adjusted 
p value 
Nitrogen compound metabolic 
process 
0.0014 
Regulation of transcription from 
RNA polymerase II promoter 
0.0025 
Cellular nitrogen compound 
metabolic process 
0.0087 
Transcription from RNA 
polymerase II promoter 
0.0028 
Nucleobase-containing compound 
metabolic process 
0.0094 Circadian rhythm 0.0032 
Cellular aromatic compound 
metabolic process 
0.0094 Regulation of mitotic anaphase 0.0151 
Heterocycle metabolic process 0.0116 Rhythmic process 0.0151 
Cellular metabolic process 0.0116 
Circadian regulation of gene 
expression 
0.0158 
Organic cyclic compound 
metabolic process 
0.0119 
Nucleobase-containing compound 
biosynthetic process 
0.0219 
Single-organism metabolic process 0.0130 
Aromatic compound biosynthetic 
process 
0.0219 
Positive regulation of endothelial 
cell differentiation 
0.0130 
Regulation of nitrogen compound 
metabolic process 
0.0219 
Positive regulation of branching 
involved in lung morphogenesis 
0.0130 
Cellular nitrogen compound 
biosynthetic process 
0.0219 
Table 5.3: Gene ontology enrichment analysis of biological processes in evening and morning peaking probes that were 
circadian in all participants under the individual fit model showed a separation of processes. Circadian probes were 
separated into evening peaking and morning peaking probes and entered into WebGestalt for GO enrichment. Under 
default settings, the top 10 significantly enriched processes were calculated using the hypergeometric test and then the 
Benjamini & Hochberg multiple test adjustment to get the adjusted p value. Processes shown are those from the biological 
process sub-root. 
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Evening Peaking Function 
(336 probes) 
Adjusted 
p value 
Morning Peaking Function 
(305 probes) 
Adjusted 
p value 
Binding 0.0191 
Transcription regulatory region 
DNA binding 
0.0055 
  
Sequence-specific DNA binding 
transcription factor activity 
0.0055 
  
Organic cyclic compound binding 0.0055 
  
Regulatory region nucleic acid 
binding 
0.0055 
  
Heterocyclic compound binding 0.0055 
  
Regulatory region DNA binding 0.0055 
  
DNA binding 0.0055 
  
Nucleic acid binding transcription 
factor activity 
0.0073 
  
RNA polymerase II regulatory 
region sequence-specific DNA 
binding 
0.0108 
  
RNA polymerase II regulatory 
region DNA binding 
0.0116 
Table 5.4: Gene ontology enrichment analysis of molecular functions of probes that were circadian in all participants 
under the individual fit model showed morning peaking probes were greatly involved in DNA transcription. Circadian 
probes were separated into evening peaking and morning peaking probes and entered into WebGestalt for GO enrichment. 
Under default settings, the top 10 significantly enriched functions were calculated using the hypergeometric test and then 
the Benjamini & Hochberg multiple test adjustment to get the adjusted p value. Functions shown are those from the 
molecular function sub-root. 
 
Similarly to GO enrichment, probes can be analysed to identify pathways that have an 
enrichment of genes. Kyoto encyclopaedia of genes and genomes (KEGG) enrichment 
analyses were carried out on the evening and morning peaking probes and a summary of 
the enriched pathways can be viewed in Table 5.5. A pathway that was enriched in both the 
evening and morning peaking probes were circadian rhythms. However, the probes 
identified differed, with BMAL1, NPAS2 and NR1D1 (REVERB-α) for the evening peaking 
probes whilst CRY2, PER1, PER2, PER3, NR1D1, basic helix-loop-helix family, member e40 
(BHLHE40/DEC1) and basic helix-loop-helix family, member e41 (BHLHE41/DEC2) for the 
morning peaking probes (Table 5.5).  
Unlike the GO enrichment, the KEGG pathway enrichment did not reveal such a pronounced 
separation of processes or a common theme within the evening or morning peaking probes 
(Table 5.5). Pathways involved in metabolism were present in the evening peaking probes, 
but there were also pathways involved in immune function, such as antigen processing and 
Identifying Circadian Transcripts in Human Subcutaneous Adipose Tissue 
189 
 
presentation. For the morning peaking probes, there were also enriched pathways relating 
to immune function, but these differed to those found in the evening peaking probes. 
Evening Peaking Pathway 
(336 probes) 
Adjusted 
p value 
Morning Peaking Pathway 
(305 probes) 
Adjusted 
p value 
Systemic lupus erythematosus 0.0003 Circadian rhythm - mammal 1.03E-10 
Circadian rhythm - mammal 0.0041 ABC transporters 0.0100 
Metabolic pathways 0.0041 
Aldosterone-regulated sodium 
reabsorption 
0.0100 
Glycine, serine and threonine 
metabolism 
0.0062 Cell cycle 0.0172 
Lysine degradation 0.0123 
Glycosylphosphatidylinositol(GPI)-
anchor biosynthesis 
0.0313 
Pathogenic Escherichia coli 
infection 
0.0205 
Progesterone-mediated oocyte 
maturation 
0.0313 
Protein export 0.0357 Small cell lung cancer 0.0313 
Antigen processing and 
presentation 
0.0359 
Fc gamma R-mediated 
phagocytosis 
0.0349 
RNA polymerase 0.0394 Amoebiasis 0.0408 
Thyroid cancer 0.0394 T cell receptor signalling pathway 0.0408 
Table 5.5: KEGG pathway enrichment analysis between the evening and morning peaking genes that were circadian in all 
5 individuals. Circadian probes were separated into evening peaking and morning peaking probes and entered into 
WebGestalt for KEGG pathway enrichment. Under default settings, the top 10 significantly enriched processes were 
calculated using the hypergeometric test and then the Benjamini & Hochberg multiple test adjustment to get the adjusted 
p value. 
 
5.3.1.2 Probes identified as circadian under a single fit model 
 
In addition to the individual fit model to identify circadian genes, a single fit model approach 
was also used to identify circadian genes. Here, a linear form of the cosinor was applied to 
the grouped individual data to generate one fit. The number of probes circadian under the 
single model approach alone was 831 (1.99% of 41,619 probes). For a list of the probes that 
were circadian under the single fit model, and ranked by R2, see Appendix 5.2. 
The circadian probes from the single fit model were separated by phase into evening 
peaking (556 probes) and morning peaking (275 probes) in the same way as described in 
section 5.3.1.1. For a histogram showing the frequency of peak time of the circadian probes, 
view Figure 5.2. GO and KEGG pathway enrichment were conducted on the circadian probes 
(Table 5.6, Table 5.7 and Table 5.8). GO enrichment analysis revealed no significant 
biological processes in the morning peaking probes (Table 5.6). However, all of the enriched 
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biological processes for the evening peaking probes related to metabolism, with a focus on 
organic acids (Table 5.6). Assessment of enriched molecular functions revealed only one 
significant function for morning peaking probes which was catalytic activity (Table 5.7). 
Similarly, the majority of the significant enriched functions for the evening peaking probes 
related to catalysis, as oxidoreductase, transferase and fructose-biphosphase aldolase 
activity were all identified (Table 5.7).  
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Figure 5.2: The frequency of the peak time of probes identified as circadian under the single fit model showed a bimodal 
distribution. Peak times were put into 0.5-hour time bins. 
 
Evening Peaking Process 
(556 probes) 
Adjusted 
p value 
Cofactor metabolic process 6.67E-06 
Coenzyme metabolic process 2.31E-05 
Carboxylic acid metabolic process 0.0002 
Acyl-CoA metabolic process 0.0003 
Organic acid metabolic process 0.0003 
Thioester metabolic process 0.0003 
Monocarboxylic acid metabolic 
process 
0.0003 
Oxoacid metabolic process 0.0003 
Carboxylic acid catabolic process 0.0009 
Organic acid catabolic process 0.0009 
Table 5.6: Gene ontology enrichment analysis of biological processes revealed significant processes only for evening 
peaking probes that were identified as circadian under a single fit model. Circadian probes were separated into evening 
peaking and morning peaking probes and entered into WebGestalt for GO enrichment. Under default settings, the top 10 
significantly enriched processes were calculated using the hypergeometric test and then the Benjamini & Hochberg 
multiple test adjustment to get the adjusted p value. Processes shown are those from the biological process sub-root. 
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Evening Peaking Function 
(556 probes) 
Adjusted 
p value 
Morning Peaking Function 
(275 probes) 
Adjusted 
p value 
Catalytic activity 0.0001 Catalytic activity 1.03E-02 
Oxidoreductase activity 0.0033 
  
Electron carrier activity 0.0055 
  
Oxidoreductase activity, acting on 
the CH-NH group of donors, NAD 
or NADP as acceptor 
0.0217 
  
Aldehyde-lyase activity 0.0231 
  
Transferase activity, transferring 
alkyl or aryl (other than methyl) 
groups 
0.0241 
  
L-ascorbic acid binding 0.0248 
  
Methylumbelliferyl-acetate 
deacetylase activity 
0.0289 
  
Glutathione transferase activity 0.0289 
  
Fructose-bisphosphate aldolase 
activity 
0.0289 
  
Table 5.7: Gene ontology enrichment analysis of molecular functions of probes that were circadian under the single fit 
model showed that evening peaking probes were involved in catalysing reactions. Circadian probes were separated into 
evening peaking and morning peaking probes and entered into WebGestalt for GO enrichment. Under default settings, the 
top 10 significantly enriched functions were calculated using the hypergeometric test and then the Benjamini & Hochberg 
multiple test adjustment to get the adjusted p value. Functions shown are those from the molecular function sub-root. 
 
KEGG pathway enrichment revealed pathways related to metabolism for both the evening 
peaking and morning peaking probes (Table 5.8). Differing from the KEGG pathway results 
on the individual fit model, a significant enriched pathway for circadian rhythms was only 
observed in morning peaking probes (Table 5.8). Pathways common to both evening 
peaking and morning peaking probes were metabolic, drug metabolism – cytochrome P450 
and biosynthesis of unsaturated fatty acids. Despite the common KEGG pathway, different 
circadian probes were found to be peaking in the evening and morning (Table 5.8). 
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Evening Peaking Pathway 
(556 probes) 
Adjusted 
p value 
Morning Peaking Pathway 
(275 probes) 
Adjusted 
p value 
Metabolic pathways 8.71E-12 Circadian rhythm - mammal 2.15E-05 
Glutathione metabolism 0.0001 Metabolic pathways 0.0005 
Propanoate metabolism 0.0002 PPAR signaling pathway 0.0106 
Valine, leucine and isoleucine 
degradation 
0.0004 
Biosynthesis of unsaturated fatty 
acids 
0.0106 
Drug metabolism - cytochrome 
P450 
0.0004 
Drug metabolism - cytochrome 
P450 
0.0106 
Pyruvate metabolism 0.0004 Vitamin digestion and absorption 0.0117 
Arginine and proline metabolism 0.0009 Sphingolipid metabolism 0.027 
Glycolysis / Gluconeogenesis 0.0018 Drug metabolism - other enzymes 0.0293 
One carbon pool by folate 0.0032 Glycerolipid metabolism 0.0293 
Biosynthesis of unsaturated fatty 
acids 
0.005 RNA transport 0.0293 
Table 5.8: KEGG pathway enrichment analysis between the evening and morning peaking genes that were circadian in 
under a single fit model. Circadian probes were separated into evening peaking and morning peaking probes and entered 
into WebGestalt for KEGG pathway enrichment. Under default settings, the top 10 significantly enriched processes were 
calculated using the hypergeometric test and then the Benjamini & Hochberg multiple test adjustment to get the adjusted 
p value. 
 
 
As shown, the model chosen to identify circadian genes can affect both the number of genes 
and subsequently the assessment of the biological function of the probes. Due to multiple 
testing issues, it was important to use a model to define circadian probes that aimed to 
reduce this. Therefore, circadian probes for further analysis were defined as fulfilling the 
dual criteria of circadian under the single fit model approach and circadian in 3 or more 
participants when fitted to individual data; this identified 448 probes which was 1.08% of 
the overall probes tested (Figure 5.3). 
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Figure 5.3: Circadian transcripts were those which fulfilled the dual criteria of having an individual fit in 3 or more 
participants (prevalence approach) and circadian under the single model fit (single model approach). A linear form of a 
cosinor was fitted to individual data and deemed circadian when the goodness of fit was greater than 0.8 and the 
amplitude of the curve had a 95% confidence interval that did not cross zero. For the single fit model a single curve was 
fitted to all the data at once, with the participants being random effects; these too needed an R
2
 > 0.8 and an amplitude 
where the 95% confidence interval did not cross zero. 
 
5.3.2 Ranking circadian probes 
 
Due to the prevalence approach requiring a probe to be circadian in at least 3 participants, 
probes could be ranked for the number of participants that had a significant fit. Table 5.9 
provides a summary of the number of probes identified within the dual criteria list of 
circadian probes as circadian in all 5 participants, circadian in 4 of the participants and 
circadian in 3 participants. For a list of the circadian genes ranked by prevalence and R2, see 
Appendix 5.3. Of all the probes, NR1D1 (REVERB-α) was the most robust gene as it was 
circadian in all 5 individuals and had a R2 of 0.94 (Appendix 5.3). 
Circadian in 
participants 
(N) 
Number of 
probes 
Percentage of 
circadian probes 
(%) 
5 76 17 
4 160 36 
3 212 47 
Total 448 100 
Table 5.9: Summary of the circadian probes that were circadian in all 5 participants, in 4 of the participants and in only 3 
of the participants as per the dual criteria. 
 
 
Circadian 
in both
448 
probes
Prevalence approach
Individual fit in 3 or 
more participants
10,933 probes
Single model 
approach
Fit to all data 
at once
383 probes
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The canonical clock genes were the most robustly circadian, as the probes were circadian in 
all 5 participants under the individual fit model (Figure 5.4). The components of the positive 
arm, BMAL1 and NPAS2 had peak expression during the evening with an acrophase of -0.93 
± 0.17 (acrophase ± SE) hours relative to the DLMO for BMAL1, and 0.99 ± 0.26 hours 
relative to the DLMO for NPAS2. The negative arm components, PER1, PER2, PER3 and CRY2 
were antiphasic to BMAL1 and NPAS2 with peak expression in the morning occurring at 
11.23 ± 0.23, 11.38 ± 0.27, 10.70 ± 0.26 and 9.75 ± 0.44 hours relative to the DLMO, 
respectively. Two clock genes, NR1D1 and DBP, were also circadian in all participants and 
had their peak expression in the morning hours. Their acrophase occurred slightly earlier 
than the negative components with acrophases of 6.15 ± 0.21 and 8.33 ± 0.48 hours relative 
to the DLMO for NR1D1 and DBP, respectively. 
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Figure 5.4: Canonical clock genes were circadian in all individuals and under the single fit model. BMAL1 and NPAS2 
(blue, top) showed peak expression during the evening around the time of the DLMO. PER1, PER2, PER3 and CRY2 (red, 
middle and bottom left) showed peak expression during the morning. Clock genes, NR1D1 and DBP (purple, bottom) also 
showed peak expression during the morning. Data were aligned relative to the average DLMO time and expressed as mean 
± SEM. 
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5.3.3 Cluster analysis 
 
The circadian probes underwent unsupervised clustering producing a heat map where 
probes were separated into 4 distinct clusters relating to their expression profile (Figure 
5.5A). These clusters were either evening peaking (Figure 5.3B, yellow, orange and red) or 
morning peaking (Figure 5.5B, green). The distribution of phases of the circadian probes was 
found to be bimodal (Figure 5.5C). 
There were different numbers of probes within each cluster with 40 probes in the yellow, 
152 probes in the orange, 110 probes in the red and 146 probes in the green cluster. These 
clusters could then be further grouped with 302 evening peaking probes, and 146 morning 
peaking probes. 
Within the yellow cluster were the genes NPAS2, gephyrin (GPHN) and glycine-N-
acyltransferase (GLYAT) and cdk5 and abl enzyme substrate 1 (CABLES1). The orange cluster 
had the most circadian probes, although interestingly it did not contain any of the canonical 
clock genes. Instead, it included fatty acid amide hydrolase (FAAH), diacylglycerol O-
acyltransferase 2 (DGAT), transaldolase 1 (TALDO1), glycogenin 2 (GYG2) and cytochrome 
B561 family member A3 (CYBASC3). The red cluster contained BMAL1, acetyl-CoA 
carboxylase alpha (ACACA), acyl-CoA thioesterase 2 (ACOT2), NAD(P)H quinine 
dehydrogenase 2 (NQO2) and poly(ADP-ribose) polymerase family member 4 (PARP4). 
Within the green (morning peaking) cluster were the clock genes from the negative arm 
(PER1, PER2, PER3, CRY2), clock genes NR1D1, NR1D2 (REVERB-β) as well as hepatic 
leukemia factor (HLF), RNA binding motif protein 17 (RBM17), WD repeat domain 6 (WDR6) 
and S-phase cyclin A-associated protein in the ER (SCAPER). 
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Figure 5.5: One percent of subcutaneous adipose tissue transcripts (448 probes) showed circadian patterns in expression 
using the dual criteria model. A) Heat map of significantly circadian transcripts which were grouped by unsupervised 
clustering B) expression profile of 4 clusters generated by unsupervised clustering and C) frequency of peak time of 
circadian probes showed a bimodal distribution. For the heat map, red indicated high levels of expression and blue 
indicated low levels of expression. Data were aligned to the DLMO. 
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5.3.4 Gene ontology enrichment analysis 
 
GO enrichment analyses were carried out on the morning and evening peaking probes 
identified using the dual criteria model. A summary table of the biological processes which 
were enriched in the evening peaking and morning peaking probes can be viewed in Table 
5.10. Most notable for the evening peaking genes were processes involved in lipid 
metabolism, such as monocarboxylic acid, fatty acid and acyl-CoA metabolic processes. In 
contrast, the morning peaking probes showed enrichment in processes involved with 
circadian rhythms and transcription as well as metabolic processes. 
Evening Peaking Process 
(302 probes) 
Adjusted 
p value 
Morning Peaking Process 
(146 probes) 
Adjusted 
p value 
Small molecule metabolic process 0.0031 Rhythmic process 2.08E-05 
Monocarboxylic acid metabolic 
process 
0.0031 Circadian rhythm 0.0006 
Coenzyme metabolic process 0.0031 RNA metabolic process 0.0042 
Fatty acid metabolic process 0.0031 
Nucleobase containing 
compound  metabolic process 
0.0042 
Acyl-CoA metabolic process 0.0040 Heterocycle metabolic process 0.0045 
Thioester metabolic process 0.0040 
Cellular aromatic compound 
metabolic process 
0.0045 
Oxoacid metabolic process 0.0040 Cellular metabolic process 0.0045 
Carboxylic acid metabolic process 0.0040 Nucleic acid metabolic process 0.0048 
Organic acid metabolic process 0.0040 
Cellular nitrogen compound 
metabolic process 
0.0070 
Aspartate family amino acid 
biosynthetic process 
0.0040 
Organic cyclic compound 
metabolic process 
0.0070 
Table 5.10: Gene ontology enrichment analysis of biological processes in evening and morning peaking probes showed a 
separation of processes identified using the dual criteria model. Circadian probes were separated into evening peaking 
and morning peaking probes and entered into WebGestalt for GO enrichment. Under default settings, the top 10 
significantly enriched processes were calculated using the hypergeometric test and then the Benjamini & Hochberg 
multiple test adjustment to get the adjusted p value. Processes shown are those from the biological process sub-root. 
 
The molecular functions that were enriched are summarised in Table 5.11. There was a 
separation of molecular functions between the evening and morning peaking probes, with 
the evening peaking probes involved with energy generation and catabolism, whilst the 
morning peaking probes were involved with histone demethylation, nucleic acid binding as 
well as metabolism. 
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Evening Peaking Function 
(302 probes) 
Adjusted 
p value 
Morning Peaking Function 
(146 probes) 
Adjusted 
p value 
Oxidoreductase 0.0028 
Histone demethylase activity (H3-
K9 specific) 
0.0069 
Electron carrier activity 0.0037 Organic cyclic compound binding 0.0189 
Catalytic activity 0.0056 Heterocyclic compound binding 0.0189 
    
Oxidoreductase activity, acting on 
single donors with incorporation 
of molecular oxygen 
0.0189 
    Dioxygenase activity 0.0189 
    Demethylase activity 0.0189 
    Histone demethylase activity 0.0189 
    
Calmodulin-dependent protein 
kinase activity 
0.0189 
    
Oxidoreductase activity, acting on 
single donors with incorporation 
of molecular oxygen, 
incorporation of two atoms of 
oxygen 
0.0189 
    Nucleic acid binding 0.0189 
Table 5.11: Summary of gene ontology enrichment analysis of molecular functions in evening and morning peaking 
probes showed a separation of functions identified using the dual criteria model. Circadian probes were separated into 
evening peaking and morning peaking probes and entered into WebGestalt for GO enrichment. Under default settings, the 
top 10 significantly enriched functions were calculated using the hypergeometric test and then the Benjamini & Hochberg 
multiple test adjustment to get the adjusted p value. Functions shown are those from the molecular function sub-root. 
 
Within each enriched biological process, individual genes were identified and the expression 
profiles of a selection are shown. For the evening peaking probes, genes involved with lipid 
metabolism are presented (Figure 5.6); they are FAAH, DGAT, ACACA, acyl-CoA 
dehydrogenase, C-2 to C-3 short chain (ACADS), stearoyl-CoA desaturase (SCD), malic 
enzyme 1 (ME1) and thymidine kinase 2 (TK2). As the evening peaking probes consisted of 3 
clusters, there was a variation in the time of acrophase. FAAH, DGAT2 and SCD were early 
evening peaking with acrophases at 16.64 (-7.36) ± 1.60, 14.29 (-9.71) ± 0.79 and 15.28        
(-8.72) ± 1.18 hours relative to the DLMO, respectively. ACADS, ACADSB, ACACA, ME1 and 
TK2 all peaked later at -3.25 ± 0.67, -4.30 ± 0.97, -0.44 ± 1.20, -5.13 ± 1.32 and -4.58 ± 0.82 
hours relative to the DLMO, respectively. 
For the morning peaking probes, genes involved in regulating transcription and translation 
are presented (Figure 5.7). They are thyrotrophic embryonic factor (TEF), RBM17, HLF, 
eukaryotic translation initiation factor 2A (EIF2A), eukaryotic translation initiation factor 5 
(EIF5), peptidylprolyl isomerise G (PPIG), zinc finger protein 90 (ZFP90) and adenosine 
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deaminase-like (ADAL). Acrophases were in the morning for all of the probes with TEF at 
8.54 ± 0.41, RBM17 at 10.10 ± 0.72, HLF at 10.17 ± 0.68, EIF2A at 7.94 ± 0.96, EIF5 at 9.99 ± 
0.54, PPIG at 8.35 ± 1.50, ZFP90 at 7.48 ± 0.97 and ADAL at 8.82 ± 1.19 hours relative to the 
DLMO. 
-2
-1
0
1
2
FAAH DG A T2
-2
-1
0
1
2
ACACA ACADS
-2
-1
0
1
2
ACAD SB S C D
-1 0 -5 0 5 1 0 1 5 2 0
-2
-1
0
1
2
M E 1
-1 0 -5 0 5 1 0 1 5 2 0
TK 2
R e la tiv e  to  2 5 %  D L M O  (H o u rs )
m
R
N
A
 E
x
p
r
e
s
s
io
n
 (
lo
g
2
, 
Z
 s
c
o
r
e
d
)
 
Figure 5.6: Genes found in gene ontology enrichment in evening peaking probes were involved with lipid metabolism. 
Genes shown were identified as forming part of an enriched gene ontology, with the gene names listed. All data were log2 
mRNA expression z-scored and aligned to the DLMO. Data were expressed as mean ± SEM. 
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Figure 5.7: Genes found in gene ontology enrichment in morning peaking probes were involved with RNA transcription 
regulation. Genes shown were identified as forming part of an enriched gene ontology, with the gene names listed. All 
data were log2 mRNA expression z-scored and aligned to the DLMO. Data were expressed as mean ± SEM. 
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5.3.5 Kyoto encyclopaedia of genes and genomes (KEGG) pathway enrichment 
analysis 
 
KEGG pathway enrichment analysis was carried out on the circadian probes identified using 
the dual criteria model and there was a separation of enriched KEGG pathways between the 
evening and morning peaking probes; these are summarised in Table 5.12. The KEGG 
pathways identified in the evening peaking probes were involved with different types of 
metabolism, with drug metabolism pathways being enriched along with insulin signalling 
and pyruvate metabolism. KEGG pathways enriched in the morning peaking probes were 
those relating to the molecular clock, as well as transcription due to the enriched 
spliceosome and RNA transport pathway. 
 
Evening Peaking Pathways 
(302 probes) 
Adjusted 
p value 
Morning Peaking Pathways 
(146 probes) 
Adjusted 
p value 
Metabolic pathways 2.28E-07 Circadian rhythm - mammal 4.96E-10 
Drug metabolism – cytochrome 
p450 
0.0003 Spliceosome 0.0260 
Arginine and proline metabolism 0.0005 RNA transport 0.0260 
Drug metabolism – other enzyme 0.0005 
 
 
 
 
 
Glutathione metabolism 0.0005 
Insulin signalling pathway 0.0013 
Caffeine metabolism 0.0013 
Propanoate metabolism 0.0013 
Pyruvate metabolism 0.0024 
Table 5.12: KEGG pathway enrichment analysis showed a separation of pathways between the evening and morning 
peaking genes identified using the dual criteria model. Circadian probes were separated into evening peaking and 
morning peaking probes and entered into WebGestalt for KEGG pathway enrichment. Under default settings, the top 10 
significantly enriched processes were calculated using the hypergeometric test and then the Benjamini & Hochberg 
multiple test adjustment to get the adjusted p value.  
 
5.3.6 Network interactions 
 
In addition to GO enrichment and KEGG pathway enrichment analyses, assessment of the 
predicted gene-protein and protein-protein interactions, based on transcripts peaking at 
similar phases, can be carried out using the online tool STRING (Szklarczyk et al. 2015) 
(www.string-db.org). For the morning peaking probes, which were enriched with genes 
involved in circadian rhythm regulation, there were many interactions between the core 
clock genes (Figure 5.8). Those with the strongest interaction score (0.999) based on 
experimental data and predicted interactions were the negative arm proteins, CRY2, PER2, 
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PER3 and PER1. In addition, NR1D1 (REVERB-α) interacted with its isoform NR1D2 (REVERB-
β), as well as the core clock genes mentioned previously (score between 0.769 and 0.940). 
There was also an interaction between proteins involved with alternative splicing and 
protein folding. Survival of motor neuron 1 (SMN1) interacted with both PPIG with a score 
of 0.721, and zinc finger, RAN-binding domain 2 (ZRANB2) with a score of 0.622.  In addition, 
proteins involved in amino acid metabolism were also identified as interacting. Pumilio RNA 
binding family member 3 (also known as KIAA0020), a gene and protein with little 
information, interacted with ADAL with a score of 0.693 and WDR6 with a score of 0.422. 
For the evening peaking probes, a much greater network of protein-protein interactions was 
observed (Figure 5.9). Two proteins that had a large number of interactions were ACACA 
and heat shock protein 90kDa alpha class A member 1 (HSP90AA1). Analysis of their 
connections revealed that ACACA interacted with many proteins involved in lipid 
metabolism, such as FAAH, aldehyde dehydrogenase 1 family, member B1 (ALDH1B1), 
aldehyde dehydrogenase 4 family, member A1 (ALDH4A1), succinate-CoA ligase ADP-
forming beta subunit (SUCLA2), ACADS, ACADSB and solute carrier family 2 member 4 
(SLC2A4). The interaction score of ACACA with these components was as follows: FAAH 
0.506; ALDH1B1 - 0.638; ALDH4A1 - 0.632; SUCLA2 - 0.922; ACADS - 0.697; ACADSB - 0.681 
and SLC2A4 - 0.719. 
HSP90AA1 had interactions with proteins tumor necrosis factor receptor superfamily, 
member 21 (TNFRSF21), serine/threonine kinase 24 (STK24), X-ray repair complementing 
defective repair in Chinese hamster cells 5 (XRCC5) involved in the regulation of apoptosis, 
cyclin-dependent kinase 11A (CDK11A) and casein kinase 2 alpha 2 (CSNK2A2) involved in 
phosphorylation and guanine nucleotide binding protein alpha 12 (GNA12) involved in 
signalling. The interaction score of HSP90AA1 with these components was as follows: 
TNFRSF21 - 0.903; STK24 - 0.460; XRCC5 - 0.561; CDK11A - 0.904; CSNK2A2 - 0.948 and 
GNA12 - 0.884. 
 
  
Identifying Circadian Transcripts in Human Subcutaneous Adipose Tissue 
203 
 
Figure 5.8: Proteins encoded by morning peaking transcripts showed interaction amongst the core clock genes as well as 
interactions between proteins which were involved with transcription and translation. Different coloured lines indicated 
the source of evidence for the interaction and are listed in the key. The network was generated by www.string-db.org 
where default settings were used to generate interactions. A minimum interaction score of 0.400 was used as a threshold 
for an interaction and the score was the sum of the known and predicted interactions. 
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Figure 5.9: Proteins encoded by evening peaking transcripts showed interactions in genes involved in lipid metabolism. 
Different coloured lines indicated the source of evidence for the interaction and are listed in the key. The network was 
generated by www.string-db.org where default settings were used to generate interactions. A minimum interaction score 
of 0.400 was used as a threshold for an interaction and the score was the sum of the known and predicted interactions. For 
ease of presentation, proteins that were in the cluster but did not have any known or predicted interaction were omitted 
from the network.  
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In addition to these large interactions, smaller networks were also evident with distinct 
roles. One network was involved in drug metabolism and was also identified in the KEGG 
pathway analysis; it consisted of cytochrome P450, family 2, subfamily A, polypeptide 6 
(CYP2A6), glutathione S-transferase mu 1 (GSTM1), glutathione S-transferase mu 4 (GSTM4), 
glutathione S-transferase mu 5 (GSTM5), glutathione peroxidise 8 (GPX8), stress-associated 
endoplasmic reticulum protein 1 (SERP1) and hydroxysteroid (11-beta) dehydrogenase 1 
(HSD11B1). The expression profiles for these genes can be viewed in Figure 5.10. The 
acrophase times were as follows: CYP2A6, -1.60 ± 1.03; GSTM1, -3.61 ± 1.13; GSTM4, -3.59 ± 
1.34; GSTM5, -3.33 ± 1.21; GPX8, -4.68 ± 1.52; SERP1, -5.17 ± 0.72 and HSD11B1, -2.13 ± 
1.13 hours relative to the DLMO. 
The other small network was involved in translation and consisted of the ribosomal protein 
(RP) L22 (RPL22), RPL24, RPS26, the mitochondrial ribosomal protein S10 (MRPS10), signal 
recognition particle 9kDa (SRP9), nuclear cap binding protein subunit 2 (NCBP2), eukaryotic 
translation initiation factor 4E family member 2 (EIF4E2) and MAP kinase interacting 
serine/threonine kinase 2 (MKNK2). The expression profiles for these genes can be viewed 
in Figure 5.11. The acrophase times were as follows: RPL22, -3.68 ± 1.59; RPL24, -2.17 ± 
2.92; RPS26, -5.17 ± 1.94; MRPS10, -3.55 ± 0.72; SRP9, -4.82 ± 1.34; NCBP2, -4.55 ± 1.82; 
EIF4E2, -5.91 ± 0.67 and MKNK2, -2.02 ± 1.28 hours relative to the DLMO.  
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Figure 5.10: Expression profiles of genes involved in drug metabolism network. 
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Figure 5.11: Expression profiles of genes involved in transcription network. 
 
5.3.7 Comparison with mouse white adipose 
 
Using CircaDB (Pizarro et al. 2013), an online repository for transcriptome data 
(www.circadb.hogeneschlab.org), the circadian transcripts that appeared in both Mouse 1. 
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OST White Adipose dataset (Affymetrix) and human subcutaneous adipose tissue was 
compared. Overall, using the default settings of the JTK Q-value probability filter, 336 
circadian transcripts in mouse white adipose were identified. Of those, only Nr1d1 (Reverb-
α), Nr1d2 (Reverb-β), Per3, Hlf, Dbp, Tef, Per2 and Gstt2 for the morning peaking probes and 
Npas2, Cables1, Tk2 and Arntl (Bmal1) for the evening peaking probes were circadian in 
both the mouse and human adipose tissue. 
Phases within the mouse data were expressed relative to circadian time (CT). Although 
there is a difference in behavioural cycles between diurnal humans and nocturnal mice, the 
phases of these genes occurred at similar times within the behavioural cycle. For example, 
PER3 in our data peaks at 8.9 hours after the DLMO, which would coincide with the time of 
awakening, whilst in the mouse white adipose data Per3 peaked at CT12, which is defined as 
the onset of activity under dark/dark conditions. Similarly, the antiphasic gene ARNTL 
(BMAL1) in human subcutaneous adipose tissue had an acrophase of -1.1 hours relative to 
the DLMO, which would indicate the beginning of biological night, whilst in mouse white 
adipose it was at CT23 which would coincide with the expected onset of sleep. A summary 
table of the phases can be found in Table 5.13. 
 
Gene 
Acrophase in human 
subcutaneous adipose tissue 
 (Hours relative to the 
DLMO) 
Acrophase in mouse white 
adipose tissue 
 (Circadian Time) 
Per3 8.9 12.0 
Per2 11.0 14.0 
Gstt2 8.2 10.0 
Dbp 8.1 11.0 
Hlf 10.2 12.0 
Tef 8.5 12.0 
Nr1d1 (Reverb-α) 7.4 8.0 
Nr1d2 (Reverb-β) 6.0 10.0 
Npas2 0.9 0.0 
Cables1 2.6 19.0 
Tk2 -4.1 8.0 
Arntl (Bmal1) -1.1 23.0 
Table 5.13: Comparison of acrophases between human subcutaneous adipose tissue and mouse white adipose tissue for 
genes that were found to be circadian in both tissues and species. 
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5.3.8 Comparison with human whole blood 
 
Transcriptomics experiments carried out at Surrey were examined to identify circadian 
transcripts that appeared in both human whole blood and human subcutaneous adipose 
tissue. The datasets were from studies examining the effects of insufficient sleep and 
sleeping out of phase with the circadian system (Möller-Levet et al. 2013; Archer et al. 
2014); data from the control constant routine (Möller-Levet et al. 2013) or baseline 
measured during forced desynchrony (Archer et al. 2014) were used. Comparison of the 
datasets identified 10 genes that were circadian in both sleep experiments and in human 
subcutaneous adipose tissue (Table 5.14). These genes included the canonical clock genes, 
ARNTL (BMAL1), NPAS2, PER2, PER3 and NR1D2 (REVERB-β), as well as  the genes coactosin-
like F-actin binding protein 1 (COTL1), family with sequence similarity 53, member C 
(FAM53C), myelin protein zero-like 1 (MPZL1), poly(A) binding protein interacting protein 2B 
(PAIP2B) and RPL22. 
GO enrichment was performed on the genes which were circadian in both blood and 
subcutaneous adipose tissue (Table 5.15). Although these genes were not separated by 
phase, it can be seen that the enriched biological processes are involved with circadian 
rhythm generation, metabolism, transcription and translation.  
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Matches with subcutaneous adipose tissue 
Sufficient sleep (Möller-Levet et al. 2013) Sleeping in phase (Archer et al. 2014) 
A_24_P196019, A_24_P255314, A_24_P598919, 
A_32_P225209, ACADSB, ADAL, ANKRD20A2, 
ARNTL (BMAL1) 
ACOT2, AK129982, ARNTL (BMAL1) 
BC035091 BOLA3 
C2orf89, CDH23, COTL1, CR609342, CYP4V2 C12orf47, C15orf57, CNTN2, COTL1, CRY2 
DAPK2, DGAT2 
 FAM53C, FKBP5 FAM53C, FUNDC2 
GNG2, GSTM4 
 HNRNPA3 
 KDM4C, KDSR 
 LOC283788 LOC100129113 
MKNK2, MME, MPZL1, MRPL42P5, MTERFD2 MPZL1, MRPS10 
NPAS2, NQO2, NR1D1 (REVERB-α), NR1D2 
(REVERB-β) 
NPAS2, NR1D2 (REVERB-β) 
OSGIN2 
 PACSIN1, PAIP2B, PDPK1, PER1, PER2, PER3, 
PLOD1, PPIG 
PAIP2B, PBLD, PER2, PER3, PGA3 
RBM17, RFFL, RPL22 RPL22, RPL24 
 
SRP9 
TTC3 TEF 
USP36 
 WDR3 
 Z25424, ZBTB7B, ZNF577 ZBED5, ZNF232 
Table 5.14: Circadian genes identified in both human subcutaneous adipose tissue and human whole blood, assessed 
under different sleep experiment. The genes in bold were circadian in both blood transcriptome experiments and in 
subcutaneous adipose tissue. 
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Sufficient sleep (Möller-Levet et 
al. 2013) 
Adjusted 
p value 
Sleeping in phase (Archer et al. 
2014) 
Adjusted 
p value 
Circadian rhythm 2.01E-05 Circadian rhythm 1.17E-05 
Rhythmic process 0.0016 Rhythmic process 1.34E-05 
Cellular metabolic process 0.0063 
Cellular macromolecule 
biosynthetic process 
0.0071 
Single-organism metabolic process 0.0267 Protein localization to organelle 0.0071 
Circadian regulation of gene 
expression 
0.0267 Protein targeting 0.0071 
Negative regulation of toll-like 
receptor signaling pathway 
0.0334 Translational elongation 0.0071 
Metabolic process 0.0382 Protein targeting to ER 0.0071 
 
  
Cotranslational protein targeting 
to membrane 
0.0071 
 
  Gene expression 0.0071 
    
Establishment of protein 
localization to endoplasmic 
reticulum 
0.0071 
Table 5.15: Gene ontology enrichment of genes which were circadian in both subcutaneous adipose tissue and either of 
the blood transcriptome experiments revealed different biological processes. Circadian probes were separated into those 
matched with subcutaneous adipose tissue and either of the blood transcriptome experiments. Probes were entered into 
WebGestalt for GO enrichment. Under default settings, the top 10 significantly enriched processes were calculated using 
the hypergeometric test and then the Benjamini & Hochberg multiple test adjustment to get the adjusted p value. 
Processes shown are those from the biological process sub-root. 
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5.4 Discussion 
 
This study revealed the number and identity of circadian transcripts in human subcutaneous 
adipose tissue taken under the controlled conditions of a constant routine. Using dual 
criteria to define circadian probes, 1% of the probes analysed were found to be circadian 
across participants. The circadian probes of subcutaneous adipose tissue were tissue-
specific and related to the function of the tissue. Furthermore, these probes had time of day 
variation that was broadly separated into evening and morning peaking probes, which 
agrees with previous studies that have shown bimodal temporal distribution (Möller-Levet 
et al. 2013; Archer et al. 2014). It was found that the transcripts that peaked in the evening 
included those that were involved with lipid metabolism, whilst those that peaked in the 
morning included transcripts that were involved with circadian rhythm generating and 
involved in transcription. Comparison of the dataset to other adipose tissue as well as other 
human tissue showed a core set of rhythmic transcripts. 
5.4.1 Defining circadian transcripts 
 
The estimate that 1% of the probes were circadian in human subcutaneous adipose tissue is 
a lower percentage than previously reported in the literature for other tissues (Duffield 
2003; Su et al. 2004; Möller-Levet et al. 2013; Archer et al. 2014; Zhang et al. 2014). It is 
often estimated that approximately 10% of a tissue’s transcriptome will be circadian 
(Duffield 2003; Möller-Levet et al. 2013; Archer et al. 2014), with around half of all 
transcripts being circadian in at least one organ (Zhang et al. 2014). Potential causes for the 
low percentage reported could be due to sample size and the analysis method. 
An important consideration in any transcriptome experiment is the approach taken in 
analysing it. An issue faced here was identifying circadian probes when there was a low 
sample resolution (5 x 6-hourly per participant) and a low number of participants (n=5). The 
low sample resolution increased the likelihood of both false positive and false negative 
identification of circadian transcripts under the individual fit model. For instance, if there 
was large variation between the 5 samples this variation could fit a cosine curve by chance 
despite not being circadian; in contrast, a circadian transcript oscillating with low amplitude 
may not fit the cosine curve due to the low resolution and only one cycle of data. The false 
positives can potentially be seen by a higher number of circadian rhythms identified under 
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the individual fit model than under the single fit model. To overcome this, the prevalence 
approach was applied to the individual fit model where a probe needed to be circadian in 3 
or more participants. This approach reduced the circadian probes identified under the 
individual fit model from a range between 25% to 42% within each participant, down to 27% 
in the prevalence approach. 
Due to the low number of participants (n=5), the single fit model is likely under reporting 
circadian rhythmicity. This would be because variation in individuals may be more likely to 
skew the model, reducing the goodness of fit and not reaching the 0.8 threshold. When 
coupled with the low sample resolution it becomes clearer why the single model reported 
only 2% of probes as circadian. However, transcripts that had robust oscillations would be 
seen in the single fit model. Due to multiple testing issues, the dual criteria model, where 
transcripts needed to be circadian in 3 or more individuals and under the single fit model, 
was used when identifying the circadian transcripts for further analysis. However, due to the 
limitations of both models resulting from the low N and sample resolution, the dual criteria 
has likely led to an under estimation of the total percentage of circadian probes in human 
subcutaneous adipose tissue.  
The strict dual criteria model also had an impact on the GO and KEGG pathway enrichment 
analysis. The significantly enriched biological processes varied between the dual criteria 
transcripts, those that were circadian in all 5 participants and those circadian under the 
single fit model. For evening peaking probes under the dual criteria, the greatest overlap 
was seen with biological processes identified under the single fit model. These common 
processes included the monocarboxylic acid, acyl-CoA, oxoacid and organic acid metabolic 
processes. This was also true for the KEGG pathway enrichment as glutathione, propanoate 
and pyruvate metabolism pathways were common to evening peaking probes under the 
dual criteria and single fit model. The opposite was true for the morning peaking probes, as 
more overlap was observed between the dual criteria and the individual fit model; circadian 
and rhythmic processes and pathways were common to both. This could have been related 
to the single fit model having a larger number of evening peaking than morning peaking 
probes (556 vs 275 probes, respectively), whilst the probes which were circadian in all 5 
participants had a more even split among the evening and morning peaking probes (336 vs 
305 probes, respectively). 
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5.4.2 Canonical clock genes in human subcutaneous adipose tissue 
 
As seen in the literature, the canonical clock genes were highly rhythmic in the 
subcutaneous adipose tissue as identified under the dual criteria model. Previous work at 
Surrey, which used the same biopsy method for obtaining subcutaneous adipose tissue, 
found a significant effect of time on the relative mRNA expression on the canonical clock 
genes studied (Otway et al. 2011). Although assessed under diurnal conditions, the highest 
levels of mRNA expression had the same evening and morning separation, with BMAL1 
expression highest in the evening, and PER1, PER2, PER3, CRY2, REVERB-α and DBP highest 
in the morning (Otway et al. 2011); NPAS2 was not studied. 
Recently, a meta-analysis of multiple transcriptome datasets identified NR1D1 (REVERB-α) 
and NR1D2 (REVERB-β) as the most robustly circadian transcript in both humans and mice 
(Laing et al. 2015). Concurrent with this, NR1D1 (REVERB-α) was found to be the most 
robust transcripts as it was circadian in all 5 participants and had the highest R2 for the 
single fit model. Although NR1D2 (REVERB-β) was circadian, the prevalence and R2 was not 
as robust; prevalence was in 4 participants and R2 was 0.858.  
5.4.3 Gene ontology and KEGG pathway enrichment  
  
Within the circadian probes identified under the dual criteria model there were different 
median expression profiles which were organised into 4 clusters by unsupervised clustering. 
The phases of these clusters were separated into morning peaking and evening peaking 
probes and were similar to the clusters generated and previously reported in human whole 
blood (Möller-Levet et al. 2013; Archer et al. 2014). Importantly, there was a separation of 
processes between the morning and evening peaking probes, as identified through GO 
enrichment.  
Biological processes in GO highlight the overall biological purpose of the gene or its product 
whilst molecular function will relate to the specific function of a gene-product (Ashburner et 
al. 2000). Due to this, the enriched molecular functions identified will likely be involved in 
the biological processes identified. For the morning peaking probes, GO enrichment was for 
processes relating to circadian rhythms due to the presence of the negative arm of the 
molecular clock, and transcription and translation. For transcription, the highlighted genes 
were transcription factors initiating transcription (TEF, HLF, ZFP90) (Hunger et al. 1996; Hata 
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et al. 2011), splicing mRNA (RBM17) (Perry et al. 2005), translation initiation (EIF2A, EIF5) (Si 
et al. 1996; Zoll et al. 2002) and protein folding (PPIG) (Bourquin et al. 1997). The significant 
molecular functions of the morning peaking probes were also related to histone 
demethylation, an important aspect in transcriptional regulation. A study examining 
subcutaneous adipose tissue in humans under diurnal conditions also found that PER1 
peaked in the morning, and genes which had similar phases were enriched for transcription 
and translation (Loboda et al. 2009). However, this study only took 3 biopsies over a 12-hour 
period and none occurred during the night. 
Evening peaking probes had GO enrichment in processes involved in lipid metabolism. As 
shown by the results in chapter 3, chapter 4 and by other groups, plasma TAG 
concentrations exhibit a circadian rhythm, with levels rising over the biological night and 
peaking in the early morning. Therefore, there is good temporal correlation between plasma 
TAG rhythms and an increase in lipid metabolism associated genes in a key tissue. Key genes 
identified were FAAH which is known to hydrolyse bioactive amides into NEFA (Giang & 
Cravatt 1997; Muller et al. 1989), as well as ACADS and ACADSB which are both involved in 
β-oxidation (Naito et al. 1989; Rozen et al. 1994). The other highlighted genes have roles in 
fatty acid synthesis, as DGAT2 catalyses the final stage in TAG synthesis (Cases et al. 2001), 
ACACA produces the enzyme which catalyses the final step in fatty acid synthesis (Brownsey 
et al. 2006), ME1 generates NADPH needed to produce fatty acids (Loeber et al. 1994), and 
SCD which produces oleic acid (Zhang et al. 1999).  
Similarly to GO enrichment, KEGG pathway enrichment uses the known pathways showing 
molecular interaction and looks for pathways containing a significantly enriched number of 
genes. This is a useful tool when an intervention causes an up- or down-regulation of genes 
as it can highlight target pathways. Interestingly, whilst the KEGG pathway enrichment for 
the morning peaking probes reinforced the circadian and transcription action of the probes, 
for the evening peaking probes KEGG analysis highlighted drug metabolism in addition to 
metabolic pathways. This was reiterated when network interactions were conducted on the 
cluster and found a smaller network of proteins with roles in drug metabolism.  
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5.4.4 Comparison of human subcutaneous adipose transcriptome with other 
tissues 
 
Comparing the subcutaneous adipose data to murine white adipose tissue showed that the 
core clock genes were rhythmic in both of the species and tissues, as well as Hlf, Tef, Gstt2, 
Cables1 and Tk2. As mentioned, Hlf and Tef are transcription factors (Hunger et al. 1996), 
Tk2 is important in mitochondrial DNA synthesis (Mancuso et al. 2003), Gstt2 catalyses 
glutathione conjugation to both hydrophilic and hydrophobic compounds (Tan et al. 1995) 
and Cables1 helps to regulate the cell cycle (Shi et al. 2015). The low overlap could be from 
the difference in species as well as the source of the white adipose tissue.  
However, when comparing the circadian probes in the human subcutaneous adipose tissue 
to those in human blood, the genes common in all three experiments differed again. The 
canonical clock genes were circadian in all three, but other common genes were COTL1, 
FAM53C, MPZL1, PAIP2B and RPL22. As above, all of these genes had very different 
functions where COTL1 helps to regulate the actin skeleton (Dai et al. 2006), MPZL1 is 
involved in signal transduction (Grossmann et al. 2015) and PAIP2B and RPL22 are involved 
in translation (Berlanga et al. 2006; Shu-Nu et al. 2000); little is known about FAM53C.  
Although few genes were circadian across all of the tissues and species analysed, circadian 
probes that were common to human subcutaneous adipose tissue and one of the whole 
blood sleep experiment results were involved in fundamental processes for cell function. 
These were circadian rhythm regulation, metabolic processes and transcription and 
translation. Although the exact genes varied, this overlap of processes indicates that 
circadian rhythmicity is conserved in these fundamental cell actions. 
A lack of consistent overlap between circadian transcripts identified in a tissue across 
different experiments is not uncommon. Although the canonical clock genes are often 
present in the circadian transcriptome (Laing et al. 2015), the remaining circadian 
transcripts identified will differ between experiments (Duffield 2003). The method used to 
define circadian transcripts is a key factor involved in this discrepancy, as shown here in the 
effect the model had on both the number and probes identified. The stringency in definition 
of a circadian probe, sample resolution and number of participants will all alter the results 
(Laing et al. 2015). The design of the experiment itself will also play a role, as mistimed sleep 
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(Archer et al. 2014), insufficient sleep (Möller-Levet et al. 2013) and the time of feeding 
(Barclay et al. 2012) all influence the circadian transcriptome. Prior to the study, all 
participants followed a strict entrainment protocol which regulated sleep timing, sleep 
duration and the timing of meals indicating that the transcripts, limiting the impact of these 
factors on results.  
To summarise, human subcutaneous adipose tissue contains transcripts with circadian 
oscillations in their expression levels that show tissue-specific and time of day variation. Few 
human tissues, especially metabolically active tissues, have been serially sampled under 
controlled constant routine conditions for transcriptome analysis. Within these circadian 
probes, the canonical clock genes showed robust rhythmicity and were comparable to the 
reported literature on clock gene rhythmicity in other tissues and species. The circadian 
probes exhibited bimodal phase distribution that showed a morning and evening peaking 
separation of probes. There was time of day specific variation in processes as probes 
involved in lipid metabolism peaked in the evening, whilst those involved in transcription 
peaked in the morning. 
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6 DISCUSSION 
 
Food is believed to be a non-photic zeitgeber in animals. Restricting the time of food 
availability has been shown to phase shift the timing of peripheral circadian rhythms in 
animals (Damiola et al. 2000; Stokkan et al. 2001). Time restricted feeding was also able to 
restore the metabolic phenotype of animals undergoing circadian disruption, through 
protocols mimicking shift work, to be comparable with controls (Salgado-Delgado et al. 
2010; Barclay et al. 2012). It also reduced the adverse effects of consuming a high-fat diet 
(Hatori et al. 2012; Sherman et al. 2012). These studies suggested that meal timing had a 
powerful effect on the timing of peripheral circadian rhythms, as well as on metabolic 
physiology and health, but the effect of meal timing on the human circadian system was 
unknown. 
This thesis investigated whether meal timing could act as a zeitgeber to the human circadian 
system. By administering food, either as a large pulse at different times or as distinct meals 
and then shifting their timing, the effect of meal timing on the circadian rhythms was 
assessed. It was hypothesised that food would act as a zeitgeber to peripheral clocks in 
humans, whilst the central clock would remain unaffected. When given as a pulse, it was 
hypothesised that food would phase-shift peripheral rhythms, but the direction and 
magnitude would depend on when the food pulse was had during the circadian phase. 
When food was consumed as three meals under a fixed light/dark cycle, the hypothesis was 
that a delay in meal timing would delay the timing of peripheral clock rhythms. 
In humans and animals, approximately 10% of genes in the transcriptome of a given tissue 
exhibits circadian rhythms in expression levels (Duffield 2003; Möller-Levet et al. 2013; 
Archer et al. 2014; Zhang et al. 2014). The circadian genes vary from tissue to tissue and will 
relate to the tissue’s function (Zhang et al. 2014). However, few human tissues can be 
serially sampled and would have also been studied under controlled constant routine 
conditions. A further aim of this thesis was to determine if human subcutaneous adipose 
tissue had a transcriptome that was under circadian regulation and to investigate how its 
transcriptome may contribute to metabolic rhythms. A technique developed at Surrey 
allowed for the serial sampling of this key metabolic tissue under controlled conditions 
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(Khan et al. 2002; Otway et al. 2011). The hypothesis was that this novel tissue would have 
genes that exhibited circadian rhythms in expression and that these genes would be 
enriched for biological processes relating to the function of subcutaneous adipose tissue.  
Through two controlled clinical trials, these aims and hypotheses were investigated. The 
studies were conducted under highly controlled laboratory conditions, and all circadian 
rhythms were determined under the gold standard of a constant routine (Duffy & Dijk 
2002). The composition of the diet given reflected that of a free-living individual and was 
adjusted in calorific content to meet each individual’s energy requirements. Young, healthy 
male participants were used for both studies and they followed a strict pre-study 
entrainment protocol to minimise variation. 
6.1 Effect of Food Timing on The Human Circadian System 
 
The ability of food and meal timing to act as a zeitgeber to the human circadian system was 
assessed for the first time. It was found that, similar to animal studies (Damiola et al. 2000; 
Stokkan et al. 2001), food did have the capacity to phase-shift peripheral clock rhythms but 
that there was a differential response of the circadian system to food. In both studies, 
plasma glucose concentration rhythms were phase-shifted as a result of meal timing and the 
magnitude of the phase shift was the largest compared with other rhythms. Glucose 
homeostasis has consistently been shown to be affected in circadian misalignment (Morgan 
et al. 1998; Lund et al. 2001; Scheer et al. 2009; Buxton et al. 2012), but the effect of meal 
timing on rhythms had not been studied. 
6.1.1 Food administered as a pulse 
 
Under a 4-hour ultradian routine protocol (Burgess et al. 2008; Burgess et al. 2010; Revell et 
al. 2012), food was administered as a pulse where 50% of an individual’s daily caloric need 
was given in one-of-twelve meals. The remainder of the calories were administered in 11 
isocaloric meals and all meals were given at 2-hourly intervals. The control session did not 
have a food pulse and all 12 meals were isocaloric.  
An unexpected result from this study was the impact that 2-hourly meals given under an 
ultradian routine had on circadian rhythms in the control session. The circadian rhythm of 
plasma glucose phase-delayed by approximately 8 hours, whilst plasma leptin and NEFA 
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phase advanced by 10 and 7.8 hours, respectively, across the whole protocol. Furthermore, 
the ultradian protocol resulted in a shortening to the period of plasma glucose and leptin 
rhythms. Interestingly, plasma TAG and whole blood relative mRNA expression were 
unaffected. This has not been previously studied and showed that an ultradian routine 
outside the range of entrainment could uncouple food-entrained rhythms from SCN-driven 
rhythms. Furthermore, the protocol caused a reduction in the amplitude of rhythms in the 
second constant routine compared with baseline, suggesting this particular protocol 
dampened the oscillations of circadian rhythms. Although the mechanism behind this is 
unclear and requires further investigation, this work shows for the first time the effect that 
4-hour ultradian protocol with 2-hourly isocaloric meals has on the human circadian system. 
When food was administered as a pulse, saliva melatonin rhythms, as assessed by 25% 
DLMO, had phase shifts of less than an hour over the course of the protocol, indicating that 
this SCN-driven rhythm was largely unaffected by meal timing. This has been seen in rodent 
studies where the SCN phase was unaffected under normocaloric conditions (Damiola et al. 
2000; Stokkan et al. 2001). Plasma glucose and leptin rhythms were shown to be the most 
affected due to meal timing, especially by afternoon and evening pulses (16:40 and 20:40). 
For plasma glucose, net phase advances of approximately 6 hours across the session were 
seen when food was administered at these times. Plasma leptin instead had phase delays of 
7.7 and 4.3 hours across the session when food pulses were administered at 16:40 and 
20:40, respectively. Diurnal plasma leptin rhythms have previously been shown to be 
affected by meal timing (Schoeller et al. 1997). Smaller shifts were seen for plasma TAG and 
whole blood PER3 and REVERB-β relative mRNA expression, and the food pulse times which 
caused the largest phase shift differed between measures. Although the phase shifts caused 
by the food pulse did not follow the “traditional” phase response curve profiles seen for 
light and melatonin, phase shifts were seen and indicated that food can be a zeitgeber to 
the human circadian system.  
This work showed that for the first time that food pulses can phase shift peripheral clock 
rhythms in humans, whilst central clock rhythms are mostly unaffected. Food pulses had the 
largest impact on plasma glucose rhythms, as well as plasma leptin, but differentially 
affected other robust, circadian rhythms.  
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6.1.2 Food administered as 3 distinct meals 
 
Determining the impact that the non-photic zeitgeber, food, had on circadian rhythms in 
humans when given in the presence of the dominant photic zeitgeber still needed to be 
determined. Adopting a 3-meal pattern, meals were given at 5-hour intervals in a fixed 
sleep/wake cycle, beginning either 0.5 (early) or 5.5 hours (late) after wake. The early meal 
schedule was maintained first for a week at home and 3 days in the controlled laboratory 
setting, and following a constant routine, the late meal schedule was then given for 6 days. 
The main finding of this study was that a change to meal schedule, when no other 
parameters were altered, resulted in a 5.8-hour phase delay in plasma glucose rhythms. In 
addition, a phase delay of approximately 1 hour was seen in PER2 and PER3 adipose relative 
mRNA expression. Phase shifts to molecular rhythms were seen in peripheral tissues in 
animal studies which restricted food availability, whilst under a light/dark cycle (Damiola et 
al. 2000; Stokkan et al. 2001). No change in phase was seen in plasma TAG or whole blood 
relative mRNA expression rhythms following the change to meal schedule. Furthermore, no 
changes were seen to central markers of SCN phase, plasma melatonin and cortisol, 
indicating that meal timing could uncouple rhythms between central and peripheral clocks 
despite the fixed light/dark cycle.  
The change to meal timing was a subtle intervention, yet it still resulted in large and 
significant phase shifts to a core metabolic rhythm and to the molecular clock of a known 
metabolic tissue. This work shows for the first time that meal timing, even in the presence 
of a dominant photic zeitgeber, is able to phase shift some components of the human 
circadian rhythm. The impact of this is that meal timing and its phase shifting effects should 
be considered when conducting experiments assessing glucose concentrations. 
Furthermore, meal timing could be used in conjunction with a light/dark cycle to regulate 
the timing of some peripheral rhythms, especially that of plasma glucose. 
6.2 Circadian Regulation of the Human Subcutaneous Adipose Tissue 
Transcriptome 
 
Apart from a few limited tissues, such as whole blood and hair follicles, serial sampling of 
human tissue is not easy. This study serially sampled a metabolically active tissue under the 
highly controlled conditions of a constant routine, which followed on from a fixed 
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sleep/wake and meal schedule maintained for a week at home and then for 3 days in 
controlled laboratory settings. Reported for the first time here, 1% of the human 
subcutaneous adipose tissue transcriptome exhibited circadian rhythms in expression. This 
was less than the 10% hypothesised and is likely to be related to the method of analysis 
used. Within the circadian genes identified, there was a clear morning/evening split in 
phase. Furthermore, genes contained in the morning or evening peaking probes had a 
separation of enriched biological processes, molecular functions and KEGG pathways, and 
these also showed tissue-specific roles. 
Probes with peak expression in the evening hours were involved in lipid metabolism, which 
coincided with the role of adipose tissue as well as the peak timing of plasma TAG and 
plasma NEFA rhythms seen during this experiment (chapter 5). Enriched biological 
processes, molecular functions and KEGG pathways were all related to lipid metabolism, and 
it was also shown that a drug metabolism pathway was rhythmic, as indicated by an 
enriched KEGG pathway and predicted protein-protein interactions. By contrast, morning 
peaking probes were enriched in biological processes, molecular functions and KEGG 
pathways involved in circadian rhythms, transcription and translation. The morning peaking 
probes contained the negative arm of the canonical clock genes, as well as many 
transcription initiation factors and histone demethylation-related genes. This showed that 
not only were genes identified as circadian, but there was a time of day variation in 
transcriptome processes.  
Importantly, there was some overlap between the genes identified as circadian in the 
subcutaneous adipose tissue, and those identified in other human tissues and in rodent 
adipose deposits. The canonical clock genes were highly rhythmic in this sample, as well as 
across all tissues and species studied (Pizarro et al. 2013; Möller-Levet et al. 2013; Archer et 
al. 2014); this validated the approach used here to identify circadian transcripts. Within 
subcutaneous adipose tissue, REVERB-α was found to be the most robust circadian probe as 
it was circadian in all participants and had the best goodness of fit for the single fit model. 
This correlated well with REVERB-α and REVERB-β being identified as the most robustly 
circadian genes across human and mouse samples (Laing et al. 2015). 
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This work has shown that human subcutaneous adipose tissue transcription has circadian 
transcripts and can be used in human trials as a peripheral clock marker. It has also provided 
a dataset for analysis by other groups of a healthy baseline population. Further investigation 
is needed into how the transcriptome changes under periods of circadian disruption, in 
diseased states such as metabolic syndrome, and under different diets. 
6.3 Limitations 
 
An obvious limitation is that both clinical trials were carried out on only male participants. 
Males were chosen to eliminate the variable of the female menstrual cycle as this is thought 
to affect the melatonin rhythm (Baker & Driver 2007). This was important due to melatonin 
being used as a key marker of SCN phase in both studies as well as for the length of time of 
the trials; one took place over two separate sessions and the other was over a continuous 
13-day period. Furthermore, two measures, plasma leptin and the subcutaneous adipose 
tissue, show gender differences in concentration levels and distribution around the body 
(Rosenbaum et al. 2001) indicating that males were a more suitable option for the initial 
investigation of meal timing on the circadian system. However, the effect that food and 
meal timing has on the female circadian system still needs to be determined.  
Furthermore, the impact of meal timing was only investigated in a young, healthy 
population. Although this was important for an initial investigation into whether food was a 
non-photic zeitgeber to reduce confounding variables, the effect that meal timing has on 
rhythms in an older and/or a diseased population is of interest. For instance, it would be 
interesting to discover if meal timing and food has the same effect on circadian rhythms in 
individuals suffering from metabolic syndrome or controlled diabetes, compared with a 
healthy population. This is also relevant for subcutaneous adipose tissue as determining if 
and how the circadian transcriptome of this tissue is altered under meal timing and in 
different populations could reveal a useful analytical tool. Due to the low sample resolution, 
small phase changes would not have been detected which is why the subcutaneous adipose 
tissue transcriptome from the post-intervention constant routine in this study was not 
assessed. 
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6.4 Conclusions 
 
Based on two separate clinical trials which gave food as either a large pulse or as three 
distinct meals, food was found to phase shift some peripheral circadian rhythms. Therefore, 
the hypothesis that food can act as a zeitgeber to the human circadian system was 
accepted. Furthermore, a separate hypothesis that a metabolic tissue, human subcutaneous 
adipose tissue, would exhibit circadian rhythmicity in its transcriptome and that the genes 
would relate to the function of the tissue was also tested. One percent of subcutaneous 
adipose tissue was found to exhibit circadian rhythmicity and there was a separation of 
morning and evening peaking probes. The identification of these probes showed tissue-
specific and time of day variation in function. Therefore, the hypothesis that subcutaneous 
adipose tissue would have a circadian transcriptome was also accepted.  
6.5 Future Work 
 
Moving forward with the results from this thesis, the more classical single pulse PRC 
protocol (Khalsa et al. 2003; St Hilaire et al. 2012) could be undertaken to view the phase 
shifting effects of meal timing on the circadian system. This could illuminate the phase 
shifting kinetics in the rhythms which were most affected in these studies, plasma glucose 
and leptin, to show if large phase shifts were evident from the first exposure. Furthermore, 
it could highlight the importance of maintaining a regular meal schedule if large effects are 
seen from one food pulse. 
Although phase shifts were seen in circadian rhythms, the mechanisms behind these shifts 
are still unknown. Focussing on plasma glucose, the key hormones regulating its 
concentration in plasma, glucagon and insulin, could be assessed to reveal if feeding or 
fasting states have a greater impact on phase shifting rhythms (Patton & Mistlberger 2013). 
It could also indicate if the phase shifts are a result of changes to sensitivity by peripheral 
organs to these key signals. It would also be interesting to assess hormones involved with 
appetite regulation to view the correlation of orexigenic and anorexigenic hormones with 
plasma glucose rhythms (Patton & Mistlberger 2013). They could also reveal a mechanism in 
how meal timing phase shifts certain peripheral rhythms. 
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A related area of interest is the role that fasting has on health. Intermittent fasting or fasting 
as a result of time restricted feeding have been shown to improve health markers, both in 
animals and humans (Mattson et al. 2014). However, the effect that both regimes have on 
the phase of circadian rhythms has yet to be investigated. This is especially pertinent as one 
factor that needs to be elucidated is whether the effects seen by meal timing are due to the 
timing of food intake, or through the timing of the fasting period. In animal studies, the 
restricted feeding window leads to a large period of fasting (Damiola et al. 2000; Stokkan et 
al. 2001), and one study suggests that the first “meal” after a large period of fasting may 
play a role in the phase resetting effect of food (Kuroda et al. 2012). As indicated by the 
results in the delayed meal timing, the phase-shift of the glucose rhythm resulted in the 
acrophase occurring a few hours after the last meal as well as the nadir occurring shortly 
after the first expected meal. This highlights that more investigation is needed in this area 
and the timing and the interaction of the feed/fast cycle on the circadian system may be 
more complex. 
A strength of the studies was the composition of the diet used was representative of a free-
living man. Studies have shown that high-fat diets have a large effect on circadian rhythms 
(Kohsaka et al. 2007; Eckel-Mahan et al. 2013). Moving forward, the effect that different 
diet compositions, such as high in fat, high in sugar or both, have on the circadian system, in 
combination with meal timing, should be explored. This is of particular importance due to 
the prevalence of obesity and the link that a high fat/high sugar diet has in the disease 
progression (Drewnowski & Specter 2004). If the timing of meals can reduce or negate 
adverse health outcomes and the dampening of circadian rhythm, similar to those seen in 
animal studies (Hatori et al. 2012; Sherman et al. 2012), it could provide an easy and cheap 
intervention for the population for this particular disease. Time restricted feeding is showing 
benefits to metabolic markers, but the impact on circadian rhythms and phase has not been 
explored. 
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Appendix 3.1: Plasma NEFA concentration rhythms (mmol/L) did not have a high prevalence of significant circadian 
rhythms, when separated by food pulse group and split into the control session (left) and food pulse session). Mean 
grouped plasma NEFA concentration from the control (left) and food pulse session (right) were assessed. Data were 
separated by time of food pulse, which was given at either 00:40, 04:40, 08:40, 12:40, 16:40 and 20:40. Significant 
circadian rhythms were determined by CNLR and depicted by the presence of a cosine curve (solid lines: p <0.05, dashed 
line: p <0.1 but >0.05). Data were grouped into 2-hour time bins relative to the DLMO and are expressed as mean ± SEM. 
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Appendix 3.2: Plasma leptin concentration (ng/ml) had no significant circadian rhythms when separated by food pulse 
group and split into the control session (left) and food pulse session). Mean grouped plasma leptin concentration from 
the control (left) and food pulse session (right) were assessed. Data were separated by time of food pulse, which was given 
at either 00:40, 04:40, 08:40, 12:40, 16:40 and 20:40. Data were grouped into 2-hour time bins relative to the DLMO and 
are expressed as mean ± SEM. 
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Appendix 3.3: Plasma TAG concentration rhythms (mmol/L) had little difference in phase, but differences in amplitude, 
when separated by food pulse group and split into the control session (left) and food pulse session (right). Mean 
grouped plasma TAG concentration from the control (left) and food pulse session (right) were assessed. Data were 
separated by time of food pulse, which was given at either 00:40, 04:40, 08:40, 12:40, 16:40 and 20:40. Significant 
circadian rhythms were determined by CNLR and depicted by the presence of a cosine curve (solid lines: p<0.05, dashed 
line: p <0.1 but >0.05). Data were grouped into 2-hour time bins relative to the 25% DLMO and are expressed as mean ± 
SEM. 
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Appendix 3.4: Whole blood BMAL1 relative mRNA expression (2
-δδCT
) did not have a high prevalence of significant 
circadian rhythms when separated by food pulse group and split into the control session (left) and food pulse session 
(right). Mean grouped whole blood BMAL1 relative mRNA expression (2
-δδCT
) from the control (left) and food pulse session 
(right) were assessed. Data were separated by time of food pulse, which was given at either 00:40, 04:40, 08:40, 12:40, 
16:40 and 20:40. Significant circadian rhythms were determined by CNLR and depicted by the presence of a cosine curve 
(solid lines: p<0.05, dashed line: p <0.1 but >0.05). Data were grouped into 2-hour time bins relative to the 25% DLMO and 
are expressed as mean ± SEM. 
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Appendix 3.5: Z-scored whole blood BMAL1 relative mRNA expression rhythms were separated by food pulse group and 
split into the control session (left) and food pulse session (right). Mean grouped whole blood BMAL1 relative mRNA 
expression (z-scored) from the control (left) and food pulse session (right) were assessed. Data were separated by time of 
food pulse, which was given at either 00:40, 04:40, 08:40, 12:40, 16:40 and 20:40. Significant circadian rhythms were 
determined by CNLR and depicted by the presence of a cosine curve (solid lines: p<0.05, dashed line: p <0.1 but >0.05). 
Data were grouped into 2-hour time bins relative to the 25% DLMO and are expressed as mean ± SEM. 
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Appendix 3.6: Whole blood GR relative mRNA expression (2
-δδCT
) did not have a high prevalence of significant circadian 
rhythms when separated by food pulse group and split into the control session (left) and food pulse session (right). 
Mean grouped whole blood GR relative mRNA expression (2
-δδCT
) from the control (left) and food pulse session (right) were 
assessed. Data were separated by time of food pulse, which was given at either 00:40, 04:40, 08:40, 12:40, 16:40 and 
20:40. Significant circadian rhythms were determined by CNLR and depicted by the presence of a cosine curve (dashed line: 
p <0.1 but >0.05). Data were grouped into 2-hour time bins relative to the 25% DLMO and are expressed as mean ± SEM. 
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Appendix 3.7: Z scored whole blood GR relative mRNA expression did not have a high prevalence of significant circadian 
rhythms when separated by food pulse group and split into the control session (left) and food pulse session (right). 
Mean grouped z scored whole blood GR relative mRNA expression from the control (left) and food pulse session (right) 
were assessed. Data were separated by time of food pulse, which was given at either 00:40, 04:40, 08:40, 12:40, 16:40 and 
20:40. Significant circadian rhythms were determined by CNLR and depicted by the presence of a cosine curve (solid lines: 
p <0.05, dashed line: p <0.1 but >0.05). Data were grouped into 2-hour time bins relative to the 25% DLMO and are 
expressed as mean ± SEM. 
Appendices 
252 
 
S
w
e
e
t
(V
is
u
a
l 
A
n
a
lo
g
u
e
 S
c
a
le
)
0
2 0
4 0
6 0
8 0
C
a
n
 E
a
t
(V
is
u
a
l 
A
n
a
lo
g
u
e
 S
c
a
le
)
0
2 0
4 0
6 0
8 0
S
a
lt
y
(V
is
u
a
l 
A
n
a
lo
g
u
e
 S
c
a
le
)
0
2 0
4 0
6 0
8 0
F
u
ll
(V
is
u
a
l 
A
n
a
lo
g
u
e
 S
c
a
le
)
0
2 0
4 0
6 0
8 0
F
a
tt
y
(V
is
u
a
l 
A
n
a
lo
g
u
e
 S
c
a
le
)
0
2 0
4 0
6 0
8 0
T im e  a fte r  w a k e  (T im e  b in n e d ,1  h o u r)
T
h
ir
s
ty
(V
is
u
a
l 
A
n
a
lo
g
u
e
 S
c
a
le
)
0 5 1 0 1 5 2 0 2 5 3 0 3 5
0
2 0
4 0
6 0
8 0
40
T im e  a fte r  w a k e  (T im e  b in n e d ,1  h o u r)
S
a
v
o
u
r
y
(V
is
u
a
l 
A
n
a
lo
g
u
e
 S
c
a
le
)
0 5 1 0 1 5 2 0 2 5 3 0 3 5
0
2 0
4 0
6 0
8 0
40
C o n s ta n t R o u tin e  1
D a y s  4 -5
C o n s ta n t R o u tin e  2
D a y s  1 2 -1 3
A )
B )
C )
D )
E )
F )
G )
Appendix 4.1: Subjective measures of appetite aligned to time after wake (hours). Subjective measures of sweet (A), salty 
(B), fatty (C), savoury (D), can eat (E), full (F) and thirsty (G) were assessed prior to every meal during the constant routines. 
Data were expressed as mean ± SEM. 
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Appendix 4.2: Subjective measures of mood and alertness aligned to time after wake (hours). Subjective measures of 
alertness (A), calm (B), cheerfulness (C) and depression (D) were assessed prior to every meal during the constant routines. 
Data were expressed as mean ± SEM. 
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Appendix 4.3: Subjective measures of appetite aligned to the dim light melatonin onset (hours). Subjective measures of 
sweet (A), salty (B), fatty (C), savoury (D), can eat (E), full (F) and thirsty (G) were assessed prior to every meal during the 
constant routines. Data were expressed as mean ± SEM. 
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Appendix 4.4: Subjective measures of mood and alertness aligned to the dim light melatonin onset (hours). Subjective 
measures of alertness (A), calm (B), cheerfulness (C) and depression (D) were assessed prior to every meal during the 
constant routines. Data were expressed as mean ± SEM. 
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Gene Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
FIBIN 0.629 0.280 0.102 17.52 
TSPAN5 0.225 0.399 0.238 17.53 
LOC643837 0.612 0.183 0.123 17.55 
SPAG9 0.282 0.143 0.052 17.56 
LOC100129113 0.806 0.262 0.072 17.60 
NFIC 0.542 0.106 0.064 17.66 
TMOD1 0.749 0.382 0.068 17.74 
SPRYD3 0.707 0.245 0.056 17.78 
CLIP4 0.611 0.234 0.056 17.87 
TMEM30A 0.559 0.166 0.045 17.90 
MAP2K5 0.419 0.144 0.073 18.22 
CR591015 0.264 0.072 0.100 18.29 
BATF 0.160 0.290 0.160 18.29 
FKSG73 0.515 0.223 0.074 18.29 
A_32_P101860 0.651 0.243 0.054 18.38 
MAP4 0.629 0.359 0.073 18.42 
AMICA1 0.520 0.082 0.147 18.44 
GCOM1 0.719 0.224 0.036 18.48 
MICAL2 0.333 0.293 0.185 18.48 
CTNNB1 0.630 0.164 0.050 18.49 
BCDIN3D 0.494 0.152 0.042 18.55 
NADK 0.365 0.167 0.070 18.62 
AK125196 0.131 0.070 0.035 18.63 
KIAA0562 0.739 0.293 0.053 18.64 
A_32_P98793 0.074 0.025 0.202 18.67 
RGS10 0.146 0.342 0.186 18.67 
MBTPS2 0.537 0.232 0.063 18.73 
CSRP2 0.804 0.317 0.054 18.77 
NDEL1 0.376 0.243 0.058 18.80 
SERP1 0.859 0.292 0.043 18.82 
C19orf20 0.557 0.225 0.059 18.87 
POLR3D 0.793 0.219 0.046 18.88 
CR620043 0.640 0.307 0.063 18.98 
TRMT12 0.487 0.113 0.030 18.99 
RIN3 0.571 0.207 0.057 19.00 
UBR7 0.740 0.167 0.033 19.02 
HIST1H2AE 0.559 0.182 0.143 19.02 
RPRD1A 0.710 0.308 0.058 19.05 
TXLNA 0.305 0.296 0.085 19.12 
BX394872 0.311 0.231 0.083 19.14 
SLC4A2 0.428 0.348 0.081 19.22 
A_24_P290257 0.639 0.238 0.053 19.24 
SRP9 0.307 0.202 0.072 19.31 
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Gene Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
A_24_P58597 0.713 0.258 0.066 19.31 
WWTR1 0.349 0.344 0.088 19.39 
A_24_P635355 0.334 0.328 0.105 19.39 
NDRG1 0.634 0.445 0.102 19.39 
HIPK1 0.627 0.334 0.073 19.41 
HIST1H3H 0.540 0.428 0.151 19.42 
RNF166 0.507 0.254 0.081 19.42 
FLCN 0.740 0.299 0.065 19.43 
NFYA 0.411 0.154 0.045 19.43 
HNRNPH3 0.382 0.127 0.050 19.45 
ARPC4 0.439 0.209 0.071 19.46 
TLN1 0.648 0.331 0.068 19.47 
PRKRA 0.456 0.184 0.037 19.48 
HIST1H3F 0.486 0.246 0.132 19.48 
ARHGDIA 0.579 0.456 0.083 19.50 
CASC3 0.268 0.266 0.084 19.53 
HIST1H2BD 0.496 0.199 0.083 19.54 
LOC647252 0.711 0.274 0.069 19.58 
UNC13B 0.201 0.205 0.077 19.61 
MFGE8 0.702 0.403 0.094 19.61 
LOC345645 0.516 0.300 0.072 19.63 
SMNDC1 0.308 0.179 0.053 19.65 
A_23_P399579 0.752 0.225 0.051 19.66 
MPRIP 0.508 0.180 0.059 19.66 
HIST1H3D 0.484 0.250 0.129 19.67 
TOLLIP 0.911 0.334 0.064 19.73 
GPR137 0.603 0.344 0.082 19.75 
NFIL3 0.712 0.728 0.099 19.76 
CAMLG 0.499 0.245 0.109 19.76 
CTH 0.687 0.264 0.059 19.78 
NAPEPLD 0.260 0.152 0.050 19.81 
IMPDH1 0.710 0.489 0.105 19.82 
ENST00000370659 0.597 0.240 0.077 19.82 
JOSD1 0.368 0.414 0.117 19.82 
MFGE8 0.680 0.430 0.108 19.84 
YKT6 0.709 0.427 0.076 19.85 
THOC5 0.491 0.294 0.076 19.87 
BECN1 0.314 0.180 0.061 19.91 
FBXW4 0.386 0.294 0.089 20.00 
FXR2 0.513 0.385 0.096 20.03 
RALBP1 0.690 0.276 0.082 20.03 
ZNF32 0.484 0.143 0.061 20.04 
TCP1 0.530 0.330 0.085 20.05 
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Gene Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
POLR1E 0.590 0.180 0.098 20.06 
NOSIP 0.527 0.246 0.056 20.06 
NT5C3L 0.686 0.267 0.078 20.06 
XPNPEP1 0.155 0.133 0.063 20.07 
C10orf46 0.714 0.265 0.056 20.07 
GCOM1 0.203 0.230 0.090 20.13 
BAT2 0.434 0.211 0.074 20.13 
OLFML3 0.705 0.383 0.111 20.13 
GABARAPL2 0.626 0.253 0.061 20.14 
IDS 0.385 0.293 0.082 20.14 
RNF40 0.490 0.342 0.088 20.15 
AK056245 0.516 0.120 0.071 20.17 
GNB4 0.384 0.201 0.107 20.18 
C12orf23 0.711 0.251 0.046 20.20 
AGPAT6 0.309 0.244 0.085 20.21 
RABL3 0.694 0.459 0.083 20.23 
POLB 0.431 0.184 0.100 20.25 
MRPS10 0.866 0.283 0.049 20.30 
TCFL5 0.589 0.174 0.061 20.30 
SERINC4 0.061 0.159 0.160 20.31 
DCTN1 0.538 0.364 0.075 20.31 
KLHL8 0.719 0.331 0.060 20.32 
A_24_P75700 0.352 0.252 0.098 20.34 
MYLIP 0.399 0.145 0.074 20.35 
CR616772 0.709 0.412 0.076 20.36 
TWSG1 0.555 0.307 0.071 20.38 
EHMT1 0.429 0.275 0.089 20.39 
LAIR1 0.883 0.408 0.083 20.40 
CYTIP 0.533 0.409 0.202 20.40 
LOC100130856 0.604 0.214 0.047 20.41 
MUS81 0.247 0.054 0.075 20.42 
MBD1 0.337 0.144 0.055 20.42 
A_24_P878388 0.794 0.152 0.105 20.42 
GCLC 0.469 0.222 0.069 20.43 
IFT140 0.470 0.117 0.063 20.43 
TH1L 0.302 0.185 0.116 20.45 
A_24_P41890 0.737 0.425 0.086 20.46 
AI216457 0.579 0.249 0.100 20.50 
KIAA0831 0.739 0.086 0.086 20.51 
HIST1H2BB 0.086 0.053 0.079 20.52 
CU674829 0.051 0.174 0.184 20.53 
ALDOAP2 0.822 0.289 0.064 20.55 
SH2B3 0.110 0.086 0.134 20.57 
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Gene Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
A_24_P401670 0.595 0.203 0.058 20.57 
ZNF853 0.472 0.491 0.097 20.57 
PHF19 0.680 0.126 0.058 20.58 
CYP2A7 0.836 0.372 0.108 20.61 
PIN1L 0.512 0.307 0.078 20.64 
ARHGAP1 0.426 0.614 0.151 20.65 
DCXR 0.678 0.217 0.074 20.67 
MAN2B1 0.474 0.204 0.077 20.68 
FAM63A 0.248 0.343 0.122 20.70 
A_24_P76008 0.462 0.319 0.092 20.71 
SAP30L 0.369 0.202 0.055 20.72 
A_24_P683734 0.658 0.090 0.060 20.74 
TBL1XR1 0.379 0.298 0.094 20.74 
LRRC23 0.800 0.251 0.067 20.75 
A_24_P161655 0.757 0.672 0.144 20.76 
EGLN1 0.421 0.155 0.049 20.77 
SRP9 0.834 0.356 0.097 20.77 
SUPT6H 0.469 0.436 0.088 20.79 
PPP1R3B 0.164 0.287 0.123 20.79 
ACTC1 0.460 0.261 0.114 20.79 
CPEB2 0.657 0.201 0.054 20.80 
HSPA8 0.610 0.317 0.081 20.82 
AGPAT6 0.361 0.177 0.073 20.83 
A_24_P358205 0.239 0.147 0.119 20.83 
OTUD1 0.262 0.275 0.091 20.84 
A_24_P281683 0.807 0.340 0.111 20.86 
ZKSCAN5 0.277 0.291 0.101 20.88 
HIST1H2AD 0.727 0.110 0.084 20.89 
TNFSF13 0.608 0.302 0.077 20.90 
PROSC 0.351 0.365 0.120 20.90 
CXorf36 0.180 0.267 0.108 20.92 
A_24_P926993 0.465 0.235 0.064 20.92 
IMMP2L 0.786 0.119 0.060 20.93 
EXOSC5 0.709 0.283 0.084 20.96 
C18orf45 0.593 0.078 0.066 20.97 
PDE4DIP 0.789 0.474 0.076 20.98 
ZBTB6 0.027 0.086 0.097 20.98 
A_32_P112531 0.861 0.179 0.074 20.99 
CNIH3 0.508 0.344 0.120 21.00 
RNF185 0.738 0.318 0.071 21.02 
NUDT4 0.684 0.469 0.073 21.09 
ZNF706 0.566 0.199 0.049 21.13 
BMP4 0.763 0.373 0.073 21.15 
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Gene Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
A_24_P118281 0.596 0.262 0.082 21.16 
HDAC9 0.697 0.290 0.108 21.17 
SNX18 0.581 0.291 0.060 21.18 
AF354444 0.767 0.228 0.100 21.19 
A_24_P254915 0.745 0.231 0.058 21.19 
MED28 0.455 0.406 0.091 21.21 
NBPF1 0.324 0.123 0.083 21.21 
ZNF20 0.545 0.147 0.056 21.23 
ZNF25 0.583 0.207 0.055 21.25 
OAZ3 0.698 0.122 0.077 21.25 
A_24_P135771 0.740 0.136 0.087 21.25 
A_24_P110541 0.721 0.118 0.090 21.26 
SHMT2 0.437 0.252 0.080 21.27 
ZHX2 0.786 0.182 0.061 21.27 
NPEPPS 0.576 0.162 0.048 21.29 
WDR8 0.415 0.140 0.047 21.33 
USP30 0.510 0.242 0.073 21.33 
SUMO1P3 0.740 0.552 0.175 21.35 
PSME1 0.544 0.189 0.060 21.37 
A_24_P280903 0.704 0.321 0.093 21.37 
CLK2 0.247 0.045 0.085 21.53 
CHCHD7 0.771 0.313 0.067 21.55 
VTI1B 0.752 0.249 0.072 21.56 
A_32_P217814 0.542 0.344 0.146 21.57 
TNFRSF11B 0.701 0.278 0.119 21.57 
GSTM3 0.722 0.152 0.082 21.60 
PPP1R3F 0.735 0.192 0.080 21.61 
A_24_P24230 0.489 0.210 0.074 21.61 
DULLARD 0.415 0.178 0.069 21.62 
STARD10 0.699 0.059 0.082 21.62 
ALDH1B1 0.772 0.207 0.074 21.67 
LYRM4 0.732 0.073 0.045 21.70 
A_24_P178654 0.640 0.304 0.132 21.76 
WDR25 0.356 0.285 0.193 21.77 
DOK1 0.736 0.308 0.086 21.77 
DKFZP586K1520 0.534 0.151 0.107 21.80 
hCG_19809 0.428 0.158 0.067 21.80 
BC022928 0.861 0.210 0.069 21.85 
A_24_P161914 0.643 0.401 0.130 21.86 
A_24_P290348 0.688 0.297 0.074 21.86 
A_24_P418189 0.768 0.460 0.141 21.88 
HCFC1 0.196 0.244 0.167 21.92 
GCAT 0.768 0.139 0.068 21.93 
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Gene Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
BC011398 0.222 0.061 0.066 21.99 
LOC100286918 0.843 0.277 0.106 21.99 
A_24_P418019 0.548 0.228 0.083 22.01 
RPL24 0.823 0.272 0.138 22.04 
DHX40 0.597 0.377 0.127 22.05 
ARNTL 0.866 1.490 0.120 22.05 
ARNTL 0.906 1.265 0.087 22.10 
ARNTL 0.913 1.317 0.086 22.12 
ARNTL 0.901 1.349 0.094 22.17 
A_24_P195724 0.513 0.171 0.065 22.18 
A_24_P545200 0.677 0.174 0.094 22.19 
PRR13 0.731 0.294 0.123 22.20 
OTUD3 0.531 0.172 0.054 22.21 
ARNTL 0.893 1.295 0.095 22.22 
A_24_P401392 0.796 0.496 0.115 22.23 
ARNTL 0.858 1.301 0.118 22.23 
CD2BP2 0.081 0.102 0.070 22.24 
NBPF14 0.027 0.051 0.092 22.28 
MOSPD2 0.723 0.269 0.068 22.28 
HPD 0.799 0.257 0.142 22.28 
ENST00000444996 0.808 0.469 0.129 22.30 
A_24_P32207 0.749 0.231 0.092 22.33 
TMCC3 0.348 0.417 0.124 22.33 
A_32_P207903 0.689 0.643 0.125 22.38 
BTG1 0.717 0.348 0.065 22.42 
ARNTL 0.872 1.339 0.104 22.45 
CLK2 0.051 0.037 0.108 22.51 
RNF185 0.670 0.297 0.073 22.53 
A_32_P751535 0.466 0.216 0.080 22.57 
Sep-05 0.419 0.422 0.114 22.69 
GPC6 0.657 0.179 0.108 22.75 
A_24_P501698 0.816 0.188 0.118 22.79 
COCH 0.713 0.190 0.097 22.81 
A_24_P306527 0.850 0.269 0.119 22.82 
TPM3 0.787 0.343 0.095 22.84 
A_24_P297798 0.748 0.242 0.093 22.85 
A_24_P324214 0.784 0.350 0.122 22.89 
B3GNTL1 0.810 0.252 0.074 23.01 
A_32_P195456 0.461 0.148 0.142 23.01 
A_24_P126902 0.815 0.227 0.097 23.03 
C11orf57 0.088 0.126 0.076 23.06 
A_32_P106615 0.631 0.118 0.121 23.11 
A_24_P41551 0.808 0.201 0.084 23.12 
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Gene Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
DIP2A 0.364 0.229 0.091 23.13 
FEZ1 0.500 0.238 0.203 23.21 
HEPH 0.097 0.125 0.125 23.24 
LOC390940 0.394 0.081 0.061 23.30 
C13orf16 0.206 0.033 0.121 23.31 
NCRNA00185 0.499 0.057 0.062 23.35 
LOC389458 0.549 0.018 0.090 23.37 
A_24_P161494 0.947 0.167 0.089 23.42 
NCAPG 0.276 0.338 0.197 23.55 
A_32_P96752 0.440 0.345 0.078 23.61 
SYTL3 0.756 0.319 0.079 23.65 
ABCB1 0.693 0.144 0.155 23.65 
Sep-05 0.102 0.328 0.183 23.78 
NPAS2 0.833 1.076 0.128 23.95 
A_24_P606663 0.820 0.199 0.112 23.97 
GPC4 0.282 0.295 0.107 24.00 
NPAS2 0.782 1.028 0.142 24.04 
AX721252 0.729 0.104 0.087 24.09 
NPAS2 0.837 1.143 0.133 24.11 
A_24_P575336 0.785 0.148 0.094 24.13 
NPAS2 0.829 1.069 0.127 24.14 
SNHG10 0.809 0.187 0.075 24.20 
CDON 0.855 0.205 0.057 24.28 
ZNF628 0.561 0.092 0.067 24.36 
LAG3 0.458 0.110 0.142 24.44 
NPAS2 0.760 1.178 0.164 24.45 
AGAP3 0.265 0.119 0.091 24.58 
NARFL 0.519 0.028 0.058 24.60 
A_24_P812018 0.669 0.272 0.131 24.78 
PCDH7 0.506 0.346 0.226 24.87 
BC025734 0.428 0.131 0.052 24.91 
A_24_P272735 0.433 0.320 0.188 24.93 
S100A11 0.219 0.078 0.108 24.94 
C2orf81 0.412 0.172 0.089 25.04 
NONO 0.526 0.062 0.042 25.07 
A_24_P238616 0.823 0.124 0.092 25.11 
CCDC74B 0.192 0.216 0.089 25.16 
A_32_P156746 0.008 0.038 0.092 25.33 
ARHGAP24 0.429 0.265 0.111 25.34 
BC062753 0.519 0.158 0.091 25.37 
ASAH1 0.065 0.202 0.173 25.70 
LOC440434 0.765 0.132 0.066 25.82 
ZNF577 0.811 0.230 0.094 25.86 
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Gene Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
CABLES1 0.824 0.424 0.068 25.91 
LIMK1 0.026 0.074 0.098 26.19 
A_32_P215475 0.584 0.246 0.134 26.24 
ESR2 0.533 0.084 0.092 26.29 
A_24_P917457 0.458 1.446 0.455 26.43 
GALNT4 0.518 0.091 0.077 26.57 
SETD8 0.180 0.092 0.055 26.73 
CROCCL2 0.043 0.129 0.123 26.89 
TLR5 0.759 0.264 0.067 27.03 
BF514006 0.638 0.186 0.077 27.14 
FBXO41 0.335 0.083 0.129 27.18 
KLF8 0.443 0.159 0.075 27.47 
C3orf50 0.233 0.223 0.157 27.53 
RBM26 0.470 0.100 0.029 27.55 
SPRR1B 0.244 0.490 0.304 27.64 
A_32_P201020 0.437 0.189 0.087 27.65 
PDCD4 0.565 0.223 0.065 27.73 
GPR120 0.670 0.047 0.087 27.97 
ZC3H13 0.664 0.205 0.079 28.09 
ATP5I 0.660 0.179 0.052 28.35 
BC031342 0.689 0.102 0.118 28.38 
KIAA1841 0.198 0.075 0.059 28.38 
AI928490 0.011 0.021 0.097 28.42 
ISOC2 0.732 0.057 0.065 28.49 
EYA4 0.526 0.125 0.166 28.50 
BM929303 0.402 0.182 0.054 28.58 
MCM3APAS 0.334 0.170 0.090 28.79 
SENP6 0.832 0.184 0.040 28.86 
A_32_P75068 0.288 0.242 0.175 28.94 
CLN8 0.014 0.046 0.085 29.13 
NR1D1 0.933 1.693 0.090 29.28 
NR1D1 0.940 1.864 0.095 29.32 
X51602 0.717 0.116 0.070 29.34 
NR1D1 0.671 0.505 0.070 29.50 
ING5 0.735 0.213 0.048 29.50 
POLH 0.139 0.078 0.037 29.52 
CA778346 0.423 0.227 0.077 29.55 
GOLGA2LY1 0.774 0.422 0.115 29.58 
UGT2A1 0.105 0.238 0.212 29.69 
BX647987 0.682 0.138 0.079 29.77 
ZNF700 0.582 0.176 0.046 29.85 
PLK1 0.555 0.284 0.059 29.85 
AK024147 0.558 0.256 0.091 29.94 
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Gene Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
A_24_P214556 0.166 0.427 0.194 29.99 
ACTN1 0.509 0.142 0.065 30.01 
TTC18 0.778 0.228 0.074 30.01 
NR1D1 0.736 0.547 0.072 30.02 
MAP6D1 0.544 0.164 0.052 30.05 
PTPN3 0.577 0.095 0.143 30.05 
TNKS 0.638 0.221 0.060 30.16 
NR1D1 0.683 0.512 0.069 30.22 
NR1D1 0.547 0.441 0.079 30.25 
RAD54B 0.569 0.051 0.051 30.25 
CR610181 0.634 0.431 0.117 30.27 
RAB14 0.158 0.139 0.061 30.29 
PER3 0.867 1.313 0.118 30.30 
NR1D1 0.472 0.421 0.085 30.31 
A_32_P29442 0.609 0.416 0.094 30.32 
PER3 0.833 1.237 0.121 30.32 
A_32_P61884 0.331 0.391 0.136 30.35 
A_32_P149676 0.559 0.123 0.093 30.38 
ZNF431 0.437 0.204 0.080 30.38 
LOC100131998 0.677 0.247 0.072 30.40 
RFX3 0.482 0.084 0.061 30.43 
OPLAH 0.742 0.185 0.038 30.49 
ACAD11 0.669 0.116 0.067 30.52 
PLIN5 0.695 0.232 0.086 30.55 
TOB1 0.311 0.169 0.068 30.56 
AK022065 0.393 0.267 0.152 30.56 
CHD7 0.697 0.315 0.068 30.58 
PER3 0.820 1.180 0.117 30.59 
CR590573 0.743 0.305 0.063 30.62 
A_24_P375227 0.568 0.323 0.101 30.64 
RAG1AP1 0.531 0.125 0.057 30.65 
PLIN3 0.342 0.213 0.097 30.70 
MS4A15 0.378 0.309 0.130 30.70 
BM475547 0.663 0.293 0.066 30.70 
AK055335 0.510 0.021 0.095 30.81 
A_32_P1036 0.446 0.185 0.085 30.83 
AB007953 0.614 0.466 0.095 30.85 
LOC729082 0.676 0.096 0.048 30.87 
S81916 0.385 0.446 0.178 30.87 
HIST1H1A 0.696 0.461 0.123 30.88 
NPIPL2 0.490 0.145 0.075 30.90 
FAM193A 0.385 0.354 0.085 30.91 
PTPN3 0.684 0.173 0.079 30.92 
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Gene Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
A_24_P693820 0.754 0.446 0.102 30.92 
A_32_P112223 0.503 0.344 0.117 30.96 
FAM178A 0.612 0.236 0.053 30.99 
A_32_P121755 0.616 0.480 0.108 31.01 
EZH2 0.400 0.288 0.118 31.10 
AK130118 0.592 0.359 0.106 31.11 
SPAG9 0.571 0.396 0.097 31.13 
CBFB 0.583 0.279 0.073 31.13 
BC012036 0.227 0.460 0.158 31.14 
ZNF175 0.181 0.086 0.118 31.20 
OR6K2 0.431 0.246 0.153 31.20 
LARP4 0.548 0.198 0.043 31.22 
C14orf159 0.541 0.301 0.066 31.22 
MPP7 0.536 0.172 0.126 31.23 
RNF216 0.274 0.073 0.059 31.24 
MAK10 0.551 0.219 0.038 31.26 
A_32_P216015 0.341 0.580 0.158 31.26 
A_32_P224926 0.813 0.123 0.068 31.26 
A_32_P18630 0.743 0.118 0.080 31.27 
A_24_P880143 0.353 0.585 0.188 31.27 
RBBP6 0.675 0.388 0.063 31.27 
A_32_P3408 0.344 0.131 0.102 31.29 
ANKRD11 0.599 0.391 0.074 31.31 
ZNF587 0.484 0.365 0.080 31.35 
C20orf72 0.498 0.230 0.079 31.36 
CCDC84 0.614 0.348 0.090 31.36 
BX648855 0.702 0.320 0.083 31.37 
DBP 0.816 0.737 0.087 31.38 
A_32_P191074 0.524 0.426 0.115 31.40 
DENND1B 0.500 0.346 0.113 31.40 
KDM5A 0.578 0.130 0.053 31.40 
PPRC1 0.609 0.175 0.052 31.42 
GOLGA2 0.471 0.143 0.050 31.42 
CRY2 0.606 0.410 0.091 31.43 
ZNF195 0.609 0.316 0.060 31.44 
CHKA 0.539 0.233 0.074 31.45 
YTHDF2 0.340 0.219 0.065 31.46 
A_24_P409420 0.536 0.443 0.137 31.48 
CN294989 0.911 0.606 0.126 31.48 
A_24_P922120 0.230 0.327 0.124 31.50 
AK096778 0.583 0.525 0.115 31.52 
NPHP3 0.584 0.341 0.083 31.52 
CATSPER2 0.660 0.361 0.101 31.54 
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Gene Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
BHLHE41 0.659 0.379 0.073 31.58 
AF318321 0.377 0.380 0.136 31.59 
RUNDC2A 0.638 0.434 0.082 31.59 
ZBED1 0.415 0.313 0.070 31.61 
PIF1 0.625 0.137 0.069 31.63 
WDR75 0.552 0.138 0.035 31.66 
A_24_P931939 0.435 0.400 0.123 31.68 
PCDHGA2 0.627 0.422 0.111 31.68 
ETV3 0.574 0.487 0.102 31.71 
A_32_P227673 0.641 0.233 0.081 31.74 
TSEN2 0.578 0.224 0.088 31.75 
BHLHE41 0.669 0.348 0.073 31.76 
HOXB3 0.638 0.216 0.078 31.76 
GTPBP5 0.595 0.168 0.041 31.76 
OSBPL3 0.391 0.223 0.153 31.77 
TEF 0.841 0.655 0.070 31.81 
A_24_P480464 0.570 0.268 0.056 31.81 
BHLHE41 0.644 0.340 0.075 31.85 
LOC100128180 0.409 0.218 0.114 31.86 
AF034187 0.167 0.131 0.074 31.87 
A_32_P149716 0.646 0.362 0.065 31.87 
ANKRD12 0.721 0.398 0.066 31.87 
FBXW7 0.533 0.247 0.074 31.88 
BHLHE41 0.649 0.368 0.071 31.90 
BHLHE40 0.787 0.375 0.069 31.90 
LOC595101 0.642 0.565 0.105 31.90 
LAMA4 0.590 0.351 0.089 31.90 
A_24_P929957 0.245 0.267 0.190 31.93 
CAND1 0.527 0.645 0.142 31.96 
MECP2 0.340 0.222 0.094 31.98 
GNL2 0.473 0.106 0.045 31.98 
ERLIN2 0.449 0.224 0.072 31.99 
BDP1 0.383 0.312 0.075 32.01 
AK025132 0.618 0.357 0.101 32.01 
AF390550 0.272 0.137 0.071 32.02 
BHLHE41 0.643 0.393 0.074 32.02 
BC001335 0.844 0.162 0.050 32.02 
SMG6 0.713 0.337 0.059 32.04 
WASF2 0.556 0.341 0.089 32.04 
BHLHE41 0.655 0.381 0.073 32.05 
LOC283701 0.471 0.485 0.144 32.05 
BHLHE41 0.650 0.360 0.067 32.06 
HSD11B2 0.141 0.617 0.290 32.07 
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Gene Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
ULK3 0.333 0.061 0.094 32.07 
COBLL1 0.491 0.212 0.118 32.08 
AF090930 0.374 0.642 0.190 32.09 
ABCA11P 0.711 0.394 0.068 32.11 
FAM172A 0.499 0.305 0.083 32.11 
ABCB7 0.608 0.214 0.067 32.13 
A_24_P936393 0.271 0.255 0.143 32.14 
TP53AIP1 0.508 0.879 0.183 32.15 
B3GNT7 0.156 0.235 0.106 32.15 
C12orf65 0.435 0.113 0.075 32.16 
AI791206 0.676 0.463 0.121 32.17 
RAB22A 0.431 0.066 0.069 32.17 
BTC 0.609 0.215 0.124 32.17 
A_32_P222612 0.698 0.348 0.095 32.19 
ESPNL 0.903 0.200 0.079 32.22 
TSEN54 0.565 0.282 0.122 32.25 
LOC442572 0.404 0.319 0.109 32.25 
NANOG 0.611 0.539 0.109 32.25 
IL1F7 0.659 0.699 0.190 32.26 
PFDN1 0.277 0.273 0.085 32.27 
A_32_P79515 0.187 0.324 0.128 32.28 
A_32_P73491 0.481 0.218 0.114 32.29 
AHI1 0.649 0.292 0.063 32.32 
WWP2 0.602 0.338 0.079 32.36 
ITPKB 0.371 0.407 0.148 32.38 
AK056073 0.607 0.303 0.089 32.41 
BHLHE41 0.655 0.363 0.071 32.42 
SMAD5 0.335 0.211 0.057 32.43 
A_32_P142625 0.659 0.319 0.079 32.44 
SLC12A7 0.644 0.218 0.062 32.45 
RAPGEF2 0.414 0.500 0.184 32.46 
SRCRB4D 0.704 0.161 0.096 32.47 
ABCA1 0.315 0.553 0.219 32.51 
KCNJ14 0.333 0.315 0.083 32.52 
ZMYM5 0.650 0.286 0.065 32.54 
PUS1 0.466 0.136 0.078 32.57 
BHLHE41 0.628 0.383 0.073 32.59 
CRY2 0.869 0.323 0.036 32.60 
RANBP17 0.508 0.184 0.094 32.62 
AK024938 0.545 0.683 0.170 32.63 
PIGL 0.591 0.279 0.061 32.63 
SETD6 0.434 0.168 0.067 32.64 
A_32_P207802 0.519 0.372 0.107 32.65 
Appendices - Summary of probes found to be circadian in all 5 participants. 
268 
 
Gene Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
B3GALNT2 0.300 0.155 0.073 32.66 
DCST2 0.726 0.198 0.072 32.67 
BU567832 0.682 0.528 0.120 32.69 
CRY2 0.874 0.340 0.034 32.69 
ADAL 0.813 0.192 0.052 32.75 
CRY2 0.852 0.329 0.037 32.75 
CRY2 0.868 0.356 0.037 32.76 
AF119913 0.709 0.469 0.089 32.78 
CRY2 0.862 0.335 0.038 32.81 
CRY2 0.894 0.378 0.035 32.82 
A_32_P114615 0.481 0.365 0.120 32.82 
LOC100133091 0.698 0.255 0.075 32.83 
SCML1 0.501 0.271 0.067 32.85 
CRY2 0.875 0.355 0.036 32.87 
LMTK3 0.309 0.076 0.126 32.91 
CRY2 0.886 0.360 0.036 32.91 
C17orf85 0.471 0.319 0.065 32.97 
SPDYE3 0.438 0.326 0.146 33.04 
SPDYE3 0.498 0.315 0.096 33.06 
CX788817 0.572 0.317 0.126 33.07 
SPDYE7P 0.209 0.254 0.170 33.19 
LOC100134228 0.200 0.144 0.065 33.21 
PER3 0.866 0.994 0.080 33.21 
ZNF396 0.754 0.128 0.047 33.22 
ABCA5 0.542 0.264 0.089 33.25 
A_24_P602348 0.734 0.817 0.104 33.31 
PER3 0.849 0.966 0.088 33.33 
PER3 0.855 0.937 0.085 33.39 
PER3 0.797 0.916 0.101 33.39 
CDC42EP4 0.530 0.272 0.057 33.44 
TRMT11 0.675 0.124 0.050 33.45 
PER3 0.848 0.952 0.088 33.45 
PER3 0.848 0.977 0.091 33.46 
NAPG 0.457 0.161 0.063 33.50 
PER3 0.669 0.847 0.133 33.54 
AK055212 0.458 0.256 0.074 33.56 
A_32_P30014 0.086 0.301 0.192 33.60 
A_24_P75994 0.832 0.371 0.138 33.62 
PER3 0.861 0.937 0.081 33.63 
PER3 0.822 0.971 0.093 33.69 
ZNF513 0.193 0.006 0.078 33.69 
RCAN3 0.626 0.241 0.100 33.70 
SPDYE8P 0.447 0.285 0.098 33.70 
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Gene Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
A_32_P140179 0.080 0.373 0.251 33.71 
A_32_P58391 0.343 0.482 0.157 33.74 
E2F3 0.658 0.216 0.065 33.74 
PER2 0.876 0.860 0.081 33.76 
PIK3R3 0.492 0.518 0.118 33.80 
GADD45G 0.673 0.505 0.097 33.82 
ZNF530 0.536 0.445 0.126 33.86 
REV1 0.643 0.267 0.062 33.86 
TNFRSF25 0.589 0.647 0.128 33.86 
A_32_P179089 0.259 0.290 0.100 33.87 
A_32_P108917 0.479 0.110 0.111 33.95 
A_24_P878419 0.205 0.492 0.183 34.17 
PER1 0.860 1.335 0.125 34.29 
PER1 0.841 1.299 0.128 34.30 
PER1 0.852 1.272 0.126 34.31 
PER1 0.840 1.276 0.126 34.32 
PER1 0.857 1.277 0.124 34.33 
PER1 0.850 1.329 0.127 34.35 
PER2 0.869 0.901 0.085 34.35 
PER1 0.846 1.302 0.130 34.35 
PER1 0.842 1.289 0.129 34.35 
GPR56 0.759 0.396 0.065 34.35 
PER1 0.848 1.274 0.126 34.36 
PER2 0.860 0.878 0.087 34.36 
AF085968 0.231 0.183 0.104 34.36 
GPX5 0.246 0.366 0.138 34.36 
PER1 0.845 1.318 0.129 34.39 
PDK1 0.695 0.108 0.071 34.58 
IKZF2 0.560 0.283 0.075 34.64 
AL133570 0.354 0.061 0.076 34.85 
BC031359 0.622 0.202 0.122 35.06 
AL133564 0.463 0.385 0.140 35.08 
C17orf88 0.574 0.194 0.068 35.22 
AI240896 0.198 0.087 0.086 35.42 
LONRF1 0.701 0.545 0.100 35.43 
LONRF1 0.783 0.521 0.087 35.49 
SERPINA12 0.485 0.155 0.334 35.53 
PMEPA1 0.452 0.430 0.116 35.60 
KANK4 0.831 0.273 0.119 35.61 
A_24_P341126 0.223 0.591 0.222 35.62 
RUNDC1 0.066 0.134 0.115 35.63 
A_32_P214011 0.125 0.526 0.268 35.72 
SLC22A5 0.677 0.171 0.085 36.00 
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Gene Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
CR627148 0.585 0.102 0.149 36.12 
KRTAP6-3 0.204 0.439 0.177 36.16 
C18orf25 0.551 0.039 0.043 36.19 
FGD2 0.502 0.131 0.104 36.32 
HIF3A 0.586 0.754 0.132 36.59 
UMOD 0.178 0.127 0.090 36.72 
LOC100132941 0.625 0.438 0.172 36.73 
BC007606 0.624 0.259 0.108 36.89 
RGL2 0.449 0.051 0.106 37.17 
LOC25845 0.042 0.241 0.288 37.24 
LOC440181 0.345 0.003 0.130 37.30 
PMEPA1 0.738 0.406 0.085 37.39 
IGKC 0.160 0.189 0.118 37.42 
PIGQ 0.282 0.062 0.114 37.49 
LOC100287723 0.162 0.118 0.123 38.18 
RASSF8 0.570 0.195 0.060 38.25 
ADCY7 0.470 0.292 0.108 38.37 
MGC34800 0.310 0.230 0.179 38.74 
SCNN1B 0.608 0.448 0.119 38.94 
SLC25A30 0.156 0.122 0.116 38.98 
BG743700 0.547 0.082 0.109 38.98 
CDC6 0.455 0.283 0.132 39.04 
CXCL2 0.601 0.553 0.201 39.15 
PTPRC 0.252 0.203 0.120 39.54 
CDH20 0.345 0.383 0.218 39.65 
CDYL2 0.563 0.167 0.095 39.68 
RIT1 0.206 0.148 0.069 40.01 
BC039524 0.282 0.180 0.110 40.27 
CLK2 0.218 0.105 0.071 40.36 
OSMR 0.348 0.084 0.127 40.38 
AK129982 0.609 0.175 0.099 40.44 
SVEP1 0.484 0.261 0.118 40.44 
TUG1 0.200 0.038 0.069 40.59 
FITM2 0.653 0.167 0.063 40.80 
KIAA1432 0.413 0.078 0.040 41.19 
ABHD4 0.682 0.182 0.042 41.32 
ATP2B4 0.488 0.103 0.060 41.45 
HOMEZ 0.827 0.049 0.051 41.48 
TM2D1 0.726 0.147 0.045 41.49 
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Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
ERAP2 0.993 0.103 0.040 34.22 10.94 
PSPH 0.990 0.107 0.044 22.95 -0.33 
SULT1C2 0.989 0.066 0.030 35.94 12.66 
STON1-GTF2A1L 0.987 0.257 0.071 18.95 -4.33 
IMPAD1 0.981 0.202 0.065 18.40 -4.88 
RPS26 0.972 0.071 0.036 21.99 -1.29 
LOC283481 0.968 0.218 0.053 19.84 -3.44 
A_23_P252125 0.968 0.155 0.059 26.59 3.31 
GSTM3 0.968 0.048 0.024 18.49 -4.79 
LOC283788 0.967 0.241 0.059 31.84 8.56 
LOC441601 0.966 0.290 0.096 22.07 -1.21 
STAT6 0.966 0.111 0.041 28.14 4.86 
RABEP1 0.962 0.199 0.051 19.13 -4.15 
LRRC36 0.958 0.263 0.111 27.04 3.76 
A_32_P168431 0.958 0.078 0.034 19.63 -3.65 
BC073929 0.957 0.186 0.079 32.78 9.50 
BC035147 0.956 0.164 0.056 40.30 17.02 
ALDOC 0.956 0.172 0.064 19.56 -3.72 
THNSL2 0.956 0.179 0.046 19.25 -4.03 
ENST00000427651 0.954 0.140 0.067 20.87 -2.41 
AKR7A2 0.954 0.145 0.054 22.38 -0.90 
AKR7L 0.952 0.111 0.046 21.17 -2.11 
ZNF232 0.952 0.121 0.047 20.34 -2.94 
PIR 0.951 0.099 0.050 21.62 -1.66 
MTHFSD 0.946 0.158 0.048 30.04 6.76 
C5orf17 0.946 0.440 0.160 29.79 6.51 
GALC 0.945 0.068 0.030 41.42 18.14 
CYP4V2 0.944 0.077 0.035 38.97 15.69 
MRPL42P5 0.944 0.204 0.050 31.66 8.38 
HMBOX1 0.944 0.169 0.052 32.32 9.04 
GSTM3 0.943 0.122 0.042 20.90 -2.38 
GSTM4 0.942 0.219 0.058 20.11 -3.17 
PSPH 0.942 0.116 0.048 22.52 -0.76 
MYOM2 0.941 0.140 0.064 20.65 -2.63 
A_32_P168727 0.940 0.151 0.065 21.40 -1.88 
NR1D1 0.940 1.864 0.095 29.32 6.04 
ARL17P1 0.940 0.093 0.031 27.42 4.14 
NAAA 0.939 0.155 0.055 22.73 -0.55 
A_32_P151747 0.939 0.182 0.089 20.38 -2.90 
PP12708 0.939 0.291 0.085 32.84 9.56 
A_32_P103966 0.937 0.322 0.156 33.75 10.47 
AMFR 0.936 0.105 0.042 40.56 17.28 
BTN3A3 0.936 0.217 0.047 20.91 -2.37 
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Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
NCBP2 0.934 0.169 0.045 21.02 -2.26 
CLSTN2 0.933 0.173 0.055 19.59 -3.69 
NR1D1 0.933 1.693 0.090 29.28 6.00 
PAIP2B 0.931 0.390 0.129 21.44 -1.84 
BX097190 0.930 0.148 0.062 19.65 -3.63 
CKMT2 0.930 0.158 0.072 41.05 17.77 
BTN3A2 0.930 0.101 0.038 21.53 -1.75 
BG777521 0.929 0.099 0.047 20.53 -2.75 
LOC283788 0.927 0.243 0.064 32.71 9.43 
GTF3C5 0.927 0.069 0.024 27.42 4.14 
BC034271 0.924 0.180 0.078 20.52 -2.76 
CR622844 0.924 0.108 0.046 31.88 8.60 
BC014871 0.923 0.368 0.112 32.74 9.46 
AF086077 0.923 0.365 0.173 24.46 1.18 
LOC644450 0.923 0.282 0.123 31.96 8.68 
CR603845 0.922 0.131 0.038 21.33 -1.95 
TALDO1 0.922 0.133 0.029 19.11 -4.17 
BC014971 0.922 0.279 0.081 31.54 8.26 
CES1 0.922 0.213 0.078 18.72 -4.56 
LOC340947 0.922 0.327 0.103 22.13 -1.15 
NUDT14 0.922 0.149 0.062 20.01 -3.27 
ICAM3 0.921 0.156 0.047 20.34 -2.94 
PCM1 0.921 0.098 0.043 28.23 4.95 
FLJ43681 0.921 0.049 0.023 21.42 -1.86 
BC006271 0.921 0.217 0.084 34.03 10.75 
DHFR 0.920 0.240 0.050 20.50 -2.78 
LOC100132288 0.920 0.233 0.090 18.44 -4.84 
LOC730091 0.920 0.111 0.055 29.41 6.13 
ZSWIM7 0.919 0.126 0.052 20.09 -3.19 
TTC3 0.919 0.203 0.048 21.15 -2.13 
PPIL3 0.918 0.065 0.033 30.29 7.01 
SCD 0.918 0.344 0.128 39.27 15.99 
ACACA 0.917 0.171 0.081 23.22 -0.06 
CHST8 0.917 0.388 0.178 38.70 15.42 
GTF2A1L 0.916 0.590 0.135 19.15 -4.13 
FAM149B1 0.916 0.082 0.040 20.33 -2.95 
PPFIBP1 0.914 0.377 0.037 33.72 10.44 
AF126109 0.914 0.068 0.026 36.33 13.05 
C12orf39 0.914 0.353 0.176 23.41 0.13 
TMEM8A 0.913 0.154 0.039 19.22 -4.06 
ARNTL 0.913 1.317 0.086 22.12 -1.16 
KIAA0020 0.913 0.127 0.026 29.65 6.37 
ERC1 0.912 0.089 0.043 21.36 -1.92 
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Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
TOLLIP 0.911 0.334 0.064 19.73 -3.55 
CN294989 0.911 0.606 0.126 31.48 8.20 
A_32_P188127 0.911 0.354 0.109 22.67 -0.61 
A_32_P16931 0.910 0.162 0.060 19.88 -3.40 
BQ948285 0.910 0.131 0.035 30.00 6.72 
PPIAL4A 0.910 0.166 0.078 21.28 -2.00 
KCNK15 0.910 0.215 0.109 41.44 18.16 
A_24_P110521 0.910 0.122 0.061 28.66 5.38 
SLC6A8 0.909 0.196 0.046 20.13 -3.15 
SERGEF 0.909 0.151 0.065 23.32 0.04 
BOD1L 0.908 0.145 0.068 19.64 -3.64 
DDT 0.908 0.070 0.033 19.65 -3.63 
C21orf81 0.908 0.323 0.148 33.13 9.85 
AL546498 0.907 0.116 0.044 22.19 -1.09 
RPL23AP7 0.907 0.190 0.039 22.14 -1.14 
A_24_P641673 0.907 0.328 0.077 21.15 -2.13 
A_24_P914062 0.907 0.192 0.092 35.52 12.24 
H1F0 0.906 0.243 0.095 33.67 10.39 
ARNTL 0.906 1.265 0.087 22.10 -1.18 
MFF 0.906 0.140 0.043 21.93 -1.35 
DNAH6 0.905 0.320 0.138 22.19 -1.09 
RAB33B 0.905 0.156 0.055 19.36 -3.92 
NQO2 0.905 0.180 0.071 20.88 -2.40 
A_32_P219377 0.905 0.109 0.047 17.60 -5.68 
FGFBP3 0.904 0.134 0.034 31.93 8.65 
UPRT 0.904 0.055 0.025 17.94 -5.34 
A_32_P57702 0.904 0.084 0.039 20.81 -2.47 
ADI1 0.904 0.175 0.033 20.90 -2.38 
ADI1 0.904 0.207 0.052 20.81 -2.47 
TRAF7 0.904 0.176 0.053 18.98 -4.30 
GSTT2 0.904 0.205 0.064 31.44 8.16 
FLJ44253 0.904 0.358 0.148 32.19 8.91 
MME 0.904 0.147 0.070 20.20 -3.08 
FRG1B 0.903 0.098 0.041 32.70 9.42 
ESPNL 0.903 0.200 0.079 32.22 8.94 
ANKRD20A2 0.903 0.428 0.080 33.38 10.10 
ADI1 0.902 0.203 0.053 20.53 -2.75 
FN3KRP 0.902 0.099 0.030 19.11 -4.17 
A_32_P93144 0.902 0.297 0.110 35.77 12.49 
ARNTL 0.901 1.349 0.094 22.17 -1.11 
SNORD123 0.901 0.161 0.077 21.09 -2.19 
CR620532 0.900 0.131 0.047 24.57 1.29 
ARL17P1 0.900 0.161 0.053 30.71 7.43 
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Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
A_24_P401051 0.900 0.109 0.040 39.33 16.05 
LOC349196 0.899 0.205 0.091 34.85 11.57 
DHFR 0.898 0.217 0.067 20.58 -2.70 
RHBDF2 0.898 0.352 0.072 35.49 12.21 
MGC70870 0.897 0.131 0.049 23.72 0.44 
TMEM8B 0.897 0.097 0.025 25.60 2.32 
ZFP90 0.897 0.163 0.033 31.80 8.52 
GAMT 0.896 0.138 0.048 20.28 -3.00 
tcag7.873 0.896 0.374 0.122 22.22 -1.06 
A_24_P594683 0.896 0.121 0.046 19.06 -4.22 
CLIC6 0.896 0.195 0.083 41.40 18.12 
MPZL1 0.896 0.207 0.034 19.33 -3.95 
HSP90AA4P 0.895 0.237 0.072 22.27 -1.01 
AFARP1 0.895 0.255 0.069 21.96 -1.32 
TIMM10 0.895 0.107 0.054 21.78 -1.50 
XRCC5 0.895 0.144 0.044 20.50 -2.78 
PARP4 0.894 0.129 0.044 21.33 -1.95 
C15orf57 0.894 0.134 0.038 17.61 -5.67 
LOC151174 0.894 0.265 0.108 21.12 -2.16 
AK055501 0.894 0.121 0.050 20.44 -2.84 
CRY2 0.894 0.378 0.035 32.82 9.54 
ANKRD20A2 0.894 0.350 0.073 33.19 9.91 
GSTM1 0.894 0.197 0.048 19.69 -3.59 
ARNTL 0.893 1.295 0.095 22.22 -1.06 
MUC20 0.893 0.377 0.093 32.16 8.88 
FAM86C 0.893 0.090 0.043 21.60 -1.68 
FRG1 0.893 0.064 0.032 41.21 17.93 
ARNTL 0.892 1.294 0.095 22.29 -0.99 
CYP2A6 0.891 0.232 0.090 20.76 -2.52 
ARSA 0.891 0.133 0.035 20.53 -2.75 
PDPK1 0.891 0.109 0.037 31.61 8.33 
RP3-398D13.1 0.890 0.296 0.129 31.75 8.47 
ENST00000354343 0.890 0.165 0.063 19.85 -3.43 
TTC32 0.890 0.250 0.053 30.65 7.37 
A_32_P101019 0.890 0.292 0.114 32.78 9.50 
PRUNE2 0.889 0.247 0.112 20.47 -2.81 
SHPK 0.889 0.128 0.026 30.43 7.15 
FGFBP2 0.888 0.368 0.106 20.38 -2.90 
TTC23 0.888 0.112 0.047 22.68 -0.60 
ALAD 0.888 0.121 0.045 20.78 -2.50 
HEXIM2 0.888 0.189 0.029 19.71 -3.57 
MGC42157 0.888 0.181 0.082 29.29 6.01 
USP36 0.887 0.254 0.055 30.71 7.43 
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Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
LOC100130794 0.886 0.330 0.113 22.70 -0.58 
CRY2 0.886 0.360 0.036 32.91 9.63 
ARNTL 0.886 1.335 0.101 22.19 -1.09 
CLPB 0.886 0.151 0.049 19.26 -4.02 
A_24_P379629 0.885 0.309 0.145 20.57 -2.71 
FBXO15 0.885 0.216 0.062 20.14 -3.14 
BX116163 0.885 0.225 0.093 23.42 0.14 
A_24_P324074 0.885 0.273 0.088 22.09 -1.19 
AK025669 0.885 0.287 0.069 31.28 8.00 
CYP20A1 0.885 0.115 0.038 22.34 -0.94 
NCOA4 0.884 0.086 0.028 41.02 17.74 
PER3 0.884 1.418 0.120 30.42 7.14 
SKA2 0.884 0.079 0.028 17.55 -5.73 
SMA5 0.883 0.202 0.054 30.43 7.15 
SLC6A10P 0.883 0.146 0.036 40.75 17.47 
LAIR1 0.883 0.408 0.083 20.40 -2.88 
SURF4 0.883 0.172 0.038 19.43 -3.85 
SGSH 0.883 0.050 0.024 30.92 7.64 
A_24_P680548 0.883 0.308 0.074 20.87 -2.41 
TMEM111 0.882 0.068 0.028 38.88 15.60 
GPAM 0.882 0.215 0.081 39.07 15.79 
NBPF1 0.882 0.376 0.067 20.46 -2.82 
PER3 0.882 1.558 0.130 30.25 6.97 
AK124841 0.881 0.215 0.087 40.48 17.20 
A_32_P226700 0.881 0.192 0.042 20.47 -2.81 
MKNK2 0.880 0.204 0.055 20.94 -2.34 
C5 0.880 0.150 0.059 22.55 -0.73 
C17orf101 0.880 0.137 0.043 19.37 -3.91 
PTN 0.880 0.339 0.104 29.32 6.04 
ENST00000428471 0.879 0.088 0.040 19.77 -3.51 
APIP 0.879 0.222 0.052 21.87 -1.41 
A_24_P238996 0.879 0.235 0.059 26.15 2.87 
SAR1A 0.879 0.134 0.032 36.44 13.16 
UTP14A 0.878 0.095 0.042 37.57 14.29 
AA666384 0.878 0.667 0.150 31.78 8.50 
MAP2K6 0.878 0.293 0.057 39.24 15.96 
ESD 0.878 0.156 0.041 21.43 -1.85 
DLAT 0.877 0.177 0.061 18.32 -4.96 
PCYT2 0.876 0.199 0.057 20.66 -2.62 
SOLH 0.876 0.407 0.178 21.72 -1.56 
ZRANB2 0.876 0.210 0.039 32.03 8.75 
A_24_P375132 0.876 0.106 0.048 20.81 -2.47 
TPM1 0.876 0.244 0.075 17.69 -5.59 
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Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
PER2 0.876 0.860 0.081 33.76 10.48 
SLC25A1 0.875 0.169 0.051 19.78 -3.50 
BG618521 0.875 0.418 0.091 18.91 -4.37 
CRY2 0.875 0.355 0.036 32.87 9.59 
A_24_P67618 0.875 0.311 0.053 20.47 -2.81 
AK126976 0.875 0.463 0.135 35.71 12.43 
CRY2 0.874 0.340 0.034 32.69 9.41 
HSPB8 0.874 0.271 0.054 18.89 -4.39 
SMURF2 0.874 0.180 0.060 18.82 -4.46 
PDPK1 0.874 0.095 0.039 28.89 5.61 
RFFL 0.874 0.141 0.038 20.90 -2.38 
A_32_P77252 0.874 0.349 0.095 30.39 7.11 
ENST00000331871 0.874 0.250 0.101 20.43 -2.85 
DHX58 0.873 0.189 0.037 32.31 9.03 
HBZ 0.873 0.242 0.102 20.30 -2.98 
KDELR2 0.873 0.086 0.033 18.58 -4.70 
ZNF658 0.873 0.147 0.030 32.71 9.43 
A_32_P152882 0.873 0.218 0.087 33.24 9.96 
A_23_P212626 0.873 0.341 0.091 30.98 7.70 
A_24_P272515 0.873 0.360 0.100 24.83 1.55 
UGT1A6 0.873 0.403 0.165 32.61 9.33 
DHFRL1 0.872 0.162 0.040 19.60 -3.68 
DHRS1 0.872 0.077 0.033 28.54 5.26 
ME1 0.872 0.195 0.062 20.27 -3.01 
ARNTL 0.872 1.339 0.104 22.45 -0.83 
Z25424 0.872 0.224 0.064 21.37 -1.91 
ADAD2 0.872 0.232 0.100 32.60 9.32 
LOC162632 0.872 0.328 0.113 31.57 8.29 
HIBCH 0.871 0.074 0.035 24.06 0.78 
CLK3 0.871 0.125 0.058 19.08 -4.20 
SKA2 0.871 0.140 0.038 40.72 17.44 
CIDEA 0.871 0.208 0.091 20.26 -3.02 
E01827 0.871 0.307 0.125 23.22 -0.06 
ATXN10 0.871 0.259 0.052 19.97 -3.31 
GLYAT 0.870 0.195 0.080 22.04 -1.24 
ARNTL 0.870 1.422 0.114 22.25 -1.03 
COTL1 0.869 0.120 0.056 41.19 17.91 
GCLC 0.869 0.238 0.089 22.64 -0.64 
SPATA18 0.869 0.196 0.090 22.15 -1.13 
PER2 0.869 0.901 0.085 34.35 11.07 
RPS26 0.869 0.138 0.055 18.65 -4.63 
TMEM107 0.869 0.072 0.029 35.56 12.28 
CRY2 0.869 0.323 0.036 32.60 9.32 
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Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
BI013473 0.869 0.167 0.049 24.44 1.16 
ZBTB1 0.868 0.226 0.080 32.67 9.39 
CENPQ 0.868 0.109 0.048 19.48 -3.80 
GGNBP2 0.868 0.083 0.022 26.55 3.27 
NARS2 0.868 0.179 0.044 22.25 -1.03 
CRY2 0.868 0.356 0.037 32.76 9.48 
CR602210 0.868 0.237 0.102 40.42 17.14 
PCNT 0.868 0.089 0.029 25.78 2.50 
TMEM129 0.867 0.217 0.053 18.71 -4.57 
PER3 0.867 1.313 0.118 30.30 7.02 
MME 0.867 0.293 0.093 21.39 -1.89 
LOC388242 0.867 0.173 0.067 29.56 6.28 
CRY2 0.867 0.332 0.036 32.65 9.37 
CRY2 0.866 0.317 0.035 33.10 9.82 
ARNTL 0.866 1.490 0.120 22.05 -1.23 
MRPS10 0.866 0.283 0.049 20.30 -2.98 
PER3 0.866 0.994 0.080 33.21 9.93 
PER3 0.865 1.186 0.114 30.54 7.26 
SLC9A6 0.865 0.119 0.020 19.63 -3.65 
C6orf141 0.864 0.200 0.059 32.10 8.82 
EIF2A 0.864 0.305 0.100 32.07 8.79 
AK125162 0.864 0.333 0.113 22.23 -1.05 
SH3BGR 0.864 0.180 0.067 20.49 -2.79 
ARNTL 0.864 1.472 0.122 22.19 -1.09 
LOC100270746 0.863 0.242 0.041 32.91 9.63 
WDR6 0.863 0.201 0.060 30.33 7.05 
RBM17 0.863 0.123 0.054 32.90 9.62 
MKKS 0.863 0.086 0.040 20.69 -2.59 
DAPK2 0.863 0.186 0.050 29.78 6.50 
A_32_P95894 0.863 0.135 0.054 24.88 1.60 
CRY2 0.862 0.335 0.038 32.81 9.53 
ENST00000331146 0.862 0.235 0.092 21.69 -1.59 
ZBTB7B 0.862 0.115 0.050 21.33 -1.95 
BC035091 0.862 0.398 0.087 30.60 7.32 
PER3 0.861 0.937 0.081 33.63 10.35 
A_32_P112531 0.861 0.179 0.074 20.99 -2.29 
JRK 0.861 0.334 0.143 20.19 -3.09 
UCP2 0.861 0.247 0.076 18.69 -4.59 
BC022928 0.861 0.210 0.069 21.85 -1.43 
ANKRD20A2 0.861 0.225 0.079 32.73 9.45 
SLC2A4 0.861 0.140 0.063 41.24 17.96 
DYNLL1 0.861 0.112 0.038 20.32 -2.96 
POU6F2 0.861 0.462 0.161 25.85 2.57 
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Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
PER2 0.860 0.878 0.087 34.36 11.08 
PBX1 0.860 0.192 0.050 19.87 -3.41 
B9D1 0.860 0.221 0.069 20.54 -2.74 
CENPN 0.860 0.184 0.086 23.08 -0.20 
PER1 0.860 1.335 0.125 34.29 11.01 
MRGPRF 0.860 0.327 0.126 23.60 0.32 
ALDH4A1 0.859 0.139 0.045 18.70 -4.58 
SERP1 0.859 0.292 0.043 18.82 -4.46 
SRXN1 0.859 0.084 0.041 38.52 15.24 
FLJ43681 0.859 0.120 0.020 21.79 -1.49 
ALDH1L1 0.859 0.187 0.071 19.94 -3.34 
HSD11B1 0.859 0.176 0.084 21.32 -1.96 
BCAP31 0.859 0.124 0.040 20.64 -2.64 
A_24_P127063 0.858 0.110 0.046 19.97 -3.31 
ZNF629 0.858 0.156 0.027 32.52 9.24 
NR1D2 0.858 0.691 0.055 30.77 7.49 
ARNTL 0.858 1.301 0.118 22.23 -1.05 
A_32_P225209 0.858 0.342 0.093 32.93 9.65 
FGF13 0.857 0.156 0.051 18.17 -5.11 
TMEM52 0.857 0.262 0.099 21.39 -1.89 
PER1 0.857 1.277 0.124 34.33 11.05 
PTN 0.857 0.389 0.118 29.60 6.32 
MUC20 0.857 0.300 0.106 32.51 9.23 
OR2A9P 0.856 0.272 0.123 29.76 6.48 
A_23_P64962 0.856 0.270 0.075 30.66 7.38 
DYNLL2 0.856 0.110 0.040 19.91 -3.37 
TRIT1 0.856 0.134 0.036 31.53 8.25 
LOC572558 0.856 0.295 0.080 25.41 2.13 
MCCC2 0.856 0.075 0.037 19.14 -4.14 
FGFBP2 0.856 0.503 0.123 20.26 -3.02 
A_24_P229616 0.856 0.158 0.061 20.38 -2.90 
CDC2L2 0.856 0.170 0.036 20.65 -2.63 
OSGIN2 0.855 0.175 0.077 40.80 17.52 
FAH 0.855 0.217 0.069 20.94 -2.34 
AK023328 0.855 0.376 0.078 31.34 8.06 
DQ786246 0.855 0.151 0.046 29.80 6.52 
MRPL10 0.855 0.128 0.030 20.59 -2.69 
CDON 0.855 0.205 0.057 24.28 1.00 
A_24_P110403 0.855 0.114 0.055 24.17 0.89 
LOC401127 0.855 0.193 0.044 21.16 -2.12 
PER3 0.855 0.937 0.085 33.39 10.11 
CK300181 0.854 0.216 0.078 20.70 -2.58 
YTHDC2 0.854 0.123 0.047 33.77 10.49 
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Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
TRIM41 0.854 0.099 0.040 21.62 -1.66 
MYO7A 0.854 0.366 0.092 19.90 -3.38 
FAM86B2 0.854 0.151 0.046 23.29 0.01 
A_24_P736638 0.853 0.245 0.058 20.59 -2.69 
SUCLA2 0.853 0.243 0.083 21.54 -1.74 
C2orf89 0.853 0.224 0.085 23.07 -0.21 
CNTN2 0.853 0.399 0.144 20.53 -2.75 
A_24_P401582 0.853 0.146 0.059 19.80 -3.48 
A_24_P771278 0.853 0.427 0.097 20.59 -2.69 
NUDT13 0.852 0.187 0.084 27.36 4.08 
KDSR 0.852 0.171 0.044 18.70 -4.58 
A_24_P75308 0.852 0.120 0.060 20.15 -3.13 
PKIA 0.852 0.208 0.071 22.36 -0.92 
A_24_P384196 0.852 0.361 0.094 22.11 -1.17 
GSTM5 0.852 0.440 0.153 20.76 -2.52 
PER1 0.852 1.272 0.126 34.31 11.03 
ZBED5 0.852 0.186 0.083 22.98 -0.30 
PER3 0.852 0.974 0.088 33.43 10.15 
CRY2 0.852 0.329 0.037 32.75 9.47 
GPR37 0.851 0.522 0.164 20.48 -2.80 
A_24_P196019 0.851 0.162 0.049 19.49 -3.79 
RNF135 0.851 0.083 0.031 25.40 2.12 
GIMAP8 0.851 0.119 0.053 32.94 9.66 
TNFRSF21 0.851 0.217 0.067 39.00 15.72 
DHDDS 0.851 0.143 0.058 20.88 -2.40 
HNRNPA3 0.851 0.095 0.039 29.59 6.31 
UBP1 0.851 0.092 0.028 37.31 14.03 
FAAH 0.851 0.194 0.050 17.66 -5.62 
PER3 0.851 0.959 0.087 33.34 10.06 
NUDT18 0.850 0.137 0.054 19.03 -4.25 
MPV17 0.850 0.166 0.047 21.14 -2.14 
A_24_P306527 0.850 0.269 0.119 22.82 -0.46 
FAM173B 0.850 0.125 0.046 20.99 -2.29 
KCTD10 0.850 0.081 0.040 40.55 17.27 
PER1 0.850 1.329 0.127 34.35 11.07 
PAK2 0.850 0.174 0.072 34.29 11.01 
TSLP 0.850 0.280 0.081 20.70 -2.58 
PLCE1 0.849 0.213 0.084 19.97 -3.31 
MTERFD2 0.849 0.098 0.037 31.21 7.93 
KIAA0040 0.849 0.301 0.111 41.49 18.21 
LRRC37B2 0.849 0.124 0.041 31.41 8.13 
PER3 0.849 0.966 0.088 33.33 10.05 
GIN1 0.849 0.090 0.026 19.24 -4.04 
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Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
BU595528 0.849 0.142 0.044 18.91 -4.37 
CCDC122 0.848 0.154 0.069 30.93 7.65 
PER1 0.848 1.274 0.126 34.36 11.08 
IMPAD1 0.848 0.198 0.052 19.55 -3.73 
PGA3 0.848 0.290 0.080 41.46 18.18 
PER3 0.848 0.977 0.091 33.46 10.18 
PER3 0.848 0.952 0.088 33.45 10.17 
MXRA7 0.848 0.301 0.083 20.55 -2.73 
MICB 0.848 0.182 0.063 19.74 -3.54 
LOC100049716 0.848 0.189 0.054 20.47 -2.81 
CDRT4 0.848 0.143 0.062 23.19 -0.09 
A_24_P307126 0.847 0.478 0.100 19.60 -3.68 
UCHL1 0.847 0.163 0.077 17.93 -5.35 
RASL10B 0.847 0.352 0.090 20.21 -3.07 
SNRPB2 0.847 0.140 0.051 19.00 -4.28 
PER3 0.847 1.140 0.104 30.43 7.15 
ALMS1P 0.847 0.202 0.070 21.40 -1.88 
FTHL17 0.847 0.380 0.097 20.02 -3.26 
COPG2 0.847 0.178 0.082 23.22 -0.06 
A_24_P692030 0.847 0.297 0.079 21.34 -1.94 
HLF 0.846 0.494 0.058 33.53 10.25 
SLC39A11 0.846 0.298 0.044 40.00 16.72 
GGNBP2 0.846 0.091 0.023 25.90 2.62 
C21orf81 0.846 0.384 0.154 33.31 10.03 
A_24_P384210 0.846 0.524 0.141 22.93 -0.35 
SURF4 0.846 0.120 0.031 19.03 -4.25 
ACOT1 0.846 0.140 0.064 20.70 -2.58 
PER1 0.846 1.302 0.130 34.35 11.07 
SCAPER 0.845 0.305 0.101 31.57 8.29 
A_24_P408981 0.845 0.322 0.082 20.96 -2.32 
A_24_P598919 0.845 0.209 0.060 40.75 17.47 
A_24_P229911 0.845 0.096 0.029 19.46 -3.82 
TXNL4A 0.845 0.109 0.028 19.04 -4.24 
SUB1 0.845 0.099 0.046 38.66 15.38 
ABCA3 0.845 0.103 0.036 21.07 -2.21 
TBC1D20 0.845 0.143 0.035 18.88 -4.40 
PER1 0.845 1.318 0.129 34.39 11.11 
CDC2L2 0.844 0.211 0.085 31.70 8.42 
ZNF259P 0.844 0.429 0.115 22.34 -0.94 
RPL23AP7 0.844 0.211 0.065 21.28 -2.00 
CTNND1 0.844 0.131 0.033 27.96 4.68 
FAM98A 0.844 0.223 0.044 20.15 -3.13 
CHPF2 0.844 0.132 0.032 32.84 9.56 
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Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
BC001335 0.844 0.162 0.050 32.02 8.74 
STK24 0.844 0.152 0.030 18.22 -5.06 
A_24_P418106 0.843 0.165 0.077 22.23 -1.05 
IMPAD1 0.843 0.219 0.048 18.47 -4.81 
GYG2 0.843 0.253 0.080 19.45 -3.83 
LOC100286918 0.843 0.277 0.106 21.99 -1.29 
A_24_P840868 0.843 0.215 0.062 20.84 -2.44 
PDE4DIP 0.843 0.272 0.071 21.33 -1.95 
NCDN 0.843 0.161 0.045 20.05 -3.23 
MSTP9 0.843 0.415 0.172 33.62 10.34 
PER1 0.842 1.289 0.129 34.35 11.07 
BC035371 0.842 0.190 0.090 32.52 9.24 
B3GALTL 0.842 0.224 0.095 25.17 1.89 
LOC644563 0.842 0.119 0.039 20.65 -2.63 
ACADS 0.842 0.354 0.065 20.54 -2.74 
TK2 0.842 0.239 0.049 19.21 -4.07 
C1orf59 0.842 0.138 0.034 22.76 -0.52 
A_32_P177843 0.842 0.498 0.114 31.21 7.93 
RNF19A 0.842 0.268 0.041 22.19 -1.09 
STK17A 0.842 0.168 0.072 38.08 14.80 
ATP6V1G2 0.842 0.175 0.084 20.58 -2.70 
PER3 0.842 1.416 0.135 31.09 7.81 
MXRA7 0.841 0.129 0.063 19.88 -3.40 
A_24_P920388 0.841 0.252 0.101 21.67 -1.61 
TRIL 0.841 0.311 0.058 23.59 0.31 
TPM3 0.841 0.069 0.026 19.91 -3.37 
SMUG1 0.841 0.102 0.050 20.02 -3.26 
PER1 0.841 1.299 0.128 34.30 11.02 
SNRNP27 0.841 0.098 0.039 18.01 -5.27 
TEF 0.841 0.655 0.070 31.81 8.53 
KDELR2 0.840 0.133 0.040 19.29 -3.99 
PER3 0.840 0.955 0.091 33.45 10.17 
CRY2 0.840 0.311 0.037 32.70 9.42 
MRPL53 0.840 0.100 0.047 20.64 -2.64 
PER1 0.840 1.276 0.126 34.32 11.04 
ESAM 0.840 0.310 0.089 18.90 -4.38 
A_24_P451992 0.840 0.484 0.103 20.71 -2.57 
ACOT2 0.840 0.245 0.079 21.05 -2.23 
AKR7A3 0.839 0.119 0.056 20.17 -3.11 
SRA1 0.839 0.109 0.036 20.49 -2.79 
NR1D2 0.839 0.759 0.064 30.73 7.45 
A_24_P84112 0.839 0.174 0.042 19.82 -3.46 
STAC 0.839 0.435 0.126 22.94 -0.34 
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Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
SHMT1 0.839 0.203 0.063 19.12 -4.16 
AK129982 0.839 0.345 0.062 31.16 7.88 
A_24_P213144 0.839 0.403 0.084 20.31 -2.97 
PSCA 0.839 0.207 0.093 30.03 6.75 
ARF1 0.839 0.094 0.025 17.90 -5.38 
A_32_P106864 0.838 0.144 0.055 25.95 2.67 
EIF4E2 0.838 0.276 0.043 18.47 -4.81 
ATXN3 0.838 0.177 0.038 20.81 -2.47 
WDR3 0.838 0.119 0.048 20.52 -2.76 
SLC14A2 0.838 0.313 0.113 20.76 -2.52 
VCAM1 0.837 0.276 0.107 21.29 -1.99 
NPAS2 0.837 1.143 0.133 24.11 0.83 
NFAT5 0.837 0.067 0.021 24.05 0.77 
FAU 0.837 0.065 0.033 24.21 0.93 
APBB1IP 0.837 0.141 0.069 25.87 2.59 
ACADSB 0.837 0.214 0.048 19.06 -4.22 
STK10 0.837 0.154 0.056 21.03 -2.25 
PEX13 0.837 0.093 0.045 19.80 -3.48 
A_24_P853302 0.836 0.414 0.122 21.53 -1.75 
RP1-21O18.1 0.836 0.406 0.098 20.61 -2.67 
BC001335 0.836 0.133 0.041 31.52 8.24 
DHDDS 0.836 0.125 0.048 20.34 -2.94 
CASP7 0.836 0.075 0.033 17.74 -5.54 
ARL17P1 0.836 0.398 0.112 32.64 9.36 
PEX1 0.836 0.105 0.019 29.67 6.39 
CYP2A7 0.836 0.372 0.108 20.61 -2.67 
AQP7P2 0.836 0.213 0.067 20.66 -2.62 
BU191598 0.835 0.207 0.080 37.41 14.13 
BAK1 0.835 0.090 0.022 31.55 8.27 
SRA1 0.835 0.074 0.031 18.47 -4.81 
CAMKK1 0.835 0.437 0.092 31.93 8.65 
A_23_P89841 0.835 0.293 0.094 31.17 7.89 
ACTR3C 0.834 0.131 0.064 20.58 -2.70 
C11orf54 0.834 0.115 0.042 31.78 8.50 
SRP9 0.834 0.356 0.097 20.77 -2.51 
MOCOS 0.834 0.155 0.075 36.56 13.28 
PDLIM5 0.834 0.130 0.045 23.17 -0.11 
PHF13 0.834 0.210 0.039 28.42 5.14 
ZNF493 0.834 0.321 0.155 20.93 -2.35 
AK057088 0.834 0.126 0.035 31.32 8.04 
LOC100133161 0.834 0.191 0.094 30.51 7.23 
A_24_P931282 0.834 0.276 0.091 20.85 -2.43 
CDH23 0.834 0.358 0.095 20.07 -3.21 
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Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
PPIL5 0.833 0.163 0.056 40.61 17.33 
BET1L 0.833 0.125 0.049 18.82 -4.46 
PIGC 0.833 0.250 0.071 17.52 -5.76 
A_24_P307205 0.833 0.285 0.118 23.82 0.54 
SPG21 0.833 0.135 0.045 20.80 -2.48 
KIF5B 0.833 0.118 0.053 39.69 16.41 
ANKRD20A2 0.833 0.303 0.094 33.21 9.93 
RNASE4 0.833 0.163 0.063 21.57 -1.71 
PER3 0.833 1.237 0.121 30.32 7.04 
NPAS2 0.833 1.076 0.128 23.95 0.67 
ACSS1 0.832 0.226 0.048 33.13 9.85 
A_32_P212373 0.832 0.182 0.062 22.36 -0.92 
KHDC1 0.832 0.393 0.109 22.17 -1.11 
C21orf122 0.832 0.194 0.064 20.34 -2.94 
A_24_P75994 0.832 0.371 0.138 33.62 10.34 
PTPN21 0.832 0.098 0.045 18.81 -4.47 
SENP6 0.832 0.184 0.040 28.86 5.58 
ENST00000340195 0.832 0.342 0.098 20.90 -2.38 
TFCP2 0.831 0.192 0.039 22.28 -1.00 
KANK4 0.831 0.273 0.119 35.61 12.33 
LOC344328 0.831 0.221 0.105 24.49 1.21 
BC029473 0.831 0.319 0.156 32.68 9.40 
PDHX 0.831 0.209 0.055 21.82 -1.46 
MPI 0.831 0.136 0.041 22.09 -1.19 
P2RY12 0.830 0.229 0.089 41.12 17.84 
PER3 0.830 1.135 0.119 31.06 7.78 
BLVRB 0.830 0.129 0.061 20.51 -2.77 
GCC2 0.830 0.101 0.047 34.38 11.10 
GLYAT 0.830 0.392 0.088 24.33 1.05 
NPAS2 0.829 1.069 0.127 24.14 0.86 
A_24_P32715 0.829 0.284 0.116 19.25 -4.03 
C10orf11 0.829 0.162 0.072 21.38 -1.90 
BE798911 0.829 0.155 0.071 25.11 1.83 
C20orf12 0.829 0.522 0.115 23.75 0.47 
CYP4V2 0.829 0.209 0.058 18.58 -4.70 
FLRT2 0.829 0.393 0.082 22.58 -0.70 
PBLD 0.829 0.191 0.056 41.40 18.12 
KCNIP2 0.828 0.213 0.076 19.33 -3.95 
MAP6 0.828 0.180 0.074 22.86 -0.42 
ADAMTS2 0.828 0.175 0.069 20.77 -2.51 
UHRF2 0.828 0.139 0.031 21.49 -1.79 
SLC36A4 0.828 0.116 0.040 33.54 10.26 
PER3 0.828 1.433 0.134 30.77 7.49 
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Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
ARF4 0.827 0.207 0.038 19.67 -3.61 
TFDP1 0.827 0.224 0.044 18.15 -5.13 
DYNLL1 0.827 0.104 0.048 21.86 -1.42 
ODC1 0.827 0.290 0.048 19.42 -3.86 
ALDH4A1 0.827 0.507 0.091 19.28 -4.00 
A_24_P186779 0.827 0.360 0.141 21.94 -1.34 
LOC644297 0.827 0.406 0.101 31.24 7.96 
UBTD1 0.827 0.187 0.076 20.31 -2.97 
RPL22 0.827 0.321 0.084 21.10 -2.18 
C12orf47 0.827 0.073 0.036 25.83 2.55 
ALDH1B1 0.827 0.171 0.073 20.91 -2.37 
ZDHHC14 0.826 0.285 0.053 30.92 7.64 
FNTB 0.826 0.234 0.057 20.04 -3.24 
LOC100127980 0.826 0.120 0.057 32.68 9.40 
SYNM 0.826 0.232 0.056 20.15 -3.13 
A_24_P910372 0.825 0.529 0.125 31.65 8.37 
PPIL5 0.825 0.165 0.062 20.87 -2.41 
EDC3 0.825 0.156 0.039 18.13 -5.15 
GCC2 0.825 0.096 0.036 34.74 11.46 
BDP1 0.825 0.104 0.042 20.07 -3.21 
GALR1 0.825 0.345 0.160 35.29 12.01 
SLC1A4 0.825 0.192 0.075 38.96 15.68 
DGAT2 0.825 0.312 0.112 38.65 15.37 
UBE2L3 0.825 0.116 0.026 18.67 -4.61 
H6PD 0.825 0.240 0.051 30.79 7.51 
NTN4 0.825 0.198 0.053 25.92 2.64 
C20orf12 0.825 0.442 0.118 23.89 0.61 
PSORS1C1 0.825 0.445 0.155 29.12 5.84 
CR617560 0.824 0.076 0.032 24.15 0.87 
ARMC6 0.824 0.121 0.035 21.88 -1.40 
ZNF91 0.824 0.170 0.043 30.17 6.89 
ELOVL5 0.824 0.191 0.059 21.71 -1.57 
RRAGD 0.824 0.258 0.066 20.70 -2.58 
A_24_P745670 0.824 0.218 0.067 20.87 -2.41 
PRELP 0.824 0.226 0.082 22.90 -0.38 
LOC253039 0.824 0.342 0.162 21.71 -1.57 
TSPAN33 0.824 0.269 0.072 19.76 -3.52 
PPIG 0.824 0.166 0.058 32.23 8.95 
CABLES1 0.824 0.424 0.068 25.91 2.63 
CYBASC3 0.823 0.255 0.070 20.29 -2.99 
FLJ45445 0.823 0.266 0.086 31.16 7.88 
LOC100128164 0.823 0.353 0.099 19.53 -3.75 
A_24_P821146 0.823 0.276 0.095 24.18 0.90 
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Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
RPL24 0.823 0.272 0.138 22.04 -1.24 
Mar-02 0.823 0.218 0.050 20.02 -3.26 
ERMAP 0.823 0.187 0.073 20.42 -2.86 
NDUFAF1 0.823 0.086 0.040 19.33 -3.95 
CYB561 0.823 0.159 0.034 30.60 7.32 
ECH1 0.823 0.222 0.077 21.76 -1.52 
OMA1 0.823 0.078 0.033 23.70 0.42 
A_32_P171225 0.822 0.256 0.097 22.13 -1.15 
FMO2 0.822 0.233 0.098 37.00 13.72 
GPAM 0.822 0.517 0.117 38.89 15.61 
ALDOAP2 0.822 0.289 0.064 20.55 -2.73 
A_24_P25020 0.822 0.216 0.098 22.40 -0.88 
A_23_P149270 0.822 0.296 0.064 19.35 -3.93 
LOC149134 0.822 0.264 0.090 31.66 8.38 
AP3S2 0.822 0.128 0.039 18.06 -5.22 
PER3 0.822 0.971 0.093 33.69 10.41 
A_24_P84482 0.822 0.530 0.126 20.53 -2.75 
GBAP 0.822 0.197 0.056 20.44 -2.84 
NPAS2 0.821 0.685 0.109 24.81 1.53 
SMN1 0.821 0.107 0.037 31.82 8.54 
GTPBP6 0.821 0.076 0.029 26.57 3.29 
AK056365 0.821 0.252 0.117 17.85 -5.43 
GNA12 0.821 0.369 0.056 19.60 -3.68 
ATPAF1 0.821 0.189 0.047 18.96 -4.32 
A_23_P89680 0.821 0.455 0.121 31.86 8.58 
SMG1 0.821 0.144 0.041 23.61 0.33 
CPSF1 0.821 0.105 0.039 28.28 5.00 
ACOX3 0.821 0.109 0.037 33.23 9.95 
ENST00000450815 0.821 0.148 0.053 19.68 -3.60 
LOC51152 0.821 0.332 0.133 32.72 9.44 
TMEM8B 0.821 0.087 0.042 21.42 -1.86 
A_32_P164477 0.820 0.217 0.093 20.25 -3.03 
SLC6A8 0.820 0.181 0.043 17.76 -5.52 
MRPL48 0.820 0.105 0.048 21.55 -1.73 
C1orf151 0.820 0.041 0.020 40.02 16.74 
REV1 0.820 0.085 0.028 33.44 10.16 
A_24_P238427 0.820 0.339 0.124 24.21 0.93 
A_24_P32646 0.820 0.194 0.066 20.36 -2.92 
GPX8 0.820 0.154 0.044 19.32 -3.96 
PER3 0.820 1.180 0.117 30.59 7.31 
P4HA2 0.820 0.161 0.035 18.90 -4.38 
RHOBTB3 0.820 0.376 0.073 23.18 -0.10 
ABCC1 0.819 0.137 0.046 36.96 13.68 
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Gene R2 Amplitude SE 
Peak Time 
(Decimal 
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Peak Time 
(Relative to 
DLMO) 
MXRA5 0.819 0.328 0.083 31.30 8.02 
LHPP 0.819 0.093 0.045 24.09 0.81 
BOLA3 0.819 0.125 0.050 20.84 -2.44 
POP5 0.819 0.138 0.042 20.41 -2.87 
USP6 0.819 0.297 0.120 29.24 5.96 
MYL12B 0.819 0.080 0.032 17.93 -5.35 
KDM4C 0.818 0.123 0.048 31.32 8.04 
NPAS2 0.818 1.138 0.138 24.06 0.78 
AK092810 0.818 0.087 0.039 24.37 1.09 
ENST00000275524 0.818 0.181 0.084 24.63 1.35 
RPP14 0.818 0.078 0.028 32.10 8.82 
S100B 0.818 0.116 0.055 21.72 -1.56 
TYRO3 0.818 0.133 0.046 19.83 -3.45 
BC008001 0.818 0.339 0.116 33.46 10.18 
P4HTM 0.817 0.088 0.025 20.55 -2.73 
DHDPSL 0.817 0.194 0.081 21.71 -1.57 
BC019599 0.817 0.188 0.083 27.53 4.25 
U69195 0.817 0.226 0.079 23.52 0.24 
FAM171A1 0.817 0.139 0.048 19.71 -3.57 
BCL2L13 0.817 0.375 0.059 39.05 15.77 
DBP 0.816 0.737 0.087 31.38 8.10 
GNG2 0.816 0.171 0.061 21.10 -2.18 
TALDO1 0.816 0.170 0.052 20.98 -2.30 
RNF141 0.816 0.124 0.037 18.79 -4.49 
PER2 0.816 0.866 0.096 34.43 11.15 
TALDO1 0.816 0.147 0.036 20.11 -3.17 
A_32_P115451 0.816 0.099 0.032 30.24 6.96 
DNAJB4 0.816 0.202 0.049 41.07 17.79 
WDR45 0.816 0.078 0.028 19.78 -3.50 
AMIGO1 0.816 0.193 0.084 21.65 -1.63 
CDH23 0.816 0.206 0.096 17.87 -5.41 
NINJ2 0.816 0.358 0.086 20.71 -2.57 
COX11 0.816 0.080 0.025 35.01 11.73 
SLC25A6 0.816 0.082 0.037 21.28 -2.00 
A_24_P324506 0.815 0.313 0.089 20.63 -2.65 
A_23_P17152 0.815 0.440 0.126 21.38 -1.90 
ACSS2 0.815 0.209 0.077 23.30 0.02 
A_24_P238525 0.815 0.195 0.067 30.95 7.67 
BC013295 0.815 0.191 0.085 36.88 13.60 
PER1 0.815 1.225 0.136 34.30 11.02 
A_24_P126931 0.815 0.274 0.099 21.84 -1.44 
A_32_P190036 0.815 0.133 0.057 23.37 0.09 
ALDOA 0.815 0.108 0.045 20.42 -2.86 
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Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
A_24_P126902 0.815 0.227 0.097 23.03 -0.25 
ZNF395 0.815 0.197 0.041 26.18 2.90 
GDE1 0.814 0.229 0.063 21.35 -1.93 
EHD1 0.814 0.304 0.049 18.02 -5.26 
FKBP5 0.814 0.819 0.107 37.70 14.42 
A_24_P24724 0.813 0.175 0.065 20.63 -2.65 
CR602702 0.813 0.103 0.032 21.17 -2.11 
NCLN 0.813 0.171 0.064 20.96 -2.32 
THAP2 0.813 0.262 0.056 21.49 -1.79 
A_24_P246591 0.813 0.400 0.113 20.56 -2.72 
KIAA0408 0.813 0.398 0.074 21.23 -2.05 
CCHCR1 0.813 0.137 0.035 32.02 8.74 
GLT8D3 0.813 0.128 0.058 20.66 -2.62 
ADAL 0.813 0.192 0.052 32.75 9.47 
DBNDD1 0.813 0.378 0.140 41.16 17.88 
A_24_P234871 0.813 0.123 0.037 18.83 -4.45 
KIF25 0.813 0.449 0.130 34.13 10.85 
LEPREL1 0.813 0.283 0.093 32.69 9.41 
PNRC1 0.813 0.145 0.045 24.92 1.64 
SPON1 0.813 0.130 0.060 19.29 -3.99 
CD81 0.813 0.209 0.043 20.20 -3.08 
TMEM136 0.813 0.154 0.032 20.17 -3.11 
SLC24A3 0.812 0.090 0.046 18.52 -4.76 
A_24_P307486 0.812 0.136 0.054 19.10 -4.18 
A_24_P174063 0.812 0.226 0.055 20.99 -2.29 
SPARC 0.812 0.171 0.058 20.07 -3.21 
TRAPPC4 0.812 0.073 0.029 19.95 -3.33 
C3orf31 0.812 0.073 0.029 26.71 3.43 
MLLT4 0.812 0.247 0.057 33.23 9.95 
HNRNPR 0.812 0.064 0.027 21.61 -1.67 
XPO6 0.811 0.380 0.150 24.54 1.26 
CSTA 0.811 0.211 0.075 21.78 -1.50 
BC035156 0.811 0.354 0.079 29.77 6.49 
C6orf57 0.811 0.075 0.037 19.44 -3.84 
DHFR 0.811 0.184 0.066 19.09 -4.19 
LOC492303 0.811 0.066 0.031 19.27 -4.01 
IMMT 0.811 0.057 0.025 18.96 -4.32 
ZNF577 0.811 0.230 0.094 25.86 2.58 
NPAS2 0.811 1.043 0.133 24.13 0.85 
SNTA1 0.811 0.236 0.049 19.13 -4.15 
MRO 0.810 0.369 0.104 20.91 -2.37 
GOSR2 0.810 0.352 0.086 19.90 -3.38 
LOC100289574 0.810 0.302 0.109 32.37 9.09 
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Peak Time 
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Peak Time 
(Relative to 
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B3GNTL1 0.810 0.252 0.074 23.01 -0.27 
PCSK4 0.810 0.128 0.052 30.68 7.40 
A_24_P315405 0.810 0.356 0.126 20.88 -2.40 
TBC1D8 0.810 0.177 0.060 30.82 7.54 
hCG_17955 0.810 0.368 0.126 20.65 -2.63 
MICB 0.810 0.184 0.068 32.73 9.45 
CCDC25 0.809 0.124 0.046 20.92 -2.36 
SLC37A4 0.809 0.059 0.027 30.62 7.34 
EXOC7 0.809 0.174 0.031 19.86 -3.42 
CCDC144B 0.809 0.269 0.104 31.42 8.14 
CA3 0.809 0.543 0.251 24.97 1.69 
ARNTL 0.809 1.130 0.129 21.10 -2.18 
STK24 0.809 0.071 0.034 39.01 15.73 
CLMN 0.809 0.199 0.091 19.83 -3.45 
SNHG10 0.809 0.187 0.075 24.20 0.92 
CIDEC 0.809 0.214 0.050 19.70 -3.58 
BC019044 0.809 0.126 0.062 34.52 11.24 
ENST00000444996 0.808 0.469 0.129 22.30 -0.98 
C13orf34 0.808 0.083 0.036 20.00 -3.28 
EIF3L 0.808 0.098 0.037 21.61 -1.67 
UGDH 0.808 0.224 0.055 18.90 -4.38 
A_24_P41551 0.808 0.201 0.084 23.12 -0.16 
CLEC18B 0.808 0.179 0.064 31.30 8.02 
ALDH4A1 0.808 0.135 0.048 41.19 17.91 
RNLS 0.808 0.273 0.089 22.72 -0.56 
C10orf78 0.808 0.098 0.033 20.40 -2.88 
NUDT1 0.808 0.080 0.040 21.99 -1.29 
TYSND1 0.807 0.174 0.067 24.08 0.80 
TMEM64 0.807 0.160 0.044 19.01 -4.27 
FUNDC2 0.807 0.311 0.079 20.93 -2.35 
CERK 0.807 0.158 0.069 40.63 17.35 
PER3 0.807 0.838 0.092 34.07 10.79 
MCART1 0.807 0.139 0.067 40.98 17.70 
A_24_P281683 0.807 0.340 0.111 20.86 -2.42 
ARMCX1 0.807 0.170 0.031 21.91 -1.37 
CLUAP1 0.807 0.083 0.036 41.30 18.02 
SIRT3 0.807 0.066 0.032 18.91 -4.37 
PLA2G15 0.807 0.095 0.027 18.22 -5.06 
OVOS2 0.807 0.221 0.077 27.95 4.67 
A_32_P161934 0.807 0.129 0.062 30.88 7.60 
FKBP7 0.807 0.148 0.065 22.45 -0.83 
BU944300 0.807 0.128 0.065 20.99 -2.29 
CD164 0.807 0.152 0.058 20.09 -3.19 
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Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
AK027091 0.807 0.289 0.135 32.54 9.26 
PLOD1 0.806 0.205 0.048 19.13 -4.15 
FAM53C 0.806 0.216 0.054 19.25 -4.03 
LOC100129113 0.806 0.262 0.072 17.60 -5.68 
LONP2 0.806 0.091 0.037 19.15 -4.13 
TRAF7 0.806 0.301 0.070 19.76 -3.52 
HRASLS2 0.806 0.229 0.077 21.56 -1.72 
CR609342 0.806 0.219 0.061 31.02 7.74 
RRP7A 0.806 0.193 0.063 19.43 -3.85 
C6orf108 0.806 0.119 0.053 20.12 -3.16 
A_24_P255314 0.806 0.236 0.112 22.37 -0.91 
EIF5 0.805 0.194 0.053 33.17 9.89 
PXDN 0.805 0.151 0.064 19.84 -3.44 
FAM63A 0.805 0.181 0.042 21.87 -1.41 
BC018099 0.805 0.240 0.101 19.62 -3.66 
CNPY2 0.805 0.028 0.013 20.81 -2.47 
MSI2 0.805 0.195 0.062 18.54 -4.74 
AF116713 0.805 0.319 0.140 38.03 14.75 
PCGF3 0.805 0.121 0.039 32.11 8.83 
SCARB1 0.805 0.163 0.054 34.19 10.91 
KIAA0892 0.805 0.221 0.046 32.15 8.87 
A_24_P92771 0.804 0.220 0.085 22.91 -0.37 
C13orf38 0.804 0.234 0.115 20.95 -2.33 
DDX18 0.804 0.190 0.034 18.58 -4.70 
X66610 0.804 0.457 0.156 21.66 -1.62 
HDAC5 0.804 0.106 0.031 29.59 6.31 
PER3 0.804 1.615 0.164 31.11 7.83 
GPHN 0.804 0.291 0.081 23.94 0.66 
CSRP2 0.804 0.317 0.054 18.77 -4.51 
NSMCE4A 0.804 0.139 0.031 22.23 -1.05 
HNRNPCL1 0.803 0.110 0.051 19.93 -3.35 
A_24_P98145 0.803 0.298 0.092 29.57 6.29 
ITPA 0.803 0.047 0.019 29.86 6.58 
PACSIN1 0.803 0.284 0.105 22.70 -0.58 
Sep-07 0.803 0.106 0.026 18.12 -5.16 
GOLT1B 0.803 0.224 0.049 18.60 -4.68 
A_24_P578641 0.802 0.175 0.059 20.95 -2.33 
RP3-377H14.5 0.802 0.236 0.071 22.30 -0.98 
A_24_P928017 0.802 0.110 0.052 19.61 -3.67 
AK023682 0.802 0.236 0.042 29.83 6.55 
KLRG1 0.802 0.371 0.135 21.46 -1.82 
PHF8 0.802 0.124 0.033 30.30 7.02 
ABCB6 0.802 0.129 0.045 20.31 -2.97 
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Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak Time 
(Relative to 
DLMO) 
A_24_P763655 0.802 0.246 0.055 19.82 -3.46 
UNC119 0.802 0.167 0.073 21.53 -1.75 
AGAP3 0.801 0.079 0.027 28.74 5.46 
A_24_P67432 0.801 0.126 0.061 20.80 -2.48 
A_24_P367063 0.801 0.139 0.051 27.51 4.23 
TPP1 0.801 0.264 0.040 20.81 -2.47 
C10orf75 0.801 0.197 0.080 19.76 -3.52 
BC028022 0.801 0.168 0.042 32.12 8.84 
RP11-138L21.1 0.801 0.169 0.071 31.08 7.80 
PER3 0.800 1.631 0.169 31.25 7.97 
LOC100293193 0.800 0.186 0.077 21.50 -1.78 
C1orf167 0.800 0.213 0.079 29.73 6.45 
LRRC23 0.800 0.251 0.067 20.75 -2.53 
CSNK2A2 0.800 0.157 0.037 20.73 -2.55 
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No. of 
participants 
Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak 
Time 
(Relative 
to DLMO) 
5 NR1D1 0.940 1.864 0.095 29.32 6.04 
5 NR1D1 0.933 1.693 0.090 29.28 6.00 
5 ARNTL 0.913 1.317 0.086 22.12 -1.16 
5 TOLLIP 0.911 0.334 0.064 19.73 -3.55 
5 CN294989 0.911 0.606 0.126 31.48 8.20 
5 ARNTL 0.906 1.265 0.087 22.10 -1.18 
5 ESPNL 0.903 0.200 0.079 32.22 8.94 
5 ARNTL 0.901 1.349 0.094 22.17 -1.11 
5 CRY2 0.894 0.378 0.035 32.82 9.54 
5 ARNTL 0.893 1.295 0.095 22.22 -1.06 
5 CRY2 0.886 0.360 0.036 32.91 9.63 
5 LAIR1 0.883 0.408 0.083 20.40 -2.88 
5 PER2 0.876 0.860 0.081 33.76 10.48 
5 CRY2 0.875 0.355 0.036 32.87 9.59 
5 CRY2 0.874 0.340 0.034 32.69 9.41 
5 ARNTL 0.872 1.339 0.104 22.45 -0.83 
5 PER2 0.869 0.901 0.085 34.35 11.07 
5 CRY2 0.869 0.323 0.036 32.60 9.32 
5 CRY2 0.868 0.356 0.037 32.76 9.48 
5 PER3 0.867 1.313 0.118 30.30 7.02 
5 ARNTL 0.866 1.490 0.120 22.05 -1.23 
5 MRPS10 0.866 0.283 0.049 20.30 -2.98 
5 PER3 0.866 0.994 0.080 33.21 9.93 
5 CRY2 0.862 0.335 0.038 32.81 9.53 
5 PER3 0.861 0.937 0.081 33.63 10.35 
5 A_32_P112531 0.861 0.179 0.074 20.99 -2.29 
5 BC022928 0.861 0.210 0.069 21.85 -1.43 
5 PER2 0.860 0.878 0.087 34.36 11.08 
5 PER1 0.860 1.335 0.125 34.29 11.01 
5 SERP1 0.859 0.292 0.043 18.82 -4.46 
5 ARNTL 0.858 1.301 0.118 22.23 -1.05 
5 PER1 0.857 1.277 0.124 34.33 11.05 
5 CDON 0.855 0.205 0.057 24.28 1.00 
5 PER3 0.855 0.937 0.085 33.39 10.11 
5 PER1 0.852 1.272 0.126 34.31 11.03 
5 CRY2 0.852 0.329 0.037 32.75 9.47 
5 A_24_P306527 0.850 0.269 0.119 22.82 -0.46 
5 PER1 0.850 1.329 0.127 34.35 11.07 
5 PER3 0.849 0.966 0.088 33.33 10.05 
5 PER1 0.848 1.274 0.126 34.36 11.08 
5 PER3 0.848 0.977 0.091 33.46 10.18 
5 PER3 0.848 0.952 0.088 33.45 10.17 
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No. of 
participants 
Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak 
Time 
(Relative 
to DLMO) 
5 PER1 0.846 1.302 0.130 34.35 11.07 
5 PER1 0.845 1.318 0.129 34.39 11.11 
5 BC001335 0.844 0.162 0.050 32.02 8.74 
5 LOC100286918 0.843 0.277 0.106 21.99 -1.29 
5 PER1 0.842 1.289 0.129 34.35 11.07 
5 PER1 0.841 1.299 0.128 34.30 11.02 
5 TEF 0.841 0.655 0.070 31.81 8.53 
5 PER1 0.840 1.276 0.126 34.32 11.04 
5 NPAS2 0.837 1.143 0.133 24.11 0.83 
5 CYP2A7 0.836 0.372 0.108 20.61 -2.67 
5 SRP9 0.834 0.356 0.097 20.77 -2.51 
5 PER3 0.833 1.237 0.121 30.32 7.04 
5 NPAS2 0.833 1.076 0.128 23.95 0.67 
5 A_24_P75994 0.832 0.371 0.138 33.62 10.34 
5 SENP6 0.832 0.184 0.040 28.86 5.58 
5 KANK4 0.831 0.273 0.119 35.61 12.33 
5 NPAS2 0.829 1.069 0.127 24.14 0.86 
5 CABLES1 0.824 0.424 0.068 25.91 2.63 
5 RPL24 0.823 0.272 0.138 22.04 -1.24 
5 ALDOAP2 0.822 0.289 0.064 20.55 -2.73 
5 PER3 0.822 0.971 0.093 33.69 10.41 
5 PER3 0.820 1.180 0.117 30.59 7.31 
5 DBP 0.816 0.737 0.087 31.38 8.10 
5 A_24_P126902 0.815 0.227 0.097 23.03 -0.25 
5 ADAL 0.813 0.192 0.052 32.75 9.47 
5 ZNF577 0.811 0.230 0.094 25.86 2.58 
5 B3GNTL1 0.810 0.252 0.074 23.01 -0.27 
5 SNHG10 0.809 0.187 0.075 24.20 0.92 
5 ENST00000444996 0.808 0.469 0.129 22.30 -0.98 
5 A_24_P41551 0.808 0.201 0.084 23.12 -0.16 
5 A_24_P281683 0.807 0.340 0.111 20.86 -2.42 
5 LOC100129113 0.806 0.262 0.072 17.60 -5.68 
5 CSRP2 0.804 0.317 0.054 18.77 -4.51 
5 LRRC23 0.800 0.251 0.067 20.75 -2.53 
4 LOC283481 0.968 0.218 0.053 19.84 -3.44 
4 LOC283788 0.967 0.241 0.059 31.84 8.56 
4 BC035147 0.956 0.164 0.056 40.30 17.02 
4 GSTM4 0.942 0.219 0.058 20.11 -3.17 
4 A_32_P151747 0.939 0.182 0.089 20.38 -2.90 
4 PAIP2B 0.931 0.390 0.129 21.44 -1.84 
4 BC014871 0.923 0.368 0.112 32.74 9.46 
4 BC014971 0.922 0.279 0.081 31.54 8.26 
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No. of 
participants 
Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak 
Time 
(Relative 
to DLMO) 
4 TTC3 0.919 0.203 0.048 21.15 -2.13 
4 PPFIBP1 0.914 0.377 0.037 33.72 10.44 
4 KIAA0020 0.913 0.127 0.026 29.65 6.37 
4 PPIAL4A 0.910 0.166 0.078 21.28 -2.00 
4 KCNK15 0.910 0.215 0.109 41.44 18.16 
4 TRAF7 0.904 0.176 0.053 18.98 -4.30 
4 ANKRD20A2 0.903 0.428 0.080 33.38 10.10 
4 ARL17P1 0.900 0.161 0.053 30.71 7.43 
4 LOC349196 0.899 0.205 0.091 34.85 11.57 
4 DHFR 0.898 0.217 0.067 20.58 -2.70 
4 GAMT 0.896 0.138 0.048 20.28 -3.00 
4 tcag7.873 0.896 0.374 0.122 22.22 -1.06 
4 MPZL1 0.896 0.207 0.034 19.33 -3.95 
4 HSP90AA4P 0.895 0.237 0.072 22.27 -1.01 
4 AFARP1 0.895 0.255 0.069 21.96 -1.32 
4 XRCC5 0.895 0.144 0.044 20.50 -2.78 
4 LOC151174 0.894 0.265 0.108 21.12 -2.16 
4 GSTM1 0.894 0.197 0.048 19.69 -3.59 
4 ARNTL 0.892 1.294 0.095 22.29 -0.99 
4 TTC32 0.890 0.250 0.053 30.65 7.37 
4 A_32_P101019 0.890 0.292 0.114 32.78 9.50 
4 FGFBP2 0.888 0.368 0.106 20.38 -2.90 
4 HEXIM2 0.888 0.189 0.029 19.71 -3.57 
4 LOC100130794 0.886 0.330 0.113 22.70 -0.58 
4 ARNTL 0.886 1.335 0.101 22.19 -1.09 
4 A_24_P324074 0.885 0.273 0.088 22.09 -1.19 
4 SURF4 0.883 0.172 0.038 19.43 -3.85 
4 A_24_P680548 0.883 0.308 0.074 20.87 -2.41 
4 C5 0.880 0.150 0.059 22.55 -0.73 
4 AA666384 0.878 0.667 0.150 31.78 8.50 
4 MAP2K6 0.878 0.293 0.057 39.24 15.96 
4 ZRANB2 0.876 0.210 0.039 32.03 8.75 
4 TPM1 0.876 0.244 0.075 17.69 -5.59 
4 A_24_P67618 0.875 0.311 0.053 20.47 -2.81 
4 HSPB8 0.874 0.271 0.054 18.89 -4.39 
4 A_32_P77252 0.874 0.349 0.095 30.39 7.11 
4 A_32_P152882 0.873 0.218 0.087 33.24 9.96 
4 ARNTL 0.870 1.422 0.114 22.25 -1.03 
4 CRY2 0.866 0.317 0.035 33.10 9.82 
4 EIF2A 0.864 0.305 0.100 32.07 8.79 
4 AK125162 0.864 0.333 0.113 22.23 -1.05 
4 ARNTL 0.864 1.472 0.122 22.19 -1.09 
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No. of 
participants 
Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak 
Time 
(Relative 
to DLMO) 
4 LOC100270746 0.863 0.242 0.041 32.91 9.63 
4 RBM17 0.863 0.123 0.054 32.90 9.62 
4 DAPK2 0.863 0.186 0.050 29.78 6.50 
4 ENST00000331146 0.862 0.235 0.092 21.69 -1.59 
4 UCP2 0.861 0.247 0.076 18.69 -4.59 
4 ANKRD20A2 0.861 0.225 0.079 32.73 9.45 
4 POU6F2 0.861 0.462 0.161 25.85 2.57 
4 B9D1 0.860 0.221 0.069 20.54 -2.74 
4 HSD11B1 0.859 0.176 0.084 21.32 -1.96 
4 NR1D2 0.858 0.691 0.055 30.77 7.49 
4 A_32_P225209 0.858 0.342 0.093 32.93 9.65 
4 TMEM52 0.857 0.262 0.099 21.39 -1.89 
4 FGFBP2 0.856 0.503 0.123 20.26 -3.02 
4 A_24_P229616 0.856 0.158 0.061 20.38 -2.90 
4 AK023328 0.855 0.376 0.078 31.34 8.06 
4 CNTN2 0.853 0.399 0.144 20.53 -2.75 
4 A_24_P771278 0.853 0.427 0.097 20.59 -2.69 
4 PKIA 0.852 0.208 0.071 22.36 -0.92 
4 A_24_P384196 0.852 0.361 0.094 22.11 -1.17 
4 ZBED5 0.852 0.186 0.083 22.98 -0.30 
4 PER3 0.852 0.974 0.088 33.43 10.15 
4 A_24_P196019 0.851 0.162 0.049 19.49 -3.79 
4 PER3 0.851 0.959 0.087 33.34 10.06 
4 TSLP 0.850 0.280 0.081 20.70 -2.58 
4 LRRC37B2 0.849 0.124 0.041 31.41 8.13 
4 LOC100049716 0.848 0.189 0.054 20.47 -2.81 
4 CDRT4 0.848 0.143 0.062 23.19 -0.09 
4 A_24_P307126 0.847 0.478 0.100 19.60 -3.68 
4 RASL10B 0.847 0.352 0.090 20.21 -3.07 
4 PER3 0.847 1.140 0.104 30.43 7.15 
4 A_24_P692030 0.847 0.297 0.079 21.34 -1.94 
4 HLF 0.846 0.494 0.058 33.53 10.25 
4 SCAPER 0.845 0.305 0.101 31.57 8.29 
4 IMPAD1 0.843 0.219 0.048 18.47 -4.81 
4 A_24_P840868 0.843 0.215 0.062 20.84 -2.44 
4 ACADS 0.842 0.354 0.065 20.54 -2.74 
4 TK2 0.842 0.239 0.049 19.21 -4.07 
4 C1orf59 0.842 0.138 0.034 22.76 -0.52 
4 A_32_P177843 0.842 0.498 0.114 31.21 7.93 
4 PER3 0.840 0.955 0.091 33.45 10.17 
4 CRY2 0.840 0.311 0.037 32.70 9.42 
4 A_24_P451992 0.840 0.484 0.103 20.71 -2.57 
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No. of 
participants 
Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak 
Time 
(Relative 
to DLMO) 
4 AKR7A3 0.839 0.119 0.056 20.17 -3.11 
4 NR1D2 0.839 0.759 0.064 30.73 7.45 
4 A_24_P84112 0.839 0.174 0.042 19.82 -3.46 
4 STAC 0.839 0.435 0.126 22.94 -0.34 
4 A_24_P213144 0.839 0.403 0.084 20.31 -2.97 
4 A_24_P853302 0.836 0.414 0.122 21.53 -1.75 
4 A_23_P89841 0.835 0.293 0.094 31.17 7.89 
4 A_24_P307205 0.833 0.285 0.118 23.82 0.54 
4 ACSS1 0.832 0.226 0.048 33.13 9.85 
4 ENST00000340195 0.832 0.342 0.098 20.90 -2.38 
4 PBLD 0.829 0.191 0.056 41.40 18.12 
4 SLC36A4 0.828 0.116 0.040 33.54 10.26 
4 LOC644297 0.827 0.406 0.101 31.24 7.96 
4 RPL22 0.827 0.321 0.084 21.10 -2.18 
4 ALDH1B1 0.827 0.171 0.073 20.91 -2.37 
4 ZDHHC14 0.826 0.285 0.053 30.92 7.64 
4 FNTB 0.826 0.234 0.057 20.04 -3.24 
4 A_24_P910372 0.825 0.529 0.125 31.65 8.37 
4 DGAT2 0.825 0.312 0.112 38.65 15.37 
4 ARMC6 0.824 0.121 0.035 21.88 -1.40 
4 ZNF91 0.824 0.170 0.043 30.17 6.89 
4 CYBASC3 0.823 0.255 0.070 20.29 -2.99 
4 Mar-02 0.823 0.218 0.050 20.02 -3.26 
4 A_32_P171225 0.822 0.256 0.097 22.13 -1.15 
4 LOC149134 0.822 0.264 0.090 31.66 8.38 
4 GBAP 0.822 0.197 0.056 20.44 -2.84 
4 NPAS2 0.821 0.685 0.109 24.81 1.53 
4 GNA12 0.821 0.369 0.056 19.60 -3.68 
4 ATPAF1 0.821 0.189 0.047 18.96 -4.32 
4 A_23_P89680 0.821 0.455 0.121 31.86 8.58 
4 SLC6A8 0.820 0.181 0.043 17.76 -5.52 
4 GPX8 0.820 0.154 0.044 19.32 -3.96 
4 RHOBTB3 0.820 0.376 0.073 23.18 -0.10 
4 MXRA5 0.819 0.328 0.083 31.30 8.02 
4 NPAS2 0.818 1.138 0.138 24.06 0.78 
4 BC008001 0.818 0.339 0.116 33.46 10.18 
4 BC019599 0.817 0.188 0.083 27.53 4.25 
4 U69195 0.817 0.226 0.079 23.52 0.24 
4 BCL2L13 0.817 0.375 0.059 39.05 15.77 
4 PER2 0.816 0.866 0.096 34.43 11.15 
4 NINJ2 0.816 0.358 0.086 20.71 -2.57 
4 A_24_P238525 0.815 0.195 0.067 30.95 7.67 
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No. of 
participants 
Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak 
Time 
(Relative 
to DLMO) 
4 PER1 0.815 1.225 0.136 34.30 11.02 
4 A_24_P126931 0.815 0.274 0.099 21.84 -1.44 
4 EHD1 0.814 0.304 0.049 18.02 -5.26 
4 FKBP5 0.814 0.819 0.107 37.70 14.42 
4 A_24_P24724 0.813 0.175 0.065 20.63 -2.65 
4 KIAA0408 0.813 0.398 0.074 21.23 -2.05 
4 KIF25 0.813 0.449 0.130 34.13 10.85 
4 CSTA 0.811 0.211 0.075 21.78 -1.50 
4 NPAS2 0.811 1.043 0.133 24.13 0.85 
4 SNTA1 0.811 0.236 0.049 19.13 -4.15 
4 MRO 0.810 0.369 0.104 20.91 -2.37 
4 CLMN 0.809 0.199 0.091 19.83 -3.45 
4 FUNDC2 0.807 0.311 0.079 20.93 -2.35 
4 A_32_P161934 0.807 0.129 0.062 30.88 7.60 
4 FKBP7 0.807 0.148 0.065 22.45 -0.83 
4 CD164 0.807 0.152 0.058 20.09 -3.19 
4 PLOD1 0.806 0.205 0.048 19.13 -4.15 
4 FAM53C 0.806 0.216 0.054 19.25 -4.03 
4 KIAA0892 0.805 0.221 0.046 32.15 8.87 
4 PER3 0.804 1.615 0.164 31.11 7.83 
4 PACSIN1 0.803 0.284 0.105 22.70 -0.58 
4 GOLT1B 0.803 0.224 0.049 18.60 -4.68 
4 RP3-377H14.5 0.802 0.236 0.071 22.30 -0.98 
4 AK023682 0.802 0.236 0.042 29.83 6.55 
4 PHF8 0.802 0.124 0.033 30.30 7.02 
4 TPP1 0.801 0.264 0.040 20.81 -2.47 
3 THNSL2 0.956 0.179 0.046 19.25 -4.03 
3 AKR7A2 0.954 0.145 0.054 22.38 -0.90 
3 AKR7L 0.952 0.111 0.046 21.17 -2.11 
3 ZNF232 0.952 0.121 0.047 20.34 -2.94 
3 MRPL42P5 0.944 0.204 0.050 31.66 8.38 
3 HMBOX1 0.944 0.169 0.052 32.32 9.04 
3 ARL17P1 0.940 0.093 0.031 27.42 4.14 
3 NAAA 0.939 0.155 0.055 22.73 -0.55 
3 PP12708 0.939 0.291 0.085 32.84 9.56 
3 NCBP2 0.934 0.169 0.045 21.02 -2.26 
3 BC034271 0.924 0.180 0.078 20.52 -2.76 
3 CR622844 0.924 0.108 0.046 31.88 8.60 
3 TALDO1 0.922 0.133 0.029 19.11 -4.17 
3 CES1 0.922 0.213 0.078 18.72 -4.56 
3 LOC340947 0.922 0.327 0.103 22.13 -1.15 
3 ICAM3 0.921 0.156 0.047 20.34 -2.94 
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participants 
Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak 
Time 
(Relative 
to DLMO) 
3 DHFR 0.920 0.240 0.050 20.50 -2.78 
3 LOC100132288 0.920 0.233 0.090 18.44 -4.84 
3 SCD 0.918 0.344 0.128 39.27 15.99 
3 ACACA 0.917 0.171 0.081 23.22 -0.06 
3 C12orf39 0.914 0.353 0.176 23.41 0.13 
3 TMEM8A 0.913 0.154 0.039 19.22 -4.06 
3 DNAH6 0.905 0.320 0.138 22.19 -1.09 
3 NQO2 0.905 0.180 0.071 20.88 -2.40 
3 ADI1 0.904 0.175 0.033 20.90 -2.38 
3 ADI1 0.904 0.207 0.052 20.81 -2.47 
3 GSTT2 0.904 0.205 0.064 31.44 8.16 
3 FLJ44253 0.904 0.358 0.148 32.19 8.91 
3 MME 0.904 0.147 0.070 20.20 -3.08 
3 ADI1 0.902 0.203 0.053 20.53 -2.75 
3 A_32_P93144 0.902 0.297 0.110 35.77 12.49 
3 RHBDF2 0.898 0.352 0.072 35.49 12.21 
3 ZFP90 0.897 0.163 0.033 31.80 8.52 
3 PARP4 0.894 0.129 0.044 21.33 -1.95 
3 C15orf57 0.894 0.134 0.038 17.61 -5.67 
3 ANKRD20A2 0.894 0.350 0.073 33.19 9.91 
3 CYP2A6 0.891 0.232 0.090 20.76 -2.52 
3 PDPK1 0.891 0.109 0.037 31.61 8.33 
3 ENST00000354343 0.890 0.165 0.063 19.85 -3.43 
3 SHPK 0.889 0.128 0.026 30.43 7.15 
3 MGC42157 0.888 0.181 0.082 29.29 6.01 
3 USP36 0.887 0.254 0.055 30.71 7.43 
3 BX116163 0.885 0.225 0.093 23.42 0.14 
3 AK025669 0.885 0.287 0.069 31.28 8.00 
3 PER3 0.884 1.418 0.120 30.42 7.14 
3 SMA5 0.883 0.202 0.054 30.43 7.15 
3 NBPF1 0.882 0.376 0.067 20.46 -2.82 
3 PER3 0.882 1.558 0.130 30.25 6.97 
3 AK124841 0.881 0.215 0.087 40.48 17.20 
3 A_32_P226700 0.881 0.192 0.042 20.47 -2.81 
3 MKNK2 0.880 0.204 0.055 20.94 -2.34 
3 APIP 0.879 0.222 0.052 21.87 -1.41 
3 RFFL 0.874 0.141 0.038 20.90 -2.38 
3 ENST00000331871 0.874 0.250 0.101 20.43 -2.85 
3 HBZ 0.873 0.242 0.102 20.30 -2.98 
3 ME1 0.872 0.195 0.062 20.27 -3.01 
3 Z25424 0.872 0.224 0.064 21.37 -1.91 
3 LOC162632 0.872 0.328 0.113 31.57 8.29 
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No. of 
participants 
Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak 
Time 
(Relative 
to DLMO) 
3 SKA2 0.871 0.140 0.038 40.72 17.44 
3 ATXN10 0.871 0.259 0.052 19.97 -3.31 
3 GLYAT 0.870 0.195 0.080 22.04 -1.24 
3 COTL1 0.869 0.120 0.056 41.19 17.91 
3 SPATA18 0.869 0.196 0.090 22.15 -1.13 
3 RPS26 0.869 0.138 0.055 18.65 -4.63 
3 NARS2 0.868 0.179 0.044 22.25 -1.03 
3 CR602210 0.868 0.237 0.102 40.42 17.14 
3 TMEM129 0.867 0.217 0.053 18.71 -4.57 
3 MME 0.867 0.293 0.093 21.39 -1.89 
3 LOC388242 0.867 0.173 0.067 29.56 6.28 
3 CRY2 0.867 0.332 0.036 32.65 9.37 
3 PER3 0.865 1.186 0.114 30.54 7.26 
3 WDR6 0.863 0.201 0.060 30.33 7.05 
3 ZBTB7B 0.862 0.115 0.050 21.33 -1.95 
3 BC035091 0.862 0.398 0.087 30.60 7.32 
3 SLC2A4 0.861 0.140 0.063 41.24 17.96 
3 MRGPRF 0.860 0.327 0.126 23.60 0.32 
3 A_23_P64962 0.856 0.270 0.075 30.66 7.38 
3 LOC572558 0.856 0.295 0.080 25.41 2.13 
3 CDC2L2 0.856 0.170 0.036 20.65 -2.63 
3 OSGIN2 0.855 0.175 0.077 40.80 17.52 
3 A_24_P736638 0.853 0.245 0.058 20.59 -2.69 
3 SUCLA2 0.853 0.243 0.083 21.54 -1.74 
3 C2orf89 0.853 0.224 0.085 23.07 -0.21 
3 A_24_P401582 0.853 0.146 0.059 19.80 -3.48 
3 KDSR 0.852 0.171 0.044 18.70 -4.58 
3 GSTM5 0.852 0.440 0.153 20.76 -2.52 
3 GPR37 0.851 0.522 0.164 20.48 -2.80 
3 TNFRSF21 0.851 0.217 0.067 39.00 15.72 
3 HNRNPA3 0.851 0.095 0.039 29.59 6.31 
3 FAAH 0.851 0.194 0.050 17.66 -5.62 
3 MTERFD2 0.849 0.098 0.037 31.21 7.93 
3 KIAA0040 0.849 0.301 0.111 41.49 18.21 
3 CCDC122 0.848 0.154 0.069 30.93 7.65 
3 IMPAD1 0.848 0.198 0.052 19.55 -3.73 
3 PGA3 0.848 0.290 0.080 41.46 18.18 
3 MXRA7 0.848 0.301 0.083 20.55 -2.73 
3 UCHL1 0.847 0.163 0.077 17.93 -5.35 
3 SNRPB2 0.847 0.140 0.051 19.00 -4.28 
3 ALMS1P 0.847 0.202 0.070 21.40 -1.88 
3 FTHL17 0.847 0.380 0.097 20.02 -3.26 
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No. of 
participants 
Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak 
Time 
(Relative 
to DLMO) 
3 COPG2 0.847 0.178 0.082 23.22 -0.06 
3 SLC39A11 0.846 0.298 0.044 40.00 16.72 
3 A_24_P384210 0.846 0.524 0.141 22.93 -0.35 
3 A_24_P598919 0.845 0.209 0.060 40.75 17.47 
3 A_24_P229911 0.845 0.096 0.029 19.46 -3.82 
3 TBC1D20 0.845 0.143 0.035 18.88 -4.40 
3 ZNF259P 0.844 0.429 0.115 22.34 -0.94 
3 FAM98A 0.844 0.223 0.044 20.15 -3.13 
3 STK24 0.844 0.152 0.030 18.22 -5.06 
3 GYG2 0.843 0.253 0.080 19.45 -3.83 
3 PDE4DIP 0.843 0.272 0.071 21.33 -1.95 
3 RNF19A 0.842 0.268 0.041 22.19 -1.09 
3 ATP6V1G2 0.842 0.175 0.084 20.58 -2.70 
3 ACOT2 0.840 0.245 0.079 21.05 -2.23 
3 AK129982 0.839 0.345 0.062 31.16 7.88 
3 A_32_P106864 0.838 0.144 0.055 25.95 2.67 
3 EIF4E2 0.838 0.276 0.043 18.47 -4.81 
3 WDR3 0.838 0.119 0.048 20.52 -2.76 
3 VCAM1 0.837 0.276 0.107 21.29 -1.99 
3 APBB1IP 0.837 0.141 0.069 25.87 2.59 
3 ACADSB 0.837 0.214 0.048 19.06 -4.22 
3 PEX13 0.837 0.093 0.045 19.80 -3.48 
3 BC001335 0.836 0.133 0.041 31.52 8.24 
3 AQP7P2 0.836 0.213 0.067 20.66 -2.62 
3 CAMKK1 0.835 0.437 0.092 31.93 8.65 
3 PHF13 0.834 0.210 0.039 28.42 5.14 
3 CDH23 0.834 0.358 0.095 20.07 -3.21 
3 PIGC 0.833 0.250 0.071 17.52 -5.76 
3 KIF5B 0.833 0.118 0.053 39.69 16.41 
3 ANKRD20A2 0.833 0.303 0.094 33.21 9.93 
3 RNASE4 0.833 0.163 0.063 21.57 -1.71 
3 C21orf122 0.832 0.194 0.064 20.34 -2.94 
3 PER3 0.830 1.135 0.119 31.06 7.78 
3 GLYAT 0.830 0.392 0.088 24.33 1.05 
3 A_24_P32715 0.829 0.284 0.116 19.25 -4.03 
3 C20orf12 0.829 0.522 0.115 23.75 0.47 
3 CYP4V2 0.829 0.209 0.058 18.58 -4.70 
3 KCNIP2 0.828 0.213 0.076 19.33 -3.95 
3 ADAMTS2 0.828 0.175 0.069 20.77 -2.51 
3 UHRF2 0.828 0.139 0.031 21.49 -1.79 
3 ARF4 0.827 0.207 0.038 19.67 -3.61 
3 ODC1 0.827 0.290 0.048 19.42 -3.86 
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No. of 
participants 
Gene R2 Amplitude SE 
Peak Time 
(Decimal 
Hours) 
Peak 
Time 
(Relative 
to DLMO) 
3 ALDH4A1 0.827 0.507 0.091 19.28 -4.00 
3 A_24_P186779 0.827 0.360 0.141 21.94 -1.34 
3 C12orf47 0.827 0.073 0.036 25.83 2.55 
3 SYNM 0.826 0.232 0.056 20.15 -3.13 
3 SLC1A4 0.825 0.192 0.075 38.96 15.68 
3 H6PD 0.825 0.240 0.051 30.79 7.51 
3 NTN4 0.825 0.198 0.053 25.92 2.64 
3 C20orf12 0.825 0.442 0.118 23.89 0.61 
3 PSORS1C1 0.825 0.445 0.155 29.12 5.84 
3 ELOVL5 0.824 0.191 0.059 21.71 -1.57 
3 RRAGD 0.824 0.258 0.066 20.70 -2.58 
3 A_24_P745670 0.824 0.218 0.067 20.87 -2.41 
3 PRELP 0.824 0.226 0.082 22.90 -0.38 
3 LOC253039 0.824 0.342 0.162 21.71 -1.57 
3 PPIG 0.824 0.166 0.058 32.23 8.95 
3 ERMAP 0.823 0.187 0.073 20.42 -2.86 
3 A_24_P25020 0.822 0.216 0.098 22.40 -0.88 
3 A_23_P149270 0.822 0.296 0.064 19.35 -3.93 
3 SMN1 0.821 0.107 0.037 31.82 8.54 
3 ENST00000450815 0.821 0.148 0.053 19.68 -3.60 
3 LOC51152 0.821 0.332 0.133 32.72 9.44 
3 A_32_P164477 0.820 0.217 0.093 20.25 -3.03 
3 A_24_P238427 0.820 0.339 0.124 24.21 0.93 
3 A_24_P32646 0.820 0.194 0.066 20.36 -2.92 
3 BOLA3 0.819 0.125 0.050 20.84 -2.44 
3 KDM4C 0.818 0.123 0.048 31.32 8.04 
3 ENST00000275524 0.818 0.181 0.084 24.63 1.35 
3 FAM171A1 0.817 0.139 0.048 19.71 -3.57 
3 GNG2 0.816 0.171 0.061 21.10 -2.18 
3 DNAJB4 0.816 0.202 0.049 41.07 17.79 
3 A_24_P324506 0.815 0.313 0.089 20.63 -2.65 
3 BC013295 0.815 0.191 0.085 36.88 13.60 
3 GDE1 0.814 0.229 0.063 21.35 -1.93 
3 A_24_P246591 0.813 0.400 0.113 20.56 -2.72 
3 CCHCR1 0.813 0.137 0.035 32.02 8.74 
3 LEPREL1 0.813 0.283 0.093 32.69 9.41 
3 TMEM136 0.813 0.154 0.032 20.17 -3.11 
3 A_24_P307486 0.812 0.136 0.054 19.10 -4.18 
3 A_24_P174063 0.812 0.226 0.055 20.99 -2.29 
3 MLLT4 0.812 0.247 0.057 33.23 9.95 
3 BC035156 0.811 0.354 0.079 29.77 6.49 
3 GOSR2 0.810 0.352 0.086 19.90 -3.38 
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Peak 
Time 
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to DLMO) 
3 A_24_P315405 0.810 0.356 0.126 20.88 -2.40 
3 hCG_17955 0.810 0.368 0.126 20.65 -2.63 
3 EXOC7 0.809 0.174 0.031 19.86 -3.42 
3 CIDEC 0.809 0.214 0.050 19.70 -3.58 
3 RNLS 0.808 0.273 0.089 22.72 -0.56 
3 C10orf78 0.808 0.098 0.033 20.40 -2.88 
3 TMEM64 0.807 0.160 0.044 19.01 -4.27 
3 PER3 0.807 0.838 0.092 34.07 10.79 
3 ARMCX1 0.807 0.170 0.031 21.91 -1.37 
3 LONP2 0.806 0.091 0.037 19.15 -4.13 
3 TRAF7 0.806 0.301 0.070 19.76 -3.52 
3 HRASLS2 0.806 0.229 0.077 21.56 -1.72 
3 CR609342 0.806 0.219 0.061 31.02 7.74 
3 A_24_P255314 0.806 0.236 0.112 22.37 -0.91 
3 EIF5 0.805 0.194 0.053 33.17 9.89 
3 AF116713 0.805 0.319 0.140 38.03 14.75 
3 A_24_P92771 0.804 0.220 0.085 22.91 -0.37 
3 DDX18 0.804 0.190 0.034 18.58 -4.70 
3 HDAC5 0.804 0.106 0.031 29.59 6.31 
3 GPHN 0.804 0.291 0.081 23.94 0.66 
3 HNRNPCL1 0.803 0.110 0.051 19.93 -3.35 
3 A_24_P98145 0.803 0.298 0.092 29.57 6.29 
3 A_24_P928017 0.802 0.110 0.052 19.61 -3.67 
3 KLRG1 0.802 0.371 0.135 21.46 -1.82 
3 A_24_P763655 0.802 0.246 0.055 19.82 -3.46 
3 C10orf75 0.801 0.197 0.080 19.76 -3.52 
3 BC028022 0.801 0.168 0.042 32.12 8.84 
3 CSNK2A2 0.800 0.157 0.037 20.73 -2.55 
Appendix 5.3: Circadian probes ranked on prevalence and goodness of fit to the single fit model. 
 
 
 
